Document RBqNnvVrnkZ54xyyyqd9OyKV

1 1 UNITED STATES DISTRICT COURT 2 E A S T E R N DISTRICT. OF NEW YORK MDL No. 381 3 4 In re : Deposition of: 5 "AGENT ORANGE" : BENJAMIN HARRIS 6 Product Liability Litigation : 7 8 9 T R A N S C R I P T of t e s t i m o n y as taken by and before 10 HELEN DOHOGNE, a Certified Shorthand Reporter and 11 N o t a r y Public of the State of New Jersey, at the 1 2 offices of KELLY, DRYE & WARREN, ESQS., 101 Park 1 3 Avenue, New York, New York, on Wednesday, November 14 11, 1 9 8 2 , 9:45 in the f o r e n o o n . 15 16 < A 17 a m i-- 18 19 20 21 22 405 Northfield Avenue West Orange, Mew Jersey 07052 2 3 (201) 7 3 1-9666 uo 24 25 \ 1 APPEARANCES: 2 YANNACONE & ASSOCIATES 3 BY: VICTOR RUSSO, ESQ. 2 4 For the Plaintiffs 5 5 MESSRS. RIVKIN, LEFF, SHERMAN & RADLER 7 BY: WIL L I A M CAVANAUGH, ESQ. 8 For Dow Chemical 9 10 MESSRS. CADWALADER, WICKERSHAM & TAFT 1 1 BY: M I C H A E L M. G O R D O N , ESQ. 12 For Diamond Shamrock 13 14 MESSRS. KELLEY, DRYE & WARREN 1 5 BY: C H A R L E S M. M A T T I N G L Y , ESQ. 1 6 For Hercules, Inc. 17 18 MESSRS. TOWNLEY & UPDIKE 19 BY: J A M E S E. T Y R R E L L , JR., ESQ. 20 For Monsanto Company 21 2 2 MESSRS. CLARK, GAGLIARDI & MILLER 2 3 BY: JOHN BURKE, ESQ. 2 4 For T h o m p s o n H a y w a r d , N o r t h A m e r i c a n P h i 11 i ps 25 II! 1 APPEARANCES: (Continued) ; 2 MESSRS. EUDD, LARNER, KENT, GROSS, j 3 PICILLO & ROSENBAUM i 4 BY: E D W I N R. M A T T H E W S , :E S Q . j; ! 5 For Thompson Chemicals 6 i [! iu 7 M E S S R S . A R T H U R , DRY: & K A L I S H j 8 BY: E U G E N E P. F E I T , ESQ. I' ! 9 For Uniroyal, Inc. 10 .M 11 M A J O R E. G L E N N PA R R 1 2 Department of Justice 1 3 For the United States of America 14 15 16 17 18 19 20 21 22 23 24 25 _4 h 3 4 1 2 WITNESS INDEX DIRECT CROSS 3 BENJAMIN HARRIS 4 Mr. Gordon 5 M r . Tyr el 1 6 Mr. Burke 114 122 7 S NUMBER EXHIBITS DESCRIPTION IDENTIFICATION 9 Harris-1 M a r c h 11, 1970 M e m o r a n d u m to 54 U d i r e c t o r of R e s e a r c h 11 L a b o r a t o r i e s from B e r n a r d 12 McNamara, Bernard Jandorf 13 an d S a m u e l Sass w i t h 1 4 16 p a g e s of a t t a c h m e n t s 15 1 6 H a r r i s - 2 J u n e 5, 1970 M e m o r a n d u m f r o m 74 17 B e r n a r d J a n d o r f to d i r e c t o r 18 of R e s e a r c h L a b o r a t o r i e s and 19 a t t a c h e d M e m o R o u t i n g S l i p f r o m 20 Dr. J a n d o r f to Dr. M c N a m a r a 21 d a t e d 6 / 1 0 / 7 0 22 23 H a r r is - 3 J u n e 8 , 1970 M e m o r a n d u m from 24 VP M c N a m a r a to D i r e c t o r of 25 Research Laboratories 82 14909 5 1 BENJAMIN H A R R I S , 11323 Glenarm Road, 2 Glenarm, Maryland, sworn: I 3 D I R E C T E X A M I N A T I O N BY MR. GORDON: ill 4 Q. G o o d m o r n i n g Dr . H a r r i s , c o u l d you s t a t e 5 y o u r full n a m e and a d d r e s s fo r the r e p o r t e r ? i: ! 6 A. Dr . B e n j a m i n H a r r i s , 1 1 3 2 3 G l e n a r m Ro a d . 7 Q. Dr. H a r r i s , are yo u r e p r e s e n t e d at t h i s 8 deposition by legal counsel? 9 A. M a j o r Parr w i l l be my c o u n s e l w i t h r e s p e c t to 10 my government operations. 11 Q. Dr. H a r r i s , in the few m i n u t e s p r i o r to 1 2 the deposition, I gave you a copy of the Special 1 3 M a s t e r ' s p r o t e c t i v e order dated October 14, 1982. 14 Did you r e v i e w t h a t o r d e r ? 15 A . Yes . 1 6 Q. Do yo u u n d e r s t a n d the t e r m s o f tha t o r d e r ? 17 A . Yes . 1 8 Q . Do yo u a g r e e to be b o u n d b y ; the t e r m s of 19 t h a t o r d e r ? 20 A . Yes. 21 Q . Thank you. 22 B e c a u s e the r e are s e v e r a l p e o p l e in 2 3 a t t e n d a n c e at the d e p o s i t i o n who have not signed the 2 4 u n d e r t a k i n g a n n e x e d as E x h i b i t A to the o r d e r it is 2 5 n e c e s s a r y that, eac h p e r s o n who h a s n ' t s i g n e d s t a t e . i ..^ *** /-<*r~>/"J f* i *-s --J - u --x u -- -- -- a . . . Harris 6 1 on the r e c o r d t h a t he a g r e e s to be bound: by the 2 t e r m s of the o r d e r . S i n c e I h a v e not ye;t s i g n e d I ' iI : ' 3 a g r e e to be b o u n d . i I! j i. 4 MR. BURKE: I agree. 5 MR.TYRRELL: I agree. 6 MR. F E I T : I agree. 1 MR. MATTHEWS: I agree. 8 MR. MATTINGLY: I agree. 9 MR. CAVANAUGH: I agree. 1 0 MAJOR PARR: I agree. 11 MR. G O R D O N : All p e o p l e in the room a s i d e 1 2 fro m the c o u r t r e p o r t e r h a v e a g r e e d to be b o u n d by 13 the t e r m s of the o r d e r . T h a n k you. 1 4 Q. Dr. Harris,; p l e a s e le t me k n o w if at a n y 1 5 time d u r i n g the d e p o s i t i o n y ou n e e d to h a v e a 1 6 q u e s t i o n c l a r i f i e d or r e p e a t e d or if at a ny time you 1 7 w o u l d like to e x p a n d up o n an a n s w e r that y o u ' v e 18 a l r e a d y g i v e n . Is tha t u n d e r s t o o d ? 1 9 A . Ye s . 20 Q. Did you m e e t w i t h a n y g o v e r n m e n t l a w y e r 2 1 in p r e p a r a t i o n for you r e x a m i n a t i o n t o d a y ? 22 A . You. 23 Q. Who did you m e e t w i t h ? 14911 2 4 a.. I'm not s u r e who all w e r e the l a w y e r s but I m e t ; j 25 wit h M a j o r Parr. A n y of those o t h e r s l a w y e r s ? Harris 7 1 MAJOR PARR: Gr e t c h e n Witt and Paul 2 Cormaier. j: j 3 Q. Wa s t h e r e a n y o n e in a t t e n d a n c e of th a t 4 meeting who was not a lawyer? 5 A . Me . :! 6 Q. W h e n did tha t m e e t i n g take p l a c e ? 7 A. M o n d a y o f t h i s w e e k . 8 Q. And h o w lon g did it las t ? j 9 A. A b o u t an hour, hour and a q u a r t e r . 1 0 0. W e r e y o u s h o w n or did you r,ecjeive a n y 11 d o c u m e n t s f r o m M a j o r P a r r or a n y o n e els e who w a s at 1 2 nha'; m e e t i n g ? 1 3 A .. Y e s . 1 4 Q. 15 t o d a y ? Did you bring those documents with you 16 A . Yes. 1 7 Q. Did yo u r e v i e w t h o s e d o c u m e n t s ? 1 3 A. P a r t i a l l y . 1 9 Q. W h e n y o u s a y p a r t i a l l y , to w h a t e x t e n t 20 did you review them? 21 A. G r e a t deal of t e c h n i c a l d e t a i l I s k i p p e d o v e r 22 a l t h o u g h if q u e s t i o n e d I c o u l d r e v i e w it q u i c k l y . 22 Q. Did you l o o k at e v e r y d o c u m e n t in the 24 p i l e ? 25 A. I l o o k e d at e v e r y one , y e s . 14912 Mf/'i'-'* e n d *--- - Harris 8 1 Q. W e r e the d o c u m e n t s t h a t yo u r e v i e w e d 2 accompanied by a cover letter? 3 A. Ye s , t h e y s e n t t h e m t o m e . 4 Q. Do you h a v e t h o s e d o c u m e n t s w i t h you h e r e 5 today? 6 A . Yes . ; i 7 Q. C o u l d you p r o d u c e the d o c u m e n t s at th i s . `;.i 8 time.- I 9 MAJOR PARR Do you w a n t them; all m a r k e d 10 for identification? 11 MR. G O R D O N : I s i m p l y w a n t the c o v e r 1 2 l e t t e r so I ca n say for the r e c o r d w h i c h d o c u m e n t s 13 t h e y a r e . 1 4 THE W I T N E S S : The c o v e r l e t t e r is no t 15 th e r e . It's in m y b r i e f c a s e o u t s i d e . 1 6 MR. GORDON: Off the record. 17 ( D i s c u s s i o n o f f the record) 18 MR. G O R D O N : T he r e c o r d s h o u l d r e f l e c t 19 that the d o c u m e n t s w h i c h w e r e s h o w n to Dr. H a r r i s 20 and w h i c h he b r o u g h t to thi s d e p o s i t i o n t o d a y w e r e 21 a c c o m p a n i e d by a c o v e r l e t t e r f r o m M i c h a e l M. G o r d o n 22 t, Mr. Maskin dated October 29, 1982. 2 3 Did you review any other written 2 4 m a t e r i a l s in ^ r e p a r a t i o n for y o u r d e p o s i t i o n t o d a y ? 2 5 A. Yes. 1413 . M* Harris 9 1 Q. W h a t w r i t t e n m a t e r i a l s w e r e t h o s e ? 2 A . My own files. i . 3 Q. W h i c h d o c u m e n t s in you r o w n f i l e s did you 4 review? ; 5 A. The l a r g e s t n u m b e r of them were a r t i c l e s from 6 the open literature which I filed over the years 7 p e r t a i n i n g e i t h e r to O r a n g e or to d i o x i n , in 8 a d d i t i o n to w h i c h t h e r e w e r e a c o u p l e of h a n d w r i t t e n 9 n o t e s to me e n c l o s i n g o t h e r d o c u m e n t s of the s a m e 10 sort. 11 Q. W e r e t h e r e an y o t h e r m a t e r i a l s in tho s e 1 2 files that you reviewed? 1 3 A . No . 14 Q. Did yo u h a v e a ny i n t e r o f f i c e 15 c o r r e s p o n d e n c e or m e m o s c o n c e r n i n g A g e n t O r a n g e ? 16 A. The h a n d w r i t t e n n o t e s , yes, I a n s w e r e d that as 1 7 yes, the handwritten notes were interoffice. 1 8 Q. A n y t h i n g e l s e ? 1 9 A. When I was t e c h n i c a l d i r e c t o r at E d g e w o o d I 20 a s k e d p e o p l e to c o m m e n t on m e t h o d s of c l e a n i n g up thi 21 l i k e O r a n g e f r o m d i o x i n and t h e y w r o t e a note ba c k 22 to me e n c l o s i n g these o t h e r p a p e r s . 149142 3 Q. W h e r e are your p e r s o n a l f i l e s l o c a t e d ? 24 A. I n m y b a r n . 25 Q. Do yo u k n o w w h e t h e r an y of the a r t i c l e s Harris I: 1 in I or the h a n d w r i t t e n n o t e s in y o u r p e r s o n a l f i l e s ar e 2 d a t e d p r i o r to 1 9 7 0 ? ;; l 3 A. I c a n ' t say at the m o m e n t . May v e r y well be. 4 Q. Do you k n o w w h e t h e r a ny of t h o s e 5 m a t e r i a l s w e r e r e c e i v e d by y o u p r i o r to. 1970 ? 6 A. It's h a r d to say. I t h i n k not but: it's h a r d to 7 say. 8 MR. RUSSO: Could I have the: last 9 question read back. 1 0 (The reco rd is r e a d ) 11 A. Non e of the i n t e r o f f i c e m e m o s were b e c a u s e I I' ; 1 2 d i d n ' t b e c o m e t e c h n i c a l d i r e c t o r at E d g e w o o d until 1 3 1970 but the open literature articles I/may have 1 4 torn out and filed at any time. ! 1 5 MR. GORDON: Mr. Parr -- 16 M A J O R P A R R :. Let me n o t e for. "he r e c o r d 17 at this time that he b r o u g h t all of t h o s e d o c u m e n t s 1 8 to the m e e t i n g on M o n d a y w h i c h wa s the f i r s t t i m e 1 9 that we learned of their existence. The Justice 2 0 D e p a r t m e n t to o k them at th a t t i m e and t h e y ' re n o w in 2 1 the h a n d s of the A r m y for r e v i e w , c u r s o r y r e v i e w to 22 see if t h e r e ' s a n y p r o b l e m w i t h p r i v i l e g e or 2 3 c l a s s i f i e d i n f o r m a t i o n after w hich they'll be 149152 4 released to you. 25 MR. G O R D O N : F i n e . So the r e c o r d is _______ _____ ________ _______ it: Harris 11 1 c l e a r then, the d o c u m e n t s ar e no w in the p o s s e s s i o n 2 o f ;th e g o v e r n m e n t and b e i n g r e v i e w e d and a f t e r 3 r e v i e w will be produ c e d . 4 iH :j MAJOR PARR: T h a t 's correct. 5 ! 1 Q. As cited from your meeting with Major j :t 6 Parr and Paul Cormaier and Gretchen Witt, have you 7 m e t or s p o k e n w i t h a n y o n e e l s e in c o n n e c t i o n w i t h 8 your deposition? 9 A . No . 10 Q. Do y o u h a v e a c u r r i c u l u m v i t a e or a job 11 resume? 1 2 A.'i Not with me. 13 Q. Do you h a v e one in yo u r f i l e s at h o m e ? 14 A . ' Yes. 15 ! M Q. C o u l d you se n d a c o p y of it to me. 16 A . : Yes. 17 'M ! Q. Thank you. 18 : i i M A J O R PARR: Let me q u a l i f y t h a t . If y ou 19 w o u l d , l e t ' s let the w i t n e s s sen d it to me and I'll 20 s e n d it to you. 21 MR. G O R D O N : F i n e . 14916 22 i M A J O R PARR: Then I'll talk to the 23 w i t n e s s a b o u t the d e t a i l s later. 24 Q. Dr. H a r r i s , w h a t is you r d a t e and p l a c e 25 of b i r t h ? Harris 12 1 A. A u g u s t the f i r s t , 1970 , Savannah!, |G.eorgia . 2 Q . Would you b r i e f l y d escribe your j1 : i j 3 e d u c a t i o n a l b a c k g r o u n d b e g i n n i n g withiihjigh s c h o o l ? 4 A. High s c h o o l at S p a r u s P o i n t in M a r y l a n d , : i, 5 academic course; college, Johns Hopkins University, j 6 b a c h e l o r s d e g r e e in gas; e n g i n e e r i n g iin 1938 , P h D in 7 c h e m i c a l e n g i n e e r i n g in 1941. Yo u want! a n y m o r e ? 8 Q. No. F o l l o w i n g r e c e i p t of yoiur PhD, did 9 you receive any further specialized training? 1 0 A. Yes. I a t t e n d e d as a r e s i d e n t s t u d e n t at the 11 a r m e d f o r c e s of the -- l e t ' s see, I n d u s t r i a l C o l l e g e 1 2 of the a r m e d f o r c e s , I C A F in 1964, 1965. 1 3 Q. W h a t is the I n d u s t r i a l C o l l e g e of the 14 armed forces? 1 5 A. T h a t ' s a s e n i o r s e r v i c e c o l l e g e for m i l i t a r y 16 o f f i c e r s to w h i c h l i m i t e d n u m b e r of h i g h l e vel 17 g o v e r n m e n t c i v i l i a n s also a t t e n d from; all 18 d e p a r t m e n t s of the g o v e r n m e n t . ; 19 Q. W h a t is the c u r r i c u l u m at I C A F ? i 20 A. E s s e n t i a l l y , l o g i s t i c s m a n a g e m e n t . T h a t ' s it. 21 Q. A s i d e fr o m ICAF, h a v e you r e c e i v e d a n y i 22 o t h e r s p e c i a l i z e d t r a i n i n g or v o c a t i o n a l t r a i n i n g ? 2 3 A. O n l y s h o r t c o u r s e s fro m tim e to tim e , r e f r e s h e r 24 c o u r s e s . 2 5 _____Q_.____Ha_v_e__y_o_u__be_e_n__a_n__au_t_h_o_r__or__a:_c_o_-1a4ut3h1o1r__of i , ,M ^ ** l --*> M - H i! , . I t _ 1 U .. --.- . I- - * --. ---4 - Harris 13 1 any article that's been published? 2 A. Y e s . 3 Q. H o w m a n y a r t i c l e s ? 4 A. In the o p e n l i t e r a t u r e , a p p r o x i m a t e l y 30. In 5 the classified literature over a hundred. 6 Q. Can you b r i e f l y s u m m a r i z e the s u b j e c t 7 m a t t e r of the a r t i c l e s that a p p e a r e d in the o p e n 8 literature? 9 A. I was the w r i t e r of a r e v i e w a r t i c l e on the 1 0 field of a d s o r p t i o n for ele v e n years and wrote an 11 a r t i c l e e a c h year on that, o n e of the j o u r n a l s . 1 2 R e m a i n d e r of the a r t i c l e s w e r e in a r e a s of c h e m i c a l 1 3 warfare agents, adsorption and, more recently, 14 r e v i e w a r t i c l e s in. the f i e l d of c h e m i c a l w a r f a r e . 1 5 Q. W h a t t y p e s of a d s o r p t i o n did y ou w r i t e 16 about? 1 7 A. Well, my d o c t o r s d e g r e e t h e s i s was a d s o r p t i o n 18 of g a s e s on s o l i d s and I c o n t i n u e d as a p r o f e s s o r 1 9 withi g r a d u a t e s t u d e n t s w o r k i n g in that s a m e f i e l d , 2 0 their theses and my own research was published. 21 :Q . Did you p erform any research on carbon 2 2 adsorption? 14918 2 3 A. U n p u b l i s h e d , yes. I a s s i s t e d the p r o f e s s o r at 24 o n e t i m e d e t e r m i n i n g s u r f a c e a r e a s , f i n e l y d i v i d e d 2 5 p a r t i c u l a t e m a t e r i a l s w i t h a t e c h n i q u e he had i Harris ii: i 14 ' i 1 i n v e n t e d u s i n q a d s o r p t i o n and I did a (w i d e r a n g e of 2 substances, possibly even carbon, likely even carbon 3 but I'm not sure. I, 4 Q. Do you r e c a l l .when that w o r k ^ w a s : I ;i p :' 5 performed? ,. ii : 6 A. 1938 to 1 94 0 . 7 Q. W h a t t y p e s of c h e m i c a l war far e ag en ts did *i I; 8 you w r i t e n o w in the o p e n l i t e r a t u r e ? 9 A. W ell, I'm a part h o l d e r of a patent on 1 0 sta b l i z a t i o n of mustard and a number of, the 11 c l a s s i f i e d l i t e r a t u r e w e r e on m u s t a r d and a n a l o g o u s 12 c o m p o u n d s . M o s t r e c e n t a r t i c l e s I -- this year was 1 3 a r e v i e w a r t i c l e in the f i e l d of c h e m i c a l w a r f a r e 14 and an a r t i c l e on i n c a p a c i t a t i n g a g e n t s , o ne in 1 5 p r e s s , w h i c h is p o l i c y of c h e m i c a l w a r f a r e . 1 6 Q. I n c i d e n t a l l y , do y o u r v a r i o u s 1 7 p u b l i c a t i o n s in the o p e n l i t e r a t u r e a p p e a r on yo u r 18 c u r r i c u l u m v i t a e ? 1 9 A. I h a v e a n u m b e r of c u r r i c u l u m v i t a e and in o n e 20 of them or more, yes. 21 Q. W o u l d you se n d us all of the c u r r i c u l u m 22 v i t a e yo u h a v e and d i f f e r e n t v e r s i o n s so t h a t w e ' r e 23 s u r e we g e t all of the a r t i c l e s t h a t y o u ' ve 1491924 p u b l i s h e d ? 2 5 A. I'll send you ail the a r t i c l e s , yes. ir*% I! - a :*: ^ _i . i,, _ i u -- . --i Ha r r i s 1 15 M A J O R PARR: The w i t n e s s is v e r y a c t i v e 2 in o r g a n i z a t i o n s s u c h as the Boy S c o u t s . I'm sure 3 you w o u l d n ' t be i n t e r e s t e d in the Boy Scouts, he has 4 separate curriculum vitaes. 5 MR. GORDON: That's correct. I do not 6 need a c u r r i c u l u m . v i t a e for the Boy Scouts. 7 MAJOR PARR: Just his professional. 8 Q. W h a t w as the s u b j e c t of the v a r i o u s 9 a r t i c l e s t h a t you w r o t e t h a t a p p e a r e d in the 10 classified literature? 11 A. T h e y had to do w i t h p r o p e r t i e s of, s t a b l i z a t i o n 12 of and m o d i f i c a t i o n of c h e m i c a l w a r f a r e m a t e r i a l s . 1 3 Q. W h e n w e r e the a r t i c l e s that a p p e a r e d b o t h 1 4 in the c l a s s i f i e d l i t e r a t u r e and the p u b l i s h e d 15 literature concerning chemical warfare agents 16 p u b 1 ished ? ' 17 A. The c l a s s i f i e d l i t e r a t u r e was d u r i n g the ti m e I 18 s p e n t in the s e r v i c e in W o r l d War II b e t w e e n the 19 y e a r s of 194 1 a n d :1 9 4 6 . The o n l y a r t i c l e s p u b l i s h e d 20 in c h e m i c a l w a r f a r e s i n c e t h a t time in the o p e n 21 literature were -- I mean -- would you repeat the 22 question. 14920 23 i' Q Yes. The question was when various 2 4 articles that you authored concerning chemical 25 w a r f a r e a g e n t s w e r e p u b l i s h e d e i t h e r in the o p e n Harris 16 i 1 l i t e r a t u r e or in the c l a s s i f i e d l i t e r a t u r e ? 2 A. You do w a n t g o v e r n m e n t ? | 3 Q. Y e s . 4 A. The open l i t e r a t u r e a r t i c l e s w e r e p u b l i s h e d 5 this year, January and March. 6 Q. F o l l o w i n g the r e c e i p t of y o u r P h D in 1941, 7 whatdidyoudo? 8 A. V e r y s h o r t l y I w a s : o r d e r e d to a c t i v e d u t y p r i o r 9 to W o r l d War II, p r i o r to P e a r l H a r b o r , and 1 0 c ontinued there until the end of 1945, retired -- 11 g o i n g off a c t i v e d u t y in A p r i l of 194 6 . 1 2 Q. W h a t wa s y o u r rank at the time you w e n t 13 o f f a c t i v e d u t y ? 14 A . M a j o r . 1 5 Q. W h e r e w e r e you s t a t i o n e d d u r i n g yo u r 16 s e r v i c e ? ii : i; I 1 7 A. E n t i r e s e r v i c e w a s : s p e n t at E d g e w o o d A r s e n a l . 1 8 Q. In the A r m y d u r i n g you r s e r v i c e ? 19 A. Yes. By in the s e r v i c e , i m p l i c a t i o n is A r m y 20 s e r v i c e . i 21 Q. W h a t did you do at E d g e w o o d d u r i n g your 22 s e r v i c e , d u r i n g yo u r ti m e in the s e r v i c e ? 23 A. I was a g r o u p l e a d e r of the l a b o r a t o r y g r o u p 24 c o n c e r n e d w i t h the s u b j e c t s of -- i n d i c a t e d r e p o r t s 1492125 w ere on the p r o p e r t i e s and m o d i f i c a t i o n s of c h e m i c a l - I * : : ..j . u. -- Harris 17 1 warfare agents. 2 Q. W h a t w a s the n a m e of the lab g r o u p that 3 you were leader of? 4 A. D i d n ' t r e a l l y h a v e a n a m e but it was p a r t of 5 t h e :P h y s i c a l O r g a n i c B r a n c h of the C h e m i c a l D i v i s i o n 6 of the Technical Command. 7 Q. Who did you r e p o r t to? 8 A. Dr. R u d o l p h M a s s e y . 9 Q. W h i c h c h e m i c a l w a r f a r e a g e n t s cid you 1 0 w o r k w i t h d u r i n g you r p e r i o d in the s e r v i c e ? 11 A. M o s t l y the a g e n t s of the m u s t a r d g r o u p and 1 2 analogous compounds, a number of other compounds 1 3 t h a t had b e e n s y n t h e s i z e d fro m time to t .lijt- to see 1 4 i f ;they w e r e of any t h r e a t to the U .S . , and we 1i 1 5 measured the prope r t i e s of them for the people who 1 6 had'developed them. 1 7 Q. Did you: w o r k w i t h a n y c o m p o u n d s th a t w e r e 18 not being e x plored for chemical warfare purp oses? 1 9 A . 1No . 20 Q. Did you- e v e r do any w o r k d u r i n g yo u r 2 1 p e r i o d in the s e r v i c e w i t h h e r b i c i d e s ? 22 A . !No . 2 3 Q. By the way, you m e n t i o n e d t h a t you w e r e a 24 part h o l d e r of a p a t e n t on m u s t a r d gas. Are you a 25 h o l d e r of any o t h e r p a t e n t s ? 14922 Harris 1 A. No . ;'"I 18 : !: I ;, 2 Q. W h a t did y o u ;do f o l l o w i n g you r d i s c h a r g e 3 f r o m the s e r v i c e in 1 9 4 6 ? 4 A. B e c a m e a s s i s t a n t p r o f e s s o r of c h e mical 5 e n g i n e e r i n g at J o h n s H o p k i n s U n i v e r s i t y ;u n t i l 1 953 . 6 In 1952, I a c c e p t e d f u l l - t i m e e m p l o y m e n t 7 at Edgewood Arsenal with the R e s e a r c h 1and 8 Engineering Command. . 9 Q. W h e n did you f i r s t r e t u r n to E d g e w o o d ? 1 0 A. I w a s a c o n s u l t a n t at E d g e w o o d f r o m 1949 to 1 1 1 9 5 2 and w e n t f u l l - t i m e iin 1952. 1 2 Q. W h a t wa s y o u r t i t l e at t h e ,t i m e y o u 1 3 r e t u r n e d in 195 2 ? 1 4 A. My h e s i t a t i o n is b e c a u s e g o v e r n m e n t a l t i t l e s 1 5 are extremely long and complex and during the 16 e n s u i n g few y e a r s , I had e i g h t or ten d i f f e r e n t 17 t i t l e s and I c a n 't r e m e m b e r at all w h a t an y of t h e m 18 w e r e . 19 Q. Do you r e c a l l for h o w l o n g ia| t i m e p e r i o d 20 yo u r e m a i n e d in the E n g i n e e r i n g and R e s e a r c h C o m m a n d ? 21 A. U n t i l its d i s s o l u t i o n -- until its,removal to 22 W a s h i n g t o n in w h i c h c a s e I w a s t r a n s f e r r e d to the 23 C h e m i c a l W a r f a r e L a b o r a t o r i e s a l s o l o c a t e d at 24 E d g e w o o d and part of the R e s e a r c h and E n g i n e e r i n g 25 C o m m a n d and it w e n t t h r o u g h a n u m b e r of n a m e c h a n g e s , _________ ;_____________________ 14923 ,-ir' pr.lnclli ,, _i 11 1 .-- * Harris 1 too, over the years. 19 2 Q. So I ' v e h e a r d . 3 A. I ca n 't r e m e m b e r all o f them. 4 Q. Do you r e c a l l the d a t e w h e n the 5 E n g i n e e r i n g and R e s e a r c h C o m m a n d was r e m o v e d to 6 Washington? 7 A. It wa s in 1955, at l e a s t t h a t ' s the time I -- 8 yes, it's simultaneous with the time I was 9 transferred . 1 0 Q . W h e n you w e r e t r a n s f e r r e d to the C h e m i c a,l 11 W a r f a r e L a b o r a t o r i e s , w h a t p a r t of the l a b o r a t o r i e s 12 were iyou t r a n s f e r r e d to? 1 3 A . , ; I carried a queer title called assistant for 1 4 CARAMU, all caps. Short for the C a s u a l t y Rate of 1 5 Munitions. This was an oversight position looking 16 into ih o w one c o u l d e s t i m a t e the e f f e c t i v e n e s s of 17 c h e m i c a l w a r f a r e . As such, my area of i n t e r e s t was 18 over; the e n t i r e l a b o r a t o r y and I was, in e f f e c t , an 1 9 a s s i s t a n t to the s c i e n t i f i c d i r e c t o r . 20 Q. Wh o did yo u r e p o r t to as a s s i s t a n t for 21 CARAMU? 22 A . , . A t f i r s t to C o m m a n d i n g G e n e r a l B u r n s and 23 s u b s e q u e n t to that to the s c i e n t i f i c di r e c t o r Dr. 24 S e y m o u r S i l v e r . 14924 25 Q. Do you r e c a l l w h e n yo u b e g a n r e p o r t i n g to Harris 20 1 D r . Silver? 2 A. In late 195 5 . ::To c l a r i f y tha t , !the a s s i s t a n t ; i; 3 for C A R A M U job had been set up just p r e v i o u s to the 4 c h a n g e , so at t h a t t i m e .I wa s a s s i s t a n t to the 5 c o m m a n d i n g g e n e r a l of R E C O M and then jwhen it 6 d i s s o l v e d , that p o s i t i o n was t r a n s f e r r e d to the labs, I! 7 R e s e a r c h and E n g i n e e r i n g Command.. j: i ; : :li ;/j iu*-j .>;. \ ! i,; ;!i ; . i- i .-.Maii '8 Q Did y o u r t i t l e c h a n g e f r o m : a s s i sta n t to : 9 s c i e n t i f i c d i r e c t o r wh en you b e g a n r e p o r t i n g to Dr . 10 Silver? 11 A. No, not r e a l l y a l t h o u g h my d u t i e s b r o a d e n e d and 12 i n c r e a s e d with time to the p o i n t that w h e n e v e r he 1 3 was away for an e x t e n d e d period, I would act as his 1 4 a l t e r n a t e . As t i m e w e n t on, in the '56, '57, '58 15 p e r i o d . i 16 Q. Do yo u r e c a l l for h o w l o n g Dr . S i l v e r 17 s e r v e d as s c i e n t i f i c d i r e c t o r ? 18 A. He had b e e n the s c i e n t i f i c d i r e c t o r of the 19 R e s e a r c h and E n g i n e e r i n g C o m m a n d and b e c a m e 20 l a b o r a t o r y -- t h e r e was a c t u a l l y q u i t e a 21 r e o r g a n i z a t i o n at the time, not just a - t r a n s f e r , and 22 he remained scientific director, I think, until I 23 le f t E d g e w c o d in 196 6 . 24 Q. As a s s i s t a n t for C A R A M U , h o w did you go 25 a b o u t p e r f o r m i n g you r f u n c t i o n s and 14925 j Harris 1 responsibilities? 21 2 A. W e ll, it was a c o o r d i n a t i n g p o s i t i o n , l a r g e l y 3 by keeping track of what was going on that would be 4 p e r t i n e n t to the s u b j e c t . I had a s m a l l g r o u p of 5 people who were working developing mathematical and 6 s y s t e m s a n a l y s i s m e t h o d o l o g y and fr o m tim e to time 7 s u g g e s t e d to the r e s e a r c h e r s in the lab a v e n u e s t h e y 8 should explore that would provide data we needed. 9 Q. Who w e r e the r e s e a r c h e r s in the labs t h a t 10 you s u g g e s t e d work to? 11 A. It's a p r e t t y w i d e s p e c t r u m of p e o p l e with 12 s o m e w h a t m o r e e m p h a s i s on p e o p l e i n v o l v e d with 13 t e s t i n g b e c a u s e t h a t ' s w h e r e you get data i n v o l v i n g 14 e ffe c tiv e n e s s . 1 5 Q. Wh o was in c h a r g e of the t e s t i n g d i v i s i o n 16 at E d g e w o o d ? 17 A. L o uis B e n j a m i n at the first and then later 18 Ed ward M i l l e r . 19 | ; Q. For h o w long did you s e r v e as a s s i s t a n t 20 for C A R A M U ? 21 A. U n t i l s o m e t i m e in the m i d d l e of 1960 w h e n I 22 became d e p u t y d i r e c t o r of d e v e l o p m e n t until 1963 23 w h e n I b e c a m e d i r e c t o r of d e v e l o p m e n t s u p p o r t , 24 h o l d i n g t h a t p o s i t i o n u n t i l 1965 in w h i c h c a s e t h e r e 25 was a r e o r g a n i z a t i o n . Harris 22 1 I ended up as chief of S ystems A n a l y s i s 2 D i v i s i o n and not b e i n g all tha t happy! I :so ug h t o t h e r 3 e m p l o y m e n t and lef t in l a t e 1966 4 MR. MATTHEWS: Could you repeat that last 5 answer. 6 (The r e c o r d is read) 7 Q. As a s s i s t a n t for C A R A M U , did: yo u d e a l 8 with Dr. Bernard J a ndorf? i' 9 A. P r o b a b l y , y e s . 1 0 Q. W h a t was the s u b j e c t of y o u r d e a l i n g s 11 w i t h Dr. J a n d o r f ? : 2 A. J a n d o r f was a b i o c h e m i s t and as such he was 1 3 c o n c e r n e d with the mode of action of chemical 14 s u b s t a n c e s on a n i m a l b o d y and we werei c o n c e r n e d w i t h 15 the f i n a l o u t c o m e of chat w h i c h w o u l d be the 16 e s t i m a t e of the t o x i c i t y of materials,.to. h u m a n 17 b e i n g s . 18 Q. Is it fa i r to sa y th a t you w e r e m o r e 19 c o n c e r n e d w i t h the p r a c t i c a l s i d e or a p p l i e d s i d e 20 and Dr. Jandorf was more concerned with the research 21 side? 22 A. A b s o l u t e l y . No q u e s t i o n a b out that. 23 Q. Did you e v e r d e a l w i t h Dr. F r i t z H o f f m a n 24 w h e n you w e r e a s s i s t a n t for C A R A M U ? 1432725 A. Well, I knew F r i t z 1and we d i s c u s s e d t e c h n i c a l Harris 23 1 m a t t e r s in p a s s i n g . I had no d i r e c t i n v o l v e m e n t 2 with him, no. 3 Q. Did you e v e r d i s c u s s p r o p o s e d c h e m i c a l 4 agents with Dr. Hoff m a n ? 5 A.; No. T h e o n l y time that I had a n y t h i n g m u c h to 6 do;with Hoffman was when I ran a c a l c u l a t i o n on some 7 e n g i n e e r i n g d e t a i l s of the p r o c e s s to m a k e VX, and 8 he m a d e a c o m m e n t or two on it, but that ' s all. 9 Q. Did you dea l w i t h Dr. B e r n a r d M c N a m a r a as 10 assistant for CARAMU? 11 A. Yes. In m u c h the sam e s e n s e that I m e n t i o n e d 1 2 for Dr. J a n d o r f and more e x p l i c i t l y with McNamara 13 b e c a u s e hi s job w a s as c h i e f of the t o x i c o l o g y w o r k 14 and he c h a i r e d w h a t we c a l l e d the H u m a n E s t i m a t e s 15 C o m m i t t e e w h e r e he took the a n i m a l d a t a and t r ied to j.-;i-'-!! i `i 16 e s t i m a t e the h u m a n d a t a and I was a m e m b e r of that 17 c o m m it t e e . 18 Q. H o w a b o u t Dr. B e n j a m i n W i t t e n , did you 19 work with Dr. W i t t e n at all as a s s i s t a n t for C A R A M U ? 2 0 A.' | I'd say the s a m e thi n g w i t h Dr. W i t t e n as I 21 said for H o f f m a n . I knew him, t a l k e d to him on 2 2 techni c a l , m a t t e r s , no d i r e c t i n v o l v e m e n t in his w o r k . 23 Q. As a s s i s t a n t for C A R A M U , w as t h e r e a n y o n e 24 at E d g e w o o d who r e p o r t e d to you? 1492825 A , I had a small g r o u p of p e o p l e , b o t h c i v i l i a n Harris i .i, 24 !;;.Ii ' 1 and m i l i t a r y , who w e r e , in e f f e c t , sy isterns a n a l y s t s . ;j 2 Q. Do yo u r e c a l l the n a m e s of a n y of t h o s e :I:i j!.; 3 persons? j j' j ' 4 A. Yes. M o r t o n S h a v i t , J o s e p h L i n d w a r m and t h r e e 5 or four GI's that I,can't r e member now.M 6 Q. W h e n you b e c a m e d e p u t y d i r e c t o r of 7 D e v e l o p m e n t in the m i d d l e of 196 0 , who did you 8 reportto? ii 9 A. Dr. S i l v e r , I g u e s s , w a s m y i m m e d i a t e 1 0 s u p e r v i s o r , he and the c o m m a n d e r at t h e ;t i m e and 11 there was a whole raft of commanders. 1 2 Q. W h a t w e r e the f u n c t i o n s and 13 r e s p o n s i b i l i t i e s of the D e p u t y D i r e c t o r ; o f 14 Development? 15 A. A s s i s t a n t D i r e c t o r a s s i s t e d the D i r e c t o r of 16 Development . 17 Q. Who was the D i r e c t o r of D e v e l o p m e n t at 18 that time 7 19 A . So 1 Ho rma 1 2 . : |,j 2 0 Q. Did yo u r e p o r t to Sol H o r m a t z in a d d i t i o n 21 to Dr. S i l v e r and the v a r i o u s c o m m a n d e r s ? 2 2 A. I h a v e to a m e n d w h a t I sa i d b e f o r e . W h e n I w a s 2 3 d e p u t y d i r e c t o r I r e p o r t e d to Sol who r e p o r t e d to Sy. 149292 4 When I was D i r e c t o r of D e v e l o p m e n t s u p p o r t , 25 s u b s e q u e n t l y I r e p o r t e d to S i l v e r . *a A l l ! --. _ l t_ . 1U -- --. --J 1 Harris 25 1 :! Q. During what time period did Sol Hormatz 2 serve at D i r e c t o r of D e v e l o p m e n t ? 3 A. S o m e time p r e v i o u s to my g o i n g w i t h him, c o u p l e 4 years or more until 1963 when there was a 5 r e o r g a n i z a t i o n of it and I d o n ' t r e m e m b e r w h a t S o l ' s 6 position was then. 7 Q. Is it Dr. H o r m a t z ? 8 A . No . 9 Q. W as Mr. H o r m a t z s u c c e e d e d by a n y o n e as 1 0 D i r e c t o r of D e v e l o p m e n t in a b o u t 1 9 6 3 ? 11 A. I c a n ' t r e m e m b e r the d e t a i l s on that. 1 2 Q. By the way, is the r e o r g a n i z a t i o n tha t 13 o c c u r r e d in 1963 t h a t you h a v e just r e f e r r e d to the 14 d i s s o l u t i o n of the C h e m i c a l C o r p s ? 15 A . Th e a n s w e r to t h a t q u e s t i o n is no. The 16 C h e m i c a l Cor p s was n e v e r d i s s o l v e d . T h e r e was a 17 r e o r g a n i z a t i o n ofi the l o g i s t i c s t r u c t u r e of the A r m y 18 in w h i c h c a s e the C h e m i c a l C o r p s as a t e c h n i c a l 19 s e r v i c e was d i s c o n t i n u e d and r e m a i n e d o n l y as an 20 o f f i c e r c o r p s , the C h e m i c a l C o r p s O f f i c e r C o r p s that 21 sti l l e x i s t s . 2 2 Q. Was t h e r e a time w h e n the f u n c t i o n s of 23 the. -Chemical R e s e a r c h and D e v e l o p m e n t L a b o r a t o r i e s 1493024 a t: E d g e w o o d were tak e n over by M U C O M from the U.S. 25 A r m y C h e m i c a l C o r p s ? Harris 26 1 A . Yes. I think that was.at the s a m e t i m e . 2 Q. In 1 9 6 3 ? i ii j' * 3 A. I t h i n k 196 3 . Now, t h i s is v e r y h a z y . I w a n t 'i 1 4 to h a s t e n to add t h a t . i;;,|,i 5 But I think 1963 was when; the Chemical 6 C o r p s as a t e c h n i c a l s e r v i c e and, of; c o u r s e , t h i s 7 w o u l d be in the r e c o r d s s o m e w h e r e , c e a s e d to e x i s t , 8 and the c h e m i c a l o p e r a t i o n s .b e c a m e a p^rt o f ; t h e 9 Munitions Command. 10 Q. Dr. H a r r i s , w h a t w e r e y o u r f u n c t i o n s and 11 r e s p o n s i b i l i t i e s as as D e p u t y D i r e c t o r , o f 1 2 Development from middle -- the middle of 1960 until 13 1963? 1 4 A. W e l l , my job, of c o u r s e , was t o ;ser v e as a 15 d e p u t y w h i c h m e a n t that b a s i c a l l y I did w h a t e v e r the 1 6 c h i e f w a n t e d . I s e r v e d in his a b s e n c e ; a s a c t i n g 17 d i r e c t o r , and I -- my job, h o w e v e r , was l a r g e l y that 18 of g e n e r a t i n g c o n c e p t s for t e s t s or for d e v e l o p m e n t 1 9 w h i c h t h e n w e r e f a r m e d to the d i v i s i o n s . T h a t w o u l d 20 be m o s t of w h a t I did on m y own. 21 Q. Do you r e c a l l a n y of the c o n c e p t s t h a t 2 2 you g e n e r a t e d as d e p u t y d i r e c t o r ? 2 3 A. Yes. I g e n e r a t e d a c o n c e p t of use of VX as an 2 4 A r e s o l instead of as a q r o s s liquid. 25 Q . W h a t is V X ? 14931 J * u. * Harris 1 A. VX is a c h e m i c a l w a r f a r e a g e n t w h i c h is 27 2 e s s entially a liquid. It's a nerve agent and I 3 c o u l d d r e a m up its f o r m u l a but I p r e f e r to ref e r to 4 it o t h e r w i s e . 5 Q. W e ' l l s a v e the r e p o r t e r so m e w o r k and 6 skip the formula. 7 Any other concepts that you can recall 8 that you w o r k e d on as d e p u t y di r e c t o " ? 9 A. N o n e of that m a g n i t u d e . T h e r e were m i n o r -- 10 m o s t l y m i n o r t h i n g s . 11 Q. Dr. H a r r i s , do you recall w h e t h e r any of 12 the c o n c e p t s or p r o g r a m s that you w o r k e d on as 13 D e p u t y D i r e c t o r of D e v e l o p m e n t p e r t a i n e d to the 1 4 d eployment or use of herbicides? 15 A .. ! Yes, I do r e c a l l . T h e y did not. 16 : Q. During the time period that you were 17 D e p u t y D i r e c t o r of D e v e l o p m e n t , are you a w a r e of 18 w h e t h e r w o r k was b e i n g p e r f o r m e d at E d g e w o o d 19 c o n c e r n i n g d e p l o y m e n t ,of h e r b i c i d e s in V i e t n a m ? 20 W o u l d you like to h a v e the q u e s t i o n read b a c k ? 21 A. : I t hink it's a n o n s e q u i t u r , isn't it? When I 22 was Deputy Director of D e v e l o p m e n t Viet n a m didn't 23 exist. 24 Q. Depends; on who you t a l k to. 1.493225 I'll rephrase it w i t h o u t V i e t n a m after Harris 28 1 it's been read. 2 (The record is read) mj 3 Q Let me rephrase the question for you. 4 During the time period that you were; `De p u t y D i r e c t o r 5 of D e v e l o p m e n t , were you aware at any time of any 6 work concerning herbicides that was being performed 7 either at E d g e w o o d or at Fort D e t r i c k ? ;8 A. I was aware of the fact that we; had an a n t i - c r o p 9 program at Fort Detrick. I knew they had a series 10 of c o m p o u n d s i d e n t i f i e d l a r g e l y by the i r -- by code 11 s y m bols and -- but I w a s n ' t aware o f : what they were 1 2 doing p a r t i c u l a r l y , no. 1 3 Q. Do you know -- 1 4 A. This was at Det r i c k . At E d g e w o o d , I d o n ' t 1 5 recall a n y t h i n g with regard to h e r b i c i d e s at that !1 16 time. hi.. 17 Q. Do you r e c a l l the m o n t h in 1963 w h e n y o u 18 b e c a m e D i r e c t o r of D e v e l o p m e n t s u p p o r t ? 19 A. No . 1 i -; 2 0 Q . Do yo u recall w h e t h e r it was in e a r l y 21 1963 or late 1963? 22 A . I haven' t the foggiest recollection o f exactly 23 w h e n it was. The r e a s o n I r e m e m b e r 19 6 3 is b e c a u s e 24 ^ 've used it on c u r r i c u l u m v i t a e s f r o m time to tim e 25 Q. During the period that you were D e p u t y ___________________________ 14933 Harris 29 j 1 Director of D e v e l o p m e n t and were you aware of the 2 a n t i - c r o p program at Fort Detrick, were you also 3 aware of who was w g r k i n q in that a n t i - c r o p p r o g r a m ? 4 A. No. 5 Q. During the period that you served as 6 Deputy Director of Development, did you know Dr. 7 Charles Minarik? 8 A. I b e l i e v e not. I knew M i n a r i k later so it's 9 hard to say e x a c t l y when I met him but I don't think 1 0 'I: knew him at all then. 11 Q. Do you know when you first met or spoke 12 with Dr. Minarik? 13 A. L e t m e c l a r i f y t h i s . 14 | : ; When I was in the R e s e a r c h and 1 5 Engineering Command headquarters, they had 16 c o g n i z a n c e over both Fort D e t r i c k and E d g e w o o d and 17 o ther o r g a n i z a t i o n s , too, and I did go to Fort 18 D e t r i c k in c o n n e c t i o n with the job from time to time. 19 Who I met and e x a c t l y what t r a n s p i r e d at that time, 2 0 I c an't recall now b e c a u s e it became all mixed up 21 with my o p e r a t i o n s with them later in my mind. 2 2 L a t e r on, w h e n I w e n t b a c k to E d g e w o o d 23 s u b s e q u e n t to 1970, I k n e w M i n a r i k w e l l b e c a u s e the 24 a n t i - c r o p p e o p l e b e c a m e p a r t of E d g e w o o d . T h e y w e r e 25 t h e n t e c h n i c a l l y s o m e w h e r e u n d e r me in the ^ Harris 1 division. I 30 Mi 2 ji Q. D u r i n g the p e r i o d th a t y o u ! s e r v e d as j 3 d e p u t y d i r e c t o r of d e v e l o p m e n t , did you ever hear 4 the term Agent Purple? -j 5 A. T h e n n o . ;! 6i Q. W h e n did you f i r s t h e a r t h e : t e r m A g e n t 7 Purple? 8 ! A. W h e n I w e n t to the P e n t a g o n we were! v e r y m u c h 9 more concerned with the herbicide program because 1 0 then V i e t n a m was in full s w i n g .and we g o t p u l l e d 11 into a n s w e r or w r i t e b r i e f s for the s e c r e t a r y 12 w h e n e v e r the W a s h i n g t o n P o s t w o u l d come out with an 1 3 article or whatever. 1 4 Q. W h e n did you go to the P e n t a g o n ? 15 A. 196 6 I w e n t o v e r kin d of on lo a n and was 16 t r a n s f e r r e d o f f i c i a l l y , I t h i n k , about; the f i r s t of 17 F e b r u a r y 1967. I 18 Q. Do you r e c a l l :w h e n you f i r s t . h e a r d of ( 1 9 Agent Purple when you were at the Pentagon? 20 A. Not p a r t i c u l a r l y . i M1 j 21 ij. How long did you r e m a i n at the P e n t a g o n ? 22 A. Until June of 1970. 23 Q. Do you recall when you first heard of 24 Agent Orange? i ;< 25 _A.____A_t__t_h_e__sa_m_e__t_i_me___th_a_t__I__h_ea_r_d__o_f__A_ge1n4t 93Pu5rple, Harris 1 but, a g a i n , I'm not sure. It was c e r t a i n l y -- 31 I j 2 c e r t a i n l y it was w i t h i n m o n t h s of g o i n g to the I 3 Pentagon. i 4 Q. Do you r e c a l l w h e t h e r w h i l e you w e r e 5 D e p u t y D i r e c t o r of D e v e l o p m e n t at E d g ewood you ever 6 heard of Agent Pink or Agent Green? 7 A.: N e v e r h e a r d of them to t h i s day. 8 Q. H a v e you e v e r h e a r d of A g e n t B l u e ? 9 A. Blu e , yes. 10 Q. W h e n did you f i r s t h e a r of A g e n t B l u e ? 11 A. It was in the same time s c a l e , in o t h e r w o r d s , 12 t h e r e was a list of a g e n t s that we had some 1 3 involvement with, the Army had some involvement with, 14 and we, of co u rse, had o v e r s i g h t of the A r m y ' s 15 p r o g r a m . 16 !I 1 i' Q . W h e n you say "we" , are you r e f e r r i n g to -- 17 a .; The o f f i c e in w h i c h I wa s e m p l o y e d a t the t i m e 18 had o v e r s i g h t of the A r m y ' s -- in fact, all o f the 19 s e r v i c e s of the R e s e a r c h a n d D e v e l o m e n t P r o g r a m . ` ; i 20 .j Q. Is this at the P e n t a g o n that y o u ' r e 21 ^ r e f e r r i n g to? 22 A . Yes. 23 ' Q. When you became Dir e c t o r of D e v e l o p m e n t 24 s u p p o r t in 1963, who did you r e p o r t to? 25 A Dr. S i l v e r Harris i|i'!; 32 1 Q. What were the f u n c t i o n s ahdj,. II `1 i 2 r e s p o n s i b i l i t i e s of the Director of D e v e l o p m e n t 3 Suppo r t? j, . 4 A. I had a number of d i v i s i o n s , i n f o r m a t i o n : j! I': 5 divi s i o n , e n g i n e e r i n g divi s i o n , s y s t e m s ;a n a l y s i s j : ;.: II 6 division and test division and the names are 7 essentially indicative of their functions. 8 Q. G e n e r a l l y s p e a k i n g , what did. those 9 divisions do? 1 0 A. Well, the test d i v i s i o n did what t e s ting went 11 on in either h i g h l y s o p h i s t i c a t e d e q u i p m e n t such as 12 Weatherometers and shake, rattle and role on 1 3 material equipment and any open air testing that was 1 4 done at Edgewood. The i n f o r m a t i o n d i v i s i o n ran the 1 5 library and the report review and that; sort of thing, 16 the usual i n f o r m a t i o n matters. S y s t e m s a n a l y s i s 17 d i v i s i o n d e v e l o p e d s ystems a n a l y s i s for e s t i m a t i o n 18 of e f f e c t i v e n e s s of w a r f a r e , e f f e c t i v e n e s s of th r e a t 19 a g e n t s and so on, and the e n g i n e e r i n g d i v i s i o n ran 2 0 the sho ps . 21 Q. As D i r e c t o r of D e v e l o p m e n t S u p p o r t , did 22 you ever have any d e a lings with Dr. M c N a m a r a ? 23 A. Well, I was p r o b a b l y still a m e m b e r of the 24 Human E s t i m a t e s C o m m i t t e e at any rate, the s y s t e m s 25 _a_na_l_y_s_i_s __wo_r_k__w_ou_l_d__h_av_e__be_e_n__i_n_v_olved wit1h4957 :|' | Harris 33 1 ^information cominq from McNamara's shoD. ' ti 2 Q. By the way, who were the other m e m b e r s of 3 the H u m a n E s t i m a t e s C o m m i t t e e in the e a r l y 1 9 6 0 ' s ? 4 A. I t h i n k W i t t e n , I t h i n k J a n d o r f at one time or 5 'another w e r e t h e r e . I t h i n k p r i o r to that, Dr. 6 Summerson, William Summerson. I'm not sure -- 7 Dr. Ludwig S t e r n b e r g e r at one time or another was a 8 member. I'm not real sure. There was continual 9 turnover there like everything else. 10 f| '1 Q. WasDr . Van Sim ever a mem b e r of the 11 H u m a n E s t i m a t e s C o m m i t t e e ? 1 2 'A .' I d o n ' t r e c a l l that he wa s a m e m b e r at the ti m e 13 'I was. 14 ' Q. H o w a b o u t Ed O w e n s ? 15 'A V T h a t ' s a p o s s i b i l i t y but I d o n ' t r e c a l l , 16 i : Q. Howabout -- 17 ;,A :.! It e x i s t e d b e f o r e my t e n u r e and a f t e r my t e n u r e 18 and so -- 19 i Q. How about Milton Christiansen? 20 A. Same c a t e g o r y as O w e n s . T h e y were two of the 21 subo r d i n a t e branch chiefs of McNamara's division and 22 might have spelled for him or actually been there 23 t h e m s e l v e s fro m time to t i m e , but I d o n ' t r e c a l l 24 s p e c i f i c a l l y . 25 Q. W h e n you b e c a m e c h i e f of the s y s t e m s 1.4938 Harris I 34 1 a n a l y s i s d i v i s i o n in 196 5 , who did y o u jt h e n r e p o r t 2 to? ; 3 A . Well, the c i v i l i a n chief of that 'directorate !. i 4 wa s Mr. L o u i s G a r a n o n o w d e c e a s e d and jat one ti m e or 5 another the chief of the division was Colonel Walter 6 Davies. !. I 7 Q. Did W a l t e r D a v i e s s u c c e e d Mr. G a r a n o ? 8 A. No, no, he was the chief. i 9 Q. The m i l i t a r y c h i e f ? 10 A. Yes, m i l i t a r y c h i e f . G a r a n o was a c i v i l i a n 11 d e p u t y c h i e f . G e n e r a l l y s p e a k i n g , the C h e m i c a l 1 2 Corps always operated with a dual team, ^civilian 1 3 m i l i t a r y team. T he m i l i t a r y ma n g a v e the 1 4 o p e r a t i o n a l flavor to things and the c i v i l i a n was 1 5 more technical, more specifically technical and j; I:; 16 p r o v i d e d c o n t i n u i t y . ; !' i 17 Q. W h a t w e r e the d u t i e s and r e s p o n s i b i l i t i e s 1 8 of the chief of systems analysis, chief of the 19 s y s t e m s a n a l y s i s d i v i s i o n ? 20 A. Run the s y s t e m s a n a l y s i s wor k . 21 Q. W h a t is e m b r a c e d by systems: a n a l y s i s w o r k ? 22 A. Wel l , s y s t e m s a n a l y s i s is a t e c h n o l o g y -- a 23 t e c h n i q u e for l o o k i n g at o p e r a t i o n a l p r o b l e m s , 24 a p p l y i n q t e c h n i c a l i n f o r m a t i o n and m a t h e m a t i c a l ____ 1493925 m e t h o d o l o g y to coming up with o p t i m i z a t i o n i , s* . ^ r>/"i IK _a: *: ^ .. J ,, ^ w-i - Harris 35 1 p r o c e d u r e s between courses of action for d e c i s i o n 2 m a k e r s to c h o o s e and m a k e the d e c i s i o n s . 3 Q. D o e s s y s t e m s a n a l y s i s i n v o l v e e n g i n e e r i n g 4 work? 5 A. I At times, m a t h e m a t i c s , and utilizes data from 6 all s o u r c e s , c h e m i c a l , p h y s i c a l , b i o l o g i c a l . 7 Q. As c h i e f of the s y s t e m s a n a l y s i s d i v i s i o n , 8 .did a n y o n e r e p o r t to yo u ? 9 A. The w h o l e d i v i s i o n . T h e r e w e r e 24 of them, I 10 think', at the time. 11 Q. W e r e t h e r e a n y b r a n c h e s w i t h i n the 12 systems analysis division? 13 A. I t h i n k at that m o m e n t b e c a u s e of the s m a l l n e s s 1 4 of the group, there were no branches. 15 Q. Do you k n o w S i g m u n d E c k h a u s ? 1 5 A. Yes 17 Q. As c h i e f of the s y s t e m s a n a l y s i s d i v i s i o n , 1 8 did yo u e v e r wo rk w i t h Mr . E c k h a u s ? 19 A. | No . 20 Q. Do yo u k n o w Me r 1 R i n g e n b e r g ? 21 A . Yes I 14940 2 2 Q. As c h i e f of the s y s t e m s a n a l y s i s d i v i s i o n 23 did yo u ever work with Me r 1 R i n g e n b e r g ? 24 A. ; My d u t i e s did not i n v o l v e the s e p e o p l e . W h e n 25 y ou say wo rk w i t h them, w e all w o r k e d t o g e t h e r , you Harris 36 1 k n ow, in the s a m e l a b o r a t o r y , sa m e o r g a n i z a t i o n , 2 k n e w t h e m . T h e y ' r e b o t h e n g i n e e r s as. am- I and so we ;i 3 w o u l d have t e c h n i c a l d i s c u s s i o n s f r o m t i m e to time 4 or they might even have asked me ques t i o n s , alt h o u g h 5 specifically I think both Eckhaus and Ringenberg had I ii . 6 no s p e c i f i c q u e s t i o n s for s y s t e m s a n a l y s i s d i v i s i o n 7 at the time I was chief. 8 Q. D u r i n g the t i m e p e r i o d th a t yo u s e r v e d as 9 chief of the s y s t e m s a n alysis d i v i s i o n , d o you 1 0 recall wh e t h e r there was any d i s c u s s ion at Edgewood 11 of the p o s s i b i l i t y of e s t a b l i s h i n g a g o v e r n m e n t 1 2 p l a n t to m a n u f a c t u r e A g e n t O r a n g e ? 1 3 A. I do not recall that there was. That was 1 4 outside the p u r v i e w of my interests at the time. I j 15 know there was the Weldon Springs plant subsequently | 16 and b e c a u s e w h e n I got b a c k as t e c h n i c a l d i r e c t o r , 17 we s t i l l had the thi n g and had to g e t -- w e r e t r y i n g 18 t o g e t r i d o f i t . : 19 Q. Had y ou h e a r d of W e l d o n S p r i n g s p r i o r to 2 0 r e t u r n i n g to E d g e w o o d ? 21 A. No, I h a d n ' t h e a r d of W e l d o n S p r i n g s p r i o r to 2 2 g o i n g b a c k to E d g e w o o d . Th a t m u c h is c l e a r . 23 MR. RU S S O : W h i c h was w h e n , D o c t o r , w h e n 2 4 did you qo to b a c k to E d g e w o o d ? 25 THE WITNESS: June of 1970 . : ^4941 Harris 37 1 Q. Now Dr. Harris, you stated that in 19 6 6 2 you left E d g e w o o d and went to the P e n t a g o n ? 3 A . Yes. 4 Q. Do you r e c a l l the m o n t h in 1966 w h e n y o u 5 left? 6 A. I t h i n k it was N o v e m b e r . As I say, I was on 7 loan for them for about three months. I believe I 8 was transferred a p p r o x i m a t e l y the first of February. 9 That w o u l d be in the CV, I'll see th a t it's in the 10 CV. 11 Q. And you w e r e o f f i c i a l l y t r a n s f e r r e d to 1 2 the P e n t a g o n in F e b r u a r y of 1 9 6 7 ? 13 A. Yes. I b e l i e v e t h a t ' s the case. 1 4 Q. D u r i n g the tim e p e r i o d b e t w e e n N o v e m b e r 15 1966 and F e b r u a r y 1967, w h a t w e r e y o u r d u t i e s at the 16 P e n t a g o n ? 17 A.; I was d e p u t y a s s i s t a n t d i r e c t o r , p a r e n t h e s i s 18 c h e m i c a l t e c h n o l o g y end p a r e n t h e s i s . Our d i v i s i o n s 19 w e r e -- or our a r e a s of o v e r s i g h t w e r e m e d i c i n e , 20 m a t e r i a l s and c h e m i c a l w a r f a r e for all of the 21 s e r v i c e s for the w h o l e D e p a r t m e n t of D e f e n s e . 22 THE WITNESS: Before you get into the 23 P e n t a g o n can we take a b r e a k ? 1494224 MR. GORDON: Sure. 25 (Recess) Harris 38 1 BY MR. GORDON: 2 Q. Dr. H a r r i s , a f t e r .F e b r u a r y 1 ,. 19 67 w h e n i- 3 you b e c a m e o f f i c i a l l y t r a n s f e r r e d to the P e n t a g o n , 4 did you c o n t i n u e to h a v e the t i t l e o f j d e p u t y : !' 5 assistant director (chemical technology);? 'i /'!.. 6 A . T h a t is w h e n I had ;the t i t l e , yes. j 1; i j, ; 7 Q. Did you h a v e a t i t l e be f o re j,,Feb r ua r y 1? 8 A. W e l l , I was a c t i n g in t h a t p o s i t i o n , but I w a s 9 still legally an e m p l o y e e of Edgewood Arsenal for 10 t h o s e t h r e e m o n t h s . 11 Q. W ho did y o u r e p o r t to as d e p u t y a s s i s t a n t 12 director chemical technology? 1 3 A. The a s s i s t a n t d i r e c t o r , Mr. Ted H a y w a r d . 1 4 Q. Who did Mr. H a y w a r d r e p o r t to? 15 A. Dr. D o n a l d M c A r t h u r . 1 6 Q. Wa s Dr. M c A r t h u r the d i r e c t o r of c h e m i c a l 17 t e c h n o l o g y? 18 A. No, he was the d e p u t y d i r e c t o r of :r e s e a r c h and 19 e n g i n e e r i n g and his d i v i s i o n was the r e s e a r c h and 20 t e c h n o l o g y d i r e c t o r a t e , as I r e c a l l . T h e D i r e c t o r 21 of R e s e a r c h and E n g i n e e r i n g is a v e r y l o s e and .j 22 r a p i d l y c h a n g i n g o r g a n i z a t i o n so that f r o m time to 23 t i m e p e o p l e c h a n g e , r e s p o n s i b i l i t i e s c h a n g e by - 24 s o m e t i m e s by the m o n t h . 25 Q. Who did Dr. M c A r t h u r r e p o r t to? 14943 Harris 39 1 A . Dr. Foster, the D i r e c t o r of R e s e a r c h and 2 Engineering 3 Q And what was Dr. Foster's title again? 4 A. D i r e c t o r of R e s e a r c h and E n g i n e e r i n g 5 Q Do you know who Dr. Foster reported to? 6 A. S e c r e t a r y of D e f e n s e . When I first went there 7 it was a c a p t a i n by the name of M c N a m a r a 8 Q I bet his first name wasn't Bernard 9 A No 10 MR. RUSSO: He was a d i r e c t o r of what, 11 t e c h n o l o g y , this last one, Dr. M c A r t h u r ? 1 2 MR. GORDON: Director of R esearch and 13 Engineering. 1 4 THE WITNESS: McArthur was deputy 15 dir e c t o r and his area was research and t e chnology. 16 MR. RUSSO: T h ank you. 1 7 Q. And Dr. Fos t e r was D i r e c t o r of R e s e a r c h 18 and E n g i n e e r i n g ? 1 9 A . Yes. 20 Q. How long did you remain as D e p u t y 21 A s s i s t a n t D i r e c t o r of C h e m i c a l T e c h n o l o g y ? 22 A. U n t i l J u n e of 1970. 23 Q. T h r o u g h o u t that period, did you c o n t i n u e 24 to report to Dr. H a y w a r d ? 25 A. Right, Mr. Hayward Harris 40 1 Q . M r . Ha yw a rd . ;: j 2 Wh o r e p o r t e d to y o u as Deputy: A s s i s t a n t 3 Director Chemical Technology? !| 4 A. No one. jI !!' 5 Q. Wh o did you wo r k w i t h -- as! D e p u t y ; i 6 Assistant Director of.Chemical Technology? !' 1 7 A. W e l l , t h e r e w e r e o n l y a :f e w . o f u s i n the o f f i c e . 8 There was a military medical man who first was 9 General Richard Taylor -- Colonel Richard Taylor, 1 0 l a t e r b e c a m e the S u r g e o n G e n e r a l , is n o w d e c e a s e d . 11 L a t e r C o l o n e l R o b e r t Joy. 1 2 There was a materials, I can't remembe r 13 his last nam e , at first , and then we h i r e d a n o t h e r 1 4 m a t e r i a l s man who was a senior of the t w o , M r . J e r r y 1 5 Pe r sh . 16 Q. C o u l d you s p e l l t h a t a g a i n ? 17 A. P - e - r - s - h , Persh, and he wa s the c h e m i c a l 18 w a r f a r e t y p e . T h e r e w e r e o n l y the three! 19 s u b d i v i s i o n s of the o f f i c e . 20 Q. Do you k n o w w h e r e J e r r y P e r s h had w o r k e d 21 p r i o r to g o i n g to -- 22 A. No, I d o n 't. 2 3 Q. -- to the -24 A. I k n e w at the time but I d o n ' t now . 'He's s t i l l 25 at the P e n t a g o n . ,^ /*^ > m . I K ! _ .1 t_ - - -- - ---- Harris 41 1 Q . By the way, w h a t is the n a m e of the 2 o r g a n i z a t i o n a l unit that you w e r e i n as D e p u t y 3 A s s i s t a n t Director of C h emical T e chnology? 4 A'. A s s i s t a n t D i r e c t o r , C h e m i c a l T e c h n o l o g y . 5 Q. Was t h e r e a d i r e c t o r a t e of C h e m i c a l 6 Technology? . 7 |A.i Th e -- I r e i t e r a t e w h a t I sai d b e f o r e , D D R & E 8 :w a s a v e r y r a p i d l y c h a n g i n g , c h a m i l e o n and n e v e r 9 :p u b l i s h e d an o r g a n i z a t i o n a l c h a r t for the r e a s o n 1 0 that as new political a p p o i n t e e s or new hirees would 11 c o m e in, t h e r e w as r e o r g a n i z a t i o n a r o u n d the s k i l l s 12 and b a c k g r o u n d of that i n d i v i d u a l and so it was a 13 ;c o m p l e t e l y d y n a m i c o r g a n i z a t i o n . 1 4 Q. So t h e -- 15 A. So t h e y d i d n ' t ca l l t h e m by d i r e c t o r a t e s , et 16 cetera. It was c a l l e d by the name of the -- of the 17 i'chief -- I m e a n the t i t l e of the c h i e f . 18 u ;; Q. Is the o v e r a l l e n t i t y w i t h i n w h i c h you 19 w e r e D e p u t y A s s i s t a n t D i r e c t o r C h e m i c a l T e c h n o l o g y 20 the D e f e n s e D i r e c t o r a t e of R e s e a r c h and E n g i n e e r i n g ? 21 A .1 D D R & E , righ t . 22 Q. And the D i r e c t o r of D e f e n s e D i r e c t o r a t e 23 of R e s e a r c h and E n g i n e e r i n g was Dr. F o s t e r ? 24 A. R i g h t . And the d i r e c t o r . 1494B 25 Q Do you k n o w w h e r e C o l o n e l R i c h a r d T a y l o r Harris 42 1 had w o r k e d b e f o r e c o m i n g to D D R & E ? 2 A. Well, he was a m i l i t a r y M e d i c a l Corps o f f i c e r . 3 I am u n f a m i l i a r w i t h the d e t a i l s of his; .career up to 4 that point. At the time we were more of less 5 personal friends. 6 Q. Do you k n o w w h e n d o c t o r -- do you k n o w . 7 when Colonel Taylor was.succeeded by Colonel Joy? 8 A. T a y l o r go t p r o m o t e d to B r i g a d i r e ;G e n e r a l and 9 was sent to V i e t n a m as -- on the staff: of M A C V . It 10 s e e m s to me that it wa s p r o b a b l y in e a r l y 196 8 or 11 t h e r e a b o u t s . I had a h e a r t p r o b l e m in: l a t e -- 1 2 m i d d l e 1968 and at that time Joy was there. T h a t ' s 1 3 the o n l y w a y I c o u l d p i n p o i n t it rig h t now. 14 Q. Do you r e c a l l w h e r e C o l o n e l J o y had b e e n 1 5 s t a t i o n e d p r i o r to c o m i n g to D D R & E ? 16 A. No. N o b o d y cnn k e e p up w i t h t h e s e . m i l i t a r y 1 7 people's p a r a g o n a t i o n s unless he has a check l i s t . 18 M A J O R PAR R : T h e y c a n ' t e v e n k e e p up w i t h 19 tlisir o w n . 20 THE W I T N E S S : T h a t j u s t w a s n ' t of a n y 21 i n t e r e s t to me so I d o n ' t b e l i e v e I eve r e v e n a s k e d 22 him. 23 Q. D u r i n g y o u r t e n u r e in D D R & E , did you h a v e 24 a n y d e a l i n g s w i t h p e r s o n n e l at E d g e w o o d ? 25 A. O n l y r e a l l y i n f o r m a l o n e s . 1 4 9 4*"* Harris 43 1 If I n e e d e d t e c h n i c a l i n f o r m a t i o n , I had 2 no o b j e c t i o n to c a l l i n g them on the p h o n e and a s k i n g 3 t h e m a t e c h n i c a l q u e s t i o n or i n d i c a t i n g to t h e m that 4 I was putting a formal request through channels and 5 they could get s t a r t e d on it, but my formal c h a n n e l 6 was to ask the A r m y in the P e n t a g o n . 7 Q. Was t h e r e any D D R & E r e p r e s e n t a t i v e or 8 liaison officer stationed at Edgewood? 9 A . No . 10 i Q . Wa s t h e r e a n y o n e at E d g e w o o d who was 11 c h a r g e d w i t h the r e s p o n s i b i l i t y for r e p o r t i n g in 12 s o m e m a n n e r to D D R & E ? 13 A .1 No, no-- O n l y t h r o u g h c h a n n e l s . 1 4 'i Q. Now, yo u t e s t i f i e d e a r l i e r thi s m o r n i n g 15 t h a t yo u f i r s t h e a r d of A g e n t P u r p l e and A g e n t '!I : i! ' ; 16 Orange in c o n n e c t i o n w i t h y o u r d u t i e s at the 17 P e n t a g o n . 18 A .; Y e s . 19 ! i Q. C o u l d you d e s c r i b e to the b e s t of y o u r 20 r e c o l l e c t i o n the c i r c u m s t a n c e s u n d e r w h i c h yo u f i r s t 21 h e a r d of A g e n t O r a n g e or A g e n t P u r p l e . 22 A. I c a n ' t r e c a l l . 23 Q. Can you -- w h a t is the f i r s t r e c o l l e c t i o n 24 y o u h a v e of wo r k that you p e r f o r m e d c o n n e c t e d w i t h 25 A g e n t O r a n q e or A g e n t P u r p l e ? 14948 Harris 44 1 MR. RUSSO: I don't think there's been ; IiI : 2 any t e s t i m o n y that t h e r e has, has there!? = :i |:; 3 MR. G O R D O N : Yes, t h e r e has.!:; , t l:; i ` 4 A. Wel l , I h a v e to p r e f a c e this by .indicating that 5 Mr. Hayward had p r e v i o u s l y been employed at Fort !I 6 D e t r i c k and so, g e n e r a l l y s p e a k i n g , w a s ;m o r e the 1 if ' 7 b i o l o g i c a l .expert i n : o u r o f f i c e . My job' w i t h r e g a r d 8 to the o f f i c e in the b i o l o g i c a l fie.ld; w a s m o n i t o r i n g i' j 9 t h e i r b u d g e t and tha t s o r t of t h i n g , so! in 10 c o n n e c t i o n w i t h t h e i r b u d g e t , I read s o m e of the 11 i n f o r m a t i o n that c a m e t h r o u g h on w h a t t h e y w e r e 12 doing. i j. 1 3 Then subsequently, when the herbicide 1 4 c o n t r o v e r s y a b o u t its use in V i e t n a m was rais e d by 1 5 e n v i r o n m e n t a l i s t s , I - - f r o m time to t i m e -- w r o t e a 1 6 p a per in r e s p o n s e to s o m e t h i n g that w o u l d c o m e out 17 in the p r e s s for i n f o r m a t i o n to the s e c r e t a r y or to 18 J o h n n y F o s t e r as the c a s e m a y be and so! in t h a t 19 c o n t e x t , I b e c a m e a w a r e of the v a r i o u s and s u n d r y 20 h e r b i c i d e a g e n t s , and t h a t ' s w h y it's h a z y now. It 21 w o u l d d e p e n d on w h e n the f i r s t p a p e r hi t the p r e s s 2 2 jr s o m e t h i n g . 23 Q. To the b e s t of y o u r r e c o l l e c t i o n , w h e n 24 wa s the f i r s t o c c a s i o n on w h i c h you w e r e a s s i g n e d to 25 p r e p a r e a p a p e r c o n c e r n i n g c o n c e r n s r a i s e d by . i Harris 45 1 e n v i r o n m e n t a l i s t s as to the use of Ag ent O r a n g e or 2 A g e n t p u r p l e in V i e t n a m ? 3 A .1 It was p r o b a b l y s o m e t i m e w i t h i n s e v e r a l m o n t h s 4 of' g o i n g t h e r e in F e b r u a r y of 1967 but I d o n ' t 5 recall specifically. 6 Q. W h a t w e r e the c o n c e r n s t h a t w e r e r a i s e d 7 by the e n v i r o n m e n t a l i s t s c o n c e r n i n g the use of A g ent 8 O r a n g e or A g e n t P u r p l e in V i e t n a m ? 9 MR. R U S S O : O b j e c t i o n to this. H e a r s a y , 10 o b j e c t i o n to the form. D o c t o r , I h a v e no c o n t r o l . 11 I h a v e to put t h i s d o w n on the r e c o r d . 12 M A J O R PARR: Go a h e a d and a n s w e r the 13 q u e s t i o n , D o c t o r . 14 A. W e ll, n o w ' t e l l me -- say a g a i n w h a t the 1 5 q u e s t i o n is. 1 6 MR. GORDON: Would the reporter read the 17 question back. 18 (The r e c o r d is read) 19 A. G e n e r a l l y s p e a k i n g , t h e y w e r e o b j e c t i n g to use 20 of h e r b i c i d e s b e c a u s e in s o m e c a s e s t h e y w o u l d kill 21 the t r e e s or ki l l the v e g e t a t i o n and no t j u s t 22 d e f o l i a t e it. It was used b a s i c a l l y , h o w e v e r , for 23 d e f o l i a t i o n to r e d u c e the a m b u s h and o p e n and c l e a r 24 f i e l d s of f i r e , et c e t e r a . 149 50 25 Q. Do y o u r e c a l l w h e t h e r t h e r e w e r e any Harris 46 1 c o n c e r n s r a i s e d by e n v i r o n m e n t a l i s t s : a s to p o s s i b l e 2 h e a l t h e f f e c t s on a n i m a l s or h u m a n s ? ii ; 3 A. I d o n ' t recall any such. I: \ i 4 Q. Do y ou r e c a l l a n y e n v i r o n m e n t a l -- s t r i k e 5 that. 6 Do you remember the names of any of the 7 e n v i r o n m e n t a l i s t s w h e t h e r i n d i v i d u a l s or; 1: 8 organizations which were raising the concerns? 9 A. W e l l , one n a m e p r o m i n e n t in b u s i n e s s , of c o u r s e , 10 w as M a t t h e w M e s e l s o n , Dr. M e s e l son of H a r v a r d who 11 has b e e n c r i t i c a l b o t h of the c h e m i c a l w a r f a r e and 1 2 the h e r b i c i d e b u s i n e s s over the years and he had 13 o t h e r a s s o c i a t e s . I o n l y r e m e m b e r thej first name of 14 one of t h e m t h a t he w e n t to V i e t n a m w i t h to look at 15 a r e a s that had b e e n d e f o l i a t e d . ii. !: I 16 Q. W h a t wa s th a t p e r s o n s ' s f i r s t n a m e ? 17 A. Fred s o m e b o d y or o t h e r . It was a | p r o f e s s o r of 18 s o m e s m a l l c o l l e g e . 19 Q. Do you r e c a l l w h e t h e r Arthur: W e s t i n g s ' 20 n a m e c a m e up in c o n n e c t i o n w i t h an y of ;the c o n c e r n s 21 tha t w e r e r a i s e d o 2 2 A . W e s t i n g s -- y o u .lenow, that m i g h t e v e n be the 23 g u y . W e s t i n g s , I m a y have c o n f u s e d the n a m e w i t h 24 Fr e d 1495125 Q. H ow were you i n f o r m e d of the c o n c e r n s - t i : _ _ i * Harris 47 1 that were being raised by the environmentalists 2 a b o u t the use of O r a n g e and P u r p l e in V i e t n a m ? 3 A .1 I d o n ' t r e c a l l . Let me i n d i c a t e this wa s an 4 e x t r e m e l y small p e r c e n t a g e of my duties. My d u t i e s 5 basically were the chemical warfare business. 6 Q. W e l l , h o w did yo u r e c e i v e y^ u r ' a s s i g n m e n t 7 concerning the concerns that were being raised by 8 the environmentalists? 9 A. Ted w o u l d say, Ben, w o u l d you w r i t e a p a p e r on 10 so and so, w h a t e v e r it h a p p e n e d to be. 11 Q. And t h e s e p a p e r s t h a t you w r o t e w e r e 12 b a s i c a l l y in r e b u t t a l to the p a p e r s that had b e e n 1 3 published by the environmentalists? 1 4 !A. No, t h e y w o u l d be to e l u c i d a t e w h a t the p r o b l e m 15 was and w h a t the fac t s w e r e as the case may be. 16 Q. Wh o r e c e i v e d t h e s e p a p e r s th a t you 17 prepared? 18 A . : W e l l , I'd g i v e t h e m to Ted and t h e y w o u l d go on 1 9 !up; the c h a i n . S o m e t i m e s t h e y w o u l d go to J o h n n y and 20 s o m e t i m e s v e r y l i k e l y w o u l d go to the s e c r e t a r y or 21 p o s s i b l y it w o u l d go to the s e c r e t a r y , d e p e n d i n g on 22 if he r a i s e d a q u e s t i o n or not. 23 MR. T Y R R E L L : J u s t so th a t the r e c o r d is 24 c l e a r , m a y I s u g g e s t , w h e n you r e f e r to t h e s e 25 i n d i v i d u a l s you use the i r las t n a m e s . It w i 1 1^ ^ Harris 48 1 h a r d e r for us to go b a c k if you use s u c h w o r d s as i: ! . 2 Jo h n n y and u n derstand who you're referring to. 3 THE WITNESS: Foster. |` ,1 4 MR. GORDON: , Thank you. j i 5 MAJOR PARR: : Before we go further, could 6 I talk to the w i t n e s s off the r e c o r d ; for j u s t a j 7 second. M j. 8 (There is a d i s c u s s i o n of f the record) 9 Q. Dr. H a r r i s , do yo u h a v e c o p i e s of a n y of 10 the p a p e r s t h a t y o u ' v e p r e p a r e d a m o n g y o u r p e r s o n a l 11 f i l e s tha t you r e f e r r e d to at the b e g i n n i n g of y o u r 12 d e p o s i t i o n ? 1 3 A. No . ; ! 1 4 Q. Do you k n o w w h e r e a ny of t h o s e p a p e r s 15 t h a t you p r e p a r e d are n o w l o c a t e d ? 16 A. W e l l , I'm not su r e t h a t t h e y e x i s t . I n o t su r e 17 t h a t t h e r e is m o r e than, y o u kno w , a c o u p l e , and 18 t h e y w o u l d be on the t e c h n i c a l m a t t e r s only, f a c t : I 19 s h e e t . k i n d of t h i n g , and I d i d n ' t h a v e ;a n y 20 i n v o l v e m e n t w i t h any p o l i c y in t h a t are a . 21 Q. To the b e s t of y o u r r e c o l l e c t i o n , h o w 22 m a n y p a p e r s did you, in fac t , p r e p a r e c o n c e r n i n g the 23 c o n c e r n s raised by the e n v i r o n m e n t a l i s t s ? 24 A. V e r y f e w . 25 Q. Is that a b o u t t h r e e or f o u r ? 14953 _ ,1! Harris 49 1 A. W e ll, p r o b a b l y not that, couple. 2 Q. Two or t h r e e ? 3 A.: Two or t h r e e , yes. 4 Q. Do you h a v e a s p e c i f i c r e c o l l e c t i o n of 5 the title of any of those papers that you p r e p a r e d ? 6 A . No 7 Q. W h a t is y o u r b e s t r e c o l l e c t i o n of the 8 date o n which any of those papers were prepared? 9 A . I can't recal1 . 1 0 Q. W o u l d it be in 1 9 6 7 ? 11 A . T h a t ' s w h a t I c a n ' t r e c a l l . W h e t h e r it was in 1 2 1967 o r in 1968 or w h a t or 1969 as the case m a y b e . 13 Q. W e r e you the o n l y a u t h o r of t h e s e p a p e r s 1 4 or were there c o - a u t h o r s ? 15 .A . I d o n ' t k n o w h o w t h e y m i g h t h a v e e n d e d up iI' : 16 'fin a l l y . W h a t e v e r I t u r n e d in was o n l y m i n e . 17 Q. Did you eve r see any of t h e s e p a p e r s t h a t 18 you t u r n e d in in a f i n a l f o r m ? 19 A . No. if 20 : Q. What was the format of -- were these 21 p a p e r s t h a t you p r e p a r e d , by that I m e a n w e r e t h e y 22 in t e r m s of m e m o r a n d u m to Mr. H a y w a r d or m e m o r a n d u m 23 to the D i r e c t o r of D D R & E ? 1495424 A. P r o b a b l y not, p r o b a b l y just tit l e d fact s h eet 25 or s o m e suc h t i t l e as that. Harris 50 1 Q. Were there any a d d r e s s e e s on .these fact 2 sheets that you prepared that you believe you 3 prepared? ;i :: j j' i'' 4 A. I would think not. Now, c e r t a i n l y jin the M | 5 course of my duties with- the,chemical warfare 6 b u s i n e s s , from time to time, I p r e p a r e d m e m o r a n d u m 7 for the Director of Resea rch and Engineering, let's a say, on a d e c i s i o n paper, for saying to: the Army, yes, 9 you can do this te s t i n g or, no, you may not or l o w h a t e v e r it h a p p e n s to be, but this had noth i n g to 11 do with h e r b i c i d e s in any case. 1 2 I d o n ' t recall ever having a n y t h i n g to do 13 with any -- and v e r y little to do at all with the 14 herbicide questions. 15 Q. Do you recall w h e t h e r the c o p i e s of these - 16 do you recall w h e t h e r copies of these fact sheets 17 that you p r e p a r e d were kept in your w o r k i n g files at 18 thePentagon? j 19 A. They m i g h t ve r y -- the c h a n c e s are. that they 20 would b e . 21 Q. Do you k n o w what h a p p e n e d to your 22 P e n t a g o n files after you r e t u r n e d to E d g e w o o d in 23 1 9 7 0 ? 24 A. Yes, I left them there. 25 Q. Do you know where those files are n o w ~ ^ ^ I! Harris 51 1 located? 2 A . I haven't the foggiest. 3 MR. GORDON: Major Parr, at this time 1 4 request that the g overnment search available files 5 for any copies of fact sheets or similar documents 6 that were prepared by Dr. Harris during his tenure 7 at D D R & E w h i c h c o n c e r n the use of h e r b i c i d e s in 8 Vie tnam . 9| M A J O R PAR R : I a s s u m e y o u ' r e g o i n g to 10 f o l l o w i n g it up in w r i t i n g ? 11 MR. G O R D O N : Yes, we will. 12 BY MR. G O R D O N : 13 Q. Dr. H a r r i s , a s i d e f r o m t h e s e fact s h e e t s 1 4 that you prepared concerning concerns that had been 15 raised by the environmentalists, what other 16 i n v o l v e m e n t did you h a v e w i t h h e r b i c i d e s w h i l e you 17 w e r e in D D R & E ? 18 A. W e l l , the o n l y one tha t I c an c l e a r l y r e c a l l 19 was at o n e -- wa s one d a y Ted s a i d to me -- 20 M A J O R PARR: La s t n a m e s p l e a s e , D o c t o r . 21 A. T h a n k you . Mr. H a y w a r d s a i d to me, w o u l d you 22 g o o v e r to the N a t i o n a l C a n c e r I n s t i t u t e on the 23 o t h e r s i d e of W a s h i n g t o n and pic k up a r e p o r t t h e r e , 24 and he g a v e me the nam e of the c h a p to c o n t a c t , and 25 I d o n ' t r e c a l l that nam e , w h i c h r e p o r t was theJ _ 4 9 5 S Harris 52 1 results of a B i onetics study on herbicides on 2 a n i m a l s , and I did so and g a v e it to him. He was 3 i n t e r e s t e d in it. T h a t !s the o n l y thi n g th a t I 4 r e c a l l v e r y c l e a r l y tha t I did tha t h a d ::h e r b i c i d e 5 labeledonit. 6 Q. Do you r e c a l l w h e n Mr. H a y w a r d r e q u e s t e d 7 that you go to the N a t i o n a l C a n c e r I n s t i t u t e and 8 pick up the Bion e t i c s study? 9 A. N o , n o . nI 10 Q. W h a t is y o u r b e s t r e c o l l e c t i o n of w h e n 11 you w e r e r e q u e s t e d by Mr. H a y w a r d to do t h a t ? 12 A. B e t w e e n 1967 and 1970. I d o n ' t recall 13 p r e c i s e l y w h e n this was. As I said b e f o r e , this is 14 a v e r y m i n o r p a r t of m y d u t i e s . In fact, h e r e I w a s 1 5 only running an errand., * i .:I. :1i 16 Q. Did you r e v i e w the B i o n e t i c s ; s t u d y a f t e r 17 y ou had p i c k e d it up for Mr. H a y w a r d ? ; 18 A . I c e r t a i n l y read it at on e tim e or; a n o t h e r but 19 I d o n ' t r e m e m b e r wha t it sa i d . :; ; 20 Q. Do you r e m e m b e r w h e n you read it? 21 A . No 22 y Do yo u r e m e m b e r -- 23 A. T h a t w o u l d p i n p o i n t w h e n I g o t it w h i c h I c a n ' t 24 do. 25 Q. Do you r e m e m b e r a t t e n d i n g a m e e t i n g at Harris 53 1 A C S F O R with r e p r e s e n t a t i v e s of Dow C h e m i c a l ? 2 A. Yes, yes, I do recall that. 3 Q. Do you r e c a l l in r e l a t i o n to t h a t m e e t i n g 4 w h e n you w e r e a s k e d by Mr. H a y w a r d to pick up the 5 results of the Bionetics study? 6 A .; W e l l , t h a t m e e t i n g , I t h i n k , wa s in e a t 1 y 1 9 7 0 . 7 T h i s is -- I d o n ' t r e m e m b e r it of m y o w n k n o w l e d g e . 8 I b e l i e v e I read it in h e r e , and it p r o b a b l y w a s n ' t 9 too very long before that. 10 Q . W o u l d it h e l p to r e f r e s h your 11 r e c o l l e c t i o n if I m a r k e d for I d e n t i f i c a t i o n a c o n e 1 2 of a memo of that m e e t i n g that was p r e p a r e d by Dr. 1 3 J a n d o r f , D o c t o r M c N a m a r a and Mr. Is that so of 1 4 Edg ewood ? 15 A. Yes. It w o n ' t h e l p me to r e m e m b e r w h e n I 16 p i c k e d up tha t r e p o r t , show, b e c a u s e I t r i e d to 17 r e m e m b e r that. 18 Q. But it w o u l d h e l p to -- but w i l l it h e l p 19 to fir m up the d a t e of t h a t m e e t i n g in y o u r 20 r e c o l l e c t i o n ? 21 A. It wil l f i r m that m e e t i n g d a t e , yes. 1495-8 22 i MR. GORDON: Miss Reporter, would you 23 please mark as Harris E x h i b i t 1 a M a r c h 11, 1970 24 m e m o r a n d u m to d i r e c t o r of R e s e a r c h L a b o r a t o r i e s from 25 B e r n a r d M c N a m a r a , Bern a r d J a n d o r f and Samuel Sass Harris 54 1 and 16 p a ges of a t t a c h m e n t s . '; 2 M A J O R PARR:: You w a n t to m a r k o n e .that he li 3 reviewed last night? 4 THE WITNESS : Yes . M |: 1' ji. j . 5 MR. GORDON: Yes, that's fine. 6 ( E x h i b i t H a r r i s -1 is m a r k e d ;for 7 Identification) ii 8 Q. Dr. H a r r i s , w h e n you say it w a s n ' t too 9 very long -- strike that. 10 First question. Dr. Harris, does the 11 d o c u m e n t tha t ha s n o w b e e n m a r k e d as; E x h i b i t 1 12 refresh your recollection that the meeting with 1 3 r e p r e s e n t a t i v e s of Dow at A C S F O R D occurred on 14 M a r c h 6 , 1 9 7 0 ? ;: 1 5 A. Yes. 1 6 Q. Now , w h e n you sa y t h a t it w a s n ' t too lo n g 17 b e f o r e t h a t m e e t i n g that Mr. H a y w a r d r e q u e s t e d you 18 to p i c k up the c o p y of the B i o n e t i c s , s t u d y f r o m the i 19 N a t i o n a l C a n c e r I n s t i t u t e , a b o u t h o w 'long is not too 20 l o n g ? ii 21 A. I h a v e no r e a s o n to m a k e any a s s e s s m e n t of w h e n 22 it was, w h e t h e r b e f o r e or a f t e r . It s e e m e d l o g i c a l 23 w h e n I m a d e that c o m m e n t a m o m e n t ago that it m i g h t 24 h a v e b e e n b e f o r e but I d o n ' t r e c a l l tha t it w a s . It 25 c e r t a i n l y w a s n ' t v e r y long a f t e r b e c a u s e I l e f t _______________________ 14958________ - I V N * - t t 1 * t` Harris 55 1 D D R & E in J u n e of 197 0 , and so I r e a l l y h o n e s t l y 2 c a n n o t recall when I p i c k e d that report up. 3 Q. Let me try to r e f r e s h your r e c o l l e c t i o n . 4 Do yo u recall h a v i n g h e a r d of the B i o n e t i c s s t u d y 5 b e f o r e you a t t e n d e d the m e e t i n g at Dow -- the 6 meeting with Dow representatives? 7 A. No, I d o n ' t r e call. I do not tecall when I 8 h e a r d it, b e f o r e , a f t e r or d u r i n g . 9 Q. Do you r e c a l l h a v i n g read the B i o n e t i c s 10 r e p o r t b e f o r e yo u r m e e t i n g -- 11 A. I r e c a l l that I p r o b a b l y read it b e c a u s e it 12 w o u l d h a v e b e e n l o g i c a l to h a v e d o n e so. I do not 13 r e m e m b e r the s u b s t a n c e o f the r e p o r t and so I m i g h t 14 or m i g h t not have read it . 15 piji-'Pjih Q .- 1 B y ' the w a y , !do yo u k n o w w h e r e Mr . Ha ywa rd 16 isi n o w l o c a t e d ? 17 A . He' s r e t i r e d and r e s i d e s in B r a d d o c k H e i g h t s , 18 M a r y l a n d 19 Q . Do you k n o w w h e n he r e t i r e d ? 20 A. I b e l i e v e he r e t i r e d in - - w i t h i n two or t h r e e 21 y ears of my l e a ving the P e n t a g o n , s h o r t l y after I 2 2 left the Pentagon. 23 Q. Did you have any d i s c u s s i o n s with Mr. 24 H a y w a r d or an y o n e else c o n c e r n i n g Agent Or a n g e prior 2 5 to your a t t e n d a n c e at the m e e t i n g with Dow i49f$n Harris ! 56 1 r e p r e s e n t a t i v e s a s i d e from the work that; you've 1 2 a l r e a d y d e s c r i b e d .concerning .the fact ,sheets? 3 A. I d o n ' t recall s p e c i f i c c o m m e n t s ori d i s c u s s i o n s ; ii ; i i 4 with anybody on Agent Orange. My concern in.the 5 fact sheets that I m e n t i o n e d , b e f o r e , Ii was c o n c e r n e d i' I;: 6 with the use of h e r b i c i d e s per se to d e f o l i a t e and 7 the p r o l e p t i c s involving^ the:-j u s t i f i c a t i o n ;of :their !I 8 use to reduce a m b u s h e s and that sort of ,thing as a 9 t r a d e o f f to the e n v i r o n m e n t a l damage, not having 10 a n y t h i n g to do with the s p e c i f i c c o m p o u n d . I d o n ' t 11 re m e m b e r ever w r i t i n g much of a n y t h i n g -- I m i g h t 1 2 have m e n t i o n e d some h e r b i c i d e name but, it was not -- 13 that was not the s u b s t a n c e of what I was c o n c e r n e d 14 w i t h . 15 Q. Well, Dr. Harris, my q u e s t i o n , w a s 16 d i r e c t e d more t o w a r d s trying to find out w h e t h e r you 17 had any d i s c u s s i o n s w i t h . M r . H a y w a r d or any o n e else 1 8 at the Pentagon concerning the m e e t i n g ; w i t h Dow 19 r e p r e s e n t a t i v e s in a d v a n c e of that m e e t i n g . 2 0 A- Well I c e r t a i n l y don't r e m e m b e r . I wish I 21 could be of more help than that. 22 M A J O R PARR: With regard to the a n s w e r to 2 3 the p r e v i o u s q u e s t i o n , would you like to w i t h d r a w 24 your request for p r o d u c t i o n of those fact sheets now 25 since he t e s t i f i e d that he d i d n ' t refer to A gent > / ^ r* *->. - . . 1 1 ; ii Harris 57 1 O r a n g e in p a r t i c u l a r or any h e r b i c i d e in p a r t i c u l a r ? 2 MR. G O R D O N : No, I think. I'd like to see 3 the f a c t s h e e t s to v e r i f y the t e s t i m o n y . 4 Q. Dr. H a r r i s , do yo u k n o w who s c h e d u l e d the 5 m e e t i n g at A C S F O R D in M a r c h 19 -- 6 A. I a s s u m e t h e y did. It was their m e e t i n g . 7 Q. By " t h e y " y ou m e a n A S C F O R ? 8 A . Yes . 9 Q. W h a t d o e s A S C F O R D s t a n d for? 10 A. A s s i s t a n t c h i e f of s t a f f of F o r c e D e v e l o p m e n t . 11 Q. Who was the A s s i s t a n t C h i e f of S t a f f of 1 2 F o r c e D e v e l o p m e n t in 1 9 7 0 ? 13 A. I d o n ' t kno w . G e n e r a l S t o n e was the c h i e f of 14 the s u b d i v i s i o n of w h i c h had to do w i t h the c h e m i c a l 15 p r o g r a m and the h e r b i c i d e p r o g r a m and so on, but who 1 6 was the a s s i s t a n t chief of staff himself, l i e u t e n a n t 17 g e n e r a l s o m e b o d y or o t h e r , I d o n ' t know. 18 ! : Q. How did y ou find ou t that the M a r c h 1970 19 m e e t i n g had b e e n s c h e d u l e d ? 20 A. S o m e b o d y in A r m y c a l l e d me, s o m e b o d y in A S C F O R D 21 c a l l e d me. 22 1 Q. Do you r e c a l l who c a l l e d you in from 23 A S C F O R D ? 14962 24 A.: No. The t u r n o v e r t h e r e is as bad as it is 25 a n y w h e r e for the m i l i t a r y and so from time to t i m e Harris 58 1 I do r e m e m b e r o n l y .that S t o n e was t h e r e and I o n l y 2 remember that because it's on this paper. 3 Q. Did t h a t p e r s o n in A S C F O R D who c a l l e d you Il 4 r e q u e s t tha t you a t t e n d the m e e t i n g --j. 5 A . I can make a presupposition but;i! don't 6 remember who called me. 7 Q. Do you r e c a l l w h e t h e r M r . ` H a y w a r d p e r h a p s 8 requested that you attend the meeting?; 9 A. No, I d o n ' t re c a l l who did. 1 0 Q. Do yo u r e c a l l h a v i n g a n y d i s c u s s i o n s w i t h 11 Mr. Hayward about the meeting after you learned of 1 2 the mee t ing ? 1 3 A. C e r t a i n l y I w o u l d h a v e reported; b a c k to him 14 whatwenton. 15 Q. Do you h a v e a s p e c i f i c r e c o l l e c t i o n of : j' j:' 16 h a v i n g a t t e n d e d t h a t m e e t i n g ? 17 A. Yes, that I do h a v e . 1 8 Q. F o l l o w i n g the m e e t i n g , d i d y o u p r e p a r e a 19 m e m o r a n d u m for Mr. H a y w a r d or a n y o n e e l s e d e s c r i b i n g 20 t h e m e e t i n g ? 21 A. It was not our h a b i t to p r e p a r e a m e m o r a n d u m of 2 2 t h a t sort, so I w o u l d g u e s s that I d i d not. I d o n ' t 23 r e m e m b e r , t h o u g h . 24 Q. Did you cake any n o t e s of the m e e t i n g ? 2 5 A _. ___I__ha_v_e__t_o__an_s_w_e_r__it__t_h_e__s_am_e__w_a_y.___I14d9o6n'3t know t N *1.' > i d s -- ! I > - . \_ ... . i l . .1 ... Harris 1 if I di d . I m i g h t h a v e , It w o u l d h a v e b e e n 59 i 2 possible certainly. 3 Q. Do you r e c a l l r e p o r t i n g on the m e e t i n g to 4 a n y o n e at DDP.&E? 5 A. Y o u m e a n o t h e r tha n Ha ywa rd ? 6 j jj . Q . Do you r e c a l l r e p o r t i n g to Mr. H a y w a r d on 7 the meeting? 8 A. No. But I'm sure I would have. 9 Q. Do yo u r e c a l l r e p o r t i n g to a n y o n e e l s e -- 1 0 A. No, that I p r o b a b l y did not. 11 '' M R . G O R D O N : Major Parr, at this time I 12 request that the g o v e r n m e n t search Pentagon and 13 o t h e r a v a i l a b l e f i l e s for a ny d o c u m e n t s r e l a t i n g to 1 4 the March 1970 meeting with r e p r e s e n t a t i v e s of Dow 15 at A C S F O R D i n c l u d i n g a n y m e m o r a n d a or n o t e s or o t h e r 16 d o c u m e n t s p r e p a r e d by Dr. H a r r i s c o n c e r n i n g th a t 17 m e e t i n g . 18 M A J O R P A R R : To be f o l l o w e d in w r i t i n g ? 1 9 MR. GORDON: Yes, I will follow this up 20 in the l e t t e r . As yo u k n o w , M a j o r P a r r , it is my 21 p o s i t i o n that we are not r e q u i r e d by a n y o u t s t a n d i n g 22 o r d e r to do that but as a m a t t e r of c o u r t e s y we h a v e 23 b e e n d o i n g that in the p a s t and I will do it in th i s 24 c a s e a l s o . 14964 25 M A J O R PARR: We are r e l y i n q on y o u r p a s t Harris 60 1 p e r f o r m a n c e , a s t a n d a r d of co n d u c t upon which we are 2 relying . : i: i |j.,j . 3 (Discussion off the r e c o r d ) ! 4 BY MR. G O R D O N : i, i 5 Q. Dr. H a r r i s , w h a t h a p p e n e d at .the M a r c h 6 1970 meeting? 7 A. I b e l i e v e it w as b a s i c a l l y a b r i e f i n g m e e t i n g 8 for General Stone where the Dow people presented 9 some i n f o r m a t i o n and all I k n o w r i g h t n o w is w h a t I 10 read here on a piece of paper. 11 Q. R e f e r r i n g you to the s e c o n d page of 1 2 E xhibit 1 w h ich lists the a t t e n d e e s at the m e e t i n g , 13 do you r e c a l l w h e t h e r t h e r e was a n y o n e in a t t e n d a n c e 1 4 at that m e e t i n g who was not listed on that page? 15 A. I do not so r e c a l l . 1 6 I n c i d e n t a l l y , D a r r o w d o e s n ' t h a v e .an N on it. 17 Q. R e f e r r i n g you to the u p p e r l e f t - h a n d 18 c o r n e r of P a g e 1 of E x h i b i t 1, t h e r e are ;the 19 i n i t i a l s S M U E A - R M T . Do you k n o w w h a t t h o s e i n i t i a l s 20 s t a nd fo r ? ; 21 A. Yes, t h a t ' s M u n i t i o n s C o m m a n d E d g e w o o d A r s e n a l , 2 2 R e s e a r c h D i v i s i o n . MT is p r o b a b l y the |branch w i t h i n 23 t h e r e s e a r c h d i v i s ion. !i 24 Q. As of M a rch 11, 1970 who was the d i r e c t o r 25 of R e s e a r c h L a b o r a t o r i e s ? 14965 . . . ! *-**- If * _i:r; ,, . i i i _ _i . * -- - - 1 - Harris 61 1 A. On, yes, that would h a v e been S i l v e r . He was 2 still there when I went there. 3 Q. Was Dr. S i l v e r the p e r s o n you r e p l a c e d 4 when you went to the R e s e a r c h L a b o r a t o r i e s ? 5 A.! Oh, no, he w as a s u b o r d i n a t e of m i n e . 6 A.| He wa s a R e s e a r c h L a b o r a t o r y d i r e c t o r , I wa s 7 the techn i c a l d i r e c t o r of the entire place. 8 ! : Q . I see . 91 Was Dr; Silver still d i rector of Research 10 L a b o r a t o r i e s when you became techn i c a l d i r e c t o r at 11 Edg e w o o d ? 12 A . Yes, y e s . 1 3 Q. You s t a t e d p r e v i o u s l y th a t G e n e r a l S t o n e 1 4 was in A C S F O R D in a p a r t i c u l a r unit. W h a t was the 15 ' n a m e of the u n i t ; in w h i c h G e n e r a l S t o n e was l o c a t e d ? 16 Ai' W e l l , the A r m y b e i n g w h a t it is, I'm sure t h e y 17 had a n a m e but I ' d o n ' t k n o w w h a t it was. 18 Q. W h a t was G e n e r a l S t o n e ' s u n i t in c h a r g e 19 of? 20 A . : C e r t a i n l y the c h e m i c a l w a r f a r e and c h e m i c a l 21 b i o l o g i c a l d e f e n s e a r e a of the A r m y ' s w o r k and I 2 2 :b e l i e v e that w o u l d i n c l u d e the s t aff r e s p o n s i b i l i t y 23 a t 'the A r m y h e a d q u a r t e r s l e v e l of all p h a s e s of th a t 24 work- 14966 7 5 ' Q. D u r i n g the p e r i o d that you w e r e at D D R & E , Harris !- j 1 did you have any dealings with Generali Stone? 62 2 A. Y e s , s u r e . hi 3 Q. W h a t was the s u b j e c t of those; d e a l i n g s ? i 4 A. W e l l , as I say, t h e y w e r e concernied w i t h the 5 total staff r e s p o n s i b i l i t y at Army level1 for the 6 c h e m i c a l b i o l o g i c a l p r o g r a m and I w a s :the D D R & E ! i, ir |.; 7 representative responsible for those same programs, 8 so w i t h r e g a r d to A r m y , my c o n t a c t s , w h e n I n e e d e d 9 information or whatever, were his office, and 1 0 a n a l o g o u s o f f i c e s in o t h e r s e r v i c e s . 11 Q. Do you r e c a l l the n a m e s of a n y o n e you 1 2 d e a l t with in G e n e r a l S t o n e ' s o f f i c e ? 1 3 A. Yes, C o l o n e l Bill D i s m o r e n o w d e c e a s e d , for on e , 1 4 Mr. Noris Sills and I've got an e n gram right now, 15 t h e r e was a n o t h e r c i v i l i a n t h e r e , super, g r a d e , B i l l - 1 6 I c a n ' t r e m e m b e r his n a m e for the m o m e n t . It w i l l 17 c o m e b a c k . W h e n you g e t :m y age you g e t t h e s e 1 8 e n g r a m s e v e r y o n c e in a w h i l e . 19 Q. Did you ev e r d i s c u s s the M a r c h 1970 20 m e e t i n g at A C S F O R D w i t h a n y o n e f r o m G e n e r a l S t o n e ' s 21 u n i t ? 22 A. W e l l , it says h e r e that K a n e l l , O s i c k and 23 Sanchez, w e r e t h e r e at that time. I k n e w the m all 24 q j i t e well and th e y w o u l d h a v e b e e n f r o m t i m e to 25 t i m e my c o n t a c t s . If I had a p a r t i c u l a r q u e s t i o n , I 14967 Harris 63 1 w o u l d call one of them or one of those two c i v i l i a n s 2 I mentioned and ask them the q u e s t ' o n , and they 3 w o u l d p r o v i d e the i n f o r m a t i o n . M o s t of it w o u l d be 4 as DDR&E normally operates, informal. 5 Do you k n o w w h e r e C o l o n e l G e o r g e K a n e l l 6 is n o w l o c a t e d ? 7 A . Yes, G e o r g e is n o w a b r i g a d i r e g e n e r a l r e t i r e d . 8 He l i v e s in W a r r e n t o n , V i r g i n i a , has a v e r y l o v e l y ';`j;.ir ' ! 9 wife, Margaret. 10 <2. W h e r e is C o l o n e l O s i c k n o w l o c a t e d ? 11 A. I d o n 't k n o w w h e r e O s i c k is or S a n c h e z . 12 Q. Y o u d o n 't k n o w w h e r e M a j o r S a n c h e z is no w 13 located e i t h e r ? 1 4 A. No, h e 's n o w a full C o l o n e l . I think h e 's 15 s t i l l on a c t i v e d u t y . I 'm no t su r e a b o u t J a c k O s i c k . 16 He p r o b a b l y is g o n e . 17 Q. Did you k n o w Dr. W a y n e V a n d e r V e n t o r 1 8 prior to 1970 at Dow? 19 A. No, I d i d n ' t k n o w hi m the n , d o n ' t k n o w him now. 20 Q. A f t e r yo u r n a m e on Pa g e 2 of E x h i b i t 1, 21 there are the initials OSD. What do those initials 22 stand for? 23 A. O f f i c e of the S e c r e t a r y of D e f e n s e . 24 Q. Did you hav e a n y d e a l i n g s w i t h an y of tl D o w - r e p r s e n t t ives pri o r to the M a r c h 1970 m e e t i n 4968 -*--f isyc.5? Harris 65 1 A . I don' t b e l i e v e so. A l t h o u g h in my own f i l e s 2 if t h e r e ' s a c o p y of it, that will n e g a t e what I'm 3 saying right now, be c a u s e they did give me some of 4 the papers when I brought this other matter up that 5 I|mentioned earlier, namely, my request for i i! 6 i n f o r m a t i o n on the Fish and Wildlife Service 7 m e t h o d o l o g y for removing dioxin, charcoal absorption. 8 Q. I d o n ' t b e l i e v e yo u had m e n t i o n e d that 9 earlier today. 1 0 :A . D i d n 1t I ? 11 Q . No . 12 '! ': MAJOR PARR: At least not on the record. 1 3 A. I d i d n ' t sa y it t h a t w a y but t h e r e was an 1 4 a r t i c l e in C h e m i c a l E n g i n e e r i n g N e w s , v e r y s h o r t 1 5 'hews article indicating fish and wildlife people had i ; 16 d e v e l o p e d a m e t h o d of u s i n g c h a r c o a l for a b s o r p t i o n ;j | i 17 of d i o x i n from h e r b i c i d e s and I sent that to 18 s o m e b o d y or o t h e r -- to the r e s e a r c h l a b o r a t o r i e s 1 9 say i n g what do you think of this and they sent back 20 a whole bunch of junk. 21 Q. W h e n did that a r t i c l e in C h e m i c a l and 22 Engineering News appear? 23 A. He took all my f i l e s a way from the o t h e r d a y so 24 I d o n ' t kno w . 14970 25 Q. W a s tha t new s c l i p p i n g in yo u r f i l e s ? Harris 66 1 A. It is -- yes, t h a t ' s i n .the i n f o r m a t i o n y o u ' l l 2 be suppli ed . 3 Q. Did thi s a r t i c l e a p p e a r b e f o r e or a f t e r i1 4 the 1970 meeting with Dow representatives? 5 A. A fter when I was a t echnical d i r e c t o r at 6 Edgewood . i' 1 7 Q. Who did you send.a memo to r e q u e s t i n g 8 information concerning that charcoal -- concerning 9 dioxin? 10 A. To the r e s e a r c h lab at Edge w o o d . And it was 11 ans w e r e d by Dr. P o z i o m e k , at least the buck slip 1 2 b r o u g h t back to to me was signed by P o zimek. 13 Q. What was Dr. P o z i o m e k ' s p o s i t i o n ? 1 4 A. That would dep e n d on what the date of the dog 15 g o n e p i e c e of p a p e r is and I c a n ' t r e m e m b e r that. 16 P o z i o m e k s u b s e q u e n t l y , a b o u t 197 5 , w as d e p u t y c h i e f 17 of the r e s e a r c h d i v i s i o n . I ' v e f o r g o t t e n the e x a c t 18 t i t l e , but t h a t ' s e s s e n t i a l l y w h a t it is, so he 1 9 w o u l d h a v e b u c k e d it b a c k as a matter, of course w h e n 20 one of the -- one of his b r a n c h e s had p r o v i d e d it to 21 him. 22 Q - Do yo u recall what m a t e r i a l s w e r e 23 inciud ed with the slip from Dr . P o z i o m e k ? 2 4 A . bay it ag a in 1497125 Q . Do you recall what m a t e r i a l s you received n r*r-v *^11 t i t " *> J ___ 1 _____ -- Harris 67 1 back from the Research Laboratories concerning 2 dio x i n with the t r a n s m i t t a l slip from Dr. P o z i o m e k ? 3 A . Well, one of the d o c u m e n t s -- one of the 4 d o c u m e n t s was a copy of the patent Fish and W i l d l i f e 5 people and I'm not sure. This one might have been 6 one but I'm not sure of that. That's what I 7 indicated earlier and there were one or two others. 8 Q. Do you recall what those one or two o t h e r 9 items were? 1 0 A. No, the o n l y one that sticks in my mind is the 11 pa t e n t itself b e c a u s e that was the s u b s t a n c e of my 1 2 q u e s t i o n to them, what do you think of this, and he 13 sent me back a whole pad. 14 !j |i' Q. Do you recall if any e x c e r p t s or part of 15 a t r i p report prepared by Fritz Hoffman was among 16 [those m a t e r i a l s ? 17 !Aj I b e l i e v e not. I r e v i e w e d those m a t e r i a l s at 18 the same time I reviewed this stuff and -- the 19 Lsantitized v e r s i o n of H o f f m a n ' s stuff. Is that in 20 here? 21 Q . Yes , it is 22 A . Ok ay. 23 Q. Do you recall w h e t h e r there was any 24 e x c e r p t from a book by Ben W i t t e n e n t i t l e d the " S e a r c 25 for Toxic Chemical A g e n t s " among the m a t e r i a l s you Harris 68 1 received concerning dioxin from the Research 2 Laboratories? Mj 3 A. W e l l , I d o n ' t r e c a l l . If it's -- if it wa s , it : !i 4 will be in the s t u f f that y o u ' l l . b e s u p p l i e d . 5 Q . Hopefully. |' 6 A. I h o p e I g e t t h e m b a c k , too. .T h e y ' r e m y o n l y I.| 7 files on this subject. i,: 8 Q. So w e ' r e c l e a r , y o u s h o u l d b e g e t t i n g 9 those m a t e r i a l s back and a copy of them should be 10 s e n t to us r a t h e r t h a n o r i g i n a l s . 11 M A J O R PARR: I p r e s u m e there will be no 1 2 c l a s s i f i e d material; o t h e r w i s e , he w o u l d n ' t have 1 3 th e m in his p r i v a t e f i l e s and I also e x p e c t th a t 1 4 t h e r e w i l l be v e r y l i t t l e in the way of p r i v i l e g e d 1 5 i n f o r m a t i o n if any. It' s j u s t a r e q u i r e m e n t th a t we 1 6 touch base with A r m y b e f o r e we r e l e a s e it. 17 Q. Dr. H a r r i s , m a y I a l s o r e q u e s t , h o w e v e r , 18 on the r e c o r d that a f t e r the o r i g i n a l m a t e r i a l s are 19 r e t u r n e d to you, that yo u r e t a i n t h o s e and not 2 0 d e s t r o y them pending the c o n c l u s i o n of this 21 litigation? 2.2 A . T h a t ' s w h y I w a n t the m b a c k , yes. 23 Q . T h a n k you. 24 Dr. H a r r i s , w h e n did you f i r s t h e a r of 1497225 d i o x i n as o p p o s e d to A g e n t O r a n g e or 2 , 4 , 5 - T ? . ,* e. r* t _ .... _ j ___ ___ Harris I 69 1 A. To the best of my r e c o l l e c t i o n , it was when I 2 picked up this report from the Bionetics people. 3 S u b s e q u e n t l y , I l e a r n e d that d i o x i n had come to the 4 a t t e n t i o n of the R e s e a r c h D i v i s i o n at E d g e w o o d from, 5 I gue s s , from the Ho f f m a n Report or s o m e w h e r e , but I 6 d i d n ' t know it then. I think the first time I heard 7 of d i o x i n was as a c o n t a m i n a n t of Orange in the work 8 the Bionetics people had done. 9 Q. When did you f i rst learn thee d i o x i n had 1 0 p r e v i o u s l y c o t .e to the a t t e n t i o n of E d g e w o o d ? 11 A. Well, right now, I think when I read it the 12 other day. 13 MR. B U R K E : C o u l d I h a v e the q u e s t i o n and 14 a n s w e r read b a c k p l e a s e . 1 5 (The record is read) 16 Q. Dr. H a r r i s , b a s e d on i n f o r m a t i o n you 17 o b t a i n e d at the M a r c h 6 , 1970 m e e t i n g , did you e n t e r 18 into d i s c u s s i o n s w i t h a n y o n e c o n c e r n i n g d i o x i n or 19 A g e n t O r a n g e or 2 , 4 , 5 - T ? 20 MR. R U S S O : I o b j e c t to that. He's just 21 a n s w e r e d that in the p r i o r a n s w e r . He s a i d he f i r s t 22 h e a r d a b o u t it w h e n he p i c k e d -- w h e n he re a d the 23 d o c u m e n t s . 14974 24 THE W I T N E S S : No, no, that was -- 2 5 MR. GORDON: This was based on the Harris i i 70 1 meeting . 2 THE WITNESS: That was, of course, I i! !; 3 u n d e r s t o o d your q u e s t i o n , it was whe n did I first 4 learn that Edgewood had gotten information. 5 Q . My or i g i n a l q u e s t i o n had been: when did 6 you first hear of dioxin. ,7 A . Well, that was when I -- the B i o n e t i c s report .8 Q. T h a t ' s w h a t you t e s t i f i e d to. 9 A . Yes. 1 0 Q. And t h e n is it yo u r t e s t i m o n y , that l a t e r 11 you subsequently learned that Edgewood had been 12 familiar with dioxin earlier? 1 3 A. Y e s , l a t e r . 14 Q. T h a t ' s w h a t I u n d e r s t o o d y o u r t e s t i m o n y 15 to h a v e bee n . 16 A . R i g h t . 17 Q . My q u e s t i o n n o w is b a s e d on the 1 8 information that you received at the March 1970 19 meeting did you have any discussions with anyone 20 c o n c e r n i n g d i o x i n or 2 , 4 , 5 - T or A g e n t O r a n g e ? 21 A. I c e r t a i n l y did. T h e r e w e r e d i s c u s s i o n s in 22 passing that dioxins are very toxic material, it's 23 t e r a t o g e n i c and so on and so on, and t h e y w o u l d h a v e 24 b e e n d i s c u s s e d w i t h a n u m b e r of p e o p l e f r o m tim e to 149752 5 time, c e r t a i n l y w o u l d have d i s c u s s e d it w i t h H a y w a r d , !> . t I t! < _ 1 II Harris 71 1 c e r t a i n l y s u b s e q u e n t l y h a v e t a l k e d to Sa s s a b o u t it. 2 He w o r k e d for me w h i l e I was at E d q e w o o d and so on 3 and they had done a n a l y s e s of a number of these 4 m a t e r i a l s and established an analysis procedure and 5 t h a t ' s all in this o t h e r s t u f f t h a t ' s c o m e to my 6 attention just recently. 7 Q. Who els e did you s p e a k w i t h f o l l o w i n g the 8 M a r c h 1 9 7 0 m e e t i n g b e s i d e s Mr. Hayv. ard and Mr. S a s s ? 9 A ,, I can only conjecture. I don't recall. 10 Q. W e l l , w h y d o n ' t you -- 11 A. M i g h t h a v e t a l k e d to J a n d o r f , m i g h t h a v e t a l k e d 1 2 to M c N a m a r a . We w e r e c o n c e r n e d , of c o u r s e , w i t h 13 a n y t h i n g that m i g h t be used as an a g e n t a g a i n s t the 14 U.S., and this is a v e r y t o xic s u b s t a n c e , but we -- 1 5 and I t h i n k as is in s o m e of th i s o t h e r s t u f f 16 c e r t a i n l y w o u l d n e v e r be i n t e r e s t e d in it as a 17 c h e m i c a l w a r f a r e a g e n t . 1 8 Q. Do you k n o w w h e n you p r o b a b l y s p o k e to 19 Mr. H a y w a r d a b o u t d i o x i n ? 20 A. P r o b a b l y w i t h i n a d a y or two a f t e r b r i n g i n g the 21 r e p o r t b a c k . 22 Q. Do you k n o w w h e n you f i r s t s p o k e to Mr. 23 Sas s a b o u t d i o x i n ? 2 4 A. I t h i n k d u r i n g this m e e t i n g and s u b s e q u e n t 2 5 thereto perhaps.. 14976 Harris 72 1 Q. Do you k n o w Dr. J o h n B o l d e s w e i l e r ? 2 A . Well, I met him once upon a timeJi.jl don't have 3 any association with him now. h; | ! i 4 Q. Do yo u r e c a l l w h e n yo u m e t !Dr. 5 Boldesweiler? Mi! 6 A. No , I thi n k he was a m e m b e r of the RDB or 7 something. 8 Q. W h a t is the RDB ? 9 A. R e s e a r c h and D e v e l o p m e n t Board. 10 Q. Do yo u r e c a l l w h e t h e r he w a s a m e m b e r of 11 the P r e s i d e n t ' s S c i e n t i f i c A d v i s o r y C o m m i t t e e ? 1 2 A. Yes, I t h i n k he was that, too, and one time or 13 a n o t h e r I b r i e f e d them. W h e t h e r he was at that 14 p a r t i c u l a r b r i e f i n g , I c o u l d n ' t say. 1 5 Q. Do y ou r e c a l l w h e t h e r you had a n y 16 d i s c u s s i o n -- s t r i k e tha t . Do you r e c a l l the 17 c o n t e x t in w h i c h y o u had y o u r d i s c u s s i o n s w i t h Dr. 18 B o l d e s w e i l e r ? 19 A. No, no. H e ' s a c t u a l l y q u i t e hazy. The name I 20 r e c a l l . H e ' s q u i t e h a z y in my r e c o l l e c t i o n , the m a n 21 h i m s e l f . 22 Q. Do you r e c a l l e v e r h a v i n g had any 2 3 c o n v e r s a t i o n s with him yourself with Dr. 24 Boldesweiler concerning dioxin? 25 rtnH eroinaHi _i-- i---- ' ---- Harris 73 1 Q. F o l l o w i n g the M a r c h 1970 m e e t i n g , did you 2 attend any other m e e t i n g s conc e r n i n g dioxin or 3 2 . 4 . 5- T or Agent Orange? 4 A. I d o n ' t recall any o t h e r m e e t i n g s . 5 Q. B a s e d on the M a r c h 1970 m e e t i n g , did you 6 take any actions c o n c e r n i n g Agent Orange or dioxin, 7 2 . 4 . 5 - T? 8 A . No . 9 (Recess) 1 0 BY MR. GORDON: 11 Q. Dr. H a r r i s , j u s t b e f o r e the b r e a k , did 1 2 y o u s t a t e t h a t at som e p o i n t in time you had b r i e f e d 13 the P r e s i d e n t ' s S c i e n c e A d v i s o r y C o m m i t t e e ? 1 4 A .: Yes, o n c e b r i e f e d the m on the c h e m i c a l w a r f a r e 15 prog r a m . 16 Q. W h e n did th a t b r i e f i n g o c c u r ? 17 A.; I d o n ' t r e c a l l . W h i l e at the D D R & E . 1 8 Q. Do you r e c a l l w h e t h e r d i o x i n was 19 m e n t i o n e d in c o n n e c t i o n with that b r i e f i n g ? 20 A.' Oh, yes. I had n o t h i n g to do w i t h d i o x i n . 21 Q. Do you r e c a l l w h e t h e r h e r b i c i d e s w e r e 22 d i s c u s s e d d u r i n g that b r i e f i n g ? 1 4 2 7'8 23 A.- N o t h i n g to do w i t h h e r b i c i d e s . It was on the 24 c h e m i c a l w a r f a r e r e s e a r c h and d e v e l o p m e n t p r o g r a m 25 w h i c h at t h a t t i m e d i d n ' t i n c l u d e this at all. Harris |::! 7 4 1 MR. GORDON: Miss Reporter,: Would you 2 please m a r k as Harris Ex h i b i t 2 a Junej'5, 1970 memo |; ! 3 fr o m B e r n a r d J. J a n d o r f to d i r e c t o r ofj, Re s e a r c h I"! 4 Labora t o r i e s and an attached :memo routing slip from I! I 5 Dr. J a n d o r f to Dr. M c N a m a r a d a t e d Junes 10, 1970. !' ! 6 (Exhibit H a r r i s - 2 is m a r k e d : f o r I d e n t i f i c a t i o n ) ; i 7 Q. Dr. H a r r i s , ha v e y o u e v e r s e e n E x h i b i t 2 8 before? 9 A . Yes , I did. 1 0 Q. W h i c h was the f i r s t time th a t you saw 11 t h a t e x h i b i t ? 12 A. To the b e s t of my r e c o l l e c t i o n , it was in 13 connection with this -- with last week. 1 4 Q. D o e s E x h i b i t 2 r e f r e s h y o u r ;r e c o l l e c t i o n 15 as to a n y d i s c u s s i o n s c o n c e r n i n g d i o x i n that you had 16 f o l l o w i n g the M a r c h 1970 m e e t i n g ? 1 7 A . Yes . 1 8 Q. W o u l d you p l e a s e d e s c r i b e f o r m e the 1 9 d i s c u s s i o n s that are r e f r e s h e d by this e x h i b i t -- 20 let me r e p h r a s e that. 21 W h a t do you r e m e m b e r a b o u t d i s c u s s i o n s 22 c o n c e r n i n g d i o x i n f o l l o w i n g the M a r c h 1970 m e e t i n g ? 23 A. I d o n ' t r e m e m b e r a t h i n q a b o u t it, but I read 24 this and it m a k e s s e n s e . 25 Do you recall c a l l i n g Dr. J a n d o r f w h i l e Harris 75 1 you w e r e still at D D R & E to d i s c u s s d i o x i n ? 2 A. I d o n ' t recall a s p e c i f i c call. 3 As I i n d i c a t e d b e f o r e , I was in the h a b i t 4 of c a l l i n g d i r e c t l y dow n to them on t e c h n i ca l 5 matters, information, can you give me toxicity 6 figures or whatever, that kind of thing and the 7 p r o t o c o l was that we would never -- DDR&E never 8 a s k e d a n y b o d y in the lab s to do a n y t h i n g . T h a t 9 w o u l d go t h r o u g h c h a n n e l s to ask for i n f o r m a t i o n . 1 0 Q. Do you r e c a l l w h a t was the p u r p o s e of 11 you r t e l e p h o n e call to Dr . J a n d o r f ? 1 2 A . Well , I d o n ' t recall it. T h a t ' s the point. I 1 3 can infer what it was from r e a ding thi 3 1 4 Q. W h y do n 1t you i n f e r w h a t the p u r p o s e of 15 the cal l was. 1 6 MR. R U S S O : You w a n t him n o w to read fr o m 17 the r e p o r t ? He s a y s it d o e s n ' t r e f r e s h his 18 r e c o l l e c t i o n . 1 9 MR. G O R D O N : I w a n t hi m to inf e r the 20 p u r p o s e of the c a l l ? 21 MR. R U S S O : I ask him to read fto m the 22 r e p o r t . The r e p o r t s p e a k s for itse l f , d o e s n ' t it? 23 MR. G O R D O N : W h a t ' s w r i t t e n in the r e p o r t 24 s p e a k s for i t s e l f . Do you see the p u r p o s e of the 25 call Harris 1 76 MR. RUSSO: No. He told you he couldn't,- 2 didn't have a recollection. 3 MR. G O R D O N : He said he c o u l d infer the 4 p u r p o s e of the r e p o r t . I'm now asking! Dr. H a r r i s to !| 5 infer what the purpose of the call was from the 6 report. 7 MR. R U S S O : I o b j e c t . A n s w e r it o v e r my 8 objection? 9 A. I p r o b a b l y a s k e d hi m w h a t the t o x i c i t y of 10 dioxinwas. 11 Q. Do you k n o w w hy yo u w e r e i n t e r e s t e d in 1 2 the toxicity of dioxin at that time? 1 3 MR. R U S S O : O b j e c t i o n to the for m . Go 14 ahead,Doctor. 15 A. W e l l , d i o x i n was a c o n t a m i n a n t ini the h e r b i c i d e 16 and m i g h t or m i g h t not h a v e b e e n an a c t i v e 1 7 i n g r e d i e n t in the t e r a t o g e n i c r e s u l t s t h a t w e r e in 18 issue as, for e x a m p l e , in the B i o n e t i c s r e p o r t . 1 9 Q. In e a r l y J u n e 1970 w e r e you c h a r g e d wi t h 20 a n y r e s p o n s i b i l i t i e s in c o n n e c t i o n w i t h d e t e r m i n i n g 21 the t o x i c i t y of d i o x i n in c o n n e c t i o n w i t h A g e n t 22 O r a n g e ? 23 A. The w ay you p h r a s e that q u e s t i o n , the a n s w e r is 2 4 no. We w e r e i n t e r e s t e d in t o x i c i t y of c o m p o u n d s 2 5 because our c o n c e r n was the d e f e n s e a g a i n s t them 14 w rrnn a n d snin^lli POrtifitaH rhnr+hnnrl Harris 77 1 should someone use them and any compound that was 2 ver y toxic, and it t u r n e d out that d i o x i n was, w o u l d 3 be of c o n c e r n fro m a d e f e n s i v e p o i n t of v i e w . It 4 might be of c o n c e r n from an o f f e n s i v e point of view 5 e x c e p t that in our p a r t i c u l a r j u d g m e n t th i s is not 6 the kind of co m p o u n d we would -- the U.S. would use. 7 Q. W h i l e y ou w e r e at D D R & E , wa s p a r t of your 8 job to d e t e r m i n e w h e t h e r t h ere were p o t e n t i a l 9 chemical agents that might call for a defensive 10 r e s p o n s e f r o m the U n i t e d S t a t e s ? 11 A. W h e n you say d e t e r m i n e , the a n s w e r is no, but 1 2 we c e r t a i n l y w e r e i n t e r e s t e d in it in tha t we 1 3 a l l o c a t e d the b u d g e t and p r o v i d e d the p o l i c y to the 1 4 services for the Research and Development including 1 5 in d e v e l o p m e n t n e w c h e m i c a l w a r f a r e p o t e n t i a l i t i e s . 1 6 Q. At the time of y o u r t e l e p h o n e 1 7 c o n v e r s a t i o n w i t h Dr. J a n d o r f in e a r l y J u n e 1970 1 8 were you i n t e r e s t e d in p u r s u i n g the i n v e s t i g a t i o n of 19 d i o x i n as a p o t e n t i a l c h e m i c a l a g e n t tha t m i g h t be 20 used a g a i n s t the U n i t e d S t a t e s ? 21 A. No . 22 Q. W h y w e r e you i n t e r e s t e d in d i o x i n at chat 2 3 time? 2 4 A. I'm s o r r y , let me -- I t h i n k I a n s w e r e d your 25 q u e s t i o n i n c o r r e c t l y . 14382 Harris 1 Q. 78 W o u l d you like to h a v e the q u e s t i o n read 2 back. , :j 3 (The r e c o r d is read) j 4 A. The a n s w e r s h o u l d be p o s s i b l y . W e ' r e a l w a y s 5 concerned about those ma t e r i a l s which might be used 6 against' the United States. 7 Q. Do yo u r e c a l l a b o u t h o w long your 8 t e l e p h o n e c o n v e r s a t i o n with Dr. J a n d o r f l a s t e d ? 9 A . No . 10 Q. Do you h a v e a n y r e c o l l e c t i o n of w h a t Dr. 1 1 Jandorf said during the telephone c o nversation? . 1 2 MR. R U S S O : O b j e c t i o n as to w h a t he said. 1 3 We've got hearsay now. 1 4 MR. G O R D O N : T h i s is a d i s c o v e r y 15 deposition. 16 MR. R U S S O : T h i s has all bee n r u l e d on. 1 7 MR. GORDON: Nothing has been ruled on. 1 8 T h i s is a d i s c o v e r y d e p o s i t i o n . W h e n you m a k e a 19 h e a r s a y o b j e c t i o n at the d e p o s i t i o n , f r a n k l y , Don, I 20 d o n ' t k n o w what y o u ' r e t a l k i n g . 21 MR. R U S S O : S c h r e i b e r m a d e a .ruling as to 22 tii.- M i n a r i k . D i d n ' t he put all the g u i d e l i n e s ? 2 3 MR. G O R D O N : I h a v e never, .heard of a n y . ?.4 ruli n g oy any S p e c i a l M a s t e r s or a n y J u d g e tha t 2 5 there's a hearsay objection made at the -- w o n n n n d sninolll CPrtifioH chorthnnH nar^r-forc Harris 79 1 MR. R U S S O : It was m a d e at the M i n a r i k 2 d e p o s i t i o n . He p u t the g u i d e l i n e s d o w n and I'm sure 3 y o u ' r e aware of them as well as I am. 4 MR. G O R D O N : I'm a w a r e in that the 5 g u i d e l i n e s h e a r s a y o b j e c t i o n is not i n c l u d e d a m o n g 6 them but I suggest you simply state your objection 7 for the record and we proceed. 8 MR. R U S S O : I'm o b j e c t i n g to it and I'm 9 g o i n g to r e q u e s t t h a t the q u e s t i o n be w i t h d r a w n . 1 0 MR. GORDON: Mr. Russo, you can make your 11 o b j e c t i o n as to a d m i s s i b i l i t y at trial w h i c h is the 1 2 u s u a l p r o c e d u r e w h i c h is f i l e d and I've n e v e r h e a r d 1 3 of any other procedure. Every time I hear this 1 4 objection I really don't know what the plaintiffs' 15 a t t o r n e y s are t a l k i n g a b o u t . 1 6 MR. RUSSO: I made the objection. I 1 7 r equest that the q u e s t i o n be w i t h d r a w n . I c a n ' t go I 18 a n y further th a n tha t . It's h e a r s a y . 19 ii j MR. G O R D O N : The q u e s t i o n will not be 20 w i t h d r a w n but I w o u l d l i k e to h a v e the r e p o r t e r read 21 it! to Dr. H a r r i s . 22 ! MR. RUSSO: I hav e no c o n t r o l over the 23 w i t n e s s . The o b j e c t i o n s t a n d s . 24 i ! (The r e c o r d is read) 2 5 A.! ! W e l l , I d o n ' t h a v e a n y r e c o l l e c t i o n . I o n l y Harris 80 1 h a v e w h a t ' s in f r o n t of me. 2 Q. Do yo u k n o w w h e t h e r f o l l o w i n g y o u r 3 telephone c o n v e r s a t i o n with Dr. Jandorf Dr. Jandorf 4 sent you any w r i t t e n m a t e r i a l s c o n c e r n i n g d i o x i n or 5 2,4,5-T? 6 A. W e l l , I d o n ' t r e c a l l it c e r t a i n l y . I b e l i e v e 7 not but I d o n ' t recall it. 8 Q. Do you r e c a l l w h e t h e r you p r e p a r e d a 9 memorandum of your telephone conversation with Dr. 10 Jandorf? 1 1 A. No , I d o n ' t r e c a l l a m e m o r a n d u m . 1 2 Q. In the n o r m a l c o u r s e of y o u r d u t i e s at 1 3 DDR& E , was it your p r a c t i c e to p r e p a r e m e m o r a n d a of 14 telephone conversations? 1 5 A. No, no, no, it was not n o r m a l p r a c t i c e . 16 Q. Did y o u on o c c a s i o n p r e p a r e s u c h 17 memoranda? 1 8 A. I c a n n o t say I did not. I d o n ' t recall any. 1 9 MR. GORDON: At this time, Major Parr, I 2 0 request that the g o v e r n m e n t perform a search of the 21 P e n t a g o n and any o t her a p p l i c a b l e files for any 22 m e m o r a n d a that may have been p r e p a r e d by Dr. Harris 23 c o n c e r n i n g his t e l e p h o n e c o n v e r s a t i o n w i t h Dr. 2 4 J a n d o r f on J u n e 4, 1970. In a c c o r d a n c e w i t h the 2 5 p r o c e d u r e s I h a v e used in the p e s t , I will send a 14985 Harris i 1 letter incorporating that request. 81 2 MAJOR PARR: Read that back, please. 3 (The r e c o r d is read.) 4 MAJOR PARR Thank you. 5 MR. GORDON I guess I preempted your 6 response, Major Parr. 7 MAJOR PARR Is a r e s p o n s e r e q u i r e d ? 8 MR. GORDON You d i d n ' t as k me to w r i t e a 9 letter . 1 0 M A J O R PARR: I a p p r e c i a t e your saving me 11 the tim e of a s k i n g yo u to do t h a t . 1 2 Q. Dr. H a r r i s , I r e f e r you to p a r a g r a p h 3 of 1 3 E x h i b i t 2. Do y o u r e c a l l the s o u r c e of any 1 4 i n f o r m a t i o n that you received c o n c e r n i n g the 15 t r i c h l o r o a n a l o g u e b e i n g 18 t i m e s m o r e t o x i c in 1 6 guinea pigs? 1 7 MR. R U S S O : 18 or 15. 18 I MR. B U R K E : 15. 19 Q . 15 t imes . 20 A. I d o n ' t r e c a l l that at all. I d o n ' t at the 21 m o m e n t k n o w w h e r e I w o u l d h a v e g o t t e n the 22 i n f o r m a t i o n u n l e s s -- well, I d o n ' t recall. 2 3 Q. Is it p o s s i b l e th a t y o u r e c e i v e d that 2 4 i n f o r m a t i o n fr o m Dr. J o h n Bo 1 d e s w e i 1 e r ? 2 5 A. ;i W e l l , I d i d n ' t b e c a u s e I d i d n ' t -- I d o n ' t 14986 Harris 82 1 recall ever having talked to B o l d e s w e i l e r about any 2 of these matters or much of anything else. 3 MR. GORDON: Miss Reporter, would you 4 please mark as Harris Exhibit 3 a June 8 , 1970 5 m e m o r a n d u m from V P M c N a m a r a to d i r e c t o r of R e s e a r c h 6 Laboratories. 7 (Exhibit Harris-3 for Identification) 8 (There is a d i s c u s s i o n off the record) 9 Q. Dr. H a r r i s , h a v e you r e v i e w e d E x h i b i t 3? 10 A . Yes. 1 1 Q. D o e s E x h i b i t 3 r e f r e s h yo u r r e c o l l e c t i o n 1 2 as to any i n f o r m a t i o n that you may have r e c e i v e d 1 3 from Dr. B o l desweiler concerning the fact that the 1 4 t r i c h l o r o a n a l o g u e is 15 t i m e s m o r e t o x i c in b e g i n 15 knee pigs? 1 6 A . Do esn 't r e f r e s h my m e m o r y at all nor is it 1 7 e s s e n t i a l tha t it w o u l d c o m e d i i e c ti y fro ni n im . 1 8 Q. Do you h a v e any idea as to who the s o u r c e 19 o f y o u r i n f o r m a t i o n c o n c e r n i n g the t r ic h 1 o r o 20 a n a l o g u e m a y hav e b e e n ? 21 A. I c a n o n l y c o n j e c t u r e . It m i g h t v e r y well h a v e 22 b e e n Mr. H a y w a r d . As I i n d i c a t e d e a r l i e r , he was 2 3 the -- more of the b i o l o g i c a l l y o r i e n c e u m ember of 24 our t e a m than I and this had b e e n a b i o l o g i c a l l y -- 25 b i o l o g i c a l l a b o r a t o r y d e v e l o p m e n t s e a r l i e r on, the Harris 83 1 whole anti-crop program. 2 Q. Dr. H a r r i s , do you k n o w w h e t h e r Mr. 3 Hayward had any dealings with Dr. Boldesweiler? 4 A. ' Well, in the s e nse that he was a m e m b e r of h i g h 5 level advisory groups, I'm sure Hayward would have 6 known him and been acquainted with him but I can't 7 speak for Mr. Hayward. . 8 Q. Do you k n o w w h e t h e r Mr. H a y w a r d eve r had 9 any dealings with the President's Science Advisory 1 0 Comm i11e e ? 11 A. W e l l , he c e r t a i n l y was t h e r e at the same 12 meeting that I briefed him and I'm -- I'm pretty 1 3 sure that he was at others. 1 4 Q. Do y o u r e c a l l the s u b j e c t of a ny of the 1 5 meetings that Mr. Hayward had with the President's 16 S c i e n c e A d v i s o r y C o m m i t t e e ? 1 7 A. ; No. 18 Q. Dr . Ha r r i s , I r e f e r you to p a r a g r a p h five 19 o f Ex h ib i t 2 w h i c h s t a t e s that " I in fo rmed Dr . 20 H arris that we have been acqua in ted with the high 21 t o x i c i t y of " -- :l 'm s o r r y , s t r i k e t h a t who 1 e 22 q u e s t i o n . 23 Dr . H a r r i s , I r e f e r yo u to p a r a g r a p h four 24 of E x h i b i t 2 w h i c h states that "Dr. Harris i n q u i r e d 2 5 w h e t h e r we should undertake work with this series 149S8 Harris 84 1 (threat evaluation) because of high l e t hality and 2 b e c a u s e of a g r e a t d e a l of i n f o r m a t i o n c o n c e r n i n g it 3 has r e c e n t l y b e e n p u b l i s h e d in the o p e n l i t e r a t u r e , 4 (C N D N e w s N e w Y o r k ) . " Do y o u r e c a l l w h e t h e r y o u 5 made that inquiry on your own or whether so m e o n e had 6 s u g g e s t e d t h a t yo u m a k e s u c h an i n q u i r y to Dr. 7 Jando rf? 8 A. I p r o b a b l y m a d e that on my own. 9 Q. Do you r e c a l l r e a d i n g in any a r t i c l e s in 1 0 the New Yorker c o n c e r n i n g Agent Orange or 2 , 4 * 5-T or 11 dioxin? 1 2 A. No. I'm not sure that h e 's saying there that I 1 3 g a v e h i m t h a t -- t h o s e r e f e r e n c e s . He may h a v e 14 appended them himself. I don't remember reeding 1 5 t h e m in the N e w Y o r k e r , no. 1 6 Q. Dr. H a r r i s , I a l s o r e f e r you tc the las t 17 s e n t e n c e of E x h i b i t 3 w h i c h s t a t e s that " D r . 18 B o l d e s w e i l e r s u g g e s t e d tha t we l o o k into this no t 1 9 only from a standpoint of an offensive CW Agent, but 20 s i n c e it has b e e n h i g h l y p u b l i c i z e d in the 21 n e w s p a p e r s , a f o r e i g n c o u n t r y m a y use it a g a i n s t us 22 c o n s e q u e n t l y , this c o uld be s t u d i e d from a d e f e n s i v e 2 3 standpo int . 24 MR. R U S S O : Let me o b j e c t to you r r e a d i n g 25 it. Y o u h a v e n ' t c o n n e c t e d t h i s w i t n e s s to th i s Harris 85 1 d o c u m e n t so I'm g o i n g to o b j e c t to it. 2 Q. Do you r e c a l l w h e t h e r the s u g g e s t i o n 3 c o n c e r n i n g i n v e s t i g a t i o n of d i o x i n from a d e f e n s i v e 4 s t a n d p o i n t m a y have come f r o m Dr. Bo 1d e s w e i 1 e r ? 5 A. I d o n ' t r e c a l l that. C e r t a i n l y that w o u l d ha v e 6 been my own concern, you know, policy wise. Our 7 o f f i c e was r e s p o n s i b l e for the p r o g r a m to a s s e s s the 8 threat a g a i n s t the U.S. and so that's -- as soon as 9 I w o u l d h a v e seen t h e s e f i g u r e s in p a r a g r a p h two of 1 0 the high toxicity, I would have said do you think we 11 o u g h t to l o o k at tha t fro m the s t a n d p o i n t of 1 2 s o m e b o d y u s i n g it a g a i n s t us. 13 MR. B U R K E : P a r a g r a p h two of E x h i b i t 2, 1 4 is that right? 15 TH E W I T N E S S : E x h i b i t 2, yes. 16 q . Dr. H a r r i s , on E x h i b i t 3 t h e r e ' s a 1 7 re f e r e n c e to C o l o n e l Uhr ig . 18 Do yo u k n o w who C o l o n e l U h r i g w a s ? 19 A .! I d o n 't r e c a l l an y C o l o n e l U h r i g . 20 Q. As of J u n e 4, 1 9 7 0 , w e r e yo u sti l l in 21 D D R & E? 22 A ., '! Yes. 23 Q. Do you recall the date that you came back 24 to Edg ewo od ? 25 A. W e l l , I w a n t to say the 29th, but I d o n ' t 14990 iH a r r i s 86 1 really have any strong r e collection of e x a c t l y the 2 date. I've got records . I can put that on the 3 c u r r i c u l u m v i t a e if y o u ' d like. 4 Q. If you w o u l d , th a t w o u l d be a p p r e c i a t e d . 5 A . I i n t e n d e d to. I m a d e a note to put the a c t u a l 6 dates of some of these things that you have 7 questioned. 8 Q. Fin e , t h a n k you. T h a t ' s g r e a t l y 9 a p p r e c ia t e d . 1 0 Dr. H a r r i s , I r e f e r you to p a r a g r a p h five 1 1 of. E x h i b i t 2. 12 A . Right. 1 3 Q. I b e l i e v e you t e s t i f i e d e a r l i e r this 1 4 morning that you had learned at some point after the 15 March 1970 meeting with Dow representatives that 1 6 Edgewood had been familiar with the toxicity of 1 7 d i o x i n p r i o r to t h a t m e e t i n g . D o e s E x h i b i t 2 18 r e f r e s h y o u r r e c o l l e c t i o n as to -- 19 A . Yes. 20 Q. -- h o w yo u b e c a m e a w a r e of that 21 information? 22 A. W e l l , that c e r t a i n l y s a y s that he -- tha t 2 3 Jandorf told me and I think that probably was the 2 4 first time I heard of that. 2 S Q. Do you h a v e an y r e c o l l e c t i o n of w h a t -- 14931 __ _ H ? Harris 87 1 of the details of what Dr. Jandorf told you about 2 E d g e w o o d ' s earlier k nowledge of the high t oxicity of 3 dioxin? 4 A. j W o u l d you read that b a c k p l e a s e . 5 (The r e c o r d is read) 6 A. I W e ll, again, I d o n ' t have any r e c o l l e c t i o n of 7 it, but I can infer what the c o n v e r s a t i o n was all 8 about from this paragraph. 9 MR. RUSSO: I'll o b j e c t to any i n f e r e n c e s 1 0 from the p a ragraph. It's his r e c o l l e c t i o n that you 11 wan t . 1 2 Q. Dr. H a r r i s , do you r e c a l l w h e t h e r Dr. 1 3 J a n d o r f r e f e r r e d to Dr. H o f f m a n d u r i n g the t e l e p h o n e 14 c o n v e r s a t i o n ? 1 5 A. ! I d o n ' t rec a l l the t e l e p h o n e c o n v e r s a t i o n per 16 s e . It w a s one of h u n d r e d s t h a t I m a d e on t e c h n i c a l 17 matters . 18 Q. Dr. H a r r i s , in p a r a g r a p h four of E x h i b i t 19 2 t h e r e is a r e f e r e n c e to t h r e a t e v a l u a t i o n . 20 A . j Yes, t h a t ' s to e v a l u a t e h o w m u c h of a t h r e a t 21 tha t m i g h t be to the s a f e t y of the U.S. and w h e t h e r 22 we s h o u l d ta k e a s p e c i f i c a c t i o n to p r e p a r e a g a i n s t 23 such a t h r e a t . 24 Q. A c c o r d i n g to E x h i b i t 2, a f t e r Dr. J a n d o r f 2 5 a.dviised y o u tha t d i o x i n wa s too h i g h a s a f e t y h a z a r d 149S2 Harris 1 for Edgewood personnel, you, quote, appeared 88 2 satisfied with this answer, close quote. 3 A . To Dr . Ja nd o r f 4 - Q. Do you recall h a v i n g been s a t i s f i e d with 5 any answer that D r . J a n d o r f gave you c o n c e r n ing 6 testing o r not test ing d i o x i n at E dgewood? 7 A . Well, I don't recall it. My own o p i n i o n would 8 be that's not a good reason. Other c o m p o u n d s that 9 are more toxic than that we have handled safely. 1 0 The effects of the agent -- of the c ompound, agent 1 1 is the w r o n g ter m , e f f e c t s of the c o m p o u n d were not 12 those of a c h e m i c a l -- of a good c h e m i c a l w a r f a r e 1 3 a g e n t , too long a d e l a y b e t w e e n the time you used it 1 4 in an a t t a c k , for e x a m p l e , and w h a t e v e r h a p p e n e d , in 1 5 m o n t h s to y e a r s . T h a t ' s not a c h e m i c a l w a r f a r e 16 agent. 17 MR. GORDON: Could I have that answer 18 r e a d b a c k . 1 9 (The r e c o r d is read) 20 Q. Dr. H a r r i s , j u s t so I'm c l e a r , is it y o u r 21 t e s t i m o n y that d i o x i n d o e s not m a k e a g o o d c h e m i c a l 22 w a r f a r e a g e n t b e c a u s e of a d e l a y of o n s e t of the 23 e f f e c t s of d i o x i n ? 24 MR. B U R K E : O b j e c t to the f o r m . 25 A. My r e c o l l e c t i o n -- my u n d e r s t a n d i n g n o w is that 14983 Harris 89 1 it c a u s e d some kind of l i v e r d a m a g e w h i c h tak e s 2 a w h i l e to d e v e l o p and in a c h e m i c a l w a r f a r e a g e n t 3 you're looking for something that acts essentially 4 i m m e d i a t e l y and we have many other things that do 5 and so no one w o u l d ch o o s e s o m e t h i n g of this sort. 6 Q. Do you r e c a l l w h e n you a c q u i r e d y o u r 7 u n d e r s t a n d i n g about any a lleged d elayed effects of 8 dioxin? ! : 1 9 A. W e ll, at the time -- at the time, very c l e a r l y , 1 0 the t e r a t o l o g y was the o n l y m a t t e r of c o n c e r n to us 11 and t h a t ' s of no v a l u e w h a t s o e v e r in c h o i c e of a 1 2 c h e m i c a l w a r f a r e agent. As a m a t t e r of fact, it 1 3 w o u l d be a r e a s o n not to do it s i n c e one l o o k s at 1 4 all aspects of an agent, and its effects. 15 And then s u b s e q u e n t l y at some time or 16 other I've learned about the liver damage and was 1 7 r e f r e s h e d in my m e m o r y of th a t he r e o n l y , but w h e n 18 i t -- s p e c i f i c a l l y w h e n it h a p p e n e d , I d o n ' t 19 r e m e m b e r now. 20 It als o c r e a t e s c h l o r a c n e or s o m e t h i n g of 21 .i the skin and t h a t ' s of no v a l u e for c h e m i c a l w a r f a r e . 22 Q. W h e n did you f i r s t he a r of c h l o r a c n e ? 23 A. I think c h l o r a c n e came a l ong as one of the 24 e f f e c t s of p e o p l e h a n d l i n g the m a t e r i a l , e a r l y on, 25 a r o u n d the time of the B i o n e t i c s r e p o r t but I d o n ' t Harris 90 1 remember that either very well. 2 Q. Do yo u r e c a l l ev e r h a v i n g h e a r d of 3 c h l o r a c n e in c o n n e c t i o n w i t h the m a n u f a c t u r e of CS 4 at E d g e w o o d in the e a r l y 1 9 6 0 ' s ? 5 A. C e r t a i n l y s k i n i r r i t a t i o n I k n o w a b o u t , but I 6 don't remember whether the term chloracne was used 7 or not. 8 Q. W h a t did you k n o w a b o u t sk i n i r r i t a t i o n 9 at E d g e w o o d in the m i d d l e 1 9 6 0 ' s ? 1 0 A. I r r i t a n t c o m p o u n d s w h i c h CS is one, g e n e r a l l y 1 1 hit moist skin surf a c e s or moist surfaces and that's 12 why they are effective, they affect your mucous 1 3 m e m b r a n e s and it w o u l d a f f e c t s w e a t i n g p e o p l e , for 1 4 example, m o i s t areas such as under your arm pits and 15 the g r o i n and so on. 1 6 'i !: Q. Do you recall any skin i r ritation 1 7 problems among workers m a n u f a c t u r i n g CS at Edgewood 18 iiin the e a r l y 196 0 's?. 19 A. No, I d o n ' t r e c a l l that. 20 MAJOR' PARR: M a y I i n t e r j e c t s o m e t h i n g 21 here on the record, when you talk about studying the 22 f e a s i b i l i t y of certain agents as chemical wa r f a r e 2 3 a g e n t s , are you c o n c e r n e d w i t h our u s i n g it or our 24 e n e m i e s u s i n g it and, thus., r e q u i r e us to d e v e l o p 25 defensesforit. 14995 Harris 91 1 MR. GORDON: I'm concerned with both and 2 I believe that Dr. Harris has stated his view that 3 insofar as dioxin was c o n c e r n e d at the time of his 4 telephone c o n v e r s a t i o n with Dr. Jandorf, his conc e r n 5 was on def e n s i v e aspects of dioxin. 6 M A J O R PARR: Say it for the record 7 whether or not he has s t ated the facts as you 3 b e l i e v e t h e m to be, Dr. H a r r i s . You n o d d e d y o u r 9 head . 10 THE WITNESS: Well, I'm not sure I 1 1 u n d e r s t a n d your q u e s t i o n . T h a t ' s kind of -- say it 12 again . 1 3 MAJOR PARR: Well, I'm wondering about 1 4 the r e c o r d p e r h a p s s i n c e t h i s is a p u b l i c d o c u m e n t 1 5 r e f l e c t i n g that per h a p s we were studying dio x i n 16 a l t h o u g h y o u h a v e s a i d in the p a s t as Mr. G o r d o n 17 said we w e r e s t u d y i n g d i o x i n for p o s s i b l e o f f e n s i v e 1 8 uses. I w a n t e d to c l e a r t h a t up on the r e c o r d , if 19 y o u can . 20 M R . G O R D O N : I t h i n k I ca n h e l p you out, 2 1 Dr;. H a r r i s . 22 ! Q. M a j o r Par r is l e g i t i m a t e l y c o n c e r n e d that 2 3 y o u r t e s t i m o n y , a l t h o u g h I b e l i e v e it is c l e a r , t h a t 2 4 it m a y b e c o n s t r u e d as r e f l e c t i n g o f f e n s i v e c h e m i c a l 1493S2 5 w a r f a r e a c t i v i t i e s by the U n i t e d S t a t e s in 1970 Harris 92 1 a l t h o u g h I d o n ' t k n o w w h a t was in e f f e c t at that 2 tim e . I a s s u m e t h e r e is s o m e s e n s i t i v i t y a m o n g 3 certain government offices about such work having 4 b e e n c o n d u c t e d or h a v i n g it v i e w e d as h a v i n g b e e n 5 c o n d u c t e d in 1970. 6 He w a n t s s i m p l y to have it c l e a r on the 7 r e c o r d that your t e s t i m o n y a b o u t d i o x i n in J u n e 1970 8 and conc e r n i n g its use as a potential chemical 9 w a r f a r e a g e n t wa s in the d e f e n s i v e c o n t e x t of the 1 0 g o v e r n m e n t k n o w i n g a b o u t d i o x i n in ca s e ic wa s used 11 against the U n i t e d S t a t e s by a n o t h e r c o u n t r y . 1 2 A.: I t h i n k it's fair to say that our c o n c e r n for 1 3 n e w t o x i c m a t e r i a l s is a l w a y s d e f e n s i v e . S h o u l d one 1 4 .come up w i t h a c o m p o u n d w h i c h met our c r i t e r i a and, i 15 t h e r e f o r e , was s a f e r or w o u l d do the job b e t t e r than 16 t h o s e a g e n t s in o ur s t o c k p i l e , we m i g h t go f u r t h e r 1 7 and i n v e s t i g a t e it as a p o s s i b l e o f f e n s i v e a g e n t . 18 M A J O R PARR: I t h i n k that c l e a r s it up 19 e n o u g h , t h a n k you. 20 MR. G O R D O N : I d o n ' t t h i n k tha t c l e a r s it i 21 u p ; a t all b ut if y o u ' r e c o n t e n t , I'll l e a v e it. 2 2 THE W I T N E S S : If your s t a t e m e n t w a s that 2 3 MR. GORDON: Off the record. 24 (There is a d i s c u s s i o n off the r e c o r d ) 2 5 Q. A s i d e f r o m y o u r t r i p to the N a t i o n a l 149S7 Harris 93 1 C a n c e r I n s t i t u t e ' to pick up a c o p y of the E i o n e t i c s 2 study, did you have any contacts with any government 3 age n c i e s c o ncerning dioxin or 2,4,5-T or Agent 4 Orange at any time? 5 A.| You mean g o v e r n m e n t a g e n c i e s other than the 6 D e p a r t m e n t of D e f e n s e ? O b v i o u s l y I t a l k e d to 7 E d g e w o o d about it. 8 Qi Yes. O t h e r than the D e p a r t m e n t of 9 Defense . 10 A . No . 11 Q. Did you eve r h a v e any c o n t a c t s w i t h the 1 2 Public Health Service at any time c o n c e r n i n g dioxin 1 3 or 2 , 4 , 5-T? 14 A. To the b e s t of my r e c o l l e c t i o n , the a n s w e r is 1 5 no. We had a liaison officer between Edgewood and 16 C D C , C e n t e r for D i s e a s e C o n t r o l in A t l a n t a . C h a t 1 7 a b o u t lots of t h i n g s . To the best of my 18 r e c o l l e c t i o n , d i o x i n was n ot one of t h o s e . 19 Q. W h a t wa s the n a m e of th a t l i a i s o n o f f i c e r , 20 sir? 21 A. B o r i s O s h e r o f f and he c a r r i e d a ra n k of c a p t a i n . 22 i Q. During what time period was Dr. O s h e r o f f 23 at E d g e w o o d ? 24 A. W e l l , he was t h e r e c e r t a i n l y in my e a r l i e r 25 t e n u r e as t e c h n i c a l d i r e c t o r at E d g e w o o d w h i c h was 1 * P ''Q 1 _ .. Harris 94 1 the d e c a d e fr o m 197 0 f o r w a r d and he was in -- the n 2 r e p l a c e d by Lou ;-- I've go t a n o t h e r e n g r a m , I c a n ' t 3 r e m e m b e r his l a s t n a m e , who I b e l i e v e is s t i l l the 4 liaison. 5 MR. R U S S O : W h a t do you b e l i e v e it is, 6 Do c to r ? 7 THE WITNESS: I believe he's still the 8 .liaison man. I've forgotten his last name. 9 Q. Do you r e c a l l e v e r h a v i n g any 10 communications with the Food and Drug A d m i n i s t r a t i o n 11 c o n c e r n i n g d i o x i n or 2 , 4 , 5 - T ? 1 2 A... Of FDA , no, I d o n ' t r e m e m b e r h a v i n g any 1 3 conversations with them. 1 4 Q. Do y o u r e c a l l h a v i n g d i s c u s s i o n s w i t h 1 5 anyone at DDR&E concerning information that you 16 r e c e i v e d f r o m E d g e w o o d that E d g e w o o d had been 1 7 f a m i l i a r w i t h d i o x i n in the 1 9 5 0 ' s and 1 9 6 0 ' s ? 1 8 A. Well, I have to a g a i n say I d o n ' t recall any. 19 It w o uld be l i k e l y that I told H a y w a r d . 2 0 Q. W h a t was y o u r t i t l e upo n y o u r r e t u r n to 21 E d g e w o o d in J u n e 197 0 ? 22 A. T e c h n i c a l d i r e c t o r , E d g e w o o d A r s e n a l . 2 3 Q. Who did you r e p o r t to as t e c h n i c a l 24 d i r e c t o r? 25 A. My i m m e d i a t e s u p e r i o r was the c o m m a n d e r of the 14989 Harris 95 1 .post. Colonel Paul Cerar for one month and then 2 Colonel George Kanell took over for one year and 3 then there was a succ e s s i o n of them. 4 Q. Who r e p o r t e d to yo u d u r i n g the p e r i o d 5 that you were technical director? 6 A. All of the d i r e c t o r s of the t e c h n i c a l 7 : directorates. 8 M Q. Who were the d i r e c t o r s of the technical 9 d i r e c t o r a t e s ? Who r e p o r t e d to you? 1 0 A.: Dr. S i l v e r of the r e s e a r c h l a b o r a t o r y , C o l o n e l 11 B l a r e of the m e d i c a l l a b o r a t o r y , C o l o n e l H e n d e r s o n 1 2 of the p r o t e c t i v e d i v i s i o n or d i r e c t o r a t e . I've 1 3 forgotten who was the colonel that was head of the 14 munitions directorate -- weapons directorate I guess 15 it; wa s c a l l e d then. P r o b a b l y was C o l o n e l Bas s l a t e r 16 M a j o r G e n e r a l Bass and I c a n ' t r e c a l l if t h e r e w e r e 17 ; o t h e r d i r e c t o r a t e s or not. W h a t e v e r d i r e c t o r a t e s 18 : had a n y t e c h n i c a l w o r k g o i n g on. Not the s a f e t y , 19 s e c u r i t y and that sor t of t h i n g . 20 Q. Ho w long did you s e r v e as t e c h n i c a l 2 1 director at Edgewood? 22 A. U n t i l t h e r e was a n o t h e r r e o r g a n i z a t i o n in w h i c h 23 case it b e c a m e the C h e m i c a l S y s t e m s L a b o r a t o r y and I 2 4 think that was M a r c h of 1977 and the title was 1500025 c h a n g e d to d e p u t y d i r e c t o r and the c o m m a n d e r was Harris 1 d e s i g n a t e d as the c o m m a n d s r / d i r e o t o r . 95 2 Q. How long did you remain as d e p u t y 3 d i r e c t o r of the Chemical S/stems Laboratory? 4 A. Until my r e t i r e m e n t . 5 Q. L a b o r a t o r y ? 6 A. W e l l , unt i l my r e t i r e m e n t , 30 A u g u s t 1980 a f t e r 7 which I was rehired as an n u i t a n t -- rehired as 8 ann u i t a n t for one year until the 31st of August, 9 1930 -- 1981, yes. I've been out that long, yes, I 10 g u e s s so. And I s t i l l d i s c h a r g e the s a m e d u t i e s . 11 W h e t h e r I had the t i t l e or not, I was r e h i r e d 12 annuitant . 1 3 Q. Your fin a l r e t i r e m e n t d a t e from E d g e w o o d 1 4 is; A u g u s t 31, 1 9 8 1 ? 1 5 A.- T h a t ' s r i g h t . 16 Q. Are you c u r r e n t l y e m p l o y e d ? 17 A . I'm c u r r e n t l y p r e s i d e n t of my own c o r p o r a t i o n , 18 j| Q. W h a t iis the n a m e of t h a t c o r p o r a t i o n ? 1 9 A. E n g i n e e r i n g r e s earch c o r p o r a t i o n of G l e n a r m , 20 M a r y l a n d , I n c o r p o r a t e d . 21 Q. W h a t d o e s the E n g i n e e r i n g R e s e a r c h 2 2 Corporation do? 23 A.; C o n s u l t i n g e n g i n e e r . 2 4 Q. D u r i n g y o u r t e n u r e as t e c h n i c a l d i r e c t o r 1500125 at :E d g e w o o d , did you have any d i s c u s s i o n s wit h Harris 97 1 anyone concerning dioxin? 2 A .: P r o b a b l y . ;! - 3 Q. Who do you b e l i e v e you had d i s c u s s i o n s 4 about dioxin with? 5 :A .; The c h a n c e s ar e that I w o u l d h a v e d i s c u s s e d the 6 t e c h n i c a l m a t t e r s with people like J a n d o r f or 7 McNamara . 8 Q. W h a t s o r t of t e c h n i c a l m a t t e r s do you 9 believe you d i s c u s s e d with Dr. M c N a m a r a and Dr. 10 Jandorf? 1 1 A. S u c h i n f o r m a t i o n as is -- w e l l , s u c h 1 2 information as the toxicity levels. 1 3 Q. Do yo u h a v e an y -- 1 4 A.: M o d e of a c t i o n and t h i n g s of t h a t sort. 15 Q. Do y ou h a v e a s p e c i f i c r e c o l l e c t i o n of 16 h a v i n g had s u c h d i s c u s s i o n s ? 1 7 A.! No, I d o n 't h a v e an y s p e c i f i c r e c o l l e c t i o n . 18 i Q. Wha t is the b a s i s for your b e l i e f that 19 .you did h a v e s u c h d i s c u s s i o n s w i t h -- 20 A. W e l l , b e c a u s e it was -- 21 | Q. Drs. Jandorf and Dr. M c N amara? 22 A.| It wa s s o m e t h i n g w i t h w h i c h E d g e w o o d wa s 23 c o n c e r n e d i n a s m u c h as Mr. Sass was d e v e l o p i n g 24 a n a l y t i c a l p r o c e d u r e s and he wa s a c t i n g in this s a m e 1500225 time f r ame in J u n e of 1970 b e t w e e n E d g e w o o d and Harris 1 p e o p l e in the P e n t a g o n . 98 2 Q. W h e n did Mr. S a s s b e g i n d e v e l o p i n g 3 analytical procedures for dioxin? 4 A. W e l l , p r i o r to the t i m e he w e n t to this m e e t i n g , 5 I g u e s s , or a b o u t the time he w e n t to this m e e t i n g . 6 I'm personally unaware of when the action started. 7 Q. Did you s p e a k w i t h Mr. Sass at the M a r c h 8 :1.9 70 m e e t i n g ? 9 :A. Oh, yes. I'm sure I d i d . 1 0 Q. At t h a t m e e t i n g , did Mr. Sas s m e n t i o n to 11 you t h a t he w a s w o r k i n g on a n a l y t i c a l p r o c e d u r e s for 12 dioxin? 1 3 A. W e l l , y o u ' r e a s k i n g me to m a k e a s p e c i f i c 1 4 r e c o l l e c t i o n of the words, you know, what he said 15 and I d o n ' t r e m e m b e r that. 16 Q. Well,: did he i n d i c a t e to y o u in any w a y 1 7 that he knew about dioxin and was working on that 18 are a ? 19 MR. R U S S O : Is t h i s in 1970 y o u ' r e 20 talking about? .i . 21 MR. G O R D O N : Yes . 22 A. I d o n ' t kno w . I k n o w t h a t -- I k n o w o v e r the 2 3 years he had run a n a l y s e s on some of the c o m p o u n d s 2 4 and a figure of one part per m i l l i o n or s o m e t h i n g 1500325 was i n d i c a t e d as a spec level but w hen that was put Harris 1 99 1 in or if it was put in, I d o n ' t know. 2 ! i Q. Do you rec a l l when he ran t h ose a n a l y s e s ? 3 A. No. 4 Q. Do you r e c a l l w h e t h e r it was b e f o r e or 5 after you became technical director of Edgewood? 6 ,A. No. 7 i : Q. Is t h e r e a n y i n f o r m a t i o n a v a i l a b l e that 8 w o u l d h e l p you to d e t e r m i n e w h e t h e r Mr. Sass was 9 w o r k i n g on a n a l y t i c a l t e c h n i q u e s for diox i n before 1 0 or after that March 1970 mee t i n g ? 11 A. I h a v e run a c r o s s it in my -- at l e a s t I d o n ' t 1 2 r e m e m b e r seeing it. 1 3 Q. A f t e r you b e c a m e t e c h n i c a l d i r e c t o r -- 14 strike that. 15 D u r i n g the p e r i o d that you were t e c h n i c a l 16 d i r e c t o r at E d g e w o o d , wa s Mr. Sass w o r k i n g on the 1 7 analytical techniques for dioxin? 18 A*' I t h i n k so, I t h i n k so. 19 i Q. W h a t was the p u r p o s e of that w o r k ? 20 MR. RUSSO: What time frame are we in? 21 1970 again? 22 THE W I T N E S S : W e ' r e in the s e v e n t i e s . 2 3 Q . Yes. 24 A. Now, e x a c t l y w h e n he did it and e x a c t l y w h a t 25 the p u r p o s e was at the m o m e n t , I c a n ' t say. I have 15004 Harris 100 1 no know l e d g e . 2 Q. Was the purpose of his work c o n n e c t e d 3 with Agent Orange? 4 A. I would a s s u m e so. 5 Q. What is the basis for that a s s u m p t i o n ? 6 A. We were not i n t e r e s t e d in it for any other 7 r e a s o n as a chemical warfare agent, for example, or 8 ;a threat agent. 9 Q. Do you know who worked with Mr. Sass on 10 analytical techniques for -- 11 A. No, I d o n ' t . He was c h ief of the a n a l y t i c a l 1 2 branch of the Chemical Division of the Research 1 3 L a b o r a t o r y and as such had a whole staff. 1 4 Q. Did you r e c e i v e or see any papers 15 prepared concerning Mr. Sass's work on analytical 16 techniques for dioxin? 1 7 A. Well, w h a t e v e r I was p a r t y to is in that 18 package of stuff that I gave up on M o n d a y and I 19 don't r e m e m b e r p r e c i s e l y what the -- I d o n ' t 20 r e m e m b e r that that was in it, let me say it that wa y 21 MR . G O R DON: Major Parr, a t this time I 22 request that the g o v e r n m e n t ' s files be s e a r c h e d for 2 3 any r e c ords r elating to work tha c was p e r f o r m e d by 2 4 Mr. Sass at any time or by anyone working under Mr. 25 Sass c o n c e r n i n g a n a l y t i c a l t e c h n i q u e s for d i o x i n . I 15005 Harris 101 1 w i l l put tha t r e q u e s t in my l e t t e r c o m p i l i n g the 2 requests that are being made at this deposition. 3 MR. RUSS O : I r e q u e s t to b r e a k now. 4 MR. G O R D O N : I w a s g o i n g to s u g g e s t t h a t 5 we break for lunch at this time. 6 MR. B U R K E : I'd like to j u s t put 7 something on the record before I forget and I'm sure 8 `I: wi 11 f o r g e t , Gl:en, w i t h r e s p e c t to the p e r s o n a l 9 p a g e s t h a t Dr. H a r r i s has p r o d u c e d to the g o v e r n m e n t , 10 in the e v e n t t h a t the g o v e r n m e n t d e t e r m i n e s tha t 11 s o m e of t h o s e p a p e r s are e i t h e r c l a s s i f i e d or 1 2 privileged, when the other documents are forwarded 1 3 to us, will t h ere be an i n d i c a t i o n that c e r t a i n 1 4 documents have been removed from the doctor's 15 p e r s o n n e l f i l e s for w h a t e v e r r e a s o n the g o v e r n m e n t 16 determines? 17 MAJOR PARR: Yes. I'll make that 1 8 i n d i c a t i o n k n o w n to you. 1 9 MR. BURKE: Thank you. 20 21 1 22 MR. GORDON: Off the record. (There is a d i s c u s s i o n off the r e c o r d ) (Recess) 23 A F T E R N O O N SE S S I O N 2 4 Q. Dr. H a r r i s , a s i d e f r o m the w o r k p e r f o r m e d 2 5 by Mr. Sass concerning analytic techniques for Harris 10 2 1 dioxin, are you aware of any other work c o n c e r n i n g 2 dioxin that was undertaken at Edgewood during your 3 t e n u r e as t e c h n i c a l d i r e c t o r in the 1 9 7 0 s ? 4 A. I d o n ' t r e c a l l any n o w t h a t I w a s a w a r e of. 5 Q. Ar e you av/are of a n y w o r k that was 5 u n d e r t a k e n at E d g e w o o d in the 1 9 7 0 ' s c o n c e r n i n g 7 Agent Orange or 2 , 4 , 5-T? 8 A. I d o n ' t k n o w w h e n t h e y did the t o x i c o l o g y w o r k . 9 I rea d it h e r e but I d o n ' t r e m e m b e r but I w a s n ' t 10 a w a r e p a r t i c u l a r l y at the time, no. 11 ; i Q. Were you aware at all that toxic o l o g y 1 2 work was being per f o r m e d on d ioxin or Agent Orange? 1 3 A. I d o n ' t r e c a l l it now. 1 4 Q. In the 1 9 7 0 s ? 15 A .; We had a h u n d r e d m i l l i o n d o l l a r p r o g r a m and 16 n o b o d y k e e p s up w i t h e v e r y l i t t l e t h i n g . 1 7 Q. A r e you a w a r e w h e t h e r a n y w o r k c o n c e r n i n g j; 18 the d i s p o s a l of A g e n t O r a n g e w as b e i n g c o n d u c t e d at I'M ; : 19 E d g e w o o d in the 1 9 7 0 ' s ? 20 A.: W e ll, I g u e s s I h e ard that the Air Force was 21 interested in d i s p o s i n g of s o m e , I d o n ' t r e c a l l the i 22 d e t a i l of it. 23 Q. Do you r e c a l l w h e t h e r E d g e w o o d was 24 i n v o l v e d in tha t w o r k ? 25 A No Harris 10 3 1 Q. You d o n ' t r e c a l l or you d o n ' t -- 2 A. I d o n ' t recall. 3 Q. W h i l e you w e r e at E d g e w o o d p r i o r to 1966, 4 in 1966 and pri o r to 1966, did you s e r v e as a m e m b e r 5 of any m a n a g e m e n t planning or policy c o m m i t t e e ? 6 A. I g u e s s id I w e r e to be c o m p l e t e l y r i g o r o u s 7 about it, the answer would be yes. I was one of the 8 d i r e c t o r s , for e x a m p l e , in the p e r i o d 1 9 6 3 to 1 9 6 5 , 9 and there was -- the directors got together with the 1 0 c o m m a n d e r o n c e in a w h i l e for one r e a s o n or a n o t h e r 11 of th a t s o r t . It w a s n ' t -- at l e a s t I w o u l d n ' t 12 c h a r a c t e r i z e it as m a n a g e m e n t per s e . It was m o s t l y 13 about -- well, talking about budget matters more 14 than anything else, I guess. 15 Q. W a s t h e r e a n a m e for those m e e t i n g s ? 16 A. Beg your p a r d o n ? 17 | ' Q. Wa s t'here a n a m e for those m e e t i n g s ? 18 A.' W e l l , t h a t ' s w h y I'm h e s i t a n t . It w a s r e a l l y 19 no t a v e r y f o r m a l t h i n g , m e e t i n g on a f o r m a l b a s i s 2 0 or a n y t h i n g , no. It w a s n ' t a s p e c i f i c m e e t i n g . 21 Q. Do you r e c a l l h o w o f t e n t h o s e m e e t i n g s 22 o c c u r r e d ? 2 3 A. I n f r e q u e n t l y . I o n l y r e m e m b e r one, w h e n we g o t , 2 4 together one of the d i r e c torates had been given a 150C825 m a n d a t e to i n c r e a s e their p r o g r a m b e c a u s e s t u d i e s Harris 104 1 had b e e n m a d e i n d i c a t i n g the U . S. was l a g g i n g in 2 the d e f e n s i v e area and so we would beef up the 3 d e f e n s i v e area and t h e y w e r e n ' t abl e to b e e f it up 4 as f a s t as t h e y s h o u l d h a v e , and so we had a m e e t i n g 5 as to s t r a t e g y of h o w we could do th 3 t . 6 Q. A s i d e f r o m the h u m a n e s t i m a t e s of w h i c h 7 you've testified you were a member of, were there 8 any other committee that you've served on at 9 Edgewood in the 1 9 6 0 ' s or 1 9 5 0 ' s ? 1 0 A. I d o n ' t r e m e m b e r a n y o t h e r c o m m i t t e e s . 11 Q. W h a t wa s the U.S. A r m y C h e m i c a l C o r p s 12 Intelligence Agency? 13 A. U.S. A r m y C h e m i c a l C o r p s I n t e l l i g e n c e A g e n c y , I 1 4 d o n ' t p l a c e it. 15 I ,j Q. Do you r e c a l l an o r g a n i z a t i o n r e f e r r e d to 16 as the C C I A ? 17 A.i No. T h e r e ' s a F o r e i g n T e c h n o l o g y C e n t e r in 18 C h a r l o t t e , V i r g i n i a . The y had p e o p l e l o o k i n g into 19 c h e m i c a l m a t t e r s . 20 Q. Do you r e c a l l w h a t the n a m e of the 21 predecessor was for the Foreign Science Technology 22 C e n t e r ? 23 A. No, no. I o n l y ev e r v i s i t e d that o n c e wh e n 24 t h e r e was a m e e t i n g of t e c h n i c a l d i r e c t o r s l o c a t e d 15QG925 the r e . We had m e e t i n g s of technics] d i r e c t o r s all Harris 10 5 j 1 a r o u n d d i f f e r e n t l a b o r a t o r i e s or i n s t i t u t e s and it ! | 2 'was t h e i r t u r n to h o s t it. j3 Q. D u r i n g your e m p l o y m e n t at E d g e w o o d and in .I 4 the Pentagon, did you everdeal with Dr.N a t h a n | 5 Gordon? j 6 A. I k n o w N a t e G o r d o n . I m e t w i t h him a n u m b e r of 7 times . 8 Q. W h e n did you m e e t w i t h Dr . G o r d o n ? 9 W e l l , he - - at one tim e it s e e m s to me it wa s 1 0 e r on , he was kind of a l i a i s o n c a p a c i t y , he 11 w o u l d s h o w up at E d g e w o o d o n c e in a w h i l e , m a y b e 1 2 q u a r t e r l y or s o m e t h i n g , and then in the c o u r s e of my 1 3 d u t i e s , I had o c c a s i o n to v i s i t the o f f i c e to w h i c h 1 4 he was a t t a c h e d and/or give o p i n i o n s on m a t t e r s , all 15 c l a s s i f i e d . 16 1 :' Q. D u r i n g w h a t t i m e p e r i o d did Dr . G o r d o n 17 s e r v e in a l i a i s o n c a p a c i t y at E d g e w o o d ? 18 A .; W e l l / I j u s t have a r e c o l l e c t i o n it wa s e a r l y 19 on , w h e n I -- you k n o w , a ro und the time I f i r s t w e n t 20 to E d g e w o o d 11 m i g h t h a v e b e e n b e f o r e , but I ' m not 21 awareofthat. 22 Q. W h a t was the o r g a n i z a t i o n to w h i c h Dr. 23 G o r d o n was a t t a c h e d ? 24 A. CIA. 25 Q. Dr. G o r d o n was w i t h the CIA? Harris 1 A. Yes. 106 2 Q. In c o n n e c t i o n w i t h your d u t i e s at 3 E d g e w o o d , did y o u d e a l w i t h a n y o n e e l s e in the CI A ? 4 A. Yes . 5 Q. Who w e r e t h o s e o t h e r p e r s o n s ? 6 A. T h e r e was a C o l o n e l B a t l o n . 7 Q. Is tha t A l e x a n d e r B a t l o n ? 8 A.. A l e x , yes an d the m o s t r e c e n t one , a g a i n , I've 9 got an engrain on him, Joe. I d o n ' t r emember -- got 10 in the h a b i t at D D R & E to a l w a y s h a n d l e by f i r s t 11 n a m e s and last n a m e s I c a n ' t r e m e m b e r . 1 2 Q. W h a t w a s the s u b j e c t of y o u r d e a l i n g s 1 3 with Nathan Gordon and Colonel Batlon? 1 4 A. Well, I'm not sure of the c l a s s i f i c a t i o n . 15 G e n e r a l l y s p e a k i n g , I g u e s s I ca n s ay t h a t t h e y we r e 16 c o n c e r n e d b e i n g an i n t e l l i g e n c e g r o u p w i t h t h r e a t s 1 7 a g a i n s t the U.S.: as we were. 1 8 MR. RUSSO: I didn't get that. Would you 1 9 read that b a c k . 20 (The r e c o r d is read) 21 Q. Did y o u ever h a v e a n y d i s c u s s i o n s w i t h 2 2 anyone from the CIA c o n c e r n i n g potential chemical 23 a g e n t s . 1501124 M A J O R PARR: Off the record. 25 ( D i s c u s s i o n off the record) Harris 107 1 A .1 I d o n ' t recall any. I was h e s i t a t i n g d r e d g i n g 2 t h r o u g h my m e m o r y to r e m e m b e r the s p e c i f i c s of 3 anything. 4 Q. Ho w o f t e n did C o l o n e l B a t l o n v i s i t 5 Edgewood? 6 A. W e l l , it was p e r i o d i c a l l y . My r e c o l l e c t i o n n o w 7 i s i it was s o m e w h a t m o r e f r e q u e n t l y d u r i n g his t e n u r e 8 than when Gordonl was there. I sus p e c t -- I have an 9 o p i n i o n that he being a c h e m i c a l o f f i c e r w a n t e d to 1 0 t o u c h b a s e and k e e p m o r e g e n e r a l l y i n f o r m e d in the 11 b a c k g r o u n d of his s p e c i a l t y in a d d i t i o n to his jo b 12 at.-- with his organization. 1 3 Q. D u r i n g w h a t time p e r i o d did C o l o n e l 14 B a t l o n s e r v e as a l i a i s o n for the CIA w i t h E d g e w o o d ? 1 5 A. I d o n ' t have any p o i n t of r e f e r e n c e to r e m e m b e r 16 t h e s e t i m e s . I'm not t r y i n g to b e f u d d l e you. I 17 just c a n ' t r e m e m b e r these t h i ngs. They w e r e n ' t t hat 18 i n t e r e s t i n g to me at the time to ke e p t r a c k of the 19 c h r o n o l o g y . 20 Q. Was t h e r e any r e p r e s e n t a t i v e of the C I A 21 who was a c t u a l l y s t a t i o n e d at E d g e w o o d d u r i n g the 22 19 6 0 's ? 2 3 A.: W e l l , I d on't have any k n o w l e d g e of it. 2 4 Q. Wa s t h e r e a l i a i s o n o f f i c e for the C I A at 25 Edgewood? jtSOiS Harris 1 ;A. I don't b e l i e v e we had one by that name 108 2 certainly. 3 Q. Do you k n o w A r t F e i s t e r ? 4 A . Art? 5 Q . Feister. 6 A. F e i s t e r . 7 Q. F e i s t e r ? 8 A . Yes. 9 Q. Who w as Ar t F e i s t e r ? 1 0 :A. He w as the i n t e l l i g e n c e o f f i c e r at E d g e w o o d 11 d u r i n g my -- he w a s n ' t at the f i r s t , it was kind of 1 2 a d e p u t y and the n he s u c c e e d e d to the job j u s t a b o u t j i| 1 3 the time I left because the chief of the group 1 4 retired or something. 15 Q. Do you r e c a l l who her e p l a c e d ? 1 6 , A.; I r e m e m b e r ,the guy , I r e m e m b e r the man, I c a n j `; 17 .Visualize him but d o n ' t r e m e m b e r his n a m e . He was 18 no t v e r y c o m p e t e n t . I ten d no t to r e m e m b e r 19 i n c o m p e tenc y . 20 Q. Ar e you r e f e r r i n g to Mr. F e i s t e r or his 21 predecessor? 22 A. P r e d e c e s s o r . No, F e i s t e r is v e r y s h a r p . 2 3 Q. W h a t did the i n t e l l i g e n c e o f f i c e r at 2 4 Edgewood do? 25 A. W e l l , he put r e q u e s t s t h r o u g h the s y s t e m when Harris 10 9 1 s c i e n t i s t s m i g h t w a n t to k n o w do we k n o w a n y t h i n g 2 a b o u t what s o m e b o d y has done a b out this, and so he 3 w o u l d put t h o s e r e q u e s t s in t h r o u g h the i n t e l l i g e n c e 4 c h a n n e l s . He w a s a c h a n n e l to the i n t e l l i g e n c e 5 community, the official channel. 6 Q. W a s the i n t e l l i g e n c e o f f i c e r u n d e r the 7 jurisdiction of the CIA? 8 A. Oh, no, no, no. T h i s is the A r m y ' s o p e r a t i o n . 9 Q. Who did the i n t e l l i g e n c e o f f i c e r r e p o r t 10 to? 11 A. W e l l , he r e p o r t e d to, I g u e s s , b e f o r e F e i s t e r , 1 2 in o t h e r w o r d s , b e f o r e the r e o r g a n i z a t i o n , he 1 3 r e p o r t e d to the c o m m a n d e r of E d g e w o o d . A f t e r the 1 4 , r e o r g a n i z a t i o n , he r e p o r t e d to the h e a d q u a r t e r s . He 15 : was an e l e m e n t of the h e a d q u a r t e r s at a R A D C O M . 16 Arm y A r m a m e n t s , R e s e a r c h and D e v e l o p m e n t C o m m a n d . 17 : ! i Q. During the 1960's, was there more than 18 one intelligence officer at Edgewood at any one time? 19 A.i D u r i n g w h e n ? 20 .1 i Q . D u r i n g the 1 9 6 0 's . 21 -:A .i I h a v e no s p e c i f i c k n o w l e d g e of the 22 i n t e l l i g e n c e s t r u c t u r e at E d g e w o o d in the s i x t i e s 23 tha t the y d i d n ' t r e p o r t to me at tha t tim e . 2 4 Q. W h e n was Art F e i s t e r s e r v i n g as an 2 5 i n t e l l i g e n c e o f f i c e r at E dgewood? Harris 110 1 A. In the s e v e n t i e s w h i l e I was t h e r e and my o n l y 2 : r e c o l l e c t i o n of h i m in d e a l i n g s w i t h hi m s e e m e d to 3 ;cluster towards the latter part of that period, the 4 1975 to 1981, 198 2 period. 5 As I: said, he was not the o f f i c e c h i e f at 6 first and I think he became the office chief only 7 about two or three years ago. 8 Q. Do yo u k n o w who L. A l l e n M o u n t e r is? 9 A. A l l e n M o u n t e r ? 1 0 ;l!';H ' Q. Yes. 1 11 :A. I'm u n f a m i l i a r w i t h tha t nam e . 1 2 Q. Do yo u k n o w Dr. D a v i d C a u t h o r n e ? 1 3 A.: Cauthorne I knew, yes, Cauthorne was there, too, 14 . e a r l i e r on. He ' s n o w an E p i s c o p a l p r i e s t , 15 : i n t e r estingly e n o u g h , after he retir e d , yes, I've 16 ; f o r g o t t e n about C a u t h o r n e . 17 ;i Q. What was Dr. C a u t h o r n e ' s p o s i t i o n at 1 8 Edg e w o o d ? 19 A. Mr. C a u t h o r n e . S e e m s to me he was the 20 i n t e l l i g e n c e o f f i c e c h i e f and m a y b e the o n l y one in 21 the o f f i c e p r i o r to the c h a p I c a n ' t r e m e m b e r . 22 Q. W a s he i n t e l l i g e n c e o f f i c e r c h i e f at 23 E d g e w o o d in the 1 9 6 0 ' s ? 24 A. W e l l , he was w h e n I w e n t t h e r e in 1970. 1501525 Q. Do you kno w who Mr. C a u t h o r n e ' s Harris 111 j 1 p r e d e c e s s o r was as i n t e l l i g e n c e o fficer chief? 2 A.' No, I d o n ' t . i I ii j i 3 Q. W h a t was the E u r o p e a n R e s e a r c h O f f i c e of 4 the U.S. Army Research and Development Liaison Group 5 A.; E u r o p e a n R e s e a r c h O f f i c e ? W e l l , t h e y -- I 6 guess their -- they at one time or another, maybe 7 the whole time, they were an adjunct of the ARmy 8 Research Office which was partly down around Duke 9 U n i v e r s i t y , isn't there now, and p a r t l y up on 1 0 C o l u m b i a Pike in the W a s h i n g t o n area in V i r g i n i a , 1 1 and t h e y were l o c a t e d at the E d i s o n H o u s e in L o n d o n 1 2 and I v i s i t e d t h e m t h e r e o n c e on one of my trips to 1 3 L o n d o n -- to E u r o p e . 1 4 Q. Do you k n o w w h e t h e r the E u r o p e a n R e s e a r c h 1 5 O f f i c e had a ny o f f i c e s in H a m b u r g , G e r m a n y ? 1 6 A. I w a s n ' t f a m i l i a r w i t h the i r -- w i t h their 17 s p e c i f i c s t r u c t u r e , so the a n s w e r to that q u e s t i o n 18 s p e c i f i c a l l y is no. I k n o w t h a t the y -- t h a t t h e y 1 9 got a r o u n d to the v a r i o u s c o u n t r i e s . At any g i v e n 20 time if t h e y m a i n t a i n e d an o f f i c e in one or a n o t h e r , 21 I d o n ' t kno w . 22 Q. Do you k n o w w h e t h e r th e y had an o f f i c e in 23 F r a n k f u r t , G e r m a n y ? 24 A. T h a t ' s the s a m e a n s w e r . I m e a n I d o n ' t k n o w -- 150162 5 I d o n ' t know. I w o u l d n ' t be s u r p r i s e d , but, n o .. Harris 112 1 Q. Did you e v e r h a v e an y d e a l i n g s w i t h a 2 Colonel free man of the European Research Office? 3 A. Do you have a first name for him? 4 i Q. No, I don't, 5 A'. W e l l , t h a t 1d o e s n 't s t r i k e any c h o r d -- a n y 6 responsive chord. 7 Q. It m i g h t ha v e b e e n E.E. F r e e m a n -- A . E . 8 Freeman. 9 A. No. 1 O 0. Did you ever h a v e a n y d e a l i n g s with 11 L i e u t e n a n t C o l o n e l M e t c a l f ? 1 2 A . I t h i n k M e t c a l f v i s i t e d me in m y o f f i c e o n c e , 13 once o r maybe twice . 14 i i Q. Do you r e c a l l w h e n that wa s ? 1 5 A. No -- wel l , w i t h i n the l a s t four y e a r s it s e e m s 16 to! m e n o w but I c a n ' t p i n p o i n t -- w e l l , not in the 1 7 l a s t y e a r c e r t a i n l y , not in the las t two y e a r s , so 1 8 maybe three or four years ago. 19 Q. Did you e v e r h a v e a n y d e a l i n g s w i t h a Dr. 20 W y m a n of the E u r o p e a n R e s e a r c h O f f i c e ? 21 A. Yes. Do you h a v e his f i r s t n a m e ? 22 Q . No . 23 A. Yes, he was at ARO. He wa s a c h i e f of the 24 c h e m i c a l b i o l o g i c a l g r o u p at A R O in the r e s e a r c h 2 5 t r i a n g l e in N o r t h C a r o l i n a and then w h e n the 1501? Harris 113 1 i n c u m b e n t of the o f f i c e over there came back, he 2 r o t a t e d to the p o s i t i o n . G e o r g e W y m a n in the E d i s o n 3 house, ERO. 4 Q. D u r i n g w h a t time p e r i o d did Dr. W y m a n 5 serve as head of the chemical b i o l o g i c a l group of 6 the ARmy Research Office? 7 A. I t h i n k he w e n t ov e r to ERO two or t h r e e y e a r s 8 ago and for the p e r i o d of s e v e r a l y e ars b e f o r e that, 9 if y o u c an c o u n t b a c k , it w o u l d hav e b e e n in the 1 0 'll, 'IS, '19 era and how much before that I d o n't 11 r e c a l l now. 12 Q. W h a t wa s the A r m y R e s e a r c h O f f i c e ? 1 3 A. A r m y R e s e a r c h O f f i c e is -- is at the m o m e n t a 1 4 subdivision of the Deve l o p m e n t and Readiness Command. 1 5 Th'ey d i s c h a r g e a b o u t 50 p e r c e n t of the b a s i c 1 6 r e s e a r c h for the A r m y most of which they do by 1 7 grants and contracts with academic institutions. 18 The o t h e r 50 p e r c e n t is d o n e in the s e v e r a l 19 l a b o r a t o r i e s of the A r m y i t s e l f . 20 ! ; Q. Do you r e c a l l w h e n the A r m y R e s e a r c h 21 O f f i c e c a m e into b e i n g ? 22 A. No, no. It's b e e n a w h i l e back, q u i t e a w h i l e 23 back . 24 Q. Dr. H a r r i s , ha v e you ever had an y 25 d e a l i n g s w i t h Hazel ton L a b o r a t o r i e s ? 1501.8 Harris 114 1 A. I h a v e n e v e r had any d e a l i n g s w i t h them. 2 Q. Do y o u k n o w of a n y o n e at E d g e w o o d who has 3 had any dealings? 4 A. E d g e w o o d had a c o n c r a c t with the m at one time 5 ,to do t o x i c o l o g i c a l r e s e a r c h . 6 Q. Do yo u r e c a l l w h a t the t e r m of tha t 7 contract was? 8 A. No. 9 Q. Do yo u k n o w wha t k ind of t o x i c o l o g i c a l 1 0 work Hazelton performed for Edgewood under that 11 c o n t r a c t ? 1 2 A. No, I d o n ' t , I d o n ' t . 1 3 MR. G O R D O N : Dr. H a r r i s , I have no f u r t h e r 14 q u e s t i o n s at this time and I a d j o u r n your d e p o s i t i o n 15 pending the p r o d u c t i o n of any further d o c u m e n t s from 16 your p e r s o n a l files or e l s e w h e r e that m ay bear on 17 your test i m o n y. Thank you very much for your time. i 18 C R O S S - E X A M I N A T I O N BY MR. T Y R R E L L : '1-i1 : 19 ; ;! Q. Dr. H a r r i s , my n a m e is J a m e s T y r r e l l . 20 I'm c o u n s e l to M o n s a n t o in t h i s l i t i g a t i o n . I h a v e 21 r e l a t i v e l y few q u e s t i o n s to a s k y o u t h i s a f t e r n o o n . 22 I : w o n d e r , i n i t i a l l y if you c o u l d tell us w h a t wa s the 2 3 Human Estimate Committee that you served on at 24 Edgewood. 25 A. W e l l , th a t was a c o m m i t t e e m a d e up of p e o p l e of 15019 Harris 115 1 differing backgrounds who would review the data from 2 the l i t e r a t u r e or from our own s tudies on a n i m a l s 3 and try to m a k e an a s s e s s m e n t as to '.'hat d o s e m i g h t 4 be for a human being as a m e a n s of assessing the 5 threat, for example. 6 Q. When was the H u man E s t i m a t e s C o m m i t t e e 7 started at Edgewood? 8 A. W e l l , I'm sur e it was in the 1 9 6 0 ' s or b e f o r e 9 It m a y e v e n have b e e n t h e r e for a l o n g e r time. I 1 O s e r v e d on it, of c o u r s e , in the s i x t i e s , m a y b e as 1 1 early as the late fifties because when I was 12 a s s i s t a n t for C A R A M U I was on it. 1 3 Q. Did the Human E s t i m a t e s C o m m i t t e e have a 14 staff that did work just for that c o m m i t t e e ? 1 5 A N o , no . 16 iQ Did the Human E s t imates Committee review 17 'all t o x i c o l o g y d a t a b a s e d on a n i m a l s t u d i e s t h a t 18 w e r e d o n e at E d g e w o o d ? 19 A. W e l l , o n l y in t h o s e a r e a s for w h i c h it was 20 d e s i r a b l e to m a k e a h u m a n e s t i m a t e . Lots of I 21 w o r k is d o n e an d yo u find a c o m p o u n d 22 isn't toxic at all or v e r y l i t t l e t o x i c i t y and it's 23 discarded . 24 Q. Have you f i n i s h e d y o u r a n s w e r ? 25 A . Yes. Harris 116 1 Q. W e r e t h e r e some e s t a b l i s h e d p r o c e d u r e s by 2 which the Human E s t i m a t e s Com m i t t e e e x t r a p o lated 3 fro m animal t o x i c o l o g y data to e f f e c t o p h u m a n s ? j 4 A . E v e r y b o d y w i s h e s there w e r e . T h e r e is no s u c h i 5 and t h a t ' s w h y one h a s to do it by p e o p l e of v a r y i n g | 5 . d i s c i p l i n e s and b a c k g r o u n d s to try to m a k e e s t i m a t e s . 7 If it w e r e p o s s i b l e to c o r r e l a t e e v e n f r o m one 8 a n i m a l s p e c i e s to a n o t h e r , tha t w o u l d be s o m e t h i n g 9 the t o x i c o l o g i s t s would be d e l e r i o u s l y h appy about. 1 0 As you can see f r o m the i n f o r m a t i o n in 11 thi s E x h i b i t 2, p a r a g r a p h two, d i o x i n is s p e c i e s 12 s p e c i f i c as e v i d e n c e d by d i f f e r e n c e s -- ver y g r eat 13 differences between rats and guinea pigs and that 1 4 s p e c i e s s p e c i f i c i t y e x i s t s for s o m e c o m p o u n d s and is 1 5 less so for o t h e r s . Some n e r v e a g e n t s , for e x a m p l e , 16 a n u m b e r of s p e c i e s h a v e a p p r o x i m a t e l y the same d o s e 17 (and, t h e r e f o r e , y o u . s a y , w e l l , the g r e a t e s t 18 l i k e l i h o o d is th a t m a n m i g h t h a v e t h a t s a m e d o s e . 19 Other n e r v e a g e n t s h a v e v e r y d i f f e r e n t v a l u e s for 20 d i f f e r e n t s p e c i e s and one has to then try to m a k e an 21 a s s e s s m e n t , w h a t the t r e n d s are as yo u go f r o m 22 a n i m a l l e a s t lik e m an to a n i m a l s m o r e like ma n and 2 3 it g e t s ver y hairy. 24 Q. H o w o f t e n w o u l d the H u m a n E s t i m a t e s . 2 5 Comm ittee meet? 15021 Harris 117 1 A . 1 It w o u l d bs m o r e l i k e by m o n t h l y i s s u e . 2 3A Q. Was t h e r e a s e c r e t a r y of the c o m m i t t e e ? Yes, I b e l i e v e it w o u l d be it wa s one of the 4 m e m b e r s was also the secretary. 5 Q. How m a n y i n d i v i d u a l s w e r e on the 6 comm i11 e e ? 7 A. T h e r e was s o m e t h i n g in the n e i g h b o r h o o d of 8 seven or so, as I remember now off the top of my 9 head, and I mentioned about that and many names 1 0 earlier that were on at one time or another. Not 11 n e c e s s a r i l y all at the s a m e time. 1 2 Q. Did t h e y all c o m e f r o m on e or a n o t h e r 13 a g e n c y at Edgewood? 1 4 A . Yes. 15 Q. Wa s t h e r e an y p a r t i c i p a t i o n by Fort 16 D e t r i c k in that c o m m i t t e e ? 17 A. I d o n ' t b e l i e v e t h e r e was at a n y time. I was 18 t r y i n g to r e m e m b e r w i t h r e s p e c t to b o t u l i n u m t o x i c 19 but I b e l i e v e the e s t i m a t e for b o t u l i n u m was m a d e at 20 Fort D e t r i c k and we just a c c e p t e d it, but o t h e r than 21 t h a t , no, t h e y w o u l d have no inp u t to the re s t of it. 22 Q. W e r e m i n u t e s k e p t of the m e e t i n g s of the 23 H u man E s t i m a t e s C o m m i t t e e ? 24 A It's my recollection that there were but I 25 w o u l d find it hard to put my f i n g e r on it. P r o b a b l y Harris 118 1 all classified, I may add. 2 Q. Dr. H a r r i s , c h a n g i n g s u b j e c t s on you, I 3 b e l i e v e you said that you studied for a period of 4 t i m e at the I n d u s t r i a l C o l l e g e of the A r m e d F o r c e s ? 5 iA. Yes . 6 Q. W h a t d i d the c u r r i c u l u m at that c o l l e g e 7 include? 8 :.A. W e l l , it -- as- I i n d i c a t e d , it was a c o u r s e in 9 'logistics man a g e m e n t . We studied gross aspects of 10 the v a r i o u s k i n d s of i n d u s t r i e s in the U n i t e d S t a t e s , 11 e l e c t r i c a l p o w e r i n d u s t r y , the s t e e l i n d u s t r y , the 12 c h e m i c a l i n d u s t r y and so on from the s t a n d p o i n t of 1 3 where its strengths and weaknesses were, how they 1 4 were managed and what their resources would be, for 15 e x a m p l e , in tim e of e m e r g e n c y . 16 Q. W e r e a n y c o u r s e s that w e r e g i v e n at the 17 I n d u s t r i a l C o l l e g e of the A r m e d F o r c e s r e l a t e d 18 d i r e c t l y to c h e m i c a l w a r f a r e a g e n t s ? 19 A . No . 20 | Q. Was there any school within the a rmed 21 forces that taught concerning chemical warfare? 22 A . Yes. 23 Q. W h a t was t h a t ? 2 4 A Well, there's the Chemical Corps School has 25 g o n e t h r o u g h v a r i o u s and s u n d r y r e o r g a n i z a t i o n s , a t Harris 119 1 lone time belonged with the Ord i n a n c e and Corps 2 i S c h o o l of A b e r d e e n is now the C h e m i c a l S c h o o l or 3 some such title' at A n n i s t o n , A l a b a m a at Fort 4 McClellan. 5 Q. Did you ever a t t e n d that s c h o o l ? 6 A . No . 7 Q. W a s t h a t o p e n to c i v i l i a n e m p l o y e e s in 8 the military? 9 A. W e l l , it w o u l d n ' t m a t t e r . I' m a r e s e r v e 10 officer. I could have gone then, but I don't recall 11 that it is. T h e r e was also a flag o f f i c e r ' s lev e l 12 c o u r s e for s e n i o r g o v e r n m e n t o f f i c i a l s at D u g w a y 13 P r o v i n g G r o u n d for a w h i l e , I g u e s s in the late 1 4 fifties, and I did attend that course as kind of as 15 a -- I took it but I also was a r e s i d e n t e x p e r t 16 r e s o u r c e p e r s o n . j 17 Q. On c h e m i c a l w a r f a r e a g e n t s ? 1 8 A. On c h e m i c a l w a r f a r e p e r i o d , c h e m i c a l and 19 b i o l o g i c a l w a r f a r e . 20 ! 1 Q. At w h a t p o i n t in tim e did you a t t e n d that 2 1 : school at Dugway? 22 A. : I ca n p i n p o i n t it in the f i f t i e s ri g h t n o w 23 Only i t m a y -- I d o n ' t know. I a t t e n d e d s u n d r y 24 c o u r s e s o f tha t s o r t . As I sa id b e f o r e , s h o r t 25 c o u r s e s . T h i s w a s o n l y a one w e e k c o u r s e . And I 15024 Harris 120 1 c o n f u s e them, run t o g e t h e r in my m i n d ns to w h i c h 2 one I a t t e n d e d whe n but it was p r o b a b l y in the 3 f i f t i e s . I t h i n k we set up the s c h o o l to e d u c a t e 4 the A r m y -- w e l l , to e d u c a t e the s e n i o r level 5 m i l i t a r y p e o p l e of all the s e r v i c e s in che t h r e a t of 6 c h e m i c a l w a r f a r e and so m e of us a t t e n d e d the f i r s t 7 :few s e s s i o n s as a r e s o u r c e p e r s o n for the f a c u l t y 8 and the student body. 9 Q. Did you d i s c u s s p a r t i c u l a r c h e m i c a l 1 0 c o m p o u n d s at that school? 1 1 A. G e n e r a l l y s p e a k i n g , they d i s c u s s e d o n l y those 12 c o m p o u n d s tha t w e r e in the -- s o m e b o d y ' s 1 3 a r m a m e n ta r i urn . 1 4 Q. W as d i o x i n ever d i s c u s s e d at that s c h o o l 1 5 to the b e s t of your r e c o l l e c t i o n ? 1 6 A. I c e r t a i n l y w a s n ' t -- it c e r t a i n l y w a s n ' t when 1 7 I was the r e and I w o u l d be v e r y s u r p r i s e d if it was 18 ever even m e n t i o n e d . 19 j :! Q. D o c t o r , I b e l i e v e yo u t e s t i f i e d at the 20 o p e n i n g this m o r n i n g that you w r o t e v a r i o u s a r t i c l e s / 21 s o m e for the o p e n p r e s s and s o m e tha t w e r e kept 22 c o n f i d e n t i a l in the m i l i t a r y ; is t h a t c o r r e c t ? 23 a . Rlght. 15025 24 Q. And you t u r n e d o v e r , if I' m c o r r e c t , 25 c o p i e s of y o u r a r t i c l e s to the l a w y e r s that y o u m e t Harris 121 1 w i t h up from the g o v e r n m e n t in W a s h i n g t o n M o n d a y ? j :! 2 A. No, no, no. Oh, w a i t a m i n u t e now -- no, no, I ! 3 turned over my files of dioxin and O r a n g e . Those j 4 a r t i c l e s I had e xcised or g o t t e n one way or a n o t h e r 5 on those two subjects, not on chemical warfare or i 6 not those of my own p u b l i c a t i o n s either. 7 M Q. Do you m a i n t a i n a c o p y of your o w n 8 p u b l i c a t i o n s on chemical warfare subjects? 9 A. W e l l , the o n l y a r t i c l e s that I have p u b l i s h e d 1 0 d i r e c t l y on c h e m i c a l w a r f a r e in the o p e n l i t e r a t u r e 11 w e r e the l a s t two, yes, I h a v e them. 12 i . Q. Do you m a i n t a i n c o p i e s of the a r t i c l e s 1 3 that do not -- that you wrote that were published 1 4 o t h e r than in the o p e n l i t e r a t u r e ? 1 5 A.i T h e y w e r e c l a s s i f i e d . . Mi ! 16 Q. D o e s tha t m e a n you did not r e t a i n a c o p y 17 of it? 18 A. T h a t ' s e x a c t l y r i g h t . T h a t ' s a g a i n s t the law. 19 i ; Q. Do you k n o w if t h e y are m a i n t a i n e d in the 20 l i b r a r y s o m e w h e r e ? 21 ::A. i Oh, yes. W e l l , t h e y c e r t a i n l y w e r e f i l e d in 22 the l i b r a r y at E d g e w o o d . To w h a t d e g r e e over the 23 ;:years they may have b e e n r e v i e w e d and d e s t r o y e d , I 24 c a n ' t say. T h e s e w e r e m o s t l y in the p e r i o d 1 9 4 0 - 1 9 4 1 25 to 1946 w h e n I was in the s e r v i c e and my g r o u p Harris 122 1 t u rned out a b o u t 115 r e p orts of w h i c h I was an 2 a u t h o r or c o - a u t h o r of 80 odd. 3 Q. Do you r e c a l l if a n y of y o u r r e p o r t s 4 dealt with any of the chlorinated aromatic 5 hyd rocarbons? 6 A. C h l o r i n a t e d a r o m a t i c h y d r o c a r b o n s . T h a t ' s a 7 f a n t a s t i c a l l y big field but the answer is no p r e t t y 8 m u ch. They were l a r g e l y on the m u s t a r d s e r i e s of 9 compounds and later on the early work on the nerve 1 0 a g e n t s which we got from G e r m a n y just about the end 11 of my t e n u r e in the l a b o r a t o r y . W h e n I c a m e b a c k I 1 2 c a m e in -- w h e n I c a m e b a c k w i t h the g o v e r n m e n t in 1 3 the fifties I went into management. 14 MR. T Y R R E L L : T h a n k you, D o c t o r . I d o n ' t 1 5 have any f u r t h e r q u e s t i o n s s u b j e c t to the same 16 c o n d i t i o n s e x p r e s s e d by Mr. G o r d o n . 1 7 MAJOR PARR: Let's take a break. 18 (Recess) 19 ( T h e r e is a d i s c u s s i o n off the record) 20 C R O SS-EXAMINATION BY MR. BURKE: 21 Q. S i n c e yo u d o n ' t r e m e m b e r a n y b o d y ' s n a m e , 22 let me r e i n t r o d u c e m y s e l f . My n a m e is J a c k B u r k e . 23 I r e p r e s e n t T.H. A g r i c u l t u r e and N u t r i t i o n , Inc., in 2 4 this c a se. I'm g o i n g to be a s k i n g you s o m e 150272 5 q u e s t i o n s b a s i c a l l y a l ong the same l i nes as have J Harris 123 1 bee n p u r s u e d a l r e a d y . I m a y be r e p e t i t i v e ju s t to 2 c r e a t e a p r o p e r f l o w so I'm t e l l i n g yo u 'his n o w so 3 you d o n ' t h a v e to p ay a t t e n t i o n to Mr. Rus s o w h e n he 4 o b j e c t s b e c a u s e :the q u e s t i o n has b e e n a s k e d and 5 answered already. 6 Yo u told us e a r l i e r , did you not, sir, 7 t h a t at so m e p o i n t in the l a t e s i x t i e s p e r h a p s 8 b e g i n n i n g in 1967 tha t a r t i c l e s w e r e a p p e a r i n g in 9 the p r e s s w i t h r e s p e c t to p o t e n t i a l e n v i r o n m e n t a l ( 1 0 d a m a g e r e s u l t i n g from the use of A g e n t O r a n g e ; is 11 that c o r r e c t ? 12 A. A p p r o x i m a t e . 13 Q. T h o s e a r t i c l e s t h a t a p p e a r e d in the p r e s s , 14 did they indicate that Agent Orange was being used 15 in S o u t h e a s t A s i a ? 16 A . Yes. 17 MR. R U S S O : O b j e c t i o n as to w h a t the 18 a r t i c l e s a i d . 19 A. W e l l , all of this is a h a z y r e c o l l e c t i o n . I 20 have to p r e f a c e it w i t h that. Our c o n c e r n w i t h the 21 e n v i r o n m e n t a l i s t s in this time f r a m e was that t h e y 22 were killing trees or killing v e g e t a t i o n which would 23 be a long ti m e to r e g e n e r a t e and the p e o p l e had an 24 e c o n o m i c d e p e n d e n c e on it, y o u kno w , and all th a t 1502825 good stuff and, t h e r e f o r e , it was a n a u g h t y thing to Harris 124 1 do. 2| Q . So, was it you r u n d e r s t a n d i n g b a c k in 3 ;t h a t 196 7 , 19 6 8 time f r a m e t h a t t n e r e w e r e c e r t a i n i 4 e n v i r o n m e n t a l i s t s her e in the U n i t e d S t a t e s who w e r e 5 raising alarm over possible permanent ecological 6 .damage to the f o l i a g e in V i e t n a m by using A g e n t 7 Orange? 8 A. W h e n y ou s a y p e r m a n e n t , you m e a n p e r m a n e n t to a 9 p a r t i c u l a r tree or p e r m a n e n t for the i n d efi n i t e 10 future? 11 Q. P e r m a n e n t to a p a r t i c u l a r tree or -- 1 2 A. To the tre e . The r e g e n e r a t i o n rate of t r e e s is 1 3 .very low. 14 i Q. B a c k w h e n t h o s e a r t i c l e s were a p p e a r i n g 15 in the p u b l i c p r e s s , is it y o u r t e s t i m o n y th a t 16 s o m e b o d y a s s o c i a t e d w i t h the O f f i c e of the S e c r e t a r y 17 of D e f e n s e a s k e d y o u to w r i t e p a p e r s or to b r i e f 18 that particular subject? 19 A.| The o n l y real r e c o l l e c t i o n I h a v e to t h a t p o i n t 20 w a s tha t a lot of p e o p l e w o u l d w r i t e in to t h e i r 21 C o n g r e s s m e n or to the P r e s i d e n t w i t h q u e s t i o n s w h i c h 22 * I could p a r a p h r a s e of the sort, Why are we k i l l i n g 2 3 the poor t r e e s , and s t a n d a r d p r a c t i c e in the 24 g o v e r n m e n t is w h e n e v e r C o n g r e s s m e n or the P r e s i d e n t 25 ge t s a letter of that sort w h i c h d eals with some 15029 Harris 125 1 s u b s t a n t i v e m a t t e r of one oi the d e p a r t m e n t s , the 2 l e t t e r is b u c k e d to the d e p a r t m e n t for an 3 'information letter upon which they can base a reply 4 land so I w o u l d p r e p a r e l e t t e r s of s o r t to be s i g n e d 5 by Dr. Foster or his deputy which would say the 6 P r e s i d e n t has a s k e d me to r e p l y to your -- or 7 Congressman so and so has a s k e d me to r e p l y to your 8 l e t t e r of so and so on the f o l l o w i n g m a t t e r . Here 9 are the facts and that sort of thing. 10 i^ Now, those came through by the h u n d r e d s 11 at the t i m e of the s h e e p i n c i d e n t in Utah, I 1 2 personally answered 585, also got a coronary 1 3 o c c l u s i o n ou t of. it. T h a t ' s w h y it's v e r y d i f f i c u l t 14 n o w w h e n you ask me a q u e s t i o n did you w r i t e a paper 1 5 : o n s o and so, I w r o t e h u n d r e d s of papers. W h e t h e r 1 6 any of them went to Ted H a y w a r d or w h e t h e r any of 1 7 1 them were for Johnny Foster versus being signed by 18 'Johnny F o s t e r that g o e s s o m e w h e r e e l s e , it's 19 i m p o s s i b l e to s a y at this p o i n t . 20 ; Q. In a n y e v e n t , t h o u g h , sir, is it you r 21 t e s t i m o n y that you did p r e p a r e some w r i t i n g s in or 22 a b o u t that time d e a l i n g w i t h the s u b j e c t of p o s s i b l e 2 3 p e r m a n e n t d a m a g e to t r ees r e s u l t i n g from use of 24 Ag ent O r a n g e ? 2 5 A . Yes . 15030 Harris 126 1 Q. Can you tel 1 me, sir, w h a t f o r m a l 2 e d u c a t i o n you h a v e had in the field of e c o l o g y ? 3 A . If you p h r a s e it th a t way, I g u e s s I h a v e n ' t 4 had a n y f o r m a l l y e d u c a t i o n in the f i e l d of e c o l o g y , , 5 j ;M... Q. Do y ou h a v e a n y e x p e r i e n c e in the fie l d 6 of e c o l o g y? 7 :A . I h a v e had a lot of c o l l a t e r a l i n f o r m a t i o n . 8 W e l l , c e r t a i n l y , the r e is an e c o l o g y 9 branch at Edgewood. I was familiar with those 1 0 people, discussed with those people. I've had a -- 1 1 kind of an a v o c a t i o n a l i n t e r e s t in the fie l d of 1 2 a g r i c u l t u r e ever s i n c e my Boy S c out days and so on, 13 but the s u b s t a n c e of my d i s c u s s i o n s was not are the 1 4 t r e e s d y i n g or is t h a t g o o d or is t h a t bad, but h e r e 15 are the f a c t s p e r t i n e n t to you r q u e s t i o n as, for 16 e x a m p l e , I g o t one l e t t e r one time that s a i d if one 1 7 of t h o s e s h i p s t h a t w e n t to V i e t n a m w i t h h e r b i c i d e s 18 in it sank in the o c e a n , it w o u l d ki l l all the 19 p l a n t a i n in the o c e a n , all the o x y g e n in the air 2 0 c o m e s from p l a n t a i n in the o c e a n and we w o u l d all 21 s u f f o c a t e . The s u b s t a n c e of my r e p l y was s o m e t h i n g 22 l i k e thi s : If all the o r g a n i c m a t t e r in the w h o l e 23 b i o s p h e r e were to be c o m b u s t e d w i t h the a t m o s p h e r i c 24 o x y g e n it w o u l d take two p e r c e n t of the o x y g e n in 2 5 the atmosphere -- one can make these calculations, 15031 Harris 127 1 offhand -- just from the gross amount of the oxy g e n 2 and o r g a n i c m a t t e : . Also, I c a l l e d the D e p a r t m e n t 3 of A g r i c u l t u r e and said w h a t is the to 1 e r a nc e l e v e l 4 for plantain for the herbicides and mentioned a 5 specific herbicide , let's say, and they said, well, 6 it's such and such a dosage . S o , I got out a slide 7 ,rule and I c a l c u l a t e d , if all of the h e r b i c i d e s that 8 we e v e r s h i p p e d to V i e t n a m up to that p o i n t w e r e to 9 s i n k in one s e c t i o n of o c e a n ten m i l e s by ten m i l e s 1 0 by on e m i l e d e e p , it w o u l d c o m e to l / 2 0 0 t h s of the 1 1 t o l e r a n c e lev e l for p l a n t a i n and I jus t said that to 1 2 the p e o p l e , y o u see, t r y i n g to put this thing in 1 3 p e r s p e c t i v e so that they w o u l d n ' t p a n i c , you know. 1 4 ! Q. You m e n t i o n e d t h a t up s p o k e to s o m e b o d y 15 at A g r i c u l t u r e w i t h r e s p e c t to that p a r t i c u l a r 16 i n q u i r y . . Do you r e m e m b e r the n a m e of the p e r s o n 1 7 ; tha t you s p o k e to at A g r i c u l t u r e ? 18 A.i It p r o b a b l y was Dr. T s c h i r l e y and he was my 19 r e f e r e n c e for a n u m b e r of t h e s e s o r t of q u e s t i o n s to 20 : a n s w e r t h i s kind of -- in o t h e r w o r d s , I did not 2 1 r e l y w h e r e it r e q u i r e d b i o l o g i c a l i n f o r m a t i o n on my 22 own e x p e r t i s e . I c a l l e d the -- you know, w h o e v e r it 23 w o u l d be . 24 Q. Now, on the o c c a s i o n s that you r e s p o n d e d 25 to i n q u i r i e s w i t h r e s p e c t to p o t e n t i a l d a m a g e to the - 1^noo Harris 128 1 l e t ' s say, the t r e e s and tne f o l i a g e in V i e t n a m , di d 2 you always c o n t a c t Dr. T s c h i r l e y at the D e p a r t m e n t 3 of Agriculture for assistance? 4 A. W h e n e v e r there was s o m e t h i n g new. 5 Q. D u r i n g y o u r c o n v e r s a t i o n s w i t h -- 6 A. Not n e c e s s a r i l y T s c h i r l e y . T h e r e was a n o t h e r 7 ichap t h e r e and I c a n ' t r e m e m b e r his nam e . He was 8 one of the -- one of his a s s o c i a t e s of Dr. T s c h i r l e y . 9 Q. Did y o u eve r s p e a k to Dr. W a r r e n S h a w at 1 0 the D e p a r t m e n t of A g r i c u l t u r e ? 1 1 'A. Yes, yes, t h a t ' s the o t h e r one. 1 2 Q. D u r i n g yo u r c o n v e r s a t i o n s w i t h e i t h e r Dr. 1 3 T s c h i r l e y or Dr. Shaw, did the d i s c u s s i o n of 14 p o t e n t i a l a d v e r s e h u m a n h e a l t h e f f e c t s c o m e up w i t h 15 r e s p e c t to the use of A g e n t O r a n g e in V i e t n a m ? 16 A.: I d i d n ' t d i s c u s s it w i t h him, no. 1 7 Q. Did t h e y ever d i s c u s s it w i t h you? 18 A . No, no. 19 I Q. P r i o r to 1967, did you e v e r b e c o m e a w a r e 20 : e i t h e r t h r o u g h the p r e s s or t h r o u g h c o n v e r s a t i o n s \ 21 wit h a n y b o d y that a l l e g a t i o n s were b e ing m a d e of 22 pote n t i a l a d v e r s e health e f f ects a s s o c i a t e d with 23 A g e n t O r a n g e in V i e t n a m ? 24 A. P r i o r to w h e n ? 25 Q. Prior to 1967. 15033 Harris 129 1 A . No . 2 1 Q. P r i o r to 1970, did it e v e r c o m e to you r 3 the a t t ention by way of c o n v e r s a t i o n or by reading 4 m a t e r i a l s that some people were claiming, and by 5 s o m e p e o p l e , I'm r e f e r r i n g to e i t h e r c i t i z e n s of the 6 United States or c i tizens of Vietnam, that there was 7 a potential adverse health effect associated with 8 the use of A g e n t O r a n g e in V i e t n a m ? 9 A. S o m e b o d y , and I'm not s u r e w h e t h e r it was Dr. 1 0 M e s e l s o n and W esting or G e o r g e Wald at Harvard, 11 s o m e b o d y , or B a r r y C o m m o n e r , t h e s e w e r e p e o p l e th a t 12 w e r e f i g h t i n g in the g e n e r a l e c o l o g y b u s i n e s s at the 1 3 tim e , m a d e c o m m e n t s , and I t h i n k it wa s on the b a s i s 1 4 of the B i o n e t i c s r e p o r t so that w o u l d h a v e bee n in 1 5 and around the 1970, 1969 or whenever that was, that 1 6 pregnant women could drink the water from their 17 s i s t e r n s w h e n they g e t the w a t e r r u n n i n g off the 18 roof and so on, and so we sat d o w n and m a d e a 19 c a l c u l a t i o n b a s e d on the rat d a t a w h i c h are the o n l y 20 data you had and the only data they had that even 21 with the Bionetics sample which apparently was 2 2 f a i r l y h i g h in d i o x i n a w o m a n w o u l d h a v e had to 23 d r i n k 160 l i t e r s of w a t e r per da y -- and a s s u m i n g a 24 certain d e p o s i t i o n on the roo f , y o u ' v e g o t to m a k e 25 an a w f u l lot of a s s u m p t i o n s , s y s t e m s a n a l y s i s she 15034. Harris 130 1 w o u l d have to d r i n k 160 l i t e r s e v e r y da y d u r i n g the 2 s e c o n d t r i m e s t e r of her p r e g n a n c y to have the s e 3 ;effects, w h i c h did not s e e m l o g i c a l . 4 Q. Who p a r t i c i p a t e d in tha t p a r t i c u l a r s t u d y ? 5 A. W hich study? 6 Q. The one that we just t a l k e d a b o u t that 7 c o n c l u d e d t h a t a w o m a n w o u l d h a v e to d r i n k a h u n d r e d 8 and -- 9 A. I said -- I t h ink I m a d e that c a l c u l a t i o n . 1 0 p. Did s o m e b o d y a s s i s t y o u in t h a t ? 1 1 A. By a s s i s t -- 1 2 Q. Or w o r k w i t h you is w h a t I r e a l l y m e a n . 1 3 A.: No, the a n s w e r to t h a t is no. The d a t a I got, 1 4 I g o t by the p e o p l e o b v i o u s l y , d i d n ' t get it out of 15 my o w n m i n d , g o t it o u t of the B i o n e t i c s r e p o r t or 16 w h a t e v e r it was and m a k i n g r e a s o n a b l e a s s u m p t i o n s of 1 7 ; the s pray level that were made, we knew how much 18 s p r a y was put d o w n on the f i e l d and so m e of that 19 s o r t o f t h i n g . 20 ;j Q. You were youdirected by s o m e b o d y within 21 the U n i t e d S t a t e s G o v e r n m e n t to c o n d u c t t h a t s t u d y ? 22 A . : Oh, no, that was as a matter of a n s w e r i n g these 23 l e t t e r s , p u t t i n g that in p e r s p e c t i v e , you k n o w , 2 4 s o m e b o d y w o u l d w r i t e in and say t h e s e p e o p l e w o u l d 25 all d i e and we said it d o e s n ' t s e e m l o g i c a l b e c a u s e Harr is 131 1 h e r e is w h a t w o u l d hav e to h a p p e n for th a t to o b t a i n . 2 Q. W o u l d it be fair to say that these 3 l e t t e r s th a t you w e r e r e f e r ring to w e r e add r e s s e d to 4 'somebody other than yourself? 5 A.! W e l l , the l e t t e r s t h a t I was p r e p a r i n g w e r e -6 a n d to w h i c h I w a s r e f e r r i n g p r e v i o u s l y w e r e in 7 an'swer to C o n g r e s s i o n a l or P r e s i d e n t i a l l e t t e r s from 8 the electorate. 9 Q. So the l e t t e r s t h a t y o u ' r e r e f e r r i n g to 1 0 c a m e f r o m a c i t i z e n to a C o n g r e s s m a n and the 11 C o n g r e s s m a n then r e f e r r e d it on to s o m e b o d y in the 1 2 S e c r e t a r y of D efense? 1 3 A. The D e p a r t m e n t of D e f e n s e and I p r e p a r e d the 1 4 l e t t e r b a c k to the C o n g r e s s m a n w h i c h was s i g n e d by 15 Dr'. F o s t e r or his d e p u t y . 1 6 Q. The i n q u i r i e s t h a t a c t u a l l y c a m e f r o m the 1 7 C o n g r e s s m a n , tho s e i n q u i r i e s wer e not a d d r e s s e d to 18 you p e r s o n a l l y ; w e r e t h ey? 19 * V No 2 0 Q. T h e y w e r e a d d r e s s e d to s o m e b o d y el s e in 21 the Sec retary of D e f e n s e ' s office and then r e ferred 22 to yo u for r e s p o n s e ; is that c o r r e c t ? 2 3 A .: Precisely. 24 Q. Who did the C o n g r e s s m e n g e n e r a l l y ref e r 25 t h o s e l e t t e r s to? 15035 Harris 132 1 A. If it c a m e to me, it w o u l d be u s u a l l y a d d r e s s e d 2 to the S e c r e t a r y of D e f e n s e . 3 Q. To y o u r k n o w l e d g e -- 4 A. Or to the P r e s i d e n t and at the W h i t e H o u s e the 5 b u c k g o e s o v e r to us als o . 6 Q. W i t h r e s p e c t to t h o s e p a r t i c u l a r l e t t e r s 7 r e c e i v e d f r o m a C o n g r e s s m a n a d d r e s s e d to the 8 S e c r e t a r y of D e f e n s e , do y ou k n o w if it was the 9 c u s t o m and p r a c t i c e of the S e c r e t a r y of D e f e n s e to 1 0 r e v i e w t h o s e l e t t e r s p r i o r to r e f e r r i n g th e m on to 1 1 you for response? 12 MR. R U S S O : Th i s is on his p e r s o n a l 1 3 k n o w l e d g e . Y ou d o n ' t want h i m to s p e c u l a t e on t h is, 14 do you? 15 MR. B U R K E : A s k i n g c u s t o m and p r a c t i c e . 16 MR. R U S S O : P e r s o n a l k n o w l e d g e . 1 7 Q. Y o u r p e r s o n a l k n o w l e d g e of the c u s t o m and 18 practice . 19 A. I d o n ' t k n o w the r o u t i n g to me. 20 ;! 'i Q. Okay.! 21 Now, t h e r e ca m e a time, did t h e r e not, 22 sir, in the l a t e 1 9 6 0 ' s that you b e c a m e a w a r e of a 23 r e p o r t that was p u b l i s h e d by the B i o n e t i c s R e s e a r c h 2 4 Labs Inc. regarding 2,4,5-T? 25 A Yes . 15O .j Harris 13 3 1 MR. R U S S O : Is that la t e 1 9 6 C 1s or 1970 2 that he t e s t i f i e d to? Do we have to go b a c k to the - 3 THE W I T N E S S : We h a v e n ' t b e e n a b l e to 4 ta c k it d o w n as to w h e t h e r -- it c e r t a i n l y was p r i o r 5 ;to this m e e t i n g but h o w p r i o r is s t i l l up in the air 6 as far as my r e c o l l e c t i o n is c o n c e r n e d . 7 Q. Ho w did you f i r s t b e c o m e a w a r e of the 8 fact that Bionetics had published a report with 9 r e s p e c t to t h e i r r e s e a r c h into 2 , 4 , 5 - T ? 1 0 A. W e ll, I d i d n ' t say that they p u b l i s h e d it. 11 W h a t I s a i d was I w e n t o v e r to the N a t i o n a l C a n c e r 1 2 Institute and picked up a c opy of their report. I'm 13 not sur e it w a s n ' t ev e n a d r a f t c o p y , you know. 1 4 Q. Let me r e p h r a s e my q u e s t i o n then. 15 ! i :I W h e n ;did you f i r s t b e c o m e a w a r e of the | 1 6 fact t h a t B i o n e t i c s p r e p a r e d a r e p o r t e i t h e r in 17 d r a f t f o r m or in final fo r m r e g a r d i n g a s t u d y tha t 18 t h e y di d on 2 , 4 , 5 - T ? 19 'A.: T h a t ' s w h a t w e ' v e b e e n t r y i n g to f i g u r e o u t for 20 a g o o d f r a c t i o n of the day. 21 I'm j u s t not s u r e . It was wh e n I w e n t 22 ov e r and p i c k e d it up at the r e q u e s t of Mr. H a y w a r d , 23 but the date of that and even the p a r t i c u l a r year 2 4 I 'm not s u r e of. 25 Q. W o u l d i t be fair to say t h a t sin c e yo u 15038 Harris 13 4 1 w e n t o v e r to NCI to p i c k up the B i o n t t i c s r e p o r t 2 that the B i o n e t i c s report had not as yet been 3 p u b l i s h e d in the o p e n l i t e r a t u r e ? 4 A. I b e l i e v e t h a t ' s the case. 5 Q. Do you r e c a l l if the r e p o r t that you 6 picked up was a . d r a f t report or a final report? 7 A. No, I d o n ' t . 8 ; Q. Has it ever c o m e to your a t t e n t i o n that 9 the Bionetics people prepared q u a r terly draft 1 0 ireports w h i c h we r e s u b m i t t e d to N C I ? 11 A., No * ) -!| .i ; > 12 Q. Was it M r . Ha ywa rd who a s k e d you to go to 1 3 NCI to p i c k up the r e p o r t ? 14 A. Yes. 15 | Q. Did he tell you w h y he w a n t e d that r e p o r t ? 16 A. He w a n t e d to read it. 17 ; ;i Q. Did he tell you w h y he w a n t e d to read it? 18 a .; No 19 Q. Did he tell you w h a t the r e p o r t d e a l t 20 w i t h 21 A. W e l l , you m e a n when I wasa s k e d to go do it? 22 Q. Yes. 23 A. No, I d o n ' t b e l i e v e so. 24 Q. W h e n you o b t a i n e d the r e p o r t fr o m 25 B i o n e t i c s , did you b r i n g it b a c k and g i v e it to Mr. 15039 Harris 13 5 1 Hayward? 2 A . Yes. 3 Q. Did you read it before you gave it to him? 4 !A. No . 5 Q. Have you since read that report? 6 A . Yes. 7 Q. How long after you gave it to Mr. H a y ward 8 was it that you read it? 9 A. I d o n ' t recall but it p r o b a b l y was wi t h i n a 1 0 matter of a few days. 1 1 Q. When did you hear -- 1 2 A. Since I was his d e p uty, I would have to cover 1 3 when he w a s n ' t there so g e n e r a l l y s p e a k i n g , I read a j 1 4 lot of the stuff that he read, but I wasn't 15 r e s p o n s i b l e for the stuff that ma n y times -- unless 16 he w a s n ' t there. 17 Q. The report that you read p r e p a r e d by the 1 8 B i o n e t i c s people, did a part of that report deal 19 with a t e r a t o g e n i c study of mice and rats with 2 0 respect to 2,4,5-T? 21 Yes . 2 2 Q. When did you learn of the term d i o x i n for 2 3 the first time? 24 MR. RUSSO: Asked and a n s w e r e d . 25 M A J O R PARR: An s w e r it again. lb04Q Harris i36 1 MR. R'JSSO: A s k e d and a n s w e r e d this 2 morning . 3 MR. BURKE: T h a t :s true. 4 A. I ' v e go t to try to r e m e m b e r it all over a g a i n 5 no w . ! 'I 6 ! Q. Let me rephrase the question- Doctor. 7 Maybe this will help. 8 MR. R U S S O : I'll ge t my n o t e s if you wi s h 9 MR. BURKE: Let me rely on my own notes, 1O Don. 11 M R . R U S S O : All r i g h t . 1 2 Q. Did you t e s t i f y th i s m o r n i n g that you 1 3 first became aware of the term dioxin when you read 1 4 the Bionetics report? 15 A.: I b e l i e v e so. T h a t ' s my r e c o l l e c t i o n . 16 Q. Let me as k yo u to take a l o o k at a 1 7 d o c u m e n t that's e n t i t l e d " E v a l u a t i o n of C a r c i n o g e n i c , 18 . T e r a t o g e n i c and M u t i n o g e n i c A c t i v i t i e s of S e l e c t e d 19 P e s t i c i d e s and I n d u s t r i a l C h e m i c a l s , " V o l u m e 2, 20 w h i c h h a s b e e n p r e v i o u s l y m a r k e d as an e x h i b i t 21 e x a m i n a t i o n of Mr. B a t e s o n J u l y 21 22 M R . R U S S O : W a s this sent to us ? 23 MR . B U R K E : S u r e , it wa s , i t 1s the 24 Bionetics report. 2 5 MR. RUS S O : W a s it s e n t to us as p a r t of c041 Harris 13 7 1 the documents on this examination? Did ;ou send 2 this to u~s~,f Mike? 3 MR . G O R D O N : No . 4 MR. B U RKE : You ' v e received it ma n y times, 5 Don . 6 MR. RUSSO: Before you answer it, Doctor, 7 can I; look at it before you an s w e r any q u e s t i o n s . 8 Q . Do you, sir, r e c o g n i z e that d o c u m e n t 9 that 's in front of you w r ite now as being part of 10 the B i o n e t i c s s t udy that you r eviewed s h o r t l y after 1 1 you picked it up at NCI 7 12 A . No . 13 Q. Can you say with any degree of c e r t a i n t y 1 4 that that d o c u m e n t is not part of the B i o n e t i c s 15 study that you picked up? 1 6 A . No . 1 7 Q. A s s u m e , if you will, for the m o m e n t that 18 the d o c u m e n t that I have just shown you is a part of 19 the B i o n e t i c s report that was pre p a r e d for NCI and 20 which you picked up, okay, a s s u m e that fact for the 21 m o m e n t . Would you take a look through that report 22 and see if you can find the word ''dioxin" in there. 23 MR. RUSSO: Please, let's not go on 2 4 assumptions, come on, now. You didn't connect him 25 to this d o c u m e n t . He d o e s n ' t k n o w w h e ther this is Harris 1 the one he read or not. N o w you w a n t him to 138 2 interpret the document. 3 MR. B U R K E : S u b j e c t to c o n n e c t i o n and 4 s u b j e c t to an o f f e r b e i n g m a d e w i t h rer.pect to th a t 5 document going into evidence. 6: MR. RUSSO: The document speaks for 7 i t s e l f . W h e t h e r it's in t h e r e or not, the d o c u m e n t 8 s p e a k s for i t s e l f . W h y m u s t you g e t it from h i m ? 9 Q. On the b a s i s of the d o c u m e n t s p e a k i n g for 1 0 i t s e l f , if I w e r e to tell you, D o c t o r , that the w o r d 11 " d i o x i n " d o e s not a p p e a r in that d o c u m e n t , w o u l d 1 2 t h a t in a n y w a y c h a n g e y o u r a n s w e r as to h o w you 1 3 first became aware of the term di o x i n ? 1 4 A .: W e l l , I d o n ' t know, b e c a u s e , y o u see, that' 1 5 Vo 1 urne 2 . P r e s u m a b l y t h e r e ' s a V o l u m e 1. 16 P r e s u m a b l y t h e r e ' s also a d r a f t , so I don' t know 17 th a t this d o c u m e n t pe l se t e l l s me t h a t . 1 8 Q. A s s u m e , if you w i l l , t h a t n o n e of the 19 r e p o r t s p r e p a r e d by B i o n e t i c s w i t h r e s p e c t to this 2 0 particular subject matter ever mentioned the word 21 " d i o x i n " w o u l d tha t c h a n g e y o u r a n s w e r as to h o w y o u 22 f i r s t b e c a m e a w a r e of the term d i o x i n ? 23 MR. R U S S O : O b j e c t i o n to the form. 2 4 A. W e l l , I g u e s s I w o u l d h a v e to s a y if I had all 25 of the B i o n e t i c s r e p o r t s and none of them used the Q Harris 139 1 w o r d " d i o x i n " , then I w o u l d h a v e to say I wa s w r o n g 2 in m a k i n g the s t a t e m e n t I m a d e e a r l i e r . 3 Q. G o i n g b a c k to the late 1 9 6 0 s , do yo u -4 A. W h i c h i n c i d e n t a l l y was a hazy r e c o l l e c t i o n , you 5 will recal1 . 6 Q . Okay. 7 G o i n g b a c k to the late 1 9 6 0 ' s , do you 8 recall s p e c i f i c a l l y d i s c u s s i n g the term dioxin with 9 any government personnel? 1 0 A. Late s i x t i e s , I do not -- I d o n ' t have any 11 c l e a r r e c o l l e c t i o n of a n y t h i n g r e g a r d i n g this w h o l e 1 2 matter with the exception of going over and getting 1 3 the report, and p r o b a b l y , as I said, r e a d i n g it, and 1 4 attending the meeting with General Stone. 15 Now , the m e e t i n g w i t h G e n e r a l S t o n e I 16 i n d e p e n d e n t l y r e m e m b e r , you kno w , r e a s o n a b l y . In 1 7 b e t w e e n t h o s e two, I'd be h a r d put to say I had 1 8 d i s c u s s e d with a n y b o d y or with any s p ecific person. 19 Q. The m e e t i n g w i t h G e n e r a l S t o n e that 20 y o u ' v e j u s t r e f e r r e d to, is t h a t the m e e t i n g t h a t ' s 21 r e f l e c t e d in a M a r c h 11, 1970 m e m o w h i c h has b e e n 22 m a r k e d t o d a y as E x h i b i t 1? 23 A . Y e s . . 24 Q. Did you eve r talk to S i g m u n d E c k h a u s in 2 5 the late 1960's about dioxin? 1504f Harris 140 1 A. I d o n ' t ha v e a n y r e c o l l e c t i o n of t a l k i n g to Sig 2 Bc k h a u s about dio x i n at any time. 3 Q. W h e n y ou w e r e l o o k i n g into the i s s u e of 4 A g e n t O r a n g e in 196 7 or there-, b o u t s w i t h r e s p e c t to 5 p o t e n t i a l e c ological, did you have an u n d e r s t a n d i n g 6 as to w h a t c h e m i c a l s m a d e up A g e n t O r a n g e ? 7 A:. Yes. The b a s i c c h e m i c a l s I kne w . The b u t y l 8 ester of 2,4-D and 2,4,5-T, 50-50 mix. 9 Q. Now, t h e r e c a m e a time, di d t h e r e not, 1 0 that you a t t e n d e d a m e e t i n g or a b r i e f i n g by Dow 1 1 Chemical Company representatives for General William 12 S t o n e w h i c h m e e t i n g o c c u r r e d on M a r c h 6, 1970. 1 3 A .i M a r c h 6. 14 Q. Yo u can r e f e r to E x h i b i t 1 to r e f r e s h 1 5 y o u r r e c o l l e c t i o n , if y o u ' d like. 16 A.| Oh, yes, I'm s o r r y . I was c o n f u s i n g the dat e j. 17 of; the m e e t i n g : w i t h the d a t e of the l e t t e r , yes. i ,1 18 : j Q. Who a s k e d yo u to go to tha t m e e t i n g ? 1 9 A.; T h a t ' s i m p o s s i b l e to s t a t e at t h i s m o m e n t . I - 20 i t j w o u l d be e i t h e r H a y w a r d had a s k e d me to go in his 21 p l a c e or S t o n e had s a i d h e r e ' s s o m e t h i n g I o u g h t to 22 k n o w a b o u t , s o m e t h i n g of t h i s sor t , in my c a p a c i t y 2 3 in D D R & E . 24 Q. Do you r e c a l l h o w m a n y d a y s p r i o r to the 25 m e e t i n g you w e r e a s k e d to a t t e n d ? 150^5 Harris 141 1 iA. No. 2 Q. W o u l d it be fair that you k n e w at l e a s t a 3 few d a y s in a d v a n c e t h a t t h e r e was g o i n g to be a 4 meeting on March? 5 A. It w o u l d be l i k e l y it w o u l d be a few d a y s in 6 a d v a n c e and o n l y a few d a y s in a d v a n c e b e c a u s e we 7 have m e e t i n g s all the time, very short notice. 8 ' Q. W h e n y ou w e r e a s k e d to go to t h i s m e e t i n g 9 on M a r c h 6th, w h e r e v e r it was that you w e r e a s k e d , 10 did the p e r s o n who a s k e d yo u to go tell you w h a t the 11 m e e t i n g was g o i n g to be a b o u t ? 1 2 A. I c a n ' t -- I just c a n ' t recallthat at all. I 1 3 can't recall a n y b o d y t a l k i n g or c a l ling me, you know. 1 4 Q. B a c k in the e a r l y p a r t of 1970, w o u l d it 1 5 be fair to say t h a t you w e n t to m e e t i n g s on a f a i r l y 16 regular basis? 1 7 A. R e g u l a r , no. F r e q u e n t , yes. 1 8 Q. It w o u l d no t be u n u s u a l for y o u to go to 19 a m e e t i n g ; is that r i g h t ? 2 0 A . No . 21 Q. And it w o u l d not be u n u s u a l for you to go 2 2 to a m e e t i n g and, in e f f e c t , be r e p r e s e n t i n g Mr. 2 3 H a y w a r d at that m e e t i n g , w o uld it? 2 4 A. P r e c i s e l y . 25 Q. And w h e n you w e n t in a r e p r e s e n t a t i v e Harris 14 2 1 c a p a c i t y s u c h as that, w o u l d you l a t e r r e p o r t to Mr. 2 Hayward on what was discussed at the meeting? 3 A. S u b s t a n c e of the m e e t i n g , r i g h t . j; 4 Q. W a s it y o u r h a b i t b a c k in e a r l y 197 0 to 5 !h a v e at l e a s t s o m e idea of the s u b j e c t m a t t e r that 6 was g o i n g to be d i s c u s s e d at a m e e t i n g that you 7 would a t t e n d as a r e p r e s e n t a t i v e of Mr. H a y w a r d ' s ? 8 MR. R U S S O : O b j e c t i o n to the form. 9 A. W e l l , I'd be d o g g e d if I w o u l d ev e r go to a j 1 0 m e e t i n g I d i d n ' t k n o w w h a t the hell it was all a b o u t i 11 u n l e s s t h e r e was s o m e r e a s o n for th e m to w i t h h o l d 1 2 the i n f o r m a t i o n and they gave me the reason. 1 3 Q. Do yo u r e c a l l a n y b o d y g i v i n g you a r e a s o n 1 4 why you s h o u l d n ' t know what the subject matter of 15 the M a r c h 6th m e e t i n g was? 1 6 A. No . 1 7 Q. Is the a n s w e r yes or is the a n s w e r no? 1 8 A . : Say it again. 19 MR. B U R K E : Read the q u e s t i o n back. 20 (The r e c o r d is read) 21 A. I d o n ' t r e c a l l a n y t h i n g a b o u t it as I said 2 2 earlier. 23 (The r e c o r d is read) 24 Q W o u l d it be fair to sa y as y o u sit h e r e 25 t o d a y tha t you in all l i k e l i h o o d k n o w w h a t the Harris 14 3 1 su b j e c t matter was of this meeting that was called 2 for March 6th, 1970? 3 A . I think that's so. 4 q . Do you r e c a l l if yo u had an y d i s c u s s i o n s 5 with Mr. Hayward concerning the substantive aspects 6 of the t o p i c s to be d i s c u s s e d at this M a r c h 6th 7 meeting? 8 A . Ahead of time? 9 Q. A h e a d of tim e 10 A . I don t recai 1 any such. Certainly told m e 11 when I got back what it was all about . 1 | 1 1 2 Q . Wo u 1d you rev iew Pag es 1 and 2 of Exhibit 1 3 1 ma rked this date. 14 A . Yes . 1 5 | Q. Do you see an ywh e r e on page 1 or 2 an y 16 r e f e r e n c e m a d e to A g e n t O r a n g e ? 1 7 MR. RUSSO: Speaks for itself; o b j e c t i o n 18 to; the q u e s t i o n . W h i c h d o c u m e n t are we r e f e r r i n g to? 19 A. Yes, Page 2, P a r a g r a p h 2, "the acid and b u t y l 2 0 e s t e r s (used in A g e n t O r a n g e . ) " 21 Q. Do you r e c a l l h o w long this p a r t i c u l a r 22 meeting took? 23 a . n o . 15048 24 Q. W o u l d it be fair to d e s c r i b e this 25 m e m o r a n d a as a s y n o p s i s of the d i s c u s s i o n s that w e r e Harris 144 1 held during the meeting of March 6th, 1970? 2 MR. R U S S O : O b j e c t i o n to the q u e s t i o n ; to 3 the form. 4 Q Do yo u u n d e r s t a n d my q u e s t i o n , Do c to r ? 5 A . Yes. You 're a s k i n g me to, in e f f e c t / say t h a t 6 these fellows reported everything that went on and I 7 have no wa y of k n o w i n g that. 8 Q. T h a t ' s no t my q u e s t i o n to you. 9 A. Okay. Then I m i s u n d e r s t o o d it. 1 0 Q. W e r e t h i n g s d i s c u s s e d at thi s m e e t i n g 1 1 t h a t are not r e c o r d e d in t h i s m e m o r a n d a ? 12 A. I h a v e n ' t a n y idea. 1 3 Q. Did y o u s a y a n y t h i n g at t h i s m e e t i n g ? 1 4 A. I d o n ' t r e c a l l . 15 Q. Do yo u r e c a l l if a n y b o d y o t h e r than the 1 6 Dow r e p r e s e n t a t i v e s said anything at this meet i n g ? 1 7 A. I do not r e c a l l . I'd be d a m n e d s u r p r i s e d if 18 t h e y d i d n ' t all say s o m e t h i n g , but I d o n ' t k n o w w h a t 19 th e y sa id . 20 Q. Do you r e c a l l Dr. B e r n a r d J a n d o r f b e i n g 21 present at this m e eting? 22 A. W e l l , I d o n ' t r e c a l l . It says h e r e he was. 2 3 Q. As yo u sit her e t o d a y , you d o n 't h a v e a 24 s p e c i f i c r e c o l l e c t i o n of h i m b e i n g a t the m e e t i n g ? 2 5 A . The only one I remember being a t the meeting 15049 Harris 145 1 s p e c i f i c a l l y , in fac t , i n c l u d i n g S t o n e and the w h o l e 2 bunch, was Sass. I know I had a meeting with Sass 3 at A C S F O R D to w h i c h a lot of p e o p l e w e r e and I d o n ' t 4 remember the guest list. 5 Q. Do y o u r e c a l l if d u r i n g thi s m e e t i n g 6 r e p r e s e n t a t i v e s f r o m D o w said in w o r d s or in 7 s u b s t a n c e t h a t d i o x i n was k n o w n to t h e m to be f o r m e d 8 during the m a n u f a c t u r e of 2,4,5-T? 9 A. I do not r e c a l l it. 1 0 Q . Do you r e c a l l the word " d i o x i n " c o m i n g up 1 1 at this meeting? 1 2 A. I d o n ' t r e c a l l that. 1 3 I'd be s u r p r i s e d if it d i d n ' t , tho u g h . The 1 4 w h o l e s u b s t a n c e of th i s has to do w i t h d i o x i n but I 15 d o n ' t r e c a l l it. 16 Q. Did yo u tell us e a r l i e r that you h a v e a 1 7 specific recollection of attending this meeting? 18 A.! W e l l , I'd h a v e to a m e n d w h a t I j u s t said a 1 9 m o m e n t ago. I r e m e m b e r d i s c u s s i n g or b e i n g in a 20 m e e t i n g w i t h Sass at w h i c h d i o x i n was d i s c u s s e d at 2 1 A C S F O R D . I am a s s u m i n g tha t this is the m e e t i n g 22 :be:. ause Sass and C o m p a n y m a d e this n o t e . This is -- 2 3 my r e c o l l e c t i o n is a l i t t l e h a z y in the s e n s e that I 2 4 w as a l r e a d y u n d e r o r d e r s to l e a v e DDRS. E > T h i s was -- 150702 5 this was day s b e f o r e I left DDR&E, so I d o n ' t Harris 14 6 1 remember, you know, whether I did any follow-up or 2 whatever afterwards. I probably just took -- went 3 back and told H a y w a r d a b o u t it and d a y s later I left 4 DDR& E . 5 Q. Is t h e r e any s p e c i f i c e v e n t or d i s c u s s i o n 6 that you recall as you sit here today that allows 7 you to r e m e m b e r that Mr. Sass was at this m e e t i n g ? 8 A. Wel l , I r e m e m b e r Sass b e i n g at a m e e t i n g to 9 w h i c h I w a s at A C S F O R D in this time f r a m e . I c a n ' t 1 0 c e r t i f y this was that same m e e t i n g . It a p p e a r s 11 l i k e l y i t w a s . 1 2 Q. Do you r e c a l l if a n y b o d y at this m e e t i n g 1 3 other than the Dow representatives made a statement 1 4 in, w o r d s or in s u b s t a n c e that they w e r e f a m i l i a r 1 5 w i t h d i o x i n for m a n y y e a r s p r i o r to t h i s m e e t i n g ? 16 A . W e l l , I d o n :'t r e c a l l an y s u c h c o m m e n t . 17 i Q. Do you recall a n y b o d y at this m e e t i n g 18 o t her than D o w r e p r e s e n t a t i v e s e x p r e s s i n g any d e g r e e 19 ofi s u r p r i s e t h a t : d i o x i n was a c o n t a m i n a n t of 2 , 4 , 5 - T ? 20 A . i No . 21 Q. W h e n you c a l l e d Dr. J a n d o r f in J u n e of 22 1970, did you recall at that time that Dr. J a n d o r f 23 had a t t e n d e d the m e e t i n g on M a r c h 4th, 1970? 24 A. W a i t a m i n u t e . I m u s t a p o l o g i z e . I ' v e b e e n 25 g e t t i n g c o n f u s e d -- m a y b e b e c a u s e of the l a t e n e s s of 15051 Harris 14 7 1 the h o u r , my c o m m e n t s w i t h r e g a r d to my l e a v i n g 2 DDR&E within days of this previous meeting were 3 i n c o r r e c t . It's this one that it was in d a y s of, 4 the m e e t i n g of -- or the d i s c u s s i o n s of -- the 5 5 J u n e m e m o r a n d u m , so we h a v e to a m e n d that p r e v i o u s 6 comment and it's really not all that pertinent 7 an yho w . 8 Now, w i t h r e g a r d to this c o m m e n t , w o u l d 9 you r e p h r a s e that q u e s t i o n or read it back. 1 0 (The r e c o r d is read) 1 1 A. I'll be d a m n e d if I r e m e m b e r . I d o n ' t r e m e m b e r 1 2 at all. I remem b e r very little of this whole ma t t e r 1 3 b e c a u s e , as I said, p e r h a p s during the break, this 1 4 was one of t h o u s a n d s of p r o b l e m s that we had and a 1 5 v e r y m i n o r one at the time w i t h r e g a r d to ou r 1 6 i n v o l v e m e n t in D D R & E , so I m a d e no real e f f o r t to 17 r e m e m b e r or r e c o r d it. 18 Q. Have you ever b e e n ask e d by the S e c r e t a r y 19 of D e f e n s e or a n y b o d y a s s o c i a t e d w i t h the D e f e n s e 2 0 D e p a r t m e n t to p r e p a r e a p o l i c y p a p e r wi t h r e s p e c t tc 21 the use of A g e n t O r a n g e in V i e t n a m ? 22 A . No . 23 MR. B U R K E : T h a n k you, Dec cor. 24 MR. M A T T H E W S : I h a v e no q u e s t i o n s 25 s u b j e c t to the p r e v i o u s e x c e p t i o n s m a l e by Mr. 15053 Harris 14 1 G o r d o n and Mr. T y r r e l l p e r t a i n i n g to p r o d u c t i o n of 2 other documents. 3 4 5 much. 6 7. 8 p .m .) MR. RUSSO: Anybody else? MR. GORDON : Dr. Harris, thank you very MR. RUSSO: Thank you very much , Doctor (The p r o c e e d i n g s are concluded at 3:45 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 15054 149 1 CERTIFICATE 2 3 I, H E L E N D O H O G N E , a C e r t i f i e d S h o r t h a n d 4 Reporter and Notary Public of the State of New 5 J e r s e y , do h e r e b y c e r t i f y t h a t pri o r to the 6 commencement of the e x a mination the witness and/or 7 w i t n e s s e s w e r e s w o r n to t e s t i f y the t r u t h , the w h o l e 8 truth and nothing but the truth. 9 I do f u r t h e r c e r t i f y th a t the f o r e g o i n g is a 1 0 true and accu r a t e c o m p u t e r - a i d e d t r a n s c r i p t of the 11 t e s t i m o n y as t a k e n s t e n o g r a p h i c a l 1 y by and b e f o r e me 1 2 at the time, place and on the date hereinbefore set 13 forth . 14 I do f u r t h e r c e r t i f y tha t I am n e i t h e r of 1 5 c o u n s e l nor a t t o r n e y for a n y p a r t y in t h i s a c t i o n 1 6 and that I am not i n t e r e s t e d in the event: nor 17 o u t c o m e of this l i t i g a t i o n . 18 19 20 21 22 Dated : -- ::A -- i| N o t a r y Pub! 23 24 15055 25 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK X In Re "AGENT ORANGE" Product Liability Litigation X MDL No. 381 (All Cases) PLAINTIFFS' PRE-TRIAL ORDER / APRIL 11, 1984 PLAINTIFFS' MANAGEMENT COMMITTEE Stephen J. Schlegel, Esq. Schlegel & Trafelet, Ltd. One North LaSalle Street Suite 3900 Chicago, Illinois 60602 Thomas W. Henderson, Esq. Henderson & Goldberg, P.C. Frick Building, Suite 1612 Pittsburgh, Pennsylvania 15219 Benton Musslewhite, Esq. Suite 517 - 609 Fannin Houston, Texas 77002 Phillip E. Brown, Esq. Hoberg, Finger, Brown, Cox & Molligan 703 Market Street, 18th Floor San Francisco, California 94103 Stanley Chesley, Esq. Phil Allen, Esq. Waite, Schneider, Bayless & Chesley 1513 Central Trust Tower Cincinnati, Ohio 45202 David Dean, Esq. Dean, Falanga & Rose One Old Country Road Carle Place, New York 11514 150 John O'Quinn, Esq. O'Quinn, Hagans & Wettman 3200 Texas Commerce Tower Houston, Texas 771)02 Gene Locks, Esq. & Neal R. Peterson, Esq. Greitzer & Locks 1500 Walnut Street, 22nd Floor Philadelphia, Pennsylvania 19102 Newton B. Schwartz, P.C. Houston Bar Center Building 723 Main, Suit-e 325 Houston, Texas 77002 Irving Like, Chairman, Law Committee Reilly, Like & Schneider 200 West Main Street P .0 . Box 218 Babylon, New York 11702 Aaron Twerski, Esq. Hofstra University School of Law Hempstead, New York 11550 V. Donald Russo, Esq. 7 Bonnie Drive Northport, New York 11768 Albert J. Fiorella, Esq. 1565 Franklin Avenue Mineola, New York 11501 15058. TABLE OF CONTENTS I. INTRODUCTION........................................... 1 - 1 II. SUPPLEMENTATION OF THE PRE-TRIAL ORDER............... II - 1 III. STIPULATION AS TO ADMITTED FACTS................... Ill - 1 IV. PLAINTIFFS' EXHIBITS (Per Paragraph IV of Magistrate's Pre-Trial Order No.17)........... .................. IV.A.1 A. Separate document list per Paragraph IV (E) (1) of Pre-Trial Order No. 17. v ................... IV.A.1 B. Separate Document list per Paragraph IV (E) (2) of Pre-Trial Order No. 17........................ IV.B.1 C. Separate Document list per Paragraph IV (E) (3) of Pre-Trial Order No. 17........................... IV.C.1 D. Demonstrative Evidence per Paragraph IV (H) of Pre-Trial Order No. 17........................... IV.D.1 V. WITNESS LISTS A. Live W i t n e s s e s ...................................... V.A.1 B. Deposition Witnesses . . . . . . . . ............. V.B.1 VI. ISSUES TO BE P R O V E D ................................ VI - 1 With respect to: A. Dow Chemical Company ................................... B. Hercules Incorporated................................... C. Monsanto Chemical Company.............................. D. Diamond Shamrock Corporation . . ...................... E. T H Agriculture & Nutrition Company.................... F. Uniroyal, Inc............................................ G. Thompson Chemical Company.............................. H. The United States Government .......................... VII. DISPUTED ISSUES OF FACT AND L A W ................... VII - 1 15059 INTRODUCTION Plaintiffs submit this Pre-Trial Order dated April 11, 1984 in response to the Magistrate's Pre-Trial Order No. 17. Wherever possible, plaintiffs have attempted to follow the format set forth in that Pre-Trial Order. The table of contents and numbering of Exhibits attempt to follow the Order as closely as possible. Where "Bates" numbers appeared on the documents produced by the defendants or by the United States Government, or where the defendants or the Government used other designations in identifying the document: produced previously, plaintiffs have designated such documents b; those numbers as a "Pretrial Identification Number" or "PIN" number i: the text of the exhibit lists comprising portions of this order. Where portions of the Pre-Trial Order are to be completed at late dates pursuant to the terms of Pre-Trial Order No. 17, the plaintiff have simply made general statements to that effect, so as to allow th format to remain in conformity with the numbering system contained i the Magistrate's Pre-Trial Order. Plaintiffs reserve the right, in view of the Magistrate' congnizance of the fact that discovery is continuing in these causes to supplement this Pre-Trial Order on the terms set forth in Pre-Tria Order N o . 17. The medical records of the individual plaintiffs are not bein tendered at this time as exhibits to this Pre-trial Order. Plaintiff and defendants continue to assemble those records and plaintiff: presume that discussions will take place between counsel for al parties attempting to reach a stipulation regarding a common set o exhibits of that kind. Plaintiffs have not in this submission copied and tendered th I-1 voluminous contracts, of each defendant relative to the sale of A Orange herbicides to the United States Government. Those contr. are on file with the Clerk of the District Court in the defendar several responses to Pre-trial Order No. 33. Plaintiffs have like\ not copied the defendants' answers to various interrogatories exhibits with this submission. They, too, are all on file with Clerk. Time constraints have made it literally impossible to eit review all of the documents produced through the course of discov or to completely paginate deposition testimony references plaintiffs respectfully request the opportunity to continue doing for the purpose of including relevant documents and testimony in th* amended submissions to be filed hereafter. 1-2 II SUPPLEMENTATION OF THE PRE-TRIAL ORDER Pursuant to the terms of the Magistrate's Pre-Trial Order No, 17, specifically paragraph "II" thereof, plaintiffs will supplement their Pre-Trial Order in conformity with those terms from time to time hereafter. II 1 i!m O/. Ill STIPULATION AS TO ADMITTED FACTS In Supplements to this Pre-trial Order, plaintiffs will set forth any stipulations achieved with respect to facts admitted in this litigation. Thus far, no such stipulations have been entered into. III 1 15063 IV. A. Plaintiffs hereby submit the following list of identified Exhibits in response to requirements of Paragraph IV (E) (1) of the Magistrate's Pretrial Order No. 17. Due to the fact that discovery in the form of depositions and document production to date has been so voluminous, plaintiffs believe that they should be allowed to supplement this list at the time that both the amendatory and final form Pretrial Orders are / filed without regard to whether or not a specific document has been previously produced. Time constraints imposed in connection with the requirement of filing this Pretrial Order have been such that it has been physically impossible to review every document produced in this litigation despite the fact that plaintiffs' counsel have deployed many of themselves and their assistants on a round-the-clock basis to attempt to compile important documents for the purpose of including them in this list. The voluminous copies of the individual plaintiffs' medical records are purposefully not being submitted at this time. Plaintiffs' and defendants' counsel have been attempting to reconcile and exchange such records in order to be certain that all parties have identical and complete sets of those records. Plaintiffs presume that it would be in all parties' best interests to attempt to stipulate as to a common set of such exhibits. Plaintiffs will attempt to achieve such stipulation prior to the time that the amendment to this Pretrial Order is due. Plaintiffs also have purposefully not recopied each of the government contracts involved in this litigation for the reason that defendants have appended each of the contracts they claim to have fulfilled in each of their responses to Pretrial Order No. 33, all of which such copies are on file with the Clerk of this Court. Plaintiffs intend to rely upon those contracts as filed and further intend to rely upon statements contained in the defendants' filed answers to interrogatories from time to time throughout the course of this trial or of the trial of these IV. A. 1 15064 cases. The plaintiffs' Exhibits are, as follows Exhibit #P0001 PIN # Date Author Addressee Description D0E1 2091 1 HELEN KRIZEK JONES, LINN Bibliography - A Technicque for Testing Acnegenic Potency in Rabbits. Exhibit #P0010 PIN # Date Author Addressee Description 120224-26 MARK WILTSE BRYANT, CLYDE memo entitled "tordon Chronology" bearing Dow Document No. 120224. Exhibit #P0011 PIN # Date Author Addressee Description A&G 500206 LABEL LABEL SAMPLE OF COMMERCIAL HERBICIDES LABEL. Exhibit #P0012 PIN * 005867-9 Date Author Addressee Description ELMER P WHEELER MEMO OF ELMER P. WHEELER. Exhibit #P0013 PIN # Date Author Addressee Description Exhibit #P0014 005995 ELMER P WHEELER DUNLAP, W. P. LETTER FROM ELMER P. WHEELER TO W. P. DUNLAP. IV. A. 2 15065 PIN * Date Author Addressee Description 006002 R EMMET KELLY MD EAKIN, FRANK LETTER FROM R. EMMET KELLY, M.D. TO FRANK EAKIN, NITRO. Exhibit #P0015 PIN # Date Author Addressee Description D0W1568528 NONE DOW NOONE Handrwitten description Boehringer process redacted. ^ Exhibit #P0016 PIN t Date Author Addressee DOW120791-2 R A HICKMAN BEUTEL, A .P . & OTHERS AT DOW Description MONTHLY MARKETING REPORT Exhibit #P0041 PIN * Date Author Addressee DOW278613 01-Aug V K ROWE MD UNINTELLIGBLE WILLIAMS, G J & SMITH, H L & OTHERS Description Letter denying the causal relationship between an exposed womans illness and her exposure to 245-T. Exhibit #P0042 PIN # Date Author Addressee Description DOW980428-41 04-Apr-40 UNKNOWN UNKNOWN PHENOXY ACETIC ACID This report goes through the different stages on how to make Phenoxy Acetic Acid. Exhibit #P0045 PIN # Date Author Addressee Description DOW0614560 24-Feb-49 UNKNOWN UNKNOWN WARD, JUSTUS C. & US DA WASHINGTON, D.C. Incomplete (p 7) memo re health precautions to be used with 2,4,-D and 2,4,5-T IV. A. 3 15066 Exhibit #P0047 PIN # Date Author Addressee Description 042221 16-Aug-49 LOUIS SCHWARTZ MD NELSON, DR. CONFIDENTIAL LETTER OF 08-16-49 FROM LOUIS SCHWARTZ M.D. TO DR. NELSON AT MONSANTO. Exhibit #P0054 PIN # Date Author Addressee D0W32707-13 23-Aug-50 VERALD K ROWE AGPROJCOMM. & DOW LYNN, GEORGE E. & IRISH,D.D. Description Results of Toxicological Tests on 2,4,5Trichlorophenoxyacetic Acid reported by V.K. Rowe,"moderate acute oral toxicity"- rat most resistant of four species;Material markedly irritating to the eyes";"slightly to moderately irritating to the skin upon prolonged exposure." Exhibit #P0061 PIN / Date Author Addressee Description 006006 06-Oct-52 C 0 KOCH KELLY, DR. MEMO TO DR. KELLY FROM C. 0. KOCH. Exhibit #P0067 PIN # Date Author Addressee Description DOW767092 27-Oct-53 F OYEN BOUNDY, R.H. & DIRECTOR OF RESEARCH GAY, H.H. & ALLINSON, R.L. SUNDERLAND,W.W. & LYNN, GEORGE E. Reply to 060970 letter to R. Maybury re residue methodology re phenoxyacetic acids. Refers to Yip's methodl111extration procedure5ction procedure. Quantitation by GLC. Refers to Pesticide Methodology Manual, Food and Drug Directorate. Also, "Analytical Methods for Pesticide Residues in Foods" Exhibit #P0071 PIN / Date Author Addressee Description DOW874256-7 09-Mar-54 WW SUNDERLAND WHITE, R.O. & PESTICIDES SECTION U.S.D.A. & PLANT PEST CONTROL W A S H . , D.C. Letter provides revised label copy for IV. A. 4 15067 Kuron to U.S.D.A.; gives information regarding similarities of herbicide to 2,4-D and 2,4,5-T formulations. Exhibit #P0077 PIN # Date Author Addressee Description DOW278614 18-Jul-55 HAROLD H GAY MD ROWE, V K. & CRANDALL, R A SMITH, H L & WILLIAMS, G J UNINTELLIGABLE, MD Letter expanding upon Dr Rowe's letter of 7/12/55 which supports claim that Esteron 245 has not caused injury to man. Exhibit #P0078 PIN # Date Author Addressee Description DOW278609 24-Aug-55 HAROLD GAY MD TAYLOR, HAROLD & SMITH, H L ROWE, V K & YOST JR, F N Letter in which Dow's Medical Director denies causal relation between human illness and 24-D Esteron Weed Spray. Exhibit #P0079 PIN # Date Author Addressee Description DOW645090 26-Aug-55 A WIDIGER CENTRAL RESEARCH & MIDLAND RES.INDEX A. GRISWOLD & W.H. WILLIAMS E.C.BRITTON & F.N. ALQUIST Letter from E. Wanless, Head, Drug Section, Canadian Department of National Health and Welfare, to H.A. Thomson outlining recommended methodology for detection of unnamed substances in phenoxy herbicides including SUILVEXZ . MENTIONS ENTIONSentions 1 ppm standard. [A Exhibit #P0083 PIN # Date Author Addressee Description 16349 07-Dec-55 R E SODEN DURLAND, DR. J. A. CONFIDENTIAL MEMO FROM R. E. SODEN TO DR. J. A. DURLAND DATED 12-07-55. Exhibit #P0087 PIN # Date Author Addressee DOW782178-98 01-Apr-56 T R TORBLAN MCCOLLISTER D.D. IV. A. 5 Description results of range finding toxicological test on M-531. the report states the problem, conclusions, hazards, precautions for safe handling and first aid meausres such as ingestion,eye contact, skin contact-irritation, skin absorbption and the forms that along with these tests. Exhibit #P0088 PIN # Date Author Addressee Description DOW782202-20 11-Apr-56 MARK A WOLF MCCOLLISTER, D. D. results of range finding toxicological tests on 2-formulations of reddon. this states the problem, conclusions and first air measures for the areas of ingestion, eye contact, akin contact - LrrLtation, skin contact - absorption, and form with rhp f r o m r h n |- n n r *1 . I..I iiii Mi i i in iii'M i I*IN # Date Author Addressee Description 1'i,'11'1 I :I 1 II!I'Il1: 'll-,.1, vllii "T " 11I I ''I, ,I Ir",<,i Ml 'm!'il i ll '':IiI'i1i ; "" ' II I1IIII11I ' I I I . il I : 11I I I 1I I I ' I I ' " i l i i l 1'' n n M ' i i i i i M l -I l a 22-KcL>- 5 / WALTER TRAPP GOERGEN & ROWE, V.K. OTHERS AT DOW Dow Chemical International Ltd. writes letter to Boehringer Sohn thanking it for information re preparation of TCP to avoid chloracne but notes 1955 skin irritation problem Givaudan Corporation, Geneva and New Jersey with cover note distributing to trap from Goergen directing return of information to Lueck. Exhibit #P0099 PIN # Date Author Addressee DOW278591-92 21-Jun-57 V K ROWE PLETCHER & CONNER, D.L. GAY, H.H & ASHWORTH, R.H. Description The pilot experienced eye, nasal, and throat irritation when applying Esteron 44. This suggests that the operation was being carried out with little regard for safety. Exhibit #P0102 PIN # Date Author Addressee Description DOW767184 06-Aug-57 MARK WOLF BOUNDY, R.H. & MCINTYRE, H.H. LYNN, G.E. & BARRONS, K. MUSSELL, D.R. & SCOLES, G. Mark Wolf of Dow Writes report of Results of Range Finding Toxicological Tests an M-1086 (a 2,4,5T and 2,4-D Alkyl Amine Formulation checked by D.D. McCollister and Distributed to many other at Dow. Shows material in undiluted form is markedly irritating and damaging to the eye, causing marked internal effects, with little healing in 7 days. Chemical workers goggles must be worn where eye contact likely and protective clothing Exhibit #P0107 PIN # Date Author Addressee Description D0W767243 20-Dec-57 K OLSEN MCINTYRE,H.H. & WOLF,MARK A. BIOCHEM RES.LAB. & MCCOLLISTER, D.D. BOUNDY R.H. & LYNN, G.E. Results of Range Finding Toxicological tests on Inverton Brush Killer showing that the undiluted material is severely damaging to the eye, resulting in conjunctivitis with extensive sweg and moderate corneal damage and internam capillary infiltration. Exhibit #P0109 PIN # Date Author Addressee Description DOW728167 14-May-58 MARK WOLF MCCOLLISTER, D.D. & HOYLE, H.R. BIOCHEM RES.LAB. Data Sheet of Properties, Health hazards, and Precautions for Safe Handling of Materials of Veon Brush Killer M-1086; corrosive to metals but apparently safe to man. Exhibit #P0110 PIN # DOW767213 IV. A. 7 Date Author Addressee Description 21-May-58 K OLSEN COULTER,L.L. & MCCOLLISTER,D. D. BOUNDY, R.H. & MCINTYRE, H.H. PERKINS, R.P. & HART, A. Results of Range Finding Toxicological tests on weed killer formulation M-1094 containing a 2,4,5T ester; the undiluted material is moderately irritating to the eye, with direct contact likely to produce conjunctival swelling and corneal damage Exhibit #P0111 PIN t Date Author Addressee DOW7 28101 16-Jun-58 MARK WOLF MCCOLLISTER, D.D. & HOYLE, H.R. Description Data Sheet of Properties, Health Hazards, and Precaution for safe Handling of Materials re; Dowanol 97B70 ester of 2,4,5T acetic acid 64.4% Exhibit #P0112 PIN # Date Author Addressee DOW727967 30-Jun-58 MARK WOLF MCCOLLISTER, D.D. & HOYLE, H. R. Description Data Sheet of Properties, Health Hazards, and Precautions for Safe Handling of Materials; May cause some permanent loss of vision; single prolonged exposure may cause reddening of the skin Exhibit #P0113 PIN # Date Author Addressee Description DOW728103 30-Jun-58 MARK WOLF MCCOLLISTER,D.D. & HOYLE, H.R. BIOCHEM RES.LAB. DATA SHEET OF HEALTH HAZARDS OF REDDON CONCENTRATE Exhibit #P0116 PIN # Date Author Addressee Description DOW123584-95 01-Jan-59 F BAHRBOHM READER'S OF & DEUTSCH, GESUNGH, WES. VOLUME 14 AN ARTICLE ON THE DANGERS INVOLVED IN BEING ASSOCIATED WITH CHLORINATED PHENOLS AND NINETEEN FATAL CASES ARE REPORTED IN THE LITERATURE OF WORKING WITH 15071 IV. A. 8 PENTACHLOROPHENOL AND SODIUM PENTACHLOROPHENOL. A SURVEY WAS ALSO PROVIDED. Exhibit #P0124 PIN # Date Author Addressee Description 005693 16-Jun-59 ELMER P WHEELER WEGER, L. C. LETTER FROM ELMER P. WHEELER TO L. C. WEGER, NITRO, WEST VIRGINIA, DATED 06-16-59 REGARDING THE "CHLORACNE PROBLEM - GERMAN ARTICLE." ' Exhibit #P0126 PIN # Date Author Addressee Description DOW728049 02-Jul-59 K OLSON OYEN, FRITZ & HOYLE, H.R. BIOCHEM.RES.LAB Data Sheet of Properties, Health Hazards, and Precautions for Safe Handling of Materials re; M-1459 formulation of Dowanol Ester 24D and 2,4,5T Exhibit #P0139 PIN # Date Author Addressee Description DOW1123078 09-Jun-60 CHEMICAL DOW THE LABEL FOR 2,4-DICHL0R0PHEN0XY-ACETIC ACID, BUTYL ESTER FOR MANUFACTURING PURPOSES. CAUTION MAY CAUSE SKIN IRRITATION. Exhibit #P0154 PIN # Date Author Addressee Description DOW1123026 09-Jan-61 CHEMICAL DOW THE DOW CHEMICAL COMPANY LABEL FOR DOW BUTYL 265 A 2,4-D WEED KILLER. FOR CONTROLLING MOST BROAD-LEAVED WEEDS ON FARMS. CONTAINS 3 1/3 LBS PER GALLON OF THE BUTYL ESTERS OF 2,4-D. 2,4-D ACID EQUIVALENT 2 2/3 PLBS PER GALLON. Exhibit #P0157 PIN # Date Author Addressee Description DOW1122109-0 22-Sep-61 CHEMICAL DOW THE DOW CHEMICAL COMPANY LABEL FOR TIPPON 2-2 BRUSH AND WEED KILLER. CAUTION: MAY IV. A. 9 .n '4 CAUSE SKIN IRRITATION Exhibit #P0194 PIN # Date Author Addressee Description DOW728053 08-Jan-63 KENNETH OLSON OYEN, FRITZ & HOYLE,H.R. B IOCHEMRESLAB Data sheet of Properties, Health Hazards, and precautions For Safe Handling of Dowanol PIB ester of 2,4,5-T (91%) -relatively no problems noted, except skin irritation, and slight eye irritation Exhibit #P0196 PIN # Date Author Addressee Description D0W816874 15-Jan-63 DEPT OF DOW BIOPRODUCTS TABLE OF CONTENT - CONTAINING TOXICOLOGICAL PROPERTIES OF TORDON AND TOXICOLOGICAL PROPERTIES OF TORDON 101 MIXTURE. A PRIVATE COMMUNICATION NOT FOR PUBLICATION REPRODUCTION, OR GENERAL DISTRIBUTION. Exhibit #P0199 PIN # Date Author Addressee Description DOW650469 01-Feb-63 GEORGE DOWNARD DOW CHEMICAL & FALSEY, BILL U.S.D.A. Notice of Registration under FIFRA issued over sig. of G. Downard, Head of Registration Section, Pesticides Regulation Division re; Esteron 2,4,5-T concentrate on the basis of information "furnished by the registrant"(Dow) Exhibit #P0203 PIN # Date Author Addressee Description DOW816959-60 07-Mar-63 CHEMICAL DOW THE DOW CHEMICAL COMPANY COPY OF A LABEL FOR TORDON 101 MIXTURE WITH USE DIRECTIONS, USE PRECAUTIONS AND WARNING STATED. Exhibit #P0204 PIN # Date Author Addressee Description DOW816955-56 07-Mar-63 CHEMICAL DOW THE DOW CHEMICAL COMPANY LABEL FOR TORDON 101 MIXTURE. THE LABEL CONTAINS USE IV. A. 10 rq 150 DIRECTIONS, USE PRECAUTIONS, AND WARNING. (SEE EXHIBIT 207) Exhibit #P0205 PIN # Date Author Addressee Description D0W818958 12-Mar-63 MARK WOLF MCINTYRE, M. M. SUBJECT: SUGGESTED PRECAUTIONARY LABELING FOR TORDON 101 MIXTURE. STATES WHAT EFFECTS THE CHEMICAL HAS AND WHAT TO DO IF CONTACT OCCURS. THIS IS A SAMPLE LABEL. Exhibit #P0207 PIN # Date Author Addressee Description DOW820879 27-Mar-63 CHEMICAL DOW CONFIDENTIAL: COMPLETE INGREDIENT STATEMENT FOR TORDON 101 MIXTUE M-2439, THIS STATES ACTIVE AND INERT INGREDIENTS AND HOW MUCH OF EACH. Exhibit #P0213 PIN # Date Author Addressee D0W119118-21 19-Apr-63 MARK A WOLF MNNAMARA, BERNARD & LYNN. G. E. Description A TABLE CONTAINING A SUMMARY OF ACUTE ORAL TESTS (BY INTUBATION) ON 2,4-D AND 2,4,5-T AND A NUMBER OF THEIR DERIVATIVES PREPARED BY BIOCHEMICAL RESEARCH LABORATORY. Exhibit #P0215 PIN # Date Author Addressee Description 0402786 22-Apr-63 GEORGE LYNN DELMORE, GEN.FRED & SHAW, DR. WARRENC. U.S. ARMY & U.S.DEPT.DEFENSE U.S.D.A. & ARMY CHEMICAL CENTER LYNN LETTER TO DELMORE RE 24D&245T TOXICITY Exhibit #P0216 PIN # Date Author Addressee D 802819-20 22-Apr-63 G E LYNN DELMORE, GEN. FRED J & SHAW, DR. WARREN C. Description G. E. lyrm's letter dated 04-22-63 to Brigadier General Fred J. Delmore. Exhibit #P0220 1 \j`4 IV. A. 11 PIN # Date Author Addressee Description Exhibit #P0221 PIN # Date Author Addressee DOW650079-83 29-Apr-63 MILT HUNT LYNN, GEORGE & JOHNSON, JULIUS COULTER, L.L. & WOLF, MARK MCINTYRE,H.H. & FALKENSTEIN, W.J. limited release for sales directed to many at Dow relating to Verton CE with Diesel Fuel Oil and with sample label attached refers to meeting customer (AT&T) specifications / DS 17940-41 02-May-63 R J MARRESE CECIL, LARRY & GUIDI, R. A. KING, J. 0. & CHANDLER, E. L. Description diamond alkali co. confidential interoffice correspondence from R. J. Marrese to Larry Cecil dated 05-02-63. Exhibit #P0226 PIN # Date Author Addressee Description DOW650262-70 17-May-63 JULIUS JOHNSON LYNN, GEORGE & BARRON, K.C. WOLF, MARK & MCINTYRE, H.H. FALKENSTEIN, W.J. & COULTER, L.L. limited release to sales of a 2,4,5-T formulation known as Verton T, with notes of Julius Johnson and George Lynn, H.H. McIntyre and others relating to use, labeling, and fact that product had to be registered to be sold to to customers identified and with reference to competing against Amchem for business. Exhibit #P0232 PIN # Date Author Addressee Description DOW820874 12-Jun-63 M W DUNDERLAND DOWNARD, C.M. & LOARY, J. S. LYNN, G. E. LETTER FROM M.W. DUNDERLAND, STAFF ASSISTANT, BIOPRODUCTS DEPARTMENT TO C.M. DOWNARD REGARDING TORDON 10 MIXTURE AND A ADDITIONAL INVESTIGATION OF THE EFFECTS. Exhibit #P0233 PIN # Date Author DOW820866 28-Jun-63 G M DOWNARD IV. A. 12 150' -j Addressee Description SUNDERLAND, W. W. LETTER DATED 06-28-63 FROM G. M. DOWNARD HEAD, REGISTRATION SECTION TO MR. W. W. SUNDERLAND OF DOW C CHEMICAL COMPANY. CONTAINING A REGISTRATION NOTICE UNDER THE FEDERAL INSECTICIDE, FUNGICIDE, AND RODENTICIDE ACT FOR TORDON 101 MIXTURE. REGISTRATION NUMBER IS 464-306. Exhibit #P0234 PIN # Date Author Addressee Description H281 14 03-Jul-63 JOHN FRAWLEY ROWE, V.K. & DUNN, C.L. HUNT, WM.H..PH.D. George Lynn, then Director of Registration, Bioproducts Department of Dow, writes Brig. General Fred J. Delmore, U.S. Army at the request of Dr. Warren C. Shaw of U.S.D.A. and encloses toxicity data re 2,4,5T and 2,4D, stating "We would like to also mention that we have been manufacturing 2,4-D and 2,4,5-T for over ten years and ...to the best of our knowledge, none of the workmen in these factories have shown any ill effects as a result of working with these Exhibit #P0235 PIN # Date Author Addressee H281 14-1 5 03-Jul-63 JOHN P FRAWLEY ROWE, V.K. & HUNT, W. H. Description john p. frawley's letter to V. K. rowe of 07-03-63. Exhibit #P0239 PIN # Date Author Addressee Description JUS215 1947 19-Jul-63 ARMY ARMY 1963 MILITARY SPECIFICATIONS. Exhibit #P0240 PIN # Date Author Addressee Description DOW981607 19-Jul-63 ARMY ARMY MILITARY SPECIFICATIONS FOR HERBICIDE N-BUTYL 2,4,5-TRICHLOROPHENOXYACETATE, Exhibit #P0253 PIN # D0W816941 1507S IV. A. 13 Date Author Addressee Description 18-Nov-63 MARK G WILTSE LYNN,G . E. & HAMMER, O.N. RITTY, P. M. & BRYANT, C. A FALSEY, W. P. & OTHERS LETTER DATED 11-18-63 FROM MARK G. WILTSE, MANAGER, TORDON PRODUCT PALNNING TEAM TO G. E. LYNN, BIOPRODUCTS DEPT. REGARDING THE CORRECTION OF TORDON 101 LABEL. Exhibit #P0256 PIN # Date Author Addressee Description DOW820863 04-De c-63 CHEMICAL DOW / CONFIDENTIAL: A LISTING OF INGREDIENTS CONTAINED IN TORDON 101 MIXTURE AND THE AMOUNT OF EACH Exhibit #P0257 PIN # Date Author Addressee Description DOW820861-63 05-Dec-63 N W MCINTYRE MR. GEORGE M BERNARD & BIOPRODUCTS WASHINGTON OFFICE Revisions in labeling due to new findings regarding purity of product. Exhibit #P0263 PIN # Date Author Addressee Description DOW820833 13-Jan-64 G M DOWNARD SIDNEY B SACHS U.S. Department of Agriculture is advising Dow Chemical Company that the proposed new labeling is not acceptable due to implied change in weight. Exhibit #P0274 PIN # Date Author Addressee Description DOW620859 09-Mar-64 ILLEGIBLE ILLEGABLE DR/MR LEARY This memorandum is totally illegible. Exhibit #P0293 PIN # Date Author Addressee Description DOW816938 18-May-64 WP FALSEY C .A . HIGHHILL & C. A. BRYANT G.E. LYNN & L.L. COULTER R. C. DOSSER & OTHERS Because there is evidence that there is a large amount of Tordon Acid below the 65% IV. A. 14 purity level, specifications are given on how to blend it with other materials going into Tordon 101 to achieve an AVERAGE of 65% purity. Mention is made that normally, this impure Tordon Acid would not be used. Exhibit #P0308 PIN # Date Author Addressee Description D0W816937 29-Jun-64 MR FALEDY A.L. HOLIDAY & G.E. LYNN J .A . TELLY & D. B< FLETCHER GLENN SHAW Request for written statements on waste disposal and statement that product is not being placed in water, streams, etc. They wish to avoid adverse publicity. Exhibit #P0313 PIN # Date Author Addressee Description A&G85-87DOW 30-Jul-64 RAY HOLMES HOYLE, H.R. 3 page letter giving history of process changes in 199 bldg, by holmes, supervisor of plant, and which documents high production and beginning of outbreak of chloracne in February, 1964 with dated summary of events on last page. Exhibit #P0314 PIN # Date Author Addressee Description DOW 766762-4 30-Jul-64 RAY HOLMES HOYLE, H. R. Ray holmes' letter to H. R. hoyle dated 07-30-64. Exhibit #P0319 PIN t Date Author Addressee Description D0W132506 08-Sep-64 L WESTOVER HOLMES, RAY Westover reports that Lab tests in 5 sample of caustic insoluble oil from TCP process estimates TCDD level at .2% and refers to the presence of other halogenated mamaterials detected as well. Exhibit #P0320 PIN # Date Author Addressee DOW 132506 08-Sep-64 L B WESTOVER HOLMES, R IV. A. 15 Description 09-10-64 westover report to holmes re: results of analysis of dioxin in certain samples. Exhibit #P0323 PIN # Date Author Addressee Description DOW568604-5 15-Sep-64 DR HANS MERTZ DOW CHEMICAL CO. Dr. Mertz related visit of Trapp, Lueck, and Silverstein and encloses confidential paper re isolation of chloracne exciters and production of 2,4,5-T acid dated 12/09/56. Exhibit #P0325 PIN # Date Author Addressee D0W132504-5 05-Oct-64 RAY HOLMES GOERGEN, G. G . & HUTCHENREUTHER,C .0. DYLEWSKI, S.W. & HABERSTROH, W.H. Description Holmes writes others at Dow re chloracne producing material, and states attempts to reduce the TCDD type materials made in our process have not been encouraging; and "I am not confident that we have done or are doing enough at 199 Bldg, to overcome the chloracne trouble" but "number of people are encouraging me..to continue" at capacity Exhibit #P0326 PIN # Date Author Addressee DOW 132504-5 05-Oct-64 R D HOLMES GOERGEN, G. G. & HUTCHENREYTHER, C DYLEWSKI, S. W. & HABERSTRCH, W. H. Description Ray holmes' letter of 10-05-64 to G. G. Goergen and others. Exhibit #P0331 PIN # Date Author Addressee Description DOW766704-8 20-Nov-64 RAY HOLMES UNKNOWN Ray Homes, Supervisor of 199 bldg.at Dow, writes Report (which has been re-dacted, in pertinent part),re; Hydrolysis of TetraChlorobenzene using Flake Caustic In (redaction);describes differences is pro cess from '46-52 and '55-62 IV. A. 16 Exhibit #P0334 PIN # Date Author Addressee Description D 0 W 1 19502-3 03-Dec-64 DAVID H GROTH E.T. UPTON Author speculates on root of skin an liver toxicity in 2,4,5-T is due to some by-product. Asks for samples of purest 2,4,5-T and commercial 2,4,5-T and product before the emulsifiers have been added for testing. ^ Exhibit #P0336 PIN # Date Author Addressee Description A&G 500040-1 04-Dec-64 DR DAVID GROTH UPTON, EDWARD T. 12-04-64 LETTER FROM DR. DAVID GROTH TO MR. UPTON. Exhibit #P0338 PIN # Date Author Addressee Description DOW33304-1 7 08-Dec-64 N E SKELLY BRADLY, K.B. & COULTER, K.E. DELISLE, N.G. & GILL, H.M. GOERGEN, G.G & OTHERS Isolation and Identification of possible Acnegens from the Caustic-Insoluble Portion of the products from the 2,4,5-T Process. Skin sensitivity tests on rabbits have positively shown 2,3,7,-T to be by far the most severe skin irritant among the group of compounds identified. Exhibit #P0339 PIN # Date Author Addressee Description 00000000 11- Dec-64 LINDLEY S DEATLEY DOSSER, P. C. 12- 11-64 LETTER FROM MR. OF DOW. DEATLEY TO DOSSER Exhibit #P0341 PIN # Date Author Addressee Description DOW568606-8 15-Dec-64 DR HANS MERTZ DOW CHEMICAL CO. Same exhibit as 370 except third page attached which shows molecular drawing of TCDD. Exhibit *P0342 PIN # DOW568609-1 3 IV. A. 17 Date Author Addressee Description 17-Dec-64 DR HANS MERTZ SILVERSTEIN, LARRY Boehringer informs Silverstein of Dow of rabbit testing data done in 1955 showing death, liver damage, kidney and lung failures. Exhibit #P0343 PIN t Date Author Addressee Description DOW820336 20-Dec-64 NONE NONE / General Memorandum regarding materials of 3,5,6-T Chemical Tordon and directions for use. Back panel with caution shown. Exhibit #P0344PIN # Date Author Addressee Description D0W14050-57 22-Dec-64 HAROLD GILL COULTER,K.E. & GOERGEN, G.G. HOLMES, RAY D. & HOYLE, H.R. KEY, M. & SILVERSTEIN, L. Harold Gill of Dow writes Analytical Method to determine TCDD in caustic insolubles of 2,4,5-TCP process and distributes it to 19 others at Dow Exhibit #P0345 PIN # Date Author Addressee Description DOW 14050-57 22-Dec-64 HAROLD GILLS COULTER, K. L. & YRBLE, R. ERLEY, D. S. & GREENE, L. M. GOARGEN 0. C. & HABERSTRCH, W. H. Harold gill's gas/liquid chromatographic procedure to analyze caustic insoluables for compounds capable of causing chlorance, principally 2,3,7,8-tetrachlorodibenzo-p-dioxin. Exhibit #P0346 PIN # Date Author Addressee Description 00000000 28-Dec-64 LINDLEY S DEATLEY DOSSER, P. C. 12-28-64 LETTER OF DEATLEY TO DOSSER OF DOW. Exhibit #P0351 PIN # Date Author 00000000 12-Jan-65 L S DEATLEY 15081 TV. A. 1ft Addressee THOMPSON, BOB & HOWARD, HAROLD Description 01-12-65 T-H INTEROFFICE MEMO. Exhibit #P0352 PIN t Date Author Addressee Description D0W7 66687-94 12-Jan-65 N POFFENBERGER SAUERS, R. & TRAPP, W.B. POFFENBERGER, N. fr WIDIGER, A. LUECK, A & OTHERS This information consists of diagrams and formulas which are difficult to interpret. Exhibit #P0355 PIN # Date Author Addressee Description 00000000 14-Jan-65 EDWIN T UPTON GROTH, DR. DAVID 01-14-65 LETTER FROM MR. GROTH. UPTON TO DR. Exhibit #P0356 PIN # Date Author Addressee Description D O W 1 120903 14-Jan-65 EDWIN T UPTON GROTH, DR. DAVID M. letter dated 01-14-65 from edwin t. upton to Dr. David M. Groth regarding the samples that were requested for the study of the chloracne problem. Exhibit #P0357 PIN # Date Author Addressee Description DOW568569-72 26-Jan-65 WALTER B TRAPP CHAMBERLAIN, L.C. & COULTER, K.E. HABERSTROH, W.H. & GOERGEN, G.G. SAUERS, R.C. Three page summary attached to cover letter admits TCDD chloracne exciter shows conditions which minimize TCDD formation and shows conditions which favor TCDD formation "the disadvantage of the non-aqueous solvent system is . . . which can plug a tube reactor." Exhibit /P0358 PIN # Date Author Addressee Description DOW569137-38 27-Jan-65 WALTER TRAPP DOW CHEMICAL CO. Graphs show Dow discovered increase in production of TCDD at higher temperature; 15083 2nd page initialed A.H.W. and dated January 28, 1964; A.H.W. is Dow's Widiger. Exhibit #P0359 PIN # Date Author Addressee Description DOW568535-7 28-Jan-65 WALTER B TRAPP MERTZ, DR. HANS This letter contains a report of a telephone conversation between four Dow people and Dr. Merz with recitation of questions and answers. Exhibit #P0360 PIN # Date Author Addressee Description D0W1120905 31-Jan-65 DAVID H GROTH KRAUS, GUNTHER E. reports stating people developing chloracne and liver damage from over exposure to 2,4,5t in industry. Exhibit #P0361 PIN # Date Author Addressee Description D0W7 66309-36 03-Feb-65 N POFFENBERGER LUECK,AL & COULTER, K. STAEHLING, E. & TRAPP, WALTER HABERSTROH,W.H. & OTHERS Preliminary process design for the man ufacture of 245-Trichlorophenol using 100% NaOH distributed to manufacturing personnel at Dow, and designed at Dow Exhibit #P0362 PIN # Date Author Addressee Description D0W7 66309-36 03-Feb-65 N POFFENBERGER A process design is presented, that advantage be taken of the high reaction rates. This document goes into detail about various Recycle, Reaction, and Analysis Profiles. Exhibit #P0363 PIN # Date Author Addressee DOW569168-92 03-Feb-65 N POFFENBERGER TRAPP, W. & COULTER, K. LUECK, A. & OTHERS AT DOW Description Poffenberger of Dow prepares and distributed processed design to prepare 1508 TV A on 2,4,5-TCP using 100 percent sodium hydroxide. Exhibit #P0364 PIN # Date Author Addressee UNKNOWN 05-Feb-65 KY HANSON SPALDING, J.L. & PATENT DEPARTMENT 566 BUILDING & DOW CHEMICAL Description Letter shows Dow sold surplus 245-T and surplus 2,4-D,to which was added 481,500 pounds iso-butyl ester 2,4,5-T and sold to Army procurement at price of $229,338. in November, 1961; Letter also refers to other sales, and bids and sales of Monsanto, Hercules & Diamond, and royalties due Dow on such sales. Exhibit #P0365 PIN # Date Author Addressee Description DOW569105-12 09-Feb-65 SAME ILLEGIBLE ANDERSON & LUCEK WOLF & WEST TRAPP & OTHERS This document provided by Dow Chemical are the Safety Techniques suggested. Exhibit #P0366 PIN # Date Author Addressee Description 00000000 10-Feb-65 LINDLEY S DEATLEY WILLIAMS, G. J & GRANT, L .B CORBIN, W. L. & HARRIS, T. W. TUCKER, J. C. & THOMPSOM, R. S. MEMO OF DISCUSSIONS AT DOW CHEMICAL CO. HELD 2/10-11/65, SIGNED BY MR. DEATLEY AND DATED 2-15-65. Exhibit #P0367 PIN # Date Author Addressee Description DOW568549 15-Feb-65 WALTER B TRAPP DOLL, DR. 0. Trapp thanks Boehringer for help, says restriction in communication because of our secrecy agreement and because of this, Koopmann not fully information of seriousness of Dow health problem. Exhibit #P0369 PIN # Date 0000000 17-Feb-65 15085 TV. A 9 1 Author EDWIN T UPTON Addressee GROTH, DR. DAVID M Description 02-17-65 LETTER TO MR. UPTON TO DR. GROTH. Exhibit #P0370 PIN # Date Author Addressee Description D0W107810-11 17-Feb-65 FRANK S DAVIS GIBSON, JOHN letter dated 02-17-65 from frank S. davis, research plant physiologist to Mr. John Gibson of dow and a paper on moisture stress based on an article given at WSA (on the Mechanism of inhibition of KAD-linked dehydrogenese Systems by Piclorax. Exhibit #P0371 PIN # Date Author Addressee Description D0W129844-6 22-Feb-65 DONALD PLETCHER ROWE, V.K. & FALSEY, W.P. HOYLE, H.R. & GILL, W.M. SILVERSTEIN, LARRY & LYNN, GEORGE E. minutes of meeting held at Dow among Dow employees; notes Dow knows rabbit ear tests sensitive to 4 ppb and "agreed that Rowe should move ahead with contact with U. S. Public Health Service and Department of Agriculture representatives as soon as our data is better corrolated." "contacts to be made with other" manufacturers; "Rowe to serve as Dow contact for any inquiries" Exhibit #P0372 PIN # Date Author Addressee Description DOW 129844-6 22-Feb-65 D E PLETCHER ROWE, V. K. 4 FALSEY, W. P. BARRON, K. C. & CORBIN, W. L HOFF, R. C. & HOYLE, H. R. D. E. pletcher report dated 2-22-65 of the "exciter problem" meeting which took place 2-18-65. Exhibit #P0374 PIN # Date Author Addressee 5972-3 24-Feb-65 EMMET KELLY FILE & MONSANTO Description Emmet Kelly, M.D. of Monsanto writes memo to file of his Telephone conversation with V.K. Rowe of Dow concerning Dow's analysis of Monsanto's 2,4,5-T at 3-10 ppm TCDD; 1508* T V A OO together with customer complaint references and meetings to be held. Exhibit #P0375 PIN # Date Author Addressee Description 005972-3 24-Feb-65 R EMMET KELLY MD MEMO FROM R. EMMET KELLY, M.D. REGARDING HIS DISCUSSIONS WITH V. K. ROWE OF DOW, DATED 02-24-65. / Exhibit #P0376 PIN # Date Author Addressee Description MON 005972-3 24-Feb-65 EMMET KELLY FILE DOW HAS 20 CASES OF CHLORACNE. DOW HAS ANALYSES SAMPLES FROM MONSANTO AND FOUND OUR 2,4,5-T AHS 3-10 PPM OF TCDD WHICH KELLY SAYS ROWE IS SURE IS THE CHLORACNE CAUSING AGENT. DOW WILL HAVE MANAGEMENT MEETING TODAY; ROWE WANTS CRASH MEETING WITH ALL PRODUCERS TO REACH A SPEC LEVEL IN ORDER TO ELIMINATE THIS PARTICULAR CONTAMINANT BEFORE THE PUBLIC HEALTH SERVICE GOT INTO THE ACT. Exhibit #P0378 PIN # Date Author Addressee Description 00000000 26-Feb-65 DR DAVID H GROTH UPTON, EDWIN T. 02-26-65 LETTER OF MR. UPTON TO DR. GROTH. Exhibit #P0379 PIN # Date Author Addressee Description DOW 19294-5 01-Mar-65 J D DOEDENS ROWE, V. K. TRICHLOROPHENOL SUMMARY D. DOEDENS OF DOW. DATED 3-1-65, BY J. Exhibit #P0380 PIN # Date Author Addressee DOW19294-5 01 -Mar-65 J D DOEDENS ROWE,V. K. t UNKNOWN Description J.D. Doedens of Dow writes a very descriptive summary of the trichlorophenol producers, his personal knowledge of toxicology, V.K. Rowe's contacts (and those of others at Dow) with other producers, the 15087 IV. A. 23 scheduled meeting in March, 1965;"most toxic materials known"..."positive action at 40 parts per billion" ..."equivocal results at 4 ppb".,J.dentif ies symmetrical dioxin as the agent. Exhibit #P0381 PIN t Date Author Addressee Description DOW569221-33 02-Mar-65 J L CORNELL ^ COULTER, K. E. & DELISLE, N. G. DYLEWSKI, S. W. & GOERGEN, G. G. HUTCHENREYTHER C 0 & OTHERS this contains the following information: authorization request, project schedule - projected targets, manpower,process review, reactor procurement, plot plan and site, research program and figures. Exhibit #P0382 PIN * Date Author Addressee Description D0W129925 02-Mar-65 V K ROWE BARRONS, K.C. & CORBIN, W.L. HOYLE, H.R. This meeting was called to discuss the disposition of the Monsanto 2,4,5-T which contains from 3 to 7 ppm. Exhibit #P0383 PIN # Date Author Addressee Description DOW569221-33 02-Mar-65 S J HARRIS LUECK, A F & COULTER, K E DELISLE, N G & GOERGEN, G G HUTCHENREUTHER, C 0 & OTHERS This project deals with Authorization Request, Project Schedule - Project Targets, Manpower, Process Review, and Discussion. Questions were raised regarding many "if's" involved with this proj ect. Exhibit #P0385 PIN # Date Author Addressee Description DOW!111-1127 10-Mar-65 LARRY SILVERSTEIN LYNN, GEORGE 6 HUTCHENREUTHER GOERGEN & STAEHLING BAILEY c UNIT INDEX Early History of the Chloracne Problem Biochem's Contribution authored by Larry Silverstein of Dow and distributed to other Dow Employee's; Describes at length the 15088 TV A ?/, chloracne outbreak, the disease,the ident ification of TCDD, liver damage, european experience, rabbit ear testing, german pro blems in '55, and '57 active samples from 199 Bldg, at Dow. Exhibit #P0386 PIN # Date Author Addressee Description D0W129927 1O-Mar-65 LARRY SILVERSTEIN ROWE, VERALD K. & TYNN, GEORGE HUTCHENREUTHER,C .0. & GILL, W.M. PLETCHER, DONALD & OTHERSDOWNUMEROUS Memo to 23 Dow employees relating the hazard found in Dow's analyses of lots of Monsanto's 2,4,5-T acid ;"Material represents a definite hazards requiring all the precautions used in 199 building.." Exhibit #P0387 PIN # Date Author Addressee Description D0W129927 1O-Mar-65 L G SILVERSTEIN RILEY, P. H. & TUCKER, J.C. SMILEY, R.N. & HARRIS, J. W. GRANT, L.B. & OTHERS Rabbit ear tests on twelve lost of Monsanto 2,4 T acid have shown moderate to severe response in eight to 20 percent concentration in ethanol. This material presents a definite hazard which would require all the precautions used in 199 Bldg and 349 Bldg. Exhibit #P0388 PIN # Date Author Addressee Description DOW172136-37 1O-Mar-65 G SILVERSTEIN RILEY, F.H. & TUCKER, J.C. SMILEY, R.N. & HARRIS, J.W. GRANT, L.B. & OTHERS Rabbit ear tests have shown moderate to severe response in eight cased as 10% concentration in ethanol. This material presents a definite hazard which would require all precautions used in 199 Bldg and 349 Bldg to prevent injury. Shipping this material to Riverdale and Woodbury is a definite risk to their employees, espcially since they are probably unaware of the problem and are probably taking no precautions. Exhibit #P0389 IV. A. 25 PIN # Date Author Addressee DOW569141-42 1O-Mar-65 A H WIDIGER TRAPP & DOW CHEMICAL CO. Description Widiger of Dow prepares graphs showing time--temperature, factors in reaction to produce tetrachlorobenzene. Exhibit #P0390 PIN # Date Author Addressee Description DOW 1111-27 11-Mar-65 LARRY SILVERSTEIN / "EARLY DOW HISTORY OF THE CHLORACNE PROBLEM--BIOCHEM'S CONTRIBUTION" DATED 03-11-65 OVER INITIALS OF LARRY SILVERSHEIN OF DOW. Exhibit #P0391 PIN t Date Author Addressee Description D0W1111-27 11-Mar-65 LARRY SILVERSTEIN BAILEY & HUTCHENSUTTEN GOERSEN & LUCEK OTHER ILLEGIBLE An outbreak of chloracne in the trichlorophenol process has resulted in approximately 40 cases of chlora in Dow people. Chloracne is a skin disorder characterized by the appearence of black heads and small bumps. Exhibit #P0393 PIN # Date Author Addressee Description DOW569239-43 15-Mar-65 R E ANDERSON DELISLE, N. G. & COULTER, K. E. WOLF, R. W. & GOERGEN, G. G. LUSCK, A & OTHERS this reports states the reason for building a new facility. Exhibit #P0394 PIN # Date Author Addressee Description DOW569239-43 15-Mar-65 R E ANDERSON COULTER, K.E. & WOLF, R LUSCK, A. & TRAPP, W. OTHERS The major consideration in the design of the new plant is to prevent the production of chloracne compounds but to minimize operator contact with process streams and equipment. Exhibit *P0395 PIN # Date Author Addressee Description DOW569251-4 17-Mar-65 UNKNOWN REA UNKNOWN Dow document, evidently internal, composed by "R.E.A." describing the Trichlorophenol Reactor cycle. / Exhibit #P0398 PIN # Date Author Addressee Description DOW569247-50 18-Mar-65 J S HARRIS ANDERSON, R. E & LUECK, A. F. DELISLE, N .G & WEH N , W. E. CORNELL, J. L. & OTHERS discussed were preliminary/drying flow sheets,steel shell and tube phenate colers with temperature controls, etc. Exhibit #P0399 PIN # Date Author Addressee Description D0W5 69247-50 18-Mar-65 J S HARRIS COULTER, K.E. & GRAVES, H.E. WOLF, R.R. & HABERSTROH, W.H. DYLEWSKI, S.W. & OTHERS The purpose of the meeting was to review the preliminary reactor and neutralization/drying flow sheets. Exhibit #P0400 PIN # Date Author Addressee D0W119084-5 19-Mar-65 CH BOEHRINGER SOHN DOW CHEMICAL & BRANCH, C.B.,V.P. Description C.H. Boehringer Sohn of Germany writes Dow letter form agreement calling for the payment by Dow to the German firm for disclosure of processes aimed at the prevention of chloracne arising out of the production of sodium 2,4,5-trichlorophenate; Calls for payment of $35,000 (sic?) (copy it not clear). Exhibit #P0401 PIN # Date Author Addressee 19193-8 19-Mar-65 LARRY SILVERSTEIN ROWE,V.K. & LYNN, GEORGE HUTCHENREUTHER C.O. & WILTSE, MARK ' V "7 Description PETERSEN, JACK & OTHERS Larry Silverstein of Dow writes detailed report concerning the discussion held at Dow on 3-24-65 among representatives of Dow, Hooker, Diamond Alkali and Hercules; document references the presentations tha t were made by Dow employees at the meet ing, together with extensive knowledge of the toxic properties of dioxin. Exhibit #P0402 PIN # Date Author Addressee Description 379-80 19-Mar-65 VERALD ROWE KELLY, EMMET, M.D. & WILKENFELD, DR.J. VERHOEZE, RAYMOND & KENNEDY, FRANCIS CHANDLER, ED & FRAWLEY, DR. JOHN P. 3-19-65 letter from V.K. Rowe of Dow to various manufacturer's representatives, describing conversations he has had with them, and setting up meeting to be held 3-24-65 at Dow, Midland, MI. Exhibit #P0403 PIN * Date Author Addressee DOW 119084-5 19-Mar-65 C H BOEHRINGER SOHN BRANCH, C. B. & DOW CHEMICAL CO. Description LETTER FROM AGREEMENT BETWEEN C. H. BOERINGER SOHN AND DOW CHEMICAL COMPANY, DATED 3-19-65. Exhibit #P0404 PIN # Date Author Addressee Description DOW19200-1 19-Mar-65 V K ROWE KELLY, EMMET & WILKENFELD, DR. J VERHOEZE, RAYMOND & KENNEDY, FRANCIS CHANDLER, DR. ED & OTHERS letter inviting each to Midland to dicusss the toxicological problems caused by the presence of certain highly toxic impurities in 2,4,5-t and related materials. Exhibit #P0405 PIN # Date Author Addressee Description DOW568796-7 19-Mar-65 SOHN BOEHRINGER DOW CHEMICAL English translation of an agreement letter. Exhibit #P0415 TV. A. ?R 15032 PIN # Date Author Addressee Description DOW 19193-98 29-Mar-65 L Q SILVERSTEIN RILEY, F. H. & SMILEY, R. N. GRANT, L. B. & HUTCHENREUTHER, C.O. AMSTUTZ, F. C. St FALSEY, W. P. 03-29-65 "REPORT ON THE CHLORACNE PROBLEM MEETING ON 03-24-65" BY L. G. SILVERSTEIN OF DOW TO V. K. ROWE AND MANY OTHERS. Exhibit #P0416 PIN # Date Author Addressee Description DOW019193 29-Mar-65 V K ROWE RILEY, F.H. GRANT, L.B. PLETCHER, D illegible & SMILEY, R.N. St LYNN, 0. St OTHERS Exhibit #P0417 PIN # Date Author Addressee Description DOW29959-64 29-Mar-65 V K ROWE RILEY,F.H. Sc SMILEY, R.H. GRANT, L.B. St HUTCHENREUTHER AMSTUTZ, F. C. St OTHERS Dr. Holder reviewd the medical side of the Dow and said that we now have approximately 60 to 70 cases of individuals with chloracne ranging from severe cases to mild cases. The limit is 1 ppm for 2,4,5-T and for 2,4,5-T Acid, either acetic or pro pionic. Exhibit #P0424 PIN # Date Author Addressee Description DOW568583 09-Apr-65 WALTER B TRAPP MERTZ, DR. HANS & FRANKFORT OFFICE DOW AMOS DOW INT'L Trapp reports results of Dow studies on Boehringer TCP samples including rabbit tests and analyses of TCBD content. Exhibit #P0427 PIN # Date Author Addressee Description DOW751869 15-Apr-65 HAROLD L GORDON FLAMMANG 6c DIVISION MANAGER MAGNA CORP. & ROWE, V.K. OTHERS AT DOW Medical Director of Dow writes Division Manager of a customer giving complete assurance that impurity present in Dowicide S3 IV. A. 29 2 could not cause chloracne even with gross overexposure and sa;ys Dow imposed standard on finished product of zero using an analytical method to 1ppm. Exhibit #P0428 PIN # Date Author Addressee DOW568577-8 22-Apr-65 CH BOEHRINGERSOHN DOW CHEMICAL & RE245TCONTRACT Description Letter in german from C.H. Boehringer Sohn to Dow Chemical Company, Midland, Michigan, re; 2,4,5-T"KontraKt" Exhibit #P0431 PIN # Date Author Addressee Description DOW012036-37 04-May-65 L C WHITE JR AMSTUTS, F.C. & HOFF, R. C. SOULATI, J. J. & SILVERSTEIN, L. DOSSER, R. C. & SMITH, K. A. a conference to discuss the dioxin addition to the specification.a tentative program of testing for the dioxin was set up. Exhibit #P0433 PIN # Date Author Addressee Description DOW765918 19-May-65 JS HARRIS COULTER, K.E. & LUECK, A.F. TRAPP, W. & HABERSTROH, W.H. WIDIGER, A.H. & OTHERS 2,4,5-trichlorophenol process data and phys- ical properties summary showing heats of re- action data "assembled to assist those work- ing on the trichlorophenol process problem Exhibit #P0434 PIN # Date Author Addressee Description D0W7 6591 8-1 9 19-May-65 J S HARRIS COULTER, K.E. & GRAVES, H.E. ANDERSON, R.E. & LUECK, A.F. WEHN, W.E. & OTHERS Existing and generated raw material, intermediate and byproduct, and product data are herein assembled assist those working on the trichlorophenol process problem. Exhibit #P0436 PIN # DOW107740-45 15094 TV. A. ID 15035 Date Author Addressee Description 01-Jun-65 UNIVERSITY COLORADO STATE an article by Colorado state university, "how safe are chemical weed killers". it states the steps of testing that is done before a chemical goes on the market. Exhibit #P0438 PIN # Date Author Addressee Description DOW 004 02-Jun-65 EDWIN T UPTON GROTH. DR. DAVID H 06-02-65 LETTER OF MR. UPTON TO DR. GROTH. Exhibit #P0441 PIN # Date Author Addressee Description 21745-48 22-Jun-65 UNKNOWN DOWCHEMICAL NOT SHOWN Dow's Method for the Determination of 2,3,7,8 TCDD in 2,4,5-T by GLC dated June 22, 1965 Exhibit #P0442 PIN # Date Author Addressee Description D0W12986061 24-Jun-65 VERALD ROWE MULHOLLAND, ROSS & SILVERSTEIN, LARRY HOLDEMAN, GRADY & GOERGEN, G. HOYLE, H. & FALSEY, W. Dow's V.K. Rowe writes, Ross Mulholland of Dow of Canada, and describes the concern arising out of the contamination of tcp and 245-t; he describes the "exceptional toxicity" of dioxin; and "P.S. Under no circumstances may this letter be repro duced, shown, or sent to anyone outside of Dow Exhibit #P0443 PIN * Date Author Addressee Description DOW 129860-1 24-Jun-65 V K ROWE MULHOLLAND, ROSS & SILVERSTEIN, L. OTIS, C. & HOLDEMAN, ORADY AMSTUTZ, F. C. & GOARGAN, 0 V. K. ROWE'S LETTER TO ROSS MULHOLLAND DATED 06-24-65. Exhibit #P0445 PIN # Date Author DOW568533-34 07-Jul-65 WALTER B TRAPP 150S8 Addressee MERZ, DR. HANS & BOEHRINGER, SOEN Description Germans ask Dow for information re analytical methods using GLC to determine T C D D ; encloses copy of method for analysis for dioxin in 2,4,5-T acid (MLW 65.11). Exhibit #P0452 PIN # Date Author Addressee Description DOW547077-82 24-Aug-65 / UNKNOWN DOW UNKNOWN Description of EWsteron T2 formulation with labeling information on Dow letterhead refers to patent and recommendations for use. Exhibit #P0454 PIN # Date Author Addressee DOW547074 02-Sep-65 SIDNEY SACHS DOWNARD, GEORGE M. & US DA HAMMER, O.H. & SUNDERLAND, W.W. Description Letter from Dow to USDA enclosing materials to review to issue registration for Esteron T2 formulation Exhibit #P0455 PIN # Date Author Addressee Description DOW547074 02-Sep-65 SIDNEY B SACHE DOWNARD, GEORGE M. & HAMMER, 0. H. SUNDERLAND, W. W. letter dated 09-02-65 from Sidney B. sache to Mr. George M. Downard on the subject: Initial registration of Est???? t2. Exhibit #P0457 PIN # Date Author Addressee 001564-69 14-Sep-65 W R UDELL TAKE - NITRO, E.F. & DUNLAP, W. P. STEPHENS, J. A. & SHARP, D. B. Description REPORT FROM W. R. UNDELL OF AGRICULTURAL RESEARCH DATED 09-14-65. Exhibit #P0459 PIN # Date Author Addressee Description D0W19800-2,4 15-Sep-65 DR KEITH C BARRONS final contract report covers the laboratory TV. A. B? Ko n\Jc^ 7' and greenhouse testing of new chemical structures synthesized as potential herbicides. Exhibit #P0461 PIN # Date Author Addressee Description D0W816919-20 ' 20-Oct-65 CONFIDENTIAL DOW a dow confidential sta-tment on the ingredients in TORDON 101 mixture (active and inert ingredients and the amount of each). Exhibit #P0462 PIN # Date Author Addressee Description DOW201091 20-Oct-65 W R DIXON BOSSCHER, H. & HENSKE, J.M. PLETCHER, D.E. Decision has been made on the Midland Division Trichlorphenol Plant. Exhibit #P0480 PIN # Date Author Addressee Description D0W124400-01 03-Mar-66 BILL GILL WILTSE, MARK & HANSON, K. Y. OTIS, C. E. & BRYANT, C. A. MCCOY, W. J. & RYAN, W. J. Questions asked by Olmstead airforce and answered by dow chemical regarding the quantity of tordon 101 and 2,4,5-t. Exhibit #P0484 PIN # Date Author Addressee Description D0W1120842 14-Apr-66 JACK MATHES BILLS, WELTON & COLLINS, GEORGE BARBARINE, AUGUST & BRUCE, JAMES HENDLEY, M. J. & OTHERS form regarding the quantities of orange. Exhibit #P0485 PIN # Date Author Addressee Description DOW009037 22-Apr-66 RICHARD G CARLSON MR. HAROLD BOSSCHER Memo is "blanked" in parts of text, but describes the two steps and overall plan being used to produce tetrachlorobenzene. Memo cites exposure to tetrachlorobenzene fumes presently exceed the long-term Industrial Hygiene Standard in exisiting facility. Exhibit #P0486 PIN # Date Author Addressee Description DOW0201033 22-Apr-66 J D VANARSDALE R.G. CARLSON Memo to Phenol Section from Production Planning and Control which projects the demand for 2,4-ST acid equivalent from 1966 to 1970 and, the portion attributed to government bid business. Exhibit #P0487 PIN # Date Author Addressee DOW765248 22-Apr-66 FD AXE ROWE, V.K. & HOYLE,H.R. Description F.D. Axe, Safety Department, Dow Chemical writes Rowe and Hyle of Dow to report that "we have just seen the first new cases of chloracne in the Tordon plant in more than six months." Since "the Pittsburg Tordon Plant (picoline process) will continue to operate to two or three years..we won't let up on the chloracne problem." Exhibit #P0489 PIN # Date Author Addressee Description D0W120843-46 13-May-66 R A HICKMAN ARNOLD, C. W. & BEUTEL, 0. E. BRYANT, C .A & HANES, J. H. MAASBERG, A. T. & OTHERS subjects covered in the Report of call tordon/orange herbicide - defoliants, trichloroethylene, anti-freeze, methylene chloride, and dursban. Exhibit #P0490 PIN # Date Author Addressee Description DOW0201026 23-May-66 H BOSSCHER MAX KEY, DIR OF MFG. Memorandum which is "blanked", cites that new equipment for removal of "?" will be at new location. Memo cites that capacity will be increased and that the removal of "?" will reduce the incidences of chloracne in the Trichlorophenol Plant. Exhibit #P0491 PIN # DOW816964-65 Date Author Addressee Description 27-May-66 CONFIDENTIAL DOW dow confidential letter stating the ingredients in tn-3083 brush killer. Composition consists of active and inert ingredients and raw materials. Exhibit #P0492 PIN # Date Author Addressee Description DOW820792-94 / 31-May-66 MR LYNN WARD, JUSTUS letter dated 05-31-66 from G. E lynn, director to Mr. Justus Ward, Director on how the chemical tordon is to be used or not used and what not to mix with. Exhibit #P0494 PIN # Date Author Addressee Description D437060-102 22-Jun-66 HOWARD H GRAVES This report is a summary of the pilot plant data obtained on the Boehringer Process for the caustic hydrolysis of 1,2,4,5-T using meOH as a solvent to produce 2,4,5-T (TCP). Exhibit #P0497 PIN # Date Author Addressee DOW1119993 05-Jul-66 C E OTIS CORBIN, W. L. & BRANAMAN, R. J. BEUTEL, DR. & YANKA, D. E. Description amendment to W. J. mccoy's july 5 letter to w. j. ryan on the subject "basis for pricing of orange." the price of orange to the government at $7.39 per gallon and the reasons why. Exhibit #P0498 PIN # Date Author Addressee Description Exhibit #P0500 D0W119541-47 11-Jul-66 ARMY ARMY military specification on herbicide; n-butyl 2,4,5-trichlorophenoxyacetate. Standard sections regarding are included: Scope, Applicable documents, etc. note: precaution - not for domestic use. 15'00 PIN * Date Author Addressee Description DOW00013078 13-Jul-66 J S JR CORT A .B . TILLMAN Appropriation request is for funds for expansion of the 2,4-D Acid facility, modification of the 2,4,5-T Acid facility, purification of TCP and additional warehousing facilities. Memo cites that TCP purification is Resigned to eliminate a major health problem at Newark and potential health problems with customers. Exhibit #P0504 PIN # Date Author Addressee Description DOW201024 0 1 - Aug-66 DOW BD OF DIRECTORS BD OF DIRECTORS Meeting addresses Tetracholobenzene Expansion on a new building. This new facility is needed to provide for sales primarily of 2,4,5-t and of silvex,ronnel and Dowicides. Exhibit #P0505 PIN # Date Author Addressee D0W816681 06-Aug-66 0 H HAMMER WOLF, M.A. & LYNN, G. E. Description technical information on tordon requested by ralph C wands. supplied on governmental agencies on a semi-confidential basis and not for reproduction, publication or general distribution. Exhibit #P0506 PIN # Date Author Addressee D0W19997-8 11-Aug-66 C E OTIS CORBIN, W. L. & GOWELL, J. H. MCCOY, W. J. & WILTSE, M. G. Description states the military needs for orange in gallons for 1966 -1967 by the month. also states what orange is composed of : 4 lbs. a/e of 2,4,5-t and 4 lbs. a/e of 2,4-d per gallon. Exhibit #P0513 PIN # Date Author Addressee D0W119483-84 08-Sep-66 SUPPLY CENTER DEFENSE GENERAL miG Description order form, contract #: dsa-400-67-c-182U for a grand total shipped 377123 gallons. Exhibit #P0515 PIN # Date Author Addressee Description DOW201022 26-Sep-66 CHESTER OTIS DIXON, W.R. & BOSSCHER, H. HARDING, K. & ARMSTRONG, C. C. PLETCHER, D. E. & OTHERS The Plant Science business feels it is necessary to defer the Tetrachlorobenzene expansion (new building), auth. no. MP-32383A. Exhibit #P0533 PIN # Date Author Addressee Description DOW770187-95 04-Nov-66 A WIDIGER JOHNSON,A. & DUGAN,G.F. COULTER,K.E. & GOERGEN.G.G LOUCK,A. & OTHERS Widiger, Johnson, and Dugan of Dow report on new process developed to prepare 245TCP from Trichlorobenzene ; claims that although the process is more complicated than the present Dow process, it is continuous oriented and of simpler design which "should require less capital, less maintenance labor, and less operating labor." Exhibit #P0535 PIN # Date Author Addressee DOW0400-406 07-Nov-66 PROJECT ARMY MU PN 6840 A040 & MILITARY SPECS Description Supercedes spec of 19-July-63. Gives military specs for ordering one type of herbicide consisting of normal-butyl 2,4,5-Trichlorophenoxyacetate molecular weight 311.60. Specs include standards requirements (composition, appearance, etc.), Quality Assurance Provisions, Packaging, Testing, Marking, etc. Gov't reserved inspection rights but vendor can use any acceptable lab. Marking specs contain provision for marking in accordance with MIL-STD-129 and in compliance with the Federal Exhibit #P0547 PIN # DOW0035-53 i-- ' Date Author Addressee Description 01-Dec-66 GEORGE F COLLINS DOW CHEMICAL CO. Contract issued by Directorate for Procurement and Production - Defense General Supply Center to Dow Chemical at the Abbott Road Bldg. This is a confirming telegraphic offer dated 11/25/66 and acceptance dated 12/01/66. Order is for 6840 NSN, Herbicide, Butyl Esters: MIPR No. MA-6-16445. Section B relates product specifications. Exhibit #P0548 PIN # Date Author Addressee Description D O W 1 19485 01-Dec-66 NONE DEFENSE SUPPLY DOW GENERAL Reference to contract DSA-400-67-C-4029/PC409 Total amount of contract cited as 128,000 gal. with a 5% increase 0% decrease variation clause. Columns relate to quantity expected and quantity shipped from 2/13/67 to 3/2/67. Exhibit #P0553 PIN # Date Author Addressee Description DOW88930-41 09-Dec-66 GEORGE LYNN HAMMER,O.H. & TOXIC LAB BIO-PRODUCTS CENTER Reports after requests for screening or application testing re: a Dow herbicide formula - includes toxicological evaluation and results of animal testing. Exhibit #P0554 PIN # Date Author Addressee Description D 0 W 1 120855 09-Dec-66 R A HICKMAN WHITESELL, RUSS & BEUTEL, A. P. CORBIN, W. L. & DIXON, W. R. GOWELL, J. H. & OTHERS Bdsa inquiry - tetrachlorobenzene capacity, states in view of the in-company shortage of tetrachlorobenzene, they were not in a position to supply the material to other producers. Exhibit #P0555 PIN # Date Author Addressee D0W1 120224-6 01-Jan-67 MARK WILTSE BRYANT, CLYDE & COWELL, JIM rr 1Oxu Description a chronological report based on information from mark wiltse, Clyde bryant and jim cowell. for the period of early 1965 thrul967 when the texas plant came on stream and the price of tordon was reduced to 6.4443. Exhibit #P0560 PIN # Date Author Addressee Description DOW1120862 14-Jan-67 SUPPLY CENTER DEFENSE GENERAL BENDALL, T. L. St BEUTEL, A. P. BYRD, B. C. & CORBIN, W. L. GOWELL, J. H. & 10 OTHERS requirements from the field still call for tremendous qunatities of orange to be shipped by 3-31. Exhibit #P0562 PIN # Date Author Addressee DOW751877 17-Jan-67 L G SILVERSTEIN GILMAN, DR. HENRY fit IOWA STATE UNIV. Description Silverstein says tetrabromodioxin sample about as potent as TCDD in rabbits. Exhibit #P0564 PIN # Date Author Addressee Description DOW120078 24-Jan-67 H D DOAN J. M. LYLE Memo stresses the safe peace time use of Tordon 101 as a brush killer. Memo further expounds upon virtues of Dow with regard to development and use of its herbicides. The ultimate debate is over price. Exhibit #P0565 PIN # Date Author Addressee D0W120836 27-Jan-67 D PLETCHER DIXON, W.R. fit HICKMAN, R.A. STACHLING, E fit MCCOY, W. Description Because of certain ineffieiencies and because of certain health problems which require extra cost for employee protection, we hope to replace our present TCB facility with on or two years. Major Concerns are: Strata not suited for wells for wasted disposal, Alternate will be expensive in dollars and time. Little or no processing 15104 equipment. Exhibit #P0566 PIN t Date Author Addressee Description DOW500-03 27-Jan-67 D E PLETCHER DIXON, W.R. & HICKMAN, R.A STROHLING, E.C. & MCCOY,W.S. DELINE, D. & OTHERS Because of certain/inefficiencies and because of certain health problems which require extra cost for employee protection, we hope to replace our present TCB facility with 1 to 2 years. Exhibit #P0569 PIN # Date Author Addressee Description D0W120840-41 30-Jan-67 R A HICKMAN BEUTEL, A .P . 5c CORBIN, W.L. DIXON, W.R. 5c GOWELL, J.H. HICKMAN, R.A. & OTHERS We advised Gen. Hebbeler that our people had called from Muscle Shoals and advised that it would be very expensive to build the plant and that we were developing an interim report based on total cost of building a plant to produce "orange" starting with the production of tetrachlorobenzene. Exhibit #P0570 PIN # Date Author Addressee Description DOW0069-87 31-Jan-67 GEORGE F COLLINS DOW CHEMICAL CO CONTRACT FOR 6840 NSN HERBICIDE, BUTYL ESTERS MIPR NO MA 6-16445 PRI 02. CONTRACT CALLS FOR 2,4-D AND 2,4,5-T IN A 50-50 BLEND CONFORMING TO MIL-H-51147 (MU) OF 19-JUL-63 EXCEPT ACID PURITY SHALL BE 99.0% MINIMUM BY WEIGHT ACID EQUIVALENT SHLL NOT BE LESS THAN 79.9% NOR MORE THAN 80.0%; THE FREE ACID SHALL NOT BE MORE THAN 0.5% 50% OF N-BUTYL 2,4,5-T CONFORMING TO MIL-H-51148 (MU) DATED 19-JUL-63, EXCEPT ACID PURITY SHALL BE 98.0% MINIMUM BY Exhibit #P0571 PIN # Date Author Addressee Description DOW119200 02-Feb-67 R H BOUNDY DOW CHEMICAL Supplement addresses the resolution for supplemental costs potentially due Dow. Exhibit #P0572 PIN # Date Author Addressee Description DOW751971 03-Feb-67 W J MCCOY CORBIN, W.L. & PLETCHER, D. E. GOWELL, J.H. Call indicating that he believed they have a severe chloracne pip^blems with some of their employees. Exhibit #P0573 PIN # Date Author Addressee DOW751874 03-Feb-67 W J MCCOY ROWE, V.K. & CORBIN, W.L. PLETCHER, D.D. & GOWELL, J.H. Description McCoy of Dow advises of phone call from Thompson Chemical indicating severe chloracne problem "we do not feel friendly towards this competitor . . . but believe that any advice would be in order." Exhibit #P0576 PIN # Date Author Addressee Description JUS 215 09-Feb-67 A P BEUTEL TRAUB,JOHN L. & CHIEF, CHEM.PROC. A R M Y ,EDGEWOOD Beutel advises Army Dow management reviewing whether it will participate in army plan to produce Orange at Wilson Dam, Alabama. Report to come. Exhibit #P0577 PIN # Date Author Addressee Description DOW0201020 13-Feb-67 D E PLETCHER E.B. BARNES & HAROLD BOSSCHER E.C. STAEHLING & G.G. GOERGEN W.R. DIXON & OTHERS Memo deals with Dow's decision that it is still more cost effective to "make" rather than "buy" Tetrachlorobenzene. Also mentioned is the fact that the new facility is necessary to correct environmental health problems. Exhibit #P0578 PIN # Date Author DOW201020-21 13-Feb-67 D E PLETCHER 1^1^ ji. CO?JtL V' :'~f Addressee Description BOSSCHER HAROLD & STAEHLING, E GOERGEN, G & DIXON, W HENSKE, J & GILL, W We are asking that we proceed at once with Phase IV engineering on this project. While this is a logical steop to meet our projected commercial requirements, it is also a first step if the situation is realized where DOW moves to provide very substantially increased^quantities of Orange for the Defense Department. Exhibit #P0579 PIN * Date Author Addressee DOW751872 13-Feb-67 V K ROWE CORBIN, W.L. COWELL, J.H. & PLETCHER, D.E. & MCCOY, W.J. Description Dow received a call from Thompson Chemical Co. stating that some men thought they had rec'd chloracne. They wondered if Dow could advise them to medical practice. Under certain circumstances the caustic insloulbe oils coulnd contain considerable amounts of a very highly toxic substance which was identified as 2,3,7,8-T. Exhibit #P0580 PIN # Date Author Addressee Description DOW751872 15-Feb-67 V K ROWE DIXON, WILLIAM B & CORBIN. W.L. PLETCHER, D.E. & GOWELL, J.H. MCCOY, W.J. & HOLDER, B.B., M.D. V.K. Rowe relates developments regarding Thompson Chemical Company request for information concerning Thompson's chloracne problem. Rowe advised existence TCDD "extremely toxic systemically . . . also . . . potent chloracnegen; extreme precautions to clean up equipment "the information on the physiological activity was perhaps even less than . . . given . . . other producers of TCP over a year ago. . . . because . . . apparent Buckley had little understanding of . . . problem." Exhibit #P0584 PIN # Date Author Addressee DOW816875 20-Feb-67 G F LYNN W. R. DIXON & D. E. PLETCHER W. L. CORBIN & J. HL COWELL 1K 1 P Description J. N. O'CONNOR & OTHERS Dow is trying to get restrictions lifted from the label of Tordon 101. Dr. Hays is reluctant to enter into a controversy with potential legal implications. The procedure of appeal to the NAS was pursued. Exhibit #P0588 PIN # Date Author Addressee Description D0W816873 , 24-Feb-67 GEORGE LYNN DIXON, W.R. & PLETCHER, D.E. CORBIN, W.L. & O'CONNOR, J.N. WILTSE, M.G. & OTHERS I called Dr. Hays concerning the Tordon 101 label. He has discussed the matter in detail with the USDA attorney, M r .Robertson, and between them, do not see any reason to do anything concerning either the TORDON 101 Label or the Barovert label. Unless we re-open the matter I gather the USDA will consider it closed. Exhibit #P0589 PIN # Date Author Addressee JUS215-524-6 24-Feb-67 A P BEUTEL TRAUB, JOHN,ARMY & EDGEWOOD Description Dow reports its attitude to army proposal to produce orange at phosphate development works, Wilson Dam, Ala.,cites large capital required, time for engineering & constructionmanpower problems, and concludes the proposal does not appear to have the potentional to meet the urgency of the U.S. Gov't requirements. Exhibit #P0591 PIN # Date Author Addressee Description DOW088969 27-Feb-67 K J OLSON F. OYEN & H. R. HOYLE DOW EMPLOYEES Data Sheet of Precautions cites possible skin disorders for Tordon 105 Mixture; 2,4,5-T Servere eye irritation possible; safety glasses required. Exhibit #P0594 PIN # Date Author DOW120107 07-Mar-67 R A HICKMAN K l fiQ Addressee Description MR. WOLTON BILLS Dow is trying to get committment of money or guarantees for building of new facility to supply government with Tordon 101 or Super Orange Exhibit #P0597 PIN # Date Author Addressee Description DOW091173-76 17-Mar-67 KEN OLSON F .OYER & R.H. BOUNDY'' B. HOLDER, MD & D. KILIAN, MD R.D. MOSS & OTHERS A sample mix of Tordon 105 composed of 21.6% 2,4,5-T, and 5.4% of 4-amino 3,5,6 tri. acid and 44.1% water proved to be only slightly irritating to intact or freshly abraded skin. Exhibit #P0598 PIN # Date Author Addressee Description 120679 21-Mar-67 R HICKMAN CLYDE BRYANT & CHET OTIS BILL RYAN Letter states that The United States Government is now Dow Chemicals Number Two Customer through the Bioproducts Department and the Tordon area. Exhibit #P0600 PIN # Date Author Addressee DOW119501 24-Mar-67 UNKNOWN UNKNOWN DOW & HICKMAN Description Letter directs Dow to accelerate delivery of existing contract for the defoliant "Orange" at a monthly rate of 93,000 gallons 4/3/67. Also directed to give monthly reports on production, shipments and inventory. Exhibit #P0602 PIN # Date Author Addressee Description D0W120720-22 29-Mar-67 R A HICKMAN HOSLEY R. KOETER Dow states experimental deliveries made to the government since 1962 and that selected type orange and tordon 101 have been supplied since fall of 1965. Dow is commenting on differential pricing and ability to provide herbicides to the government in the future based on financial committment by government. Exhibit #P0603 PIN # Date Author Addressee 120671,720-2 29-Mar-67 R A HICKMAN BILLS, WELTON & KOSTER, WOALEY R Description R. A. hickman letter of 3-30-67 to Mr. Welton Bills , Defense'' General SUpply Center Exhibit #P0605 PIN # Date Author Addressee Description DOW120671 30-Mar-67 R A HICKMAN MR. WELTON BILLS Confidential report attached (not with exhibit) was prepared for BDSA outlining Dow's ability to supply defoliation chemicals. They further request contracts for Tordon 101 and Orange ASAP. Exhibit #P0609 PIN # Date Author Addressee Description D0W120432-58 17-Apr-67 GEORGE F COLLINS DSASR an award/contract between dow chemical company and directorate of procurement & production Attn:pc433 it states what the product herbicide, butyl esters should consist of, how to be shipped and supply warranty. Exhibit #P0610 PIN # Date Author Addressee Description DOW119947-52 17-Apr-67 W R NUMMY PLETCHER, D. E. & BOSSCHER, H. TIMM, W. C. & COULTER, K.E. TRACEY, W. J. & OTHERS Fredricks' Letter dated March 31,1967 solicited reasonable solutions to the problem of supplying all or any part of the estimated additonal requir- ment of 8,000,000 gallons of "Orange" per year. It further stated that more detailed proposals would be requested for those solutions considered to be most feasible. Exhibit #P0613 PIN # D0W1120723 15111 Date Author Addressee Description 21-Apr-67 R A HICKMAN HEATH, OTIS & GILL, W. HANES, J H & NUMMY, W R PATTERSON, R. M. & OTHERS letter dated 04-21-67 from R. A. hickman to Otis heath regarding the conversation with jane lewis confirming no relaxation in waivers of import dut^ on 2,4,5-t and 2,4-d. if imported and duty was paid, it may be sold in civilian market and not subject to directive issued by BDSA recently. Exhibit #P0614 PIN # Date Author Addressee D0W120724,26 25-Apr-67 R A HICKMAN BALLMAN, DONALD K. & BEUTEL, A. P. EVERSON, J. W. & WILLIAMS, G. J. COFFEY, W. H. & OTHERS Description report states a contract of 167,000 gallons a month from august 1967 thru march 1969, the government asked this be kept confidential because of the size of the contract, other suppliers were also bidding. Exhibit #P0622 PIN # Date Author Addressee DOW650139-45 22-May-67 BARRY BYRD DOW SALES & JOHN SPALDI Description Sales release cites that Tordon 155 mixture should never be mixed with water and should not be allowed to contaminate soil used to grow desirable plants such as vegetables, etc. Do not store near food, seeds, etc. Avoid breathing mist, harmful if swallowed, may cause irritation Exhibit #P0623 PIN # Date Author Addressee Description Exhibit #P0626 PIN # Date Author Addressee DOW650139 22-May-67 BARRY BYRD DOW201049-50 31-May-67 RICHARD G CARLSON HAROLD BOSSCHER 151i Description Blanked out memo relates to step one of 2 step expansion plan. New 819 building is to be constructed. Existing 636 building is cited as being congested and in violation of long term Industrial Hygiene Standard. Exhibit #P0629 PIN # Date Author Addressee Description DOW201044 08-Jun-67 HAROLD BOSSCHER ' DR. E. B. BARNES Memo cites 636 building is extremely congested and resulting in problems in safety, maintenance and operation. They hope to reduce chloracne problem. Exhibit #P0633 PIN # Date Author Addressee 0000000 28-Jun-67 GEORGE F COLLINS THOMPSON-HAYWARD & CHEMICAL CO. Description JUNE 1967 CONTRACT TO PRODUCE AGENT ORANGE. Exhibit #P0634 PIN # Date Author Addressee Description DOW120735 28-Jun-67 R A HICKMAN BALLMAN, DONALD K & BEUTEL, A. P. EVERSON, J. W. & WILLIAMS, G. J. COFFEY, W. H. & OTHERS states a shortage due to increased military use of orange and tordon 101, the shipments of other weed killing agents increased, a new plant to be built in two untis in weldon springs, missouri for production of 2,4-d and 2,4,5-t. purchase of this product will be transferred from DSA to army, and coded as a weapon rather than a herbicide. Exhibit #P0636 PIN # Date Author Addressee Description DOW0426-36 30-Jun-67 ARMY ARMY DOW Supercedes MIL-9-51 239(MU) 30-Dec-65. Mostly illegible, but contains standard paragraphs regarding inspection, labeling, precautions, etc. Exhibit #P0647 PIN # D0W1120680 Date Author Addressee Description 01-Aug-67 R A HICKMAN BALLMAN, DONALD K. Sc BEUTEL, A. P. EVERSON, J. W. Sc WILLIAMS, G. J. COFFEY, W. H. Sc OTHERS military increases consumption of tordon and orange . 2,4-d and 2,4,5-t forced into short supply, other weed killers are being bought by government agencies (Esteron 99 Concentrate). ^ Exhibit #P0654 PIN # Date Author Addressee Description D0W1120687 30-Aug-67 R A HICKMAN BALLMAN, DONALD K. Sc BEUTEL, A. P. EVERSON, J.W. Sc WILLIAMS, G. J. COFFEY, W. H. & OTHERS due to continued shortage of 2,4-d and 2,4,5-t through shipments of orange is accelerating shipment of esteron 99, sodium tea, and other herbicides. Exhibit #P0655 PIN # Date Author Addressee Description DOW979868 01-Sep-67 R W WRIGHT BARNES, E. B. Sc BEUTEL, A. P. BOSSCHER, H. Sc COFFEY, W. H. HICKMAN, R. & OTHERS Exhibit #P0656 PIN # Date Author Addressee DOW979868-74 01-Sep-67 R A HICKMAN BEUTEL,A.P. Sc NUMMY.W.R. PLETCHER,D.E. & MANYOTHER DOW Description Hickman prepared lengthy call report describing conversations with various government representatives concerning the policies and needs of the Gov't for Orange; report cites many of these conversations. Exhibit #P0658 PIN # Date Author Addressee D0WH15454-56 05-Sep-67 M A TAVES REGAN J M Sc RANO P J TURK E DR. Sc GIVENS K T WILDER H K Sc OTHERS Description On September 1, 1967, Bill Clark and Regan visited the Defense Center to discuss the procedure used to analyze "orange" herbicide mixture. Exhibit #P0659 PIN * Date Author Addressee HI 5454-56 05-Sep-67 M A TAVES / WILDER, H. E. & SIDWELL, DR. A. E. CLARK, W. H. & RENO, P. J. TURK, DR. E. & SCOTT, DR. R. B. Description Herculesletter from M. A. Taves to Mr. J. M. Eagan, dated 09-05-67. Exhibit #P0661 PIN # Date Author Addressee DOW979869 06-Sep-67 W J TACEY C. BAILEY & R. CARLSON F. CHASE & J. COPPAGE D. DELINE & OTHERS Description The accompanying chart list the Unit Ratios for use in the new 8.1 MM gallon Orange Plant Study. The Ratios list are, in general, the 1967 standards. Exhibit #P0662 PIN # Date Author Addressee DOW1120692-3 07-Sep-67 R A HICKMAN GOWELL, J. H. & BEUTEL, A. P. KEIL, R. M. & NUMMY, W. R. ROBERTSON, R. W. & OTHERS Description when first discussed tordon there were only laboratory results and mini-plant production, dow states that sales to the civilian market would be more profitable for them than to the government and proven an effective weapon in Vietnam. this is the only other effective weapon for its specific use except orange. Exhibit #P0667 PIN # Date Author Addressee Description D0W817294-99 13-Sep-67 M LONG points to consider in connection with use of tordon - 2,4-d in rangeland and pasture are what it does to the grass, cattle and crops. Exhibit #P0670 PIN # Date Author Addressee Description D0W3444 26-Sep-67 J M ILLEGIBLE DOW LAB Report of laboratory analysis on t-acid from drier. Concentration of dioxin of t.c.p. used to produce t-acid=1.9 to get 1.5 in t-acid. Exhibit #P0678 PIN * Date Author Addressee D0W1124975 11-Oct-67 L C WHITE SCULATI, J. J. & HAWLEY, H. M. Description dow chemical co. raw material specification form for 2,4,5-t. it states test items, limits and test methods. Exhibit #P0684 PIN # Date Author Addressee Description D0W1 1251 24 24-Oct-67 V K ROWE SNYDER, FRED H this is in response to a letter of 10-18-67 regarding acnegens and laboratory methond for evaluatin same. 1511g Exhibit #P0686 PIN # Date Author Addressee Description D0W119486-7 30-Oct-67 SUPPLY CENTER DEFENSE GENERAL order form, contract # dsa-400-67-c-5534 /pc440, total amount of contract - 170,000 gallons with a 5% increase 0% decrease variation clause. also contract # dsa-400-67-c-8032. / Exhibit #P0691 PIN t Date Author Addressee Description D0W852482-3 08-Nov-67 C L DUNN MEMBERS NATIONAL & AGRICULTURAL CHEMICALS ASSOC. report states tolerances of phenoxy herbicides on range and pasture grasses at high residue levels shortly after application. Exhibit #P0694 PIN # Date Author Addressee Description DOW1120713 09-Nov-67 R A HICKMAN HEATH, OTIS & GILL, W COWELL, J. M. & RYAN, W. J. YANKS, D. E. the conversation entailed questions like: it tc3 imported, could it be converted to 2.4.5- t and sold to customers other than government. the directive that had been issued against dow and industry called all 2.4.5-t capacity and production be made available to government. Exhibit #P0695 PIN # Date Author Addressee Description D0W1120714-5 09-Nov-67 R A HICKMAN GOWELL, J. H & GILL, W. HEATH, 0 & RYAN, W. J. YANKA, D. E. 1511?memo states the requirements for 1968 to be 6? gallons of herbicide.mr. Minarik stated the figures for 1969 in the area of 11-15m gallons. Exhibit #P0697 PIN t Date Author Addressee D0W852481 27-NOV-67 C L DUNN MEMBERS NATIONAL CHEMICALS ASSOC. / & AGRICULTURAL & ?, J. A. Description the conference dealt with the farmers and the prod uct phenoxy herbicides. Exhibit #P0700 PIN # Date Author Addressee Description D0W1120717 29-Nov-67 R A HICKMAN BALLMAN, DONALD K regarding a bid for supplying a quantity of tetrachlorobenzene to be used in the production of orange at weldon springs. Exhibit #P0701 PIN # Date Author Addressee Description DOW817053 02-Dec-67 UNKNOWN UNKNOWN NANCY note to nancy regarding tordon 155 mixture and the label for this product, stating something about a new ingredient. Exhibit #P0706 PIN t Date Author Addressee DOW1112041-2 22-Dec-67 R A HICKMAN MCCOY, V. J. & HANSON, K. Y. Description reason for call was to review the oct. report filed by otis heath of dow. There was an error in the report which caused BDSA to make an incorrect analysis of the ability to produce trichlorophenol and 2,4,5-t. Exhibit #P0707 PIN # Date Author Addressee D0W1120743-5 27-Dec-67 R A HICKMAN BALLMAN, DONALD K & BEUTEL, A.P. EVERSON, J. W. & QUIGLEY, F. K. COFFEY, H. H. & OTHERS Description a review states, tordon and orange requirements for fiscal year 1969 the period 4/1/68 thru 3/31/69. a team went to edgewood arsonal, and dow's management decided not to bid the 30,000,000 lbs. tetrachlorobenzene plant and bid on the 10,000,000 lbs. plant whose end product to be used by the government operated plant at weldon springs, missouri, in production of orange. Exhibit #P0711 PIN # Date Author Addressee Description DOW119555-6 31-Dec-67 COMPANY DOW CHEMICAL NONE analysys of competitive bidding on orange delivered for the year ended 12-31-67 contains: contract No., gallons delivered, dow's unit price and amount, lowest non-dow bid unit price and amount, and average nondow high and low bid unit price and amount, the comparison with competitive prices received on solicitation of orange bid proposals (furnished by eastern regional renegotiation board) contains: contract date nad number, bids received per gallon for dow and all competitors by number. Exhibit #P0712 PIN # Date Author Addressee DOW893805-8 01-Jan-68 C E MINARIK 15119 Description the article states how the herbicides were used in Vietnam and what some effects were, it also contains when and where some of the spraying took place. Exhibit #P0717 PIN # Date Author Addressee D0W817423 08-Jan-68 ^ GEORGE E LYNN NUMMY, W.R. & BARRONS, K.C. HAMMER, O.H. & SUNDERLAND, WW WILTSE,M.G. & LENG, M.L. Description Lynn writes report to Nummy and others at Dow, of Conference with Pesticides Regulation Division, USDA, of 1-4-68; reference the Division's position that Tordon does not appear useful for the purposes for which tolerances were being sought. Exhibit #P0720 PIN # Date Author Addressee Description DOW820921-36 11-Jan-68 0 H HAMMER ALFORD, HAROLD G. & USDA LICHY, C.T. & SUNDERLAND, W.W. TALCOTT, A.T. Hammer of the Registration Section of Dow encloses a report of the Toxicological Properties and Industrial Handling Hazards of Tordon 144 mixture Herbicide Exhibit #P0728 PIN # Date Author Addressee DOW821106-7 26-Jan-68 HAROLD ALFORD MCINTYRE, H.H. & DOW CHEMICAL LABELING & REG'N & MIDLAND, MI. Description Alford, of USDA writes McIntyre of Dow Labeling and Product Registration Section that the labelling submitted previously was not acceptable and gives form letter advising Dow of additional materials 1512 required. Exhibit #P0729 PIN # Date Author Addressee DOW!20759-60 26-Jan-68 R A HICKMAN BEUTEL,A.P. & DOUGLAS, BURKE HANSON, K.Y. & MCCOY,* W.J. RYAN,W .J . & YANKA,D.E. Description Hickman, U.S. Gov't Marketing Mgr.of Dow, advises others at Dow as to details of situation regarding Dow's bids to supply orange and efforts to supply Tordon. Exhibit #P0733 PIN # Date Author Addressee Description D0W120761-3 31-Jan-68 R A HICKMAN DOW EMPLOYEES Example of monthly report written to numerous Dow employees by the Gov't Marketing Mg r . , and also refers to efforts of Dow to sell Tordon to the Gov't for use in S.E.Asia Exhibit #P0734 PIN # Date Author Addressee D0W120766 02-Feb-68 R A HICKMAN BEUTEL,A.P. & DOUGLAS, BURKE HANSON, K.Y. & MCCOY, W.J. RYAN,W.J. & YANKA,D.E. Description Hickman reports that he spoke with Miss Jane Lewis and Mr. Carl Rolle separately and they advised as to herbicide require ments and fact of gov't disappointment that Dow did not bid on TCP plant of the Edgewood Arsenal, "we were not too concerned about keeping other chemical companies honest" TV A Exhibit #P0737 PIN # Date Author Addressee Description D0W816698 09-Feb-68 GEORGE LYNN DRAFT & DISTRIBUTORS TORDON Draft of "Important Notice" to be sent to distributors advising that the labeling of Tordon and Borolin h^s been revised to delete the use on cropland Exhibit #P0738 PIN # Date Author Addressee D0W120769 16-Feb-68 R A HICKMAN BEUTEL, A.P. MCCOY, W.J. YANKA, D.E. & GOWELL, J. & RIDNER, J.H. & DOW INTERNAL Description Hickman, Gov't Marketing Mgr. of Dow writes memo of telephone conf. with Jane Lewis of government advising that Hoffman-Taft in position to make Orange; Other producers had their equipment ordered. Exhibit #P0740 PIN # Date Author Addressee DOW120770-1 21-Feb-68 R A HICKMAN BEUTEL, A.P. & YANKA, D.E. BYRD, B.C. & GOWELL, J.H. NUMMY, W.R. & PAC Description Hickman writes a summary of a strategy meeting where it was agreed to try to reconfirm strategy for future herbicide production by Dow. Exhibit #P0744 PIN # Date Author Addressee D0W817051 26-Feb-68 DOW UNKNOWN UNKNOWN & DOW EMPLOYEES 1512? Description Dow Confidential description of composition of active ingredients, inerts and acid equivalence of Tordon 155. Exhibit #P0747 PIN # Date Author Addressee Description D0W120772-4 27-Feb-68 R A HICKMAN / BEUTEL, A.P. & BALLMAN, D.K. EVERSON, J.W. & QUIGLEY, F.K. SALES DEPARTMENT Hickman writes monthly report of sales activities to Department Personnel and Supervisor "strategies have been developed for pushing Super-Orange as a long range replacement for both Tordon and Orange" -- Edgewood requests the Dow bid again on TCB plant "for all practical purposes, the door closed for future opportunities to bid on this plant." Exhibit #P0751 PIN # Date Author Addressee D0W816696-7 04-Mar-68 G E LYNN NUMMY, W.R. & JOHNSON, J.E. WILTSE, M.G. & GOWELL, J.H. BARRONS, K.C. & OTHERS AT DOW Description Lynn reports his telephone conference with Harold Alfred, U.S.D.A., re Tordon registration difficulties Exhibit #P0752 PIN # Date Author Addressee D0W120775 04-Mar-68 R A HICKMAN BARRONS, K.C. & GOWEL, J.H. Description Hickman reports Jane Lewis interested in Gowel's comments in view of many criticisms directed at use of herbicides in Vietnam. Exhibit #P0755 PIN # Date Author Addressee Description D0W12779 19-Mar-68 R A HICKMAN BEUTEL, A .P . & GOWEL, J.H. MCCOY, W.H. & YANKA, D.E. OTHERS AT DOW The Hickman reports that Miss Lewis discussed slowdown on shipments of Orange to the Government an/d fact that Government would let industry police itself in sale of 2,4,5-T to existing customers to make sure of no black market. Exhibit #P0756 PIN # Date Author Addressee Description D0W120776-78 22-Mar-68 R A HICKMAN GOWEL, J.H. & WILTSE, M. G . OTHERS AT DOW Hickman discusses strategy meeting re Super-Orange and fulfillment of Tordon contract and notes concerns about attitude at Fort Detrick involving Army's indicated need for additional data; shows Dow actively pursuing government market. Exhibit #P0757 PIN t Date Author Addressee D0W120781 28-Mar-68 R A HICKMAN BEUTEL, A .P . & GOWEL, J.H. MCCOY, W.J. & OTHERS AT DOW Description Hickman rpports discussions at St. Louis meeting between he and five others (non-Dow); further references Thompson Chemical and Sterans and Roger. Exhibit #P0758 PIN # Date Author Addressee DOW538350-1 08-Apr-68 DREW M BAKER DUNN, C.L. & CHAIRMAN NACA IV. A. 58 15124 INDUSTRY TASK FORCE & USDA PEST. DIV. Description Mr. Baker of HEW describes the residued data HEW wants submitted in order to support industry requests for residue tolerances of 2,4,5-T. Exhibit #P0770 PIN # Date Author Addressee / D0W120795-6 14-May-68 R A HICKMAN CORBIN, W.L. & GILL, W.M. GOWEL, J.H. & OTHERS AT DOW Description Hickman describes telephone conversations with Jane Lewis, BBSA, and George Collins, DGSC, re supply of TCP to Woodbury Chemical "we might . . . help her . . . if we could supply TCP to Woodbury * * * this . . . might hurt our obtaining as large a portion of future Orange contracts as we would like." Exhibit #P0773 PIN # Date Author Addressee DOW720805-31 01-Jun-68 J L ENGER DOW PERSONNEL & DOW SUB-PERSONNEL Description A report of Dow marketing research regarding pesticide exports during 1967 re 2,4-D and 2,4,5-T. Exhibit #P0775 PIN # Date Author Addressee Description D0W120804-5 07-Jun-68 R A HICKMAN DOW INTERNAL Hickman reports "we have kept very close to Miss Lewis as a source of factual . . . completely accurate information." Discusses quantity of herbicide to be sprayed in fiscal 1969 developed from pilot information; also discusses lack off Tordon acceptance. Exhibit #P0779 PIN # Date Author Addressee Description DOW014082-3 17-Jun-68 E MONROE GREENE, L. M. letter states the analytical method, along with the letter is a^routine sheet for the release of technical information regarding the determination of 2,3,7,8-tetrachlorodibenzo-p-dioxin in 2,4,5- trichlorophenoxyacetic acid by gas-liquid chromatography. Exhibit #P0780 PIN # Date Author Addressee Description DOW120808-9 21-Jun-68 R A HICKMAN INTERNAL DOW Hickman summarizes quality control and shipping problems in calls made to various government employees and inspectors to solve the same "planes flew Sorties like hell all last month." Exhibit #P0782 PIN # Date Author Addressee DOW811635-48 28-Jun-68 0 H HAMMER MCCOLLISTER, D.D. & LYNN, BLAIR, E.H. & WILTSE, M. LENG, M.L. & OTHERS G.E. Description Hammer responds to McCollister request to pull together his thoughts on "what seems to be needed prior to . . . any further requests to USDA for registration of use of Tordon . . .. on crop land. Exhibit #P0786 PIN # Date D0W120816 17-Jul-68 1512.6 Author Addressee Description A P BEUTEL ASST. CHIEF OF STAFF & FORCE DEVELOPMENT ARMY & PENTAGON, WASH. D.C. GENERAL HEBBELER Beutel, Vice-President and Director of Government affairs at Dow writes Brig. Gen. J.A. Hebbeler attempting to extol the merits of Super-Orange. Exhibit #P0787 PIN # Date Author Addressee Description 9369 23-Jul-68 NONE NONE Excerpts of the Twenty-First Meeting of Research Laboratories Review Point I Committee, dated July 23, 1968. Exhibit #P0788 PIN # Date Author Addressee D0W120829 31-Jul-68 R A HICKMAN BEUTEL, A.P. ECCLES, R.P. & BALLMAN, D.K. & QUIGLEY, F.K. Description Monthly report for July, 1968, re Government Exhibit #P0792 PIN # Date Author Addressee Description DOW580567-85 22-Aug-68 UNKNOWN UNKNOWN DOW Technology Review on products-Dowanol Chloroacetate, Butuil Chloracetate, Iso-Octyl Chloroacetate. Uses - 2,4,D Weed Killers and 2,4,5 T Weed Killers Exhibit #P0793 PIN # Date Author D0W1 20818-22 28-Aug-68 R A HICKMAN i ei A X J"i .< ' Addressee BEUTEL, A .P . & BALLMAN, D.K. ECCLES, R.P. & QUIGLEY, F.K. Description Hickman's report includes reference to presentation made on Super-Orange and requirements for Tordon 101 together with bulk movement of defoliants and possible storage and mixing facilities in Vietnam but states if supply depot damaged by bomb possibly too much liquid herbicide in the area to ever again us-d the land for growth of any kind and other uses of 55 gallons drums of such wide variety; drums have advantages in and of themselves. Exhibit #P0794 PIN # Date Author Addressee DOW979845-61 30-Aug-68 A P BEUTEL SHEAD, COL. C.G. & KELLY AIR FORCE BASE Description Buetel writes Col. Shead enclosing a Dow proposal planning document re bulk shipment (converting from drums), suggests Dow should manage program and again seeks to sell Super-Orange Exhibit #P0795 PIN # Date Author Addressee D0W120827 04-Sep-68 R A HICKMAN BEUTEL, A .P . & GOWEL, J.H. MCCOY, W.J. & OTHERS AT DOW Description Hickman writes of his concerns and those of industry people that Weldon Springs plant would produce Orange causing industry to supply TCB and referencing serious situation regarding pollution such plant would cause. Exhibit #P0798 PIN # Date Author DOW119942 17-Sep-68 W J ZEPP I Addressee HICKMAN, R.A. & ROLLE, CARL LEWIS, JANE & OTHER GOVT. EMP. Description W.J. Zepp of the Government relieves Dow of the 93,000 additional gallons per month over base of 222,000 gallons per month on Orange contract cited. Exhibit #P0800 PIN # Date Author Addressee Description / DOW120655-7 25-Sep-68 R A HICKMAN BEUTEL, A .P . & BALLMAN, P.K. OTHERS AT DOW hickman r Hickman reports 222,000 gallons per month continue to be shipped and references opportunity to bid on Tordon. Exhibit #P0802 PIN # Date Author Addressee Description DOW979843-63 30-Sep-68 K E HONEYCUTT BEUTEL, A .P . OTHERS AT DOW & HICKMAN, R.A. Exhibit #P0804 PIN # Date Author Addressee Description D0W17180-83 04-Oct-68 M F WILKERSON HOCHBERG M Based upon present industry capacity to produce both D and T as opposed to present purchase patterns of the military, it was concluded we have a case to present to the defense and Commerce Departments. Exhibit #P0805 PIN # Date Author Addressee Description DS 17180-3 04-Oct-68 M F WILKERSON HOCHBERG, H INTEROFFICE CORRESPONDENCE DATED 10-04-68 IV. A. 63 FROM M. F. WILKERSON TO H. HOCHBERG OF DIAMOND SHAMROCK. Exhibit *P0807 PIN # Date Author Addressee Description DOW120633 07-Oct-68 R A HICKMAN HOLDEMAN, GRADY & /MCCOY, W.J. OTHERS AT DOW Hickman writes Dow sales people re conversations with Carl Rolle and Fred Knapp where they asked Dow to write specs for Super-Orange and to quote in their procurement when order is placed; Knapp also asked Dow to update Tordon specifications. Exhibit #P0809 PIN # Date Author Addressee Description 125528-32 18-Oct-68 R A HICKMAN BEUTEL, DR. A P R. A. Hickman letter of 10-18-68 to Dr. A. P. Beutel and others. Exhibit #P0810 PIN # Date Author Addressee D0W125528-32 18-Oct-68 RA HICKMAN BEUTEL, A .P . GOWELL, J.H. & CORBIN,W.L. & OTHERS AT DOW Description Hickman reports because of the "concern" of his department and other departments at Dow on the status of the military herbicide business and Dow's efforts to sell to the Gov't with predicitions as to effects on business if bombing stops in North Viet Nam, and other considerations. Exhibit #P0812 PIN # D0W120654 15130 Date Author Addressee 30-Oct-68 R A HICKMAN CORBIN,W.L. & DOW AG PROD SALES Description Hickman report of conversation with Jane Lewis of Gov't indicates industry had a law firm deliver a letter which concerned her; re; deliveries of 2,4-D and 2,4,5-T and reports his info, re actual gallons required by U.S. / Exhibit #P0825 PIN # Date Author Addressee D0W119490 31-Dec-68 R G GOVT KNOTT DOW CHEMICAL & USGOV'TAGENCIES Description Sample Shipping and Receiving Form issued by U.S. Gov't appropropriate agencies re; some of Orange delivered by Dow to U.S. Exhibit #P0831 PIN # Date Author Addressee Description D7 25 522-44 06-Jan-69 UNKNOWN UNKNOWN PRODUCT SPECIFICATION FOR BRUSH KILLER T- 334 Exhibit #P0837 PIN # Date Author Addressee Description DOW53837 5 25-Jan-69 C L DUNN DUBRIDGE,LE E , DR. & DIR.OFFICE OF SCIENCE & TECH. & PRES. USA OTHERS Author states that a soundly designed experiment is absolutely necessary to determine if a teratologic hazard is associated with 245-T. Requests support in request to FDA to defer action on 245-T until additional information is available for study and evaluation. Exhibit #P0839 PIN # Date Author Addressee DOW85245U 07-Feb-69 JAMES B LAMB DUNN, C.L. & NACA INDUST.TASK FORCE & USDA Description HEW writes Industry Task Force on Phenoxy Herbicides regarding deficiencies in the petitions proposing tolerances for residues of 2,4,5-T,2,4-D,Silvex,and MCPA.and noting further info.required. Exhibit #P0843 PIN # Date Author Addressee Description 001502-3 21-Feb-69 J C STRUM NITRO PROGRESS RPT NITRO PLANT PROGRESS DATED 02-21-69. REPORT FROM J.C. STRUM Exhibit #P0845 PIN # Date Author Addressee DOW2 76151-52 27-Feb-69 EUGENE BENEGNA RIDER, J.M. & RITTY, P.M. SHAVER, R.J. & SHELDON N.W. SOUTHWICK, R & OTHERS Description Comparison of the toxicological effect of herbicides to fish is difficult because of the wide variation in test methods. Exhibit #P0848 PIN # Date Author Addressee D0W124722-7 18-Apr-69 D E YANKA BEUTEL,A.P. & COFFEY, W.H. GOWELL, J.H. & HICKMAN,R.A. WRIGHT,R.W. & OTHERS AT DOW Description Yanka of Dow writes Report on Renegotiable Dow Contracts to 10 Dow co-employees; The 15132 report argues that only renegotiable area of Dow's business for 1967 involve sales of Tordon and Agent Orange to the United States. Complains of fact that Dow had large (millions) investment in comm'l market, and huge demands of U.S.,which caused industry to expand capacity beyond comm'l market; complains of low U.S.gov't price com- pared to comm'l market. / Exhibit #P0854 PIN * Date Author Addressee DOW856385 23-Jul-69 B C BYRD LYNN,GEORGE E. & MOSS, R.D. LANING, E.R. & HYMAS, T.A. HANSEN,J.C. & DAVIDSON, J.H. Description Product Technical Specialist of Ag. Dep't Dow writes memo to co-employees of tel. call from Al Young, Lt.,USAF, advising Young said he had to "go to the top" to get permission for joint Dow-Air Force publication-with references to permission to classify if results not in interest of either Dow or the Air Force;"There is no way of predicting whether normal degradation of phenoxies would occur under this regime" Exhibit #P0856 PIN # Date Author Addressee DOW 817491-0 04-Aug-69 GEORGE E LYNN MCCOLLISTER,D.D. & LANING,E.R. BLAIR,ETCYL H. & NUMMY,W.R. LENG.M.L. h OTHERS AT DOW Description Five Dow employees attended a meeting with the USDA Pesticides Regulation Division on 7/29/65 re; application for registration of Tordon 225 to control mesquite on permanent rangelands and pastures;and proposing tolerances for residues in forage grasses, meat & Milk. This is the Dow internal report of that meeting. Exhibit #P0861 PIN # Date Author Addressee Description DOW981 71 2-18 26-Sep-69 GSA USFEDSUPPSERV USA federal specifications for herbicide 2,4,5-T (both salts and esters) superceding prior specs. / Exhibit #P0862 PIN # Date Author Addressee DOW550401-07 30-Sep-69 J E MUTCHLER TREE R M & PLEPYS R A BAILEY C Z & KRAMER C G MORSE D B & OTHERS Description Temperature controls have been installed on penta feed line to the prill pot. September wipe tests are now nearing completion. Four samples are active including two new active samples, both located near the fluid bed drier. Exhibit #P0864 PIN # Date Author Addressee DOW124858-61 1O-Nov-69 C L DUNN NACA & INDUSTRY TASK FORCE ON PHENOXY & HERBICIDE MEMBERS Description Report of urgent meeting of Oct.28, 1969 between industry and gov't reps.; re ;Bionetics indications of teratogenicity,and reports of birth defects in Vietnam;also references DuBridge's announcement and positions of the parties in attendance, with listing of persons present; On Hercules letterhead. Exhibit #P0867 PIN # Date DOW754888-89 25-Nov-69 1, 5- 1i 3Q 4,, Author Addressee Description G E LYNN ROWE V.K. Dow identified the principal chloracnegen as the sym Tetrachlorodibenzyl-p-Dioxin in late 64'.Dow was bu Herculos is late 65' and sample was from 3rd or 4th batch shipped and high dioxin thought to "pushing" capacity of plant. / Exhibit #P0868 PIN # Date Author Addressee DOW 754888-9 25-Nov-69 G E LYNN JOHNSON, J. E. & ROWE, V. K. Description Notes for J. E. Johnson from G. E. Lynn and V. K. Rowe dated 11-25-69. Exhibit #P0869 PIN # Date Author Addressee DOW754888-9 25-Nov-69 GEORGE E LYNN ROWE,V.K. & JOHNSON, JULIUS E. Description These notes outline knowledge lynn & rowe claim Dow had of acnegen, Dow Feb.,1964 problems, 2,4,5- T also contained the chloracnegen; the 3/24/65 meeting; and an outline of contamination of various manufacturers' products.Also cites Hercules at up to 3 ppm. Exhibit #P0871 PIN # Date Author Addressee Description DOW549692-93 01-Dec-69 CHEMICAL EXP LOG Statistical Analysis on Report // 23.14-23-6/5065. Exhibit #P0874 PIN # DOW 28610-11 Dace Author Addressee 1O-Dec-69 GEORGE LYNN HANSEN, J C & JOHNSON, J E MCCOLLISTER, D D & NAEGELE, ROBINSON, V B & OTHERS RE Description / Exhibit #P0875 PIN # Date Author Addressee DOW766734-36 12-Dec-69 ALEX WIDIGER CHANG,K Y & LEAVITT, F C DEMONTT, D N & POFFENBERGER, SCHMIDTKE, D & OTHERS N Description Chemical companies are offering flake 2,4,5 T on world market which is strongly rsistent to blooming. We have found the following affects reduce the tendancy to bloom: proglonged heat treating, thinner flakes, the presence of caustic insoluable methoxy compounds. Exhibit #P0883 PIN # Date Author Addressee Description DOW538377 29-Dec-69 CL DUNN F. MCFARLAND & FDA HARRY HAYS & NED BAYLEY L.L. DANIELSON LETTER NOTES THERE HAS BEEN NO RESPONSE TO REQUEST OF 12/5/69 REGARDING EXTENTION FOR ACTION ON PESTICIDE PETITION 8F0669 (2,4,5-T) AND IN ACCORDANCE WITH FEDERAL REGULATIONS WITHDRAWS WITHOUT PREJUDICE SAID PETITION. Exhibit #P0884 PIN # Date Author Addressee 000657-660 07-Jan-70 H H STEHL ROWE, V K & GILL, H SKELLY, N & HALLEY, C DUNN, F 1 x Description JANUARY 7, 1970 DOW SCIENTISTS DETERMINED THAT SAMPLES TESTED OF DIAMOND SHAMROCK 2,4,5-T (trichloro- phenoxyacetic acid) AVERAGED 27 PPM (PLUS OR MINUS 8 PPM THEREFORE, AVERAGED 19 PPM - 35 PPM) USING GAS LIQUID-LIQUID CHROMATOGRAPHY METHOD OF EXTRACTION. Exhibit #P0885 PIN # Date Author Addressee Description D817130-218 08-Jan-70 M MCCLURE MORGAN R.W. Meeting to discuss the reasons given by PRD for rejection of the Dow Applications for Temporary Permit to Ship Tordon 166 Mixture and Tordon 169 Mixture herbicides. The outcome of this parley was assent by PRD to reconsider issurance of the Permits is resubmitted. Exhibit #P0886 PIN # Date Author Addressee DOW 1257-59 12-Jan-70 GEORGE E LYNN EGEBERG, DR. &LINDSAY DALE DR. KOTIN, PAUL DR. &BURGEREDWARD DR. MITCHELL IAN DR. & OTHERS Description Concerned that the sample used could have contained a highly toxic impurity. We stronly urge that action concerning the status of 2,4,5-T be held in abeyance until the testing program is completed. Exhibit #P0887 PIN * Date Author Addressee DOW23034-36 12-Jan-70 GEORGE E LYNN EGEBERG, DR. ROGER & HEW LINDSAY, DALE, FBA & BAYLEY, NED D. USDA & KOTIN, PAUL, ETAL. Description Lynn's letter to Egeberg and other governmental officials advises Dow's knowledge in 50's; activity of TCDD, Dow's 1 ppm spec. , bionetics samples 27+ ppm contamination; describes Dow's coming territological testing. Exhibit #P0888 PIN # Date Author Addressee Description DOW746134-38 15-Jan-70 / V K ROWE BURGER, E.J. & OST PRESIDENT USA Rowe encloses summary data oral toxicity TCDD. Exhibit #P0889 PIN # Date Author Addressee 1232987-91 16-Jan-70 V K ROWE BURGER, EDWARD J. & CC: OTHERS Description IN RESPONSE TO INQUIRY OF OFFICE OF SCIENCE AND TECHNOLOGY, EXECUTIVE OFFICE OF PRESIDENT, WASH., D.C., JANUARY 1970, DR. ROWE MERELY INDICATES THAT HE HAS ENCLOSED TABLES ON RATS AND GUINEA PIGS FOR THE GOVERNMENT TO INTERPRET. "NO RELIABLE DATA FOR RABBITS LD50 TO BE ESTABLISHED." RABBITS DIED. Exhibit #P0891 PIN # Date Author Addressee DOW746169 19-Jan-70 G E LYNN VERRETT, J.M. & FDA RICHARDSON, H.L. & FDA Description Letter recites Dow sending 25 gr. 2,4,5-T representing that sample meets Dow's 1 ppm specification. Exhibit #P0892 PIN # 999600-02 TV. A. 7? 1 *5. R Date Author Addressee Description 19-Jan-70 RUDOLPH H STEHL ROWE, V K St DUNN, F GILL, H & SKELLY, K. BAILEY, C IN SAMPLES OF DOW 2,4,5-T TESTED BY DOW'S OWN LABORATORY, RESIDUES WERE LEFT IN THE 100-150 PPM, BUT DOW'S CLAIMS THE TCDD RESIDUE IS ONLY IN THE 3-8 PPM RANGE. / Exhibit #P0893 PIN # Date Author Addressee DOW028238-42 21-Jan-70 G E LYNN BLAIR, E. H. & BROWER, H. H. CRUMMETT, W. R. St FERNANDEZ, J. E. HANSEN, J.C. & 8 OTHERS Description stating he is keeping a record of all samples of 2,4,5-t , 2,4-d and silvex (including derivatives) that are sampled. Exhibit #P0894 PIN # Date Author Addressee 028238-42 21-Jan-70 GEL LYNN ROWE, VK & BLAIR, E H CRUMMETT, W R St FERNANDEZ, GETZENDANER, M E St HANSEN, JB J C. ET AL Description DOW IN-HOUSE MEMO REGARDING ANY OUTGOING SAMPLES TO BE SENT TO THE EPA OR ANY OTHER GOVERNMENTAL AGENCY MUST BE CLEARED THROUGH LYNN. THE SAMPLES SUPPLIED MUST MEET THE DOW SPEC, AND LAB REFERENCE STANDARD OF VERY HIGH PURITY- LIMITED IN SUPPLY MUST BE CAREFUL NOT TO LET JUST ANY OLD SAMPLE OF 2,4,5-T OUT OF THIS COMPANY. Exhibit #P0898 PIN * Date Author Addressee 746158-616 06-Feb-70 V K ROWE FALK, HANS DEPT. HEW St TRIANGLE PARK, NC 1513 Description LETTER OF ROWE, FROM DOW TO DR. HANS FALK, DIRECTOR OF LABORATORY RESEARCH, RESEARCH PARK, NORTH CAROLINA, DEPARTMENT OF HEALTH, EDUCATION AND WELFARE DISCUSSING SENDING THE SAMPLES OF PURIFIED 2,3,7,8 -TCDD AND THE EXTREME TOXICITY OF THIS COMPOUND. THE REASONS GIVEN FOR THE DELAY IN SHIPPING WAS THE NECESSARY PRECAUTIONS THAT HAD TO BE TAKEN NOT TO CONTAMINATE OTHERS. ALSO DOW INFORMED GOVERNMENT THAT IT HAD A NEW METHOD OF DETECTING TGDD,"DOW ANALYTICAL METHOD MLW -65.11" WHICH ROWE FORGOT TO INCLUDE, SEE NEXT EXHIBIT IN WHICH DR. FALK RESPONDS. Exhibit #P0902 PIN # Date Author Addressee Description DOW1119842 10-Feb-70 UNKNOWN UNKNOWN LOGAN? DOCUMENT ENTITLED PURCHASE DESCRIPTION HERBICIDE ORANGE SETTING FORTH AN AMENDMENT TO PURCHASE DESCRIPTION AFFID 6840-1, 1/2/70 WITH REGARD TO PARAGRAPH 4.2.4.1. Exhibit #P0903 PIN # Date Author Addressee Description DOW028605 10-Feb-70 HANS L FALK ROWE, DR. V.K. letter of thanks for information and a request for missing data, dow called and the problem of shipment of the dioxin is solved, now the next set of experiments can get under way. Exhibit #P0904 PIN # Date Author Addressee Description 028605 10-Feb-70 151 HANS FALK HEW & TO ROWE, VK RE 434 DR. HANS FALK OF THE DEPARTMENT HEALTH, EDUCATION AND WELFARE, DIRECTOR FOR LABORATORY RESEARCH NATIONAL INSTITUTE OF HEALTH, TRIANGLE PARK, NORTH CAROLINA IS ASTONISHED AT THE EXTREME TOXICITY DATA THAT DR. V.K.ROWE HAS JUST SENT IN EXHIBIT 434. Exhibit #P0905 PIN # Date Author Addressee Description DOW445809 11-Feb-70 / UNKNOWN UNKNOWN LEGATOR, FDA & VERRETT, FDA RICHARDSON, FDA & MANY OTHER FDA AND USDA Notice of meeting of government scientists with technical personnel of Dow to discuss chick edema factor methodology shows Dow reps to attend. Exhibit #P0907 PIN # Date Author Addressee Description D0W1130312 13-Feb-70 UNKNOWN DOW AGRI PRODUCTS DOCUMENT ENTITLED SALES SPECIFICATION WITH RESPECT TO 2,4,5-T ACID SETS FORTH 2,3,7,8-TCDD AT 1 PPM. Exhibit #P0908 PIN # Date Author Addressee DOW028232-36 13-Feb-70 GEORGE LYNN WILLIAMS, C G & NAEGELE, R E DONALDS, JOHN E & SPARTA, TOM JOHNSON, JULIUS & ROWE, VK ET AL Description GEORGE LYNN GOVERNMENT REGULATORY RELATIONS FOR DOW CHEMICAL REPORTS IN A CONFIDENTIAL MEETING MEMO THE MEETING BETWEEN DOW (CRUMMETT, HOLDER, LEAVITT LYNN) AND THE FDA HELD IN WASHINGTON, FEBRUARY 11,1970. DR. CAMPBELL MADE THE PRESENTATION FOR FDA; CRUMMETT AND HOLDER MADE THE PRESENTATION FOR DOW. THE FDA IS CONCERNED THAT C DD'S MAY BE WIDESPREAD IN ENOUGH QUANTITY TO BE HAZARD TO HUMANS; CARCINOGENIC RISK;SAME PERSISTENCE AS DDT AND BIOMAGNIFICATION ;DR KRAYHILL SAID SHOULD NOT BE PERMITTED; "ONE MOLECULE IS TOO MUCH." DR KRAYBILL. DR. A. D. CAMPBELL, CHIEF CONTAMINANTS BRANCH, FDA WASHINGTON, DC Exhibit #P0909 PIN # Date Author Addressee Description DOW7 51916-7 20-Feb-70 RALPH C WANDS LONGENECKER, W.H. & FT. DETRICK ROWE, V.K. Wands' director, Advisory Center on Toxicology, NAS, suggests Longenecker arrange meeting with V.K. Rowe to learn something of the toxicology of TCDD. Exhibit #P0912 PIN # Date Author Addressee DOW040862-66 27-Feb-70 GEORGE LYNN MASON, JOHN & WILLIAMS, G.J. SPARTA, TOM & NAEGELE, R.E. DONALDS, JOHN & OTHERS Description Goal: To establish the principal uses of Chlorophenols and to utilize this information in seeking out the ways in which they could possibly be related to the presence of chlorodebenzp-p-dioxins in fats, soap stocks,etc. Exhibit #P0914 PIN # Date Author Addressee Description DOW538598 10-Mar-70 HAROLD ALFORD FED REG & ECONOMIC POISON Letter states additional safety studies are needed for 2,4,5-T currently registered, among others and that data on carcinogenicity or teratogenicity should be submitted immediately. If such data is not available studies are requested immediately. Epidemiological studies also 15142 requested. Exhibit #P0917 PIN # Date Author Addressee Description DOW007830 17-Mar-70 JAMES ILLEGIBLE Dow scientists presented detailed evidence showing that a contaminant rather than the compound 2,4,5-T was probably the cause of birth abnormalities. The National Cancer Institute indicated higher than normal rates of birth defects in test animals treated with massive doses of 2,4,5-T. Exhibit #P0918 PIN * Date Author Addressee 392436-38 17-Mar-70 G L SPARSCHU DUNN, F L & ROWE, V K Description PAPER PRESENTED AT THE MEETING OF THE SOCIETY OF TOXICOLOGY ATLANTA, GEORGIA, MARCH 17, 1970 RESULTS INDICATE A HIGH LEVEL OF MATERNAL AND FETAL TOXICITY TOXICITY TO BE ASSOCIATED WITH 2,3,7,8-TCDD, STUDY BY DOW. TERATOGENIC Exhibit #P0919 PIN # Date Author Addressee D0W392434-35 17-Mar-70 J L EMERSON GERBIG, C G & ROBISON, V B Description THIS ABSTRACT WAS PRESENTED SIMULTANEOUSLY WITH THE EXHIBIT NO'S 437 AT THE SOCIETY OF TOXICOLOGY IN ATLANTA, GA; HOWEVER THE FINDINGS OF THIS GROUP OF DOW SCIENTISTS DISAGREE WITH THE BIONETICS RESEARCH LABS, BETHESDA, MD. Exhibit #P0921 T U "7 -J 15143 PIN # Date Author Addressee D0W120584 18-Mar-70 GEORGE E LYNN HAYS.HARRY W. & USDA LINDSAY,DR.DALE & FDA/HEW BCCDOW OTHERS & & ACTION FILE 245T Description leteter seeks to assure Department of Agriculture about the quality of the composition of commercial 2,4,5-T acid produced by Dow Chemical. Claims that in 1965 a rigid production standard was imposed by Dow of less than 1 ppm of TCDD in 2,4,5-T. Exhibit #P0924 PIN # Date Author Addressee DOW582853 23-Mar-70 C DOW JOHNSON, J.E. & LUECK, A.T. LYNN, G.E. & BLAIR, E.H. Description Memo re status of 2,4,5-T backup program. Exhibit #P0926 PIN # Date Author Addressee D0W28243-44 26-Mar-70 GEORGE LYNN JOHNSON, J & WILLIAMS, C J NAEGELE, R & DONALDS, JOHN BLAIR, E & OTHERS Description Dow and Monsanto can begin to predict where the bulk of the chlorophenols are going and evaluate some of the potentials for contaminent problems. Exhibit #P0927 PIN # Date Author Addressee DOW028243-44 26-Mar-70 GEORGE E LYNN WILLIAMS, C J & NAEGELE, R. E. DONALDS, JOHN E. & SPARTA, TOM A. LEAVITT, F. C. & OTHERS 151 w . -> Description the report is from meetings 2/25, 3/19, 3/23. Exhibit #P0928 PIN # Date Author Addressee Description DOW582854-55 26-Mar-70 GEORGE E LYNN JOHNSON, JULIUS & WILLIAMS, G.J. OTHERS AT DOW Lynn writes Johnson, Rowe and 12 others at Dow to report on meetings of 02/25, 03/19, and 03/23, re dioxin and Monsanto koppers human health problems. Exhibit #P0929 PIN # Date D0W1104-8 31-Mar-70 Author Addressee BENJAMIN B HOLDER LYNN, GEORGE E. & NO OTHERS SHOWN Description Letter is a summary of clinical information distirbuted to various institutions by Dow regarding the 1964 chloracne episode at the Midland Plant. Attached to the letter is a "Review of occupational health problems associated with th the manufacture of chlorinated phenols a t Midland, MI in 1964. Notes that disease primarily affects the skin and with extreme exposure "... a general organ toxicity can result." Liver and nervous disords ders naote noted and no specific treatment for disease is known. Exhibit #P0930 PIN # Date Author Addressee 1170342 31-Mar-70 V K ROWE DUNN, F L & GORDON, H L HOLDER, B B & HINMAN, C W HOYLE, H R & JOHNSON, J E Description WE DO NOT HAVE ENCLOSURE Exhibit #P0932 PIN # Date Author Addressee Description D0W1103 02-Apr-70 GEORGE LYNN In discussing the attached information with Dr. Holder he says the chloracne problem was related to the "acrcident" in the 2,4,5-T plant and the culprit was principally 2,3,7,8-T. Exhibit #P0934 PIN # Date Author Addressee Description DOW999363-67 07-Apr-70 CHARLES KRAMER JOHNSON, JULIUS One hundred thirty employees who have worked more than six months in areas where exposure to 2,4,5-T occurred and on whom recent medical examination data was available. Exhibit #P0935 PIN # Date Author Addressee Description D0W119849-68 07-Apr-70 CHARLES KRAMER JULIUS JOHNSON At present we are involved in an extensive reworking of the program based on review of the "first cycle" results. Approximately 10 percent of the subjects participating in the health inventory have prompt follow up by a physician on the basis of suspected abnormalities detected during inventory. Exhibit #P0936 PIN # D0W549641-91 Date 10-Apr-70 Author F D AXE V. Addressee DOW Description Measurements to describe the chemical exposures of workmen engaged in the 15147 manufacture of 2,4,5-T. Dry Dust of 2,4,5-T has the capacity to produce upper respiratory irritation. Dust levels are frequently high enough to be very noticebly irritating. Observations indicate nasal irritation sneezing and a bitter taste may result from brief exposures. Exhibit #P0937 PIN # Date Author Addressee 549641-660 10-Apr-70 F D AXE FILE & LYNN, G E DELINE, DD & SCHMIDTKE, D J HODSON, R E & MILLER, D E OTHERS Description BIOCHEMICAL RESEARCH LAB AT DOW CHEMICAL CO., F. D. AXE DISTRIBUTED A STUDY OF CHEMICALLY EXPOSED WORKERS IN BUILDING 267 BUILDING (2,4,5-T PLANT); ALTHOUGH HE STATES THE LEVELS OF EXPOSURE ARE BELOW MINIMUN THRESHOLD LIMIT VALUE, DRY DUST HAS CAPACITY TO PRODUCE UPPER RESIRATORY IRRITATION AT LEVELS MUCH LOWER THAN TLV; RECOMMENDS IMPROVE DUST CONTROL AT THE PACKING STATION- DUST ESCAPES FROM SEAL(FAULT OF EITHER SEAL OR INSUFFICIENT AIR VELOCITY). Exhibit #P0939 PIN # Date Author Addressee Description DOW392412-23 15-Apr-70 JULIUS JOHNSON SENATE COMMITTEE Reference to birth defects observed in tests. The most sensitive toxic reaction observed in humans to this inpurity was manifested by a condition known as chloracne, a skin disorder suffered by teenagers. Exposure to this waste oil was the cause of the acne in the workmen. Exhibit #P0940 PIN# Date DW 392412-23 15-Apr-70 151 48 idl TV. A. 1 Author Addressee JULIUS E JOHNSON SUBCOMMITTEE ON & ENERGY Description STATEMENT BY JULIUS E. JOHNSON, VICE PRESIDENT AND DIRECTOR OF RESEARCH, THE DOW CHEMICAL COMPANY, BEFORE THE SUBCOMMITTEE ON ENERGY, NATURAL RESOURCES AND THE ENVIRONMENT OF THE SENATE COMMITTEE ON COMMERCE, DATED 04-15-70. / Exhibit #P0941 PIH # Date Author Addressee DOW130436-7 15-Apr-70 JULIUS JOHNSON USA PUBLIC & HART SENATE COMM. Description Copies from Dow produced documents of minutes of Julius Johnson's testimony given April15, 1970, before Hart Senate sucommittee on the environment, presumably from the Federal Register or Congressional Record; confirms Johnson of Dow made disclosures contained in full text of speech drafted for him at Dow. Exhibit #P0945 PIN # Date Author Addressee Description DOW547219-20 20-Apr-70 HARRY W HAYS ECONOMIC POISONS This herbicide may present an imminent health hazard to women of child-bearing age and has recommended suspension of certain registered uses of 2,4,5-T. In order to prevent an imminent hazard containing 2,4,5-T to the public it is necessary to suspend the registration for these products. Exhibit #P0946 PIN # Date Author Addressee Description DOW547221 151 20-Apr-70 HARRY HAYES DOW CHEMICAL It is hereby found that in order to prevent an imminent hazard to the public it is necessary to suspend the registration for purducts containing 2,4,5-T. Exhibit #P0947 PIN # Date Author Addressee Description 999173 23-Apr-70 R L LAPE / LYNN, G E & ROWE, V K FERNANDEZ, J DOW TESTED 10 BATCHES OF AGENT ORANGE FROM FT DETRICK AND FOUND IT CONTAINED BETWEEN 1-15PPM OF 2,3,7,8-TCDD Exhibit #P0948 PIN # Date Author Addressee Description DOW119606 01-May-70 G J WILLIAMS Letter written by G.J. Williams stating how he feels that Dow should make its position known to the rest of the Government rather than give the Department of Defense an option. Exhibit #P0949 PIN # Date Author Addressee Description D0W130323-24 11-May-70 PROD AND MKT CANADA DEPT AGR Further evidence show that 2,4,5-T is potentially capable of causing abnormal development. This dioxin can also cause a serious skin condition known as chloracne. Findings suggest that this couldd constitute a hazard to children and women exposed during pregnancy. Exhibit #P0950 PIN # Date Author DOW582846-7 11-May-70 FRED LEAVITT Addressee BLAIR, E. & 31 OTHER DOW EMP. Description Memo re environmental problems re chlorinated phenols. Exhibit #P0951 PIN # Date Author Addressee Description D0W119791-7 14-May-70 / GARETH OWEN LYNN, GEORGE E along with the letter are the results of teratological studies done in Charles river cd rats. Exhibit #P0952 PIN # Date Author Addressee DOW582836-7 22-May-70 R A PLEPYS LYNN, G. & BLAIR, E.H. ROWE, V.K. & HOLDER, V.B. LUECK, A. & 19 OTHER DOW EMP. Description Minutes of meeting eco-studies of chlorophenols. Exhibit #P0954 PIN # Date Author Addressee DOW770705-09 25-May-70 P BRADY HABERSTROH W.H & WILLIAMS L VOGELSANG P & CHASE F KENSICKI R & SCHMIDTKE D Description The manufacture of Phenoxy-Herbicides requires the removal of unreacted phenols from the reactor product mix. Laboratory data indicates that a flow of ------ lbs. of Trichlorobenzene for each pound of Silvex solution using --- stages will remove ------ of the unreacted phenol. Exhibit #P0955 151 PIN # Date Author Addressee Description DOW956820-24 28-May-70 GEORGE LYNN US DEPT OF AGRIC. CanceLLationof 2,4,5-T Products bearing certain directions for use. All uses on food crops intended for human consumption shall cease. / Exhibit #P0956 PIN # Date Author Addressee Description D0W119607 03-Jun-70 BARSTOW BLDG DOW CHEMICAL CLIFFORD M. HARDIN T0RD0N has limited registration for use on non-food cropland and right of way maintenance in the United States. Requests for registration on pasture and rangeland have been submitted. Exhibit #P0960 PIN # Date Author Addressee DOW424633-64 15-Jun-70 C J WILLIAMS LAIRD, MELVIN & DR. LEE DUBRIDGE ELLIOT RICHARDSON & WALTER J. HICKEL Description There is abundant evidence that 2,3,7,8-T is highly toxic. The Dow Company recommends stronly that the government set appropriate specifications and controls to insure that no 2,4,5-T be used if it contains more than on part per million 2,3,7,8-T. Exhibit #P0961 PIN # Date Author Addressee Description DOW392412-23 15-Jun-70 JULIUS JOHNSON SENATE COMMITTEE The possibility of a highly toxic impurity being formed in 2,4,5-T as a side reaction under conditions of elevated processing temperatures. This impurity is a condition known as chloracne, a skin disorder. It is 15152 r r in these oils that the impurities are con centrated. Exposure to this waste oil was the cause of the acne in the workmen. Exhibit #P0962 PIN # Date Author Addressee Description DOW 424633-4 15-Jun-70 G J WILLIAMS / LAIRD, HON MELVIN R G. J. WILLIAMS , VICE PRESIDENT OF DOW, LETTER TO HON. MELVIN R. LAIRD, SECRETARY OF DEFENSE, DATED 06-15-70. Exhibit #P0966 PIN # Date Author Addressee DOW119979 29-Jun-70 D D MCCOLLISTER DREW BAKER, JR. & DR. W. UPHOLT MR. K.K. KRAUSCHE & MR. C.L. DUNN Description Analytical chemists of the Dow Chemical Co. have utilized a GLC procedure essential that for analyzing 2,3,7,8-T. The procedure was sensitive enough to detect as little as 0.1 ppm. Exhibit #P0967 PIN # Date Author Addressee Description DOW129637-42 01-Jul-70 SAMUEL EPSTEIN READER OF ENVIRON Linking birth defects to the week killer 2,4,5-T have resulted in restrictionson the use of this product. The warnings stem from the discovery that several variants, or esters of 24-D including the one commonly used in weed control, have caused birth defects in animals. Exhibit #P0968 PIN # Date DOW766740-50 20-Jul-70 Author Addressee KOU YUAN CHANG TOU,JAMES C. & LOOK, A. SHEETZ, D. & DEMOTT, D.N. POFFENGERGER N. & OTHERS Description Two major concerns in the production of 2,4,5 T are the chloracne problem and the product quality. It is unlikely that a change in the reaction con- dition of the present process can eliminate the formation of methxydichlorophehols. Exhibit #P0970 PIN # Date Author Addressee Description DOW149715-42 23-Jul-70 PRESIDENT ADVISORY COMM In general, 2,4,5-T residues can be expected to be unstable materials in the environment. Chemistry analysis is provided. Exhibit *P0972 PIN # Date Author Addressee DOW367964-66 11-Aug-70 MARGUERITE L LONG K.C. BARRONS & E.M. BLAIR J.M. DAVIDSON & G.E. BLAIR D.D. MCCOLLISTER & OTHERS Description Studies by the Dow Chemical have shown that cows fed 700 ppm 2,4,5-T in the total diet gave milk containing in the neighborhoold of 0.3 ppm 2,4,5-T. Exhibit #P0974 PIN # Date Author Addressee Description DOW12388-423 26-Aug-70 JULIUS JOHNSON DOW CHEMICAL The purpose is to explore possible public health consequences of widespread use. The data presented will emphasize exposure toxicity and chemistry. There were detectable levels of 2,4-D and 2,4,5-T in ;* q 1. TV A 7 til r the air up to 0.06 micrograms per cubic meter. Direct skin contact, together with vapor and mist exposure are encountered in varying degress by applicators and employees in manufacturing plants. Exhibit #P0975 PIN # Date Author Addressee Description DOW018868-83 ' 15-Sep-70 UNKNOWN UNKNOWN MOUNTAIN LAKE & ROW MAINTENANCE CONFERENCE. this was an oral presentation, along with the article are chemical diagrams. Exhibit #P0978 PIN # Date Author Addressee DOW538823-30 01-Nov-70 G L SPARSCHU DUNN F L (AUTHOR) & ROWE V K (AUTHOR) Description Exhibit #P0979 PIN # Date Author Addressee DOW751854-55 18-Nov-70 D D MCCOLLISTER J.E. JOHNSON & G.E. LYNN E.H. BLAIR & P.M. RITTY E.E. KENAGA & OTHERS Description One notable void in this package is the information that Dr. Danielson requested on the acute oral toxicity of the various chlordioxins. A group of experts from EP Board in Sweden have been appointed to evaluate the phenoxy herbicide situation. Exhibit #P0982 PIN # Date Author DOW538372 05-Dec-70 CL DUNN Addressee JAMES LAMB & HEW FDA DUBRIDGE & H.L. LEY NED BAYLEY & H. W, HAYS Description requests an extension until April 1970 on the Pesticide Petition 870669 on 2,4,5, -T which deadline was set for January 1,197 J January 1 1970. Letter states that additional studies are underway which will would present aimportant data to be reeviewed. / Exhibit #P0984 PIN # Date Author Addressee Description DOW 00842 11-Dec-70 L A DALTON J.E.JOHNSON Conclusion of tested showed that all skin contact with the test material should be avoided. Exhibit #P0985 PIN # Date Author Addressee Description DOW120142-9 30-Dec-70 MATTHEW MESELSON WESTING, ARTHUR H. & CONSTABLE, JOHN D. COOK, ROBERT E. herbicide assessment commission of the american association for the advancement of science. Exhibit #P0986 PIN # Date Author Addressee Description DOW579003-9 31-Dec-70 MIKE SIEDEL This spec has no written description, it is a diagram of the Alkaline Hydrolysis. Exhibit #P0995 PIN # Date JUS215-704-8 08-Mar-71 15158 Date Author Addressee 1O-Dec-69 GEORGE LYNN HANSEN, J C & JOHNSON, J E MCCOLLISTER, D D & NAEGELE, ROBINSON, V B & OTHERS RE Description / Exhibit #P0875 PIN # Date Author Addressee D0W7 66734-36 12-Dec-69 ALEX WIDIGER CHANG, K Y & LEAVITT, F C DEMONTT, D N & POFFENBERGER, SCHMIDTKE, D & OTHERS N Description Chemical companies are offering flake 2,4,5 T on world market which is strongly resistent to blooming. We have found the following affects reduce the tendancy to bloom: proglonged heat treating, thinner flakes, the presence of caustic insoluable methoxy compounds. Exhibit #P0883 PIN # Date Author Addressee Description DOW538377 29-Dec-69 CL DUNN F. MCFARLAND & FDA HARRY HAYS & NED BAYLEY L.L. DANIELSON LETTER NOTES THERE HAS BEEN NO RESPONSE TO REQUEST OF 12/5/69 REGARDING EXTENTION FOR ACTION ON PESTICIDE PETITION 8F0669 (2,4,5-T) AND IN ACCORDANCE WITH FEDERAL REGULATIONS WITHDRAWS WITHOUT PREJUDICE SAID PETITION. Exhibit #P0884 PIN # Date Author Addressee 000657-660 07-Jan-70 H H STEHL ROWE, V K & GILL, H SKELLY, N & HALLEY, C DUNN, F Cir 151b Description JANUARY 7, 1970 DOW SCIENTISTS DETERMINED THAT SAMPLES TESTED OF DIAMOND SHAMROCK 2,4,5-T (trichloro- phenoxyacetic acid) AVERAGED 27 PPM (PLUS OR MINUS 8 PPM THEREFORE, AVERAGED 19 PPM - 35 PPM) USING GAS LIQUID-LIQUID CHROMATOGRAPHY METHOD OF EXTRACTION. Exhibit #P0885 PIN # Date Author Addressee Description D817130-218 08-Jan-70 M MCCLURE MORGAN R.W. Meeting to discuss the reasons given by PRD for rejection of the Dow Applications for Temporary Permit to Ship Tordon 166 Mixture and Tordon 169 Mixture herbicides. The outcome of this parley was assent by PRD to reconsider issurance of the Permits is resubmitted. Exhibit #P0886 PIN # Date Author Addressee DOW 1257-59 12-Jan-70 GEORGE E LYNN EGEBERG, DR. & LINDSAY DALE DR. KOTIN, PAUL DR. & BURGER EDWARD DR. MITCHELL IAN DR. & OTHERS Description Concerned that the sample used could have contained a highly toxic impurity. We stronly urge that action concerning the status of 2,4,5-T be held in abeyance until the testing program is completed. Exhibit #P0887 PIN # Date Author Addressee DOW23034-36 12-Jan-70 GEORGE E LYNN 1 K1^ ID EGEBERG, DR. ROGER & HEW LINDSAY, DALE, FBA & BAYLEY, NED D. USDA & KOTIN, PAUL, ETAL. Description Lynn's letter to Egeberg and other governmental officials advises Dow's knowledge in 50's; activity of TCDD, Dow's 1 ppm spec., bionetics samples 27+ ppm contamination; describes Dow's coming territological testing. Exhibit #P0888 PIN # Date Author Addressee Description DOW746134-38 15-Jan-70 / V K ROWE BURGER, E.J. & OST PRESIDENT USA Rowe encloses summary data oral toxicity TCDD. Exhibit #P0889 PIN # Date Author Addressee 1232987-91 16-Jan-70 V K ROWE BURGER, EDWARD J. & CC: OTHERS Description IN RESPONSE TO INQUIRY OF OFFICE OF SCIENCE AND TECHNOLOGY, EXECUTIVE OFFICE OF PRESIDENT, WASH., D.C., JANUARY 1970, DR-. ROWE MERELY INDICATES THAT HE HAS ENCLOSED TABLES ON RATS AND GUINEA PIGS FOR THE GOVERNMENT TO INTERPRET. "NO RELIABLE DATA FOR RABBITS LD50 TO BE ESTABLISHED." RABBITS DIED. Exhibit #P0891 PIN # Date Author Addressee DOW746169 19-Jan-70 G E LYNN VERRETT, J.M. & FDA RICHARDSON, H.L. & FDA Description Letter recites Dow sending 25 gr. 2,4,5-T representing that sample meets Dow's 1 ppm specification. Exhibit #P0892 PIN # 999600-02 15 Date Author Addressee Description 19-Jan-70 RUDOLPH H STEHL ROWE, V K Sc DUNN, F GILL, H Sc SKELLY, K. BAILEY, C IN SAMPLES OF DOW 2,4,5-T TESTED BY DOW'S OWN LABORATORY, RESIDUES WERE LEFT IN THE 100-150 PPM, BUT DOW'S CLAIMS THE TCDD RESIDUE IS ONLY IN THE 3-8 PPM RANGE. / Exhibit *P0893 PIN # Date Author Addressee DOW028238-42 21-Jan-70 G E LYNN BLAIR, E. H. & BROWER, H. H. CRUMMETT, W. R. & FERNANDEZ, J. E. HANSEN, J.C. & 8 OTHERS Description stating he is keeping a record of all samples of 2,4,5-t , 2,4-d and silvex (including derivatives) that are sampled. Exhibit #P0894 PIN # Date Author Addressee 028238-42 21-Jan-70 GEL LYNN ROWE, VK Sc BLAIR, E H CRUMMETT, W R Sc FERNANDEZ, J B GETZENDANER, M E Sc HANSEN, J C. ET AL Description DOW IN-HOUSE MEMO REGARDING ANY OUTGOING SAMPLES TO BE SENT TO THE EPA OR ANY OTHER GOVERNMENTAL AGENCY MUST BE CLEARED THROUGH LYNN. THE SAMPLES SUPPLIED MUST MEET THE DOW SPEC, AND LAB REFERENCE STANDARD OF VERY HIGH PURITY- LIMITED IN SUPPLY MUST BE CAREFUL NOT TO LET JUST ANY OLD SAMPLE OF 2,4,5-T OUT OF THIS COMPANY. Exhibit #P0898 PIN # Date Author Addressee 746158-616 06-Feb-70 V K ROWE FALK, HANS DEPT. HEW Sc TRIANGLE PARK, NC 15161A Description LETTER OF ROWE, FROM DOW TO DR. HANS FALK, DIRECTOR OF LABORATORY RESEARCH, RESEARCH PARK, NORTH CAROLINA, DEPARTMENT OF HEALTH, EDUCATION AND WELFARE DISCUSSING SENDING THE SAMPLES OF PURIFIED 2,3,7,8 -TCDD AND THE EXTREME TOXICITY OF THIS COMPOUND. THE REASONS GIVEN FOR THE DELAY IN SHIPPING WAS THE NECESSARY PRECAUTIONS THAT HAD TO BE TAKEN NOT TO CONTAMINATE OTHERS. ALSO DOW INFORMED GOVERNMENT THAT IT HAD A NEW METHOD OF DETECTING fCDD/'DOW ANALYTICAL METHOD MLW -65.11" WHICH ROWE FORGOT TO INCLUDE, SEE NEXT EXHIBIT IN WHICH DR. FALK RESPONDS. Exhibit #P0902 PIN # Date Author Addressee Description DOW1119842 10-Feb-70 UNKNOWN UNKNOWN LOGAN? DOCUMENT ENTITLED PURCHASE DESCRIPTION HERBICIDE ORANGE SETTING FORTH AN AMENDMENT TO PURCHASE DESCRIPTION AFFID 6840-1, 1/2/70 WITH REGARD TO PARAGRAPH 4.2.4.1. Exhibit #P0903 PIN # Date Author Addressee Description DOW028605 10-Feb-70 HANS L FALK ROWE, DR. V.K. letter of thanks for information and a request for missing data, dow called and the problem of shipment of the dioxin is solved, now the next set of experiments can get under way. Exhibit #P0904 PIN # Date Author Addressee Description 028605 10-Feb-70 HANS FALK HEW & TO ROWE, VK RE 434 DR. HANS FALK OF THE DEPARTMENT HEALTH, EDUCATION AND WELFARE, DIRECTOR FOR LABORATORY RESEARCH NATIONAL INSTITUTE OF HEALTH, TRIANGLE PARK, NORTH CAROLINA IS ASTONISHED AT THE EXTREME TOXICITY DATA THAT DR. V.K.ROWE HAS JUST SENT IN EXHIBIT 434. Exhibit #P0905 PIN # Date Author Addressee Description DOW445809 11-Feb-70 / UNKNOWN UNKNOWN LEGATOR, FDA Sc VERRETT, FDA RICHARDSON, FDA & MANY OTHER FDA AND USDA Notice of meeting of government scientists with technical personnel of Dow to discuss chick edema factor methodology shows Dow reps to attend. Exhibit #P0907 PIN # Date Author Addressee Description D0W1130312 13-Feb-70 UNKNOWN DOW AGRI PRODUCTS DOCUMENT ENTITLED SALES SPECIFICATION WITH RESPECT TO 2,4,5-T ACID SETS FORTH 2,3,7,8-TCDD AT 1 PPM. Exhibit #P0908 PIN # Date Author Addressee DOW028232-36 13-Feb-70 GEORGE LYNN WILLIAMS, C G & NAEGELE, R E DONALDS, JOHN E Sc SPARTA, TOM JOHNSON, JULIUS & ROWE, VK ET AL Description GEORGE LYNN GOVERNMENT REGULATORY RELATIONS FOR DOW CHEMICAL REPORTS IN A CONFIDENTIAL MEETING MEMO THE MEETING BETWEEN DOW (CRUMMETT, HOLDER, LEAVITT LYNN) AND THE FDA HELD IN WASHINGTON, FEBRUARY 11,1970. DR. CAMPBELL MADE THE PRESENTATION FOR FDA; CRUMMETT AND HOLDER MADE THE PRESENTATION FOR DOW. THE FDA IS CONCERNED THAT CDD'S MAY BE WIDESPREAD IN ENOUGH QUANTITY TO BE HAZARD TO HUMANS; CARCINOGENIC RISK;SAME PERSISTENCE AS DDT AND BIOMAGNIFICATION ;DR KRAYHILL SAID SHOULD NOT BE PERMITTED; "ONE MOLECULE IS TOO MUCH." DR KRAYBILL. DR. A. D. CAMPBELL, CHIEF CONTAMINANTS BRANCH, FDA WASHINGTON, DC Exhibit #P0909 PIN # Date Author Addressee Description / DOW751916-7 20-Feb-70 RALPH C WANDS LONGENECKER, W.H. & FT. DETRICK ROWE, V.K. Wands' director, Advisory Center on Toxicology, NAS, suggests Longenecker arrange meeting with V.K. Rowe to learn something of the toxicology of TCDD. Exhibit #P0912 PIN # Date Author Addressee DOW040862-66 27-Feb-70 GEORGE LYNN MASON, JOHN & WILLIAMS, G.J. SPARTA, TOM & NAEGELE, R.E. DONALDS, JOHN & OTHERS Description Goal: To establish the principal uses of Chlorophenols and to utilize this information in seeking out the ways in which they could possibly be related to the presence of chlorodebenzp-p-dioxins in fats, soap stocks,etc. Exhibit #P0914 PIN # Date Author Addressee Description DOW538598 10-Mar-70 HAROLD ALFORD FED REG & ECONOMIC POISON Letter states additional safety studies are needed for 2,4,5-T currently registered, among others and that data on carcinogenicity or teratogenicity should be submitted immediately. If such data is not available studies are requested immediately. Epidemiological studies also requested. Exhibit #P0917 PIN # Date Author Addressee Description DOW007830 17-Mar-70 JAMES ILLEGIBLE Dow scientists presented detailed evidence showing that a contaminant rather than the compound 2,4,5-T was probably the cause of birth abnormalities. The National Cancer Institute indicated higher than normal rates of birth defects in test animals treated with massive doses of 2,4,5-T. Exhibit #P0918 PIN # Date Author Addressee 392436-38 17-Mar-70 G L SPARSCHU DUNN, F L & ROWE, V K Description PAPER PRESENTED AT THE MEETING OF THE SOCIETY OF TOXICOLOGY ATLANTA, GEORGIA, MARCH 17, 1970 RESULTS INDICATE A HIGH LEVEL OF MATERNAL AND FETAL TOXICITY TOXICITY TO BE ASSOCIATED WITH 2,3,7,8-TCDD, STUDY BY DOW. TERATOGENIC Exhibit #P0919 PIN # Date Author Addressee DOW392434-35 17-Mar-70 J L EMERSON GERBIG, C G 5c ROBISON, V B Description THIS ABSTRACT WAS PRESENTED SIMULTANEOUSLY WITH THE EXHIBIT NO'S 437 AT THE SOCIETY OF TOXICOLOGY IN ATLANTA, GA; HOWEVER THE FINDINGS OF THIS GROUP OF DOW SCIENTISTS DISAGREE WITH THE BIONETICS RESEARCH LABS, BETHESDA, MD. Exhibit #P0921 15164 PIN # Date Author Addressee D0W120584 18-Mar-70 GEORGE E LYNN HAYS,HARRY W. & USDA LINDSAY,DR.DALE & FDA/HEW BCCDOW OTHERS & & ACTION FILE 245T Description leteter seeks to assure Department of Agriculture about the quality of the composition of commercial 2,4,5-T acid produced by Dow Chemical. Claims that in 1965 a rigid production standard was imposed by Dow of less than 1 ppm of TCDD in 2,4,5-T. Exhibit #P0924 PIN # Date Author Addressee DOW582853 23-Mar-70 C DOW JOHNSON, J.E. & LUECK, A.T. LYNN, G.E. & BLAIR, E.H. Description Memo re status of 2,4,5-T backup program. Exhibit #P0926 PIN # Date Author Addressee D0W28243-44 26-Mar-70 GEORGE LYNN JOHNSON, J & WILLIAMS, C J NAEGELE, R & DONALDS, JOHN BLAIR, E & OTHERS Description Dow and Monsanto can begin to predict where the bulk of the chlorophenols are going and evaluate some of the potentials for contaminent problems. Exhibit #P0927 PIN # Date Author Addressee DOW028243-44 26-Mar-70 GEORGE E LYNN WILLIAMS, C J 4 NAEGELE, R. E. DONALDS, JOHN E. & SPARTA, TOM A. LEAVITT, F. C. & OTHERS A i Description the report is from meetings 2/25, 3/19, 3/23. Exhibit #P0928 PIN # Date Author Addressee Description DOW582854-55 26-Mar-70 GEORGE E LYNN JOHNSON, JULIUS 5c WILLIAMS, G.J. OTHERS AT DOW Lynn writes Johnson, Rowe and 12 others at Dow to report on meetings of 02/25, 03/19, and 03/23, re dioxin and Monsanto koppers human health problems. -Exhibit #P0929 PIN # Date D0W1104-8 31-Mar-70 Author Addressee BENJAMIN B HOLDER LYNN, GEORGE E. & NO OTHERS SHOWN Description Letter is a summary of clinical information distirbuted to various institutions by Dow regarding the 1964 chloracne episode at the Midland Plant. Attached to the letter is a "Review of occupational health problems associated with th the manufacture of chlorinated phenols a t Midland, MI in 1964. Notes that disease primarily affects the skin and with extreme exposure "... a general organ toxicity can result." Liver and nervous disords ders naote noted and no specific treatment for disease is known. Exhibit #P0930 PIN # Date Author Addressee 1170342 31-Mar-70 V K ROWE DUNN, F L & GORDON, H L HOLDER, B B 5c HINMAN, C W HOYLE, H R 5c JOHNSON, J E Description WE DO NOT HAVE ENCLOSURE 151 b Exhibit #P0932 PIN # Date Author Addressee Description D0W1103 02-Apr-70 GEORGE LYNN In discussing the attached information with Dr. Holder he says the chloracne problem was related to the "adcident" in the 2,4,5-T plant and the culprit was principally 2,3,7,8-T. Exhibit #P0934 PIN # Date Author Addressee Description DOW999363-67 07-Apr-70 CHARLES KRAMER JOHNSON, JULIUS One hundred thirty employees who have worked more than six months in areas where exposure to 2,4,5-T occurred and on whom recent medical examination data was available. Exhibit #P0935 PIN # Date Author Addressee Description D0W119849-68 07-Apr-70 CHARLES KRAMER JULIUS JOHNSON At present we are involved in an extensive reworking of the program based on review of the "first cycle" results. Approximately 10 percent of the subjects participating in the health inventory have prompt follow up by a physician on the basis of suspected abnormalities detected during inventory. Exhibit #P0936 PIN # Date Author Addressee Description D0W549641 -91 10-Apr-70 F D AXE DOW Measurements to describe the chemical exposures of workmen engaged in the 1 hi manufacture of 2,4,5-T. Dry Dust of 2,4,5-T has the capacity to produce upper respiratory irritation. Dust levels are frequently high enough to be very noticebly irritating. Observations indicate nasal irritation sneezing and a bitter taste may result from brief exposures. Exhibit #P0937 PIN # Date Author Addressee / 549641-660 10-Apr-70 F D AXE FILE & LYNN, G E DELINE, DD & SCHMIDTKE, D J HODSON, R E & MILLER, D E OTHERS Description BIOCHEMICAL RESEARCH LAB AT DOW CHEMICAL CO., F. D. AXE DISTRIBUTED A STUDY OF CHEMICALLY EXPOSED WORKERS IN BUILDING 267 BUILDING (2,4,5-T PLANT); ALTHOUGH HE STATES THE LEVELS OF EXPOSURE ARE BELOW MINIMUN THRESHOLD LIMIT VALUE, DRY DUST HAS CAPACITY TO PRODUCE UPPER RESIRATORY IRRITATION AT LEVELS MUCH LOWER THAN T L V ; RECOMMENDS IMPROVE DUST CONTROL AT THE PACKING STATION- DUST ESCAPES FROM SEAL(FAULT OF EITHER SEAL OR INSUFFICIENT AIR VELOCITY). Exhibit #P0939 PIN # Date Author Addressee Description DOW392412-23 15-Apr-70 JULIUS JOHNSON SENATE COMMITTEE Reference to birth defects observed in tests. The most sensitive toxic reaction observed in humans to this inpurity was manifested by a condition known as chloracne, a skin disorder suffered by teenagers. Exposure to this waste oil was the cause of the acne in the workmen. Exhibit #P0940 PIN # Date DW 392412-23 15-Apr-70 Author Addressee JULIUS E JOHNSON SUBCOMMITTEE ON 6c ENERGY Description STATEMENT BY JULIUS E. JOHNSON, VICE PRESIDENT AND DIRECTOR OF RESEARCH, THE DOW CHEMICAL COMPANY, BEFORE THE SUBCOMMITTEE ON ENERGY, NATURAL RESOURCES AND THE ENVIRONMENT OF THE SENATE COMMITTEE ON COMMERCE, DATED 04-15-70. / Exhibit #P0941 PIN # Date Author Addressee DOW130436-7 15-Apr-70 JULIUS JOHNSON USA PUBLIC 6c HART SENATE COMM. Description Copies from Dow produced documents of minutes of Julius Johnson's testimony given April15, 1970, before Hart Senate sucommittee on the environment, presumably from the Federal Register or Congressional Record; confirms Johnson of Dow made disclosures contained in full text of speech drafted for him at Dow. Exhibit #P0945 PIN # Date Author Addressee Description DOW547219-20 20-Apr-70 HARRY W HAYS ECONOMIC POISONS This herbicide may present an imminent health hazard to women of child-bearing age and has recommended suspension of certain registered uses of 2,4,5-T. In order to prevent an imminent hazard containing 2,4,5-T to the public it is necessary to suspend the registration for these products. Exhibit #P0946 PIN # Date Author Addressee Description DOW547221 20-Apr-70 HARRY HAYES DOW CHEMICAL It is hereby found that in order to prevent aT V A 1516 an imminent hazard to the public it is necessary to suspend the registration for purducts containing 2,4,5-T. Exhibit #P0947 PIN # Date Author Addressee Description 999173 23-Apr-70 R L LAPE / LYNN, G E & ROWE, V K FERNANDEZ, J DOW TESTED 10 BATCHES OF AGENT ORANGE FROM FT DETRICK AND FOUND IT CONTAINED BETWEEN 1-15PPM OF 2,3,7,8-TCDD Exhibit #P0948 PIN # Date Author Addressee Description DOW119606 01-May-70 G J WILLIAMS Letter written by G.J. Williams stating how he feels that Dow should make its position known to the rest of the Government rather than give the Department of Defense an option. Exhibit #P0949 PIN # Date Author Addressee Description D0W130323-24 11-May-70 PROD AND MKT CANADA DEPT AGR Further evidence show that 2,4,5-T is potentially capable of causing abnormal development. This dioxin can also cause a serious skin condition known as chloracne. Findings suggest that this couldd constitute a hazard to children and women exposed during pregnancy. Exhibit #P0950 PIN # Date Author DOW582846-7 11-May-70 FRED LEAVITT T17 OO 15170 Addressee BLAIR, E. & 31 OTHER DOW EMP. Description Memo re environmental problems re chlorinated phenols. Exhibit #P0951 PIN # Date Author Addressee Description D0W119791-7 14-May-70 / GARETH OWEN LYNN, GEORGE E along with the letter are the results of teratological studies done in Charles river cd rats. Exhibit #P0952 PIN # Date Author Addressee DOW582836-7 22-May-70 R A PLEPYS LYNN, G. & BLAIR, E.H. ROWE, V.K. & HOLDER, V.B. LUECK, A. & 19 OTHER DOW EMP. Description Minutes of meeting eco-studies of chlorophenols. Exhibit #P0954 PIN # Date Author Addressee DOW770705-09 25-May-70 P BRADY HABERSTROH W.H 6c WILLIAMS L VOGELSANG P 6c CHASE F KENSICKI R & SCHMIDTKE D Description The manufacture of Phenoxy-Herbicides requires the removal of unreacted phenols from the reactor product mix. Laboratory data indicates that a flow of ------ lbs. of Trichlorobenzene for each pound of Silvex solution using --- stages will remove ------ of the unreacted phenol. Exhibit #P0955 IV. A. 84 i 1;t ^ & PIN # Date Author Addressee Description DOW956820-24 28-May-70 GEORGE LYNN US DEPT OF AGRIC. Cancellationof 2,4,5-T Products bearing certain directions for use. All uses on food crops intended for human consumption shall cease. / Exhibit #P0956 PIN # Date Author Addressee Description D0W119607 03-Jun-70 BARSTOW BLDG DOW CHEMICAL CLIFFORD M. HARDIN TORDON has limited registration for use on non-food cropland and right of way maintenance in the United States. Requests for registration on pasture and rangeland have been submitted. Exhibit #P0960 PIN # Date Author Addressee DOW424633-64 15-Jun-70 C J WILLIAMS LAIRD, MELVIN & DR. LEE DUBRIDGE ELLIOT RICHARDSON & WALTER J. HICKEL Description There is abundant evidence that 2,3,7,8-T is highly toxic. The Dow Company recommends stronly that the government set appropriate specifications and controls to insure that no 2,4,5-T be used if it contains more than on part per million 2,3,7,8-T. Exhibit #P0961 PIN # Date Author Addressee Description D0W392412-23 15-Jun-70 JULIUS JOHNSON SENATE COMMITTEE The possibility of a highly toxic impurity being formed in 2,4,5-T as a side reaction under conditions of elevated processing temperatures. This impurity is a condition known as chloracne, a skin disorder. It is 151 i OJ,.V Tir o c in these oils that the impurities are con centrated. Exposure to this waste oil was the cause of the acne in the workmen. Exhibit *P0962 PIN # Date Author Addressee Description DOW 424633-4 15-Jun-70 G J WILLIAMS / LAIRD, HON MELVIN R G. J. WILLIAMS , VICE PRESIDENT OF DOW, LETTER TO HON. MELVIN R. LAIRD, SECRETARY OF DEFENSE, DATED 06-15-70. Exhibit #P0966 ... PIN # Date Author Addressee DOW119979 29-Jun-70 D D MCCOLLISTER DREW BAKER, JR. & DR. W. UPHOLT MR. K.K. KRAUSCHE & MR. C.L. DUNN Description Analytical chemists of the Dow Chemical Co. have utilized a GLC procedure essential that for analyzing 2,3,7,8-T. The procedure was sensitive enough to detect as little as 0.1 ppm. Exhibit #P0967 PIN # Date Author Addressee Description DOW129637-42 01-Jul-70 SAMUEL EPSTEIN READER OF ENVIRON Linking birth defects to the week killer 2,4,5-T have resulted in restrictionson the use of this product. The warnings stem from the discovery that several variants, or esters of 24-D including the one commonly used in weed control, have caused birth defects in animals. Exhibit #P0968 PIN # Date D0W766740-50 20-Jul-70 1n j. i Author Addressee KOU YUAN CHANG TOU,JAMES C. & LOOK, A. SHEETZ, D. & DEMOTT, D.N. POFFENGERGER N. & OTHERS Description Two major concerns in the production of 2,4,5 T are the chloracne problem and the product quality. It is unlikely that a change in the reaction con- dition of the present process can eliminate the formation of methxydichlorophehols. Exhibit #P0970 PIN # Date Author Addressee Description DOW149715-42 23-Jul-70 PRESIDENT ADVISORY COMM In general, 2,4,5-T residues can be expected to be unstable materials in the environment. Chemistry analysis is provided. Exhibit #P0972 PIN # Date Author Addressee DOW367964-66 11-Aug-70 MARGUERITE L LONG K.C. BARRONS & E.M. BLAIR J.M. DAVIDSON & G.E. BLAIR D.D. MCCOLLISTER & OTHERS Description Studies by the Dow Chemical have shown that cows fed 700 ppm 2,4,5-T in the total diet gave milk containing in the neighborhoold of 0.3 ppm 2,4,5-T. Exhibit #P0974 PIN # Date Author Addressee Description DOW12388-423 26-Aug-70 JULIUS JOHNSON DOW CHEMICAL The purpose is to explore possible public health consequences of widespread use. The data presented will emphasize exposure toxicity and chemistry. There were detectable levels of 2,4-D and 2,4,5-T in 15174 tt; a O 7 the air up to 0.06 raicrograms per cubic meter. Direct skin contact, together with vapor and mist exposure are encountered in varying degress by applicators and employees in manufacturing plants. Exhibit #P0975 PIN # Date Author Addressee Description DOWOl8868-83 ' 15-Sep-70 UNKNOWN UNKNOWN MOUNTAIN LAKE & ROW MAINTENANCE CONFERENCE. this was an oral presentation, along with the article are chemical diagrams. Exhibit #P0978 PIN # Date Author Addressee DOW538823-30 01-Nov-70 G L SPARSCHU DUNN F L (AUTHOR) & ROWE V K (AUTHOR) Description Exhibit #P0979 PIN # Date Author Addressee DOW7 51854-55 18-Nov-70 D D MCCOLLISTER J.E. JOHNSON & G.E. LYNN E.H. BLAIR & P.M. RITTY E.E. KENAGA & OTHERS Description One notable void in this package is the information that Dr. Danielson requested on the acute oral toxicity of the various chlordioxins. A group of experts from EP Board in Sweden have been appointed to evaluate the phenoxy herbicide situation. Exhibit #P0982 PIN # Date Author DOW538372 05-Dec-70 CL DUNN TT7 A UU Addressee JAMES LAMB & HEW FDA DUBRIDGE & H.L. LEY NED BAYLEY & H. W, HAYS Description requests an extension until April 1970 on the Pesticide Petition 870669 on 2,4,5, -T which deadline was set for January 1,197 J January 1 1970. Letter states that additional studies are underway which will would present aimportant data to be reeviewed. / Exhibit #P0984 PIN # Date Author Addressee Description DOW 00842 11-Dec-70 L A DALTON J.E.JOHNSON Conclusion of tested showed that all skin contact with the test material should be avoided. Exhibit #P0985 PIN # Date Author Addressee Description DOW120142-9 30-Dec-70 MATTHEW MESELSON WESTING, ARTHUR H. & CONSTABLE, JOHN D. COOK, ROBERT E. herbicide assessment commission of the american association for the advancement of science. Exhibit #P0986 PIN # Date Author Addressee Description DOW579003-9 31-Dec-70 MIKE SIEDEL This spec has no written description, it is a diagram of the Alkaline Hydrolysis. Exhibit #P0995 PIN # Date JUS215-704-8 08-Mar-71 Author Addressee Description RICHARD M PATTERSON CHMN.ARMED FORCES & PEST CONTROL BOARD WASH.,D.C. Gov't relations mgr. Dow writes AFPCB to advise Dow's capabilities in destroying herbicides, the combustion of TCDD on incineration, and encloses report re same given 2-24-71; states "more than 40%) of the Orange inventory is unusable because of a dioxin level higher than one part per million". ^ Exhibit #P1000 PIN # D0W120239-40 Date 31-Mar-71 Author A T TALCOTT Addressee KANESHIRO K.R. & O'CONNOR J.N MCCOLLISTER D.D. & LYNN G.E. PIPPENGER P. & OTHERS Description This letter contains the total number of containers of 2,4,5-T in inventory on April 29, 1970. Exhibit #P1001 PIN # Date Author Addressee Description D0W119670-84 01-Apr-71 DOW DOW CHEMICAL The EPA has also advised that a specific tolerance for phenoxies in grass is necessary: a tolerance in grass had not been requested by ITFPHT as it did not appear necessary. Exhibit #P1005 PIN # Date Author Addressee DOW 047457 01-Jun-71 GEORGE LYNN R.E. NAEGELE & JULIUS JOHNSON F.H. BLAIR & T.A. BYMAS D.D. MCCOLLISTER & OTHERS Description A letter stating that a report will be considered by the Administrator of EPA in making his descions about the suspended and cancelled registrations of 2,4,5-T. Exhibit #P1009 PIN # Date Author Addressee DOW550150-71 06-Jul-71 R D OLSEN / D. D. DELIN&E C.Z. BAILEY E. M. SEIDE&L R.E. SNYDER B.B. HOLDER & OTHERS Description Particular emphasis placed on potential chloracne hazards. Wipe Samples indicate an increase to an all time high of 38% in February and May, 1971. Exhibit #P1010 PIN # Date Author Addressee Description H27741 29-Jul-71 F STEHL CRUMMETT, W & CHAMPLAIN,C .E OTHERSAT DOW Report of Analysis of Hercules, 2,4,5-T sample x-17394-21-5 showing .18ppmTCDD and reports 50 ppb in dow sample. Exhibit #P1013 PIN # Date Author Addressee Description D0W119883-89 19-Aug-71 V K ROWE BATES, RICHARD DR. h LYNN, G.E. ROWE VK Summary of Toxicological information. graphd and diagrams. Many Exhibit #P1014 PIN # Date Author Addressee H4E1-2 28-Oct-71 DONALD D MCCOLLISTER WEIR,DR. ROBERT & BIONETICS LABS FRAWLEY, J.P. Description Dow encloses their lab reports analyzing the 245T used by Bionetics in their rat study indicating more recent studies in mice used Hercules product .18ppm TCDD Exhibit #P1016 PIN # Date Author Addressee Description D0W7 67059-60 01-Nov-71 DOW DOW / This is directions on how to use Veon Brush Killer. Exhibit #P1017 PIN # Date Author Addressee Description H4(E)0000 09-Nov-71 E ROSS HART MCCOLLISTER,D.D. & FALSEY, DR.J.P. WEIR.DR.R.J. Weir asked Hart of Bionetics to respond to Dow's 10-28-71 re use of Hercules 245T in continuing bionetics lab mice studies; Hart unable to comment but agrees that "caution must be exercised in statements that would appear in publication". Invites Dow to make specific suggestions re that. Exhibit #P1018 PIN # Date Author Addressee H4(E)813 09-Nov-71 E ROSS HART FRAWLEY,DR.J.P. & NO OTHERS Description Hart enclosed abstract submitted for inclusion in program of Toxicology Society in March, referencing fact that no specific results were obtained and solicits suggestions from Frawley as to how to state results obtained. Exhibit #P1019 PIN # 538832-630 *5k t ^ r Date Author Addressee 09-Nov-71 G L SPARSCHU DUNN, F L & ROWE, V K Description ARTICLE WHICH IS PUBLISHED OF THE DOW STUDY AGREEING WITH BIONETICS REPORT AND COMPORTS WITH THE PREVIOUSLY SUBMITTED ABSTRACT. Exhibit #P1020 PIN # Date Author Addressee / H4(K)240 15-Nov-71 W C KENYON SHEARER,P.W. HALL,DR.R.T. & TAVES, DR.M.A. & F0RD,J.J. Description Hercules cannot refute results reported, but notes ambiguity in statements of reports, which ref- erence both .18ppm and elevations corresponding to 3.8ppra TCDD. Exhibit #P1022 PIN # Date Author DOW129635-36 17-Nov-71 G LYNN Addressee Description Exhibit #P1023 PIN # Date Author Addressee Description DOW026811-2 04-Dec-71 J C WILSON the dow chemical company request for preliminary toxicological studies form on the product 2,4,5-t acid, analysis for this is on form ml-al-24-6??? Exhibit #P1028 PIN # Date Author Addressee H4(K)254-5 17-Jan-72 D D MCCOLLISTER HART, DR.E.ROSS & BIONETICS LABS 15 DUNN,C .L. & WEIR,DR.R.J . Description USDA & FDA had published that Hercules lot of 245-T used in animal studies was "less than .05ppm"; Dow states "in our opinion there was no method available in 1970 which could be shown with adequate documentation to detect as little as .05ppm". Dow suggests bionetics ignores the differences of opinion and merely present their results as "on the order of .05pf>m". Exhibit #P1031 PIN # Date Author Addressee Description D0W126112-18 15-May-72 DOW CHEMICAL RENEGOTIATION BOARD Text of presentation of Dow to May 15, 1972 meeting of statutory renegotiation board where Dow attempts to obtain renegotiation of the price that received for its Orange and gives argument and support thereof. Exhibit #P1032 PIN # Date Author Addressee Description DOW053909 10-Jul-72 B A SCHWETZ GEHRING P J Work to be done to supplement the existing information on the toxicity of the chlorinated dibenzo-p-dioxins. Exhibit #P1033 PIN * Date Author . Addressee Description D0W123061-68 06-Oct-72 COMPANY DOW CHEMICAL two bibliography's - 1) determination of chlorinated dibenzo-p-dioxins and 2)analytical chemistry of herbicides Exhibit #P1034 T W A O /. 15181 PIN # Date Author Addressee Description D0W119557 22-Nov-72 T YATES DCASR DETROIT Award Contract Exhibit #P1049 PIN # Date Author Addressee D0W710839-56 ' 21-Feb-74 G J ROUSH J.L. DEGEER & R.E. WINTERS F.L. WILLIAMS & R.R. LANGER B.B. HOLDER & OTHERS Description Bldg. 267 of the Midland Division is slated to be ravaged. The chemicals of concern were judged to be TBC and TCBD. Tertiary Butyl dust is highly irritating to the skin and eyes. Eye contact may cause permanent loss of vision. Exhibit #P1050 PIN # Date Author Addressee Description DOW 005592 08-Jul-74 MARGUERITE LENG MCCOLLISTER, D. D. HANDWRITTEN MEMOS BETWEEN MARGUERITE LENG AND D. D. MCCOLLISTER OF DOW DATED 07-08-74. Exhibit #P1060 PIN # Date Author Addressee Description DOW119974-77 29-Mar-77 UNKNOWN WJR DOW Four page document contains Dow's capability for pro- duction of 2,4-D and 2,4,5-T and delinates herbicide contracts , Defense General Supply Center, dated March 29, 1967. Exhibit #P1061 15182 PIN # Date Author Addressee Description NONE 15-Sep-77 PAUL F OREFFICE ALL DOW SUP'RS President Orrefice of Dow writes all Dow U.S.A. Supervisors regarding Dow's Records Retention Policy and contains "WHEN IN DOUBT, THROW IT AWAY!!!" Exhibit #P1066 PIN # Date Author Addressee Description DOW047290 21-Jun-78 P J GEHRING CROW DR. This letter states by Mr. Gehring that he cannot support a study using doses which are likely to produce discernible effects. Exhibit #P1091 PIN # Date Author Addressee Description DOW1132503 03-Mar-81 LU LAPOINTE RAY HOLMES LETTER INDICATES THAT HOLMES REFERRED TO THE TCDD PROBLEM AS 10/5/64 WHICH ACCORDING TO THE AUTHOR WAS SOME TWO MONTHS PRIOR TO THE ANALYTICAL LABS ISOLATION OF THE CHLORAGEN. LETTER STATES THAT IT APPEARS THAT SOME "PRESSURE" WAS APLLIED TO HOLMES TO CONTINUE PLANT OPERATIONS WITH ONLY MINOR CHANGES THAT HOLMES WAS NOT IN AGREEMENT WITH. Exhibit #P1107 PIN # Date Author Addressee Description NO NUMBER 16-Dec-83 ARVIN MASKIN WITT, GRETCHEN LEAH EXCERPTS FROM DECLASSIFIED RANCH HAND DOCUMENTS PRODUCED BY THE GOVERNMENT. Exhibit #P0009 PIN # Date Author Addressee Description 1079 27-Dec-OO G P RUSSELL MONSANTO COMPANY Document requesting constant temperature control to reduce TDD. Exhibit #P0017 PIN # Date Author Addressee Description 006005 R EMMET KELLY M D UNINTELLIGIBLE Document referring to medical history of 2,4,5-T manufacturers. Exhibit #P0018 PIN # Date Author Addressee Description 73256-62 J AND K H KIMMIG SCHULTZ UDELL, W Kimmig & Schultz article translated 3/59 with copy sent to Udell. Title of said article is "Occupational Acne". Exhibit #P0019 PIN # Date Author Addressee Description 1570-1577 UNKNOWN UNKNOWN UDELL? HAND WRITTEN NOTES FROM FEBRUARY-AUGUST 1965 ENTITLED 2,4,5-T QUALITY NUMBERED 9-23-76001-2102 WITH PROBLEM AS REDUCTION OF CONCENTRATION OF CHLORACNa GENIC T.D.D. IN 2,4,5-T PRODUCT AND IMPROVEMENT OF COLOR OF PRODUCT. Exhibit #P0020 PIN # Date Author Addressee Description 1079,1068 G P RUSSELL NITRO Document states in part that TDD can be reduced via the utilization of automatic temperature controls in the autoclaves. The manual controls are '"very crude" and permits variations of plus and minus 4 degrees while the auto control will limit this to plus or minus 1 degree. Exhibit #P0021 PIN # Date Author Addressee Description 46112-13 UNKNOWN UNKNOWN UNKNOWN Page 3 & 4 of 16, Professional and Technical Personnel Required. Exhibit #P0022 PIN # Date Author Addressee Description 73992 JAMES M REA SIDO, G ROBERT 2,4-D/2,4,5-T Butyl Esters, USDA Reg. No. 524-150. Your application of April 8, 1970, is the subject of this document. Exhibit #P0023 PIN # Date Author Addressee Description 89678-92 JUDITH A ZACK ET AL UNKNOWN The Mortality Experience of Workers to Tetrachlorodibenzodioxin in a Trichlorophenol Process Accident. Draft of Dr. Suskinds mortality study. Exhibit #P0024 PIN # Date Author Addressee Description 88248-51 JUDITH A ZACK ET AL UNKNOWN The Mortality Exerience of Workers Exposed to Tetrachlorodibenzodioxin in a Trichlorophenol Process Accident. / Exhibit #P0044 PIN # Date Author Addressee 4872 14-Sep-48 M C MCKONE R L SIBLEY & W G KRUMRICH C A HOCHWALT & D J BEAVER SCOTT-RUABON & FILE COPY Description Final Report on 2,4,5-T dated 9/14/48. Exhibit #P0046 PIN # Date Author Addressee 71386 23-May-49 C J MCKONE W G KRUMMRICH & DR D J BEAVER P G MARSH & H R NASON DR R L SIBLEY & DR W P METZER Description Interim Report on an Investigation of the 2,4,5- Trichlorophenol Process. Nitro Report No. ?107 dated May 23, 1949. Exhibit #P0048 PIN # Date Author Addressee Description 042220 16-Aug-49 LOUIS SCHWARTZ M D (?) C. NELSON Document discusses medical descriptions of individuals affected by the Nitro incident of 1949. 1518  'V Exhibit #P0053 PIN # Date Author Addressee Description 73928 01-Mar-50 J CRESCE 2,4,5-T EMPLOYEES Hygiene requirements in 2,4,5-T the subject of this document. plant is / Exhibit #P0055 PIN # Date Author Addressee Description 74618-42 30-Jan-51 G ROBERT SIDO DEPT OF AGRICULTURE Registration of 2,4,5-T with U.S.D.A. the subject of this document. is Exhibit #P0056 PIN # Date Author Addressee Description 75359 02-Apr-51 F V REAGEL MONSANTO CHEMICAL CO User of 2,4,5-T developed health condition working at Missouri State Highway Department. Exhibit JP0057 PIN # Date Author 75360 09-Apr-51 R EMMET KELLY M D Addressee F V REAGEL Description Letter indicating that injury related to 2,4,5-T use was unrelated. TT T 1 r\ r\ .1 '4 $ Exhibit #P0058 PIN * Date Author Addressee Description 33391 03-Jan-52 WILLIAM F ASHE M D DR HORACE D DAVIDSON Letter requesting liver biopsy of Jessie Steele from Dr. Wallace. / Exhibit #P0059 PIN # Date Author Addressee Description 42047 03-Mar-52 XYZ BOWLES VIRGINIA WEBB Document refers to list of 119 employees injured at Nitro in 1949. Exhibit #P0060 PIN # Date Author Addressee Description 1771 08-Aug-52 W H AND E A SEATON AND FIKE L C WEGER & M C THRODAHL W P METZNER & R L SIBLEY OTHER EMPLOYEES Nitro Progress Report regarding atmospheric pressure hydrolysis of TCB and TCP. Exhibit #P0062 PIN # Date Author Addressee 15.87-89 07-Nov-52 E A FIKE DR W P METZNER 4 DR G W STEAHLY Description Proposal that TCP be distilled as a means of reducing toxicity. Exhibit #P0063 PIN # Date Author Addressee Description 1580-86 17-Nov-52 W G CANHAM W A GARLETTE JR & L C WEGER H G KIRTLEY & E R HAMILTON E G VOLZ Minutes of Meeting November 11, 1952 Sodium Trichlorophenate Purification with the hopes of reducing toxicity was the subject of the document. Exhibit #P0065 PIN # Date Author Addressee Description 41815 03-Jun-53 H H SCHRENK PH D MR. SMITH Document referring to report on rabbit-ear chloracne tests utilized prior to June 1953. Exhibit #P0066 PIN # Date Author Addressee Description 4675-80 13-Oct-53 H L HUBBARD ET AL UNKNOWN Final report on Minor Plant investigation 1952 through 1953 is the title of this document. Exhibit #P0068 PIN # Date Author Addressee Description 71194-222 24-Nov-53 T R BOCH NITRO INDIVIDUALS Process Description For The Manufacture of 2,4,5-T in Department 57. 1511-8 Exhibit #P0069 PIN # Date Author Addressee Description 71223-66 03-Dec-53 L P HARICH ET AL NUMEROUS PERSONNEL Process Description for The Manufacture of Sodium 2,4,5-Trichlorophenate in Department 64 Building 51. Exhibit #P0070 PIN # Date Author Addressee 73930 07-Jan-54 J CRESCE BILLY HICKS ET AL & LISTED EMPLOYEES Description Memo notifying 32 workers that they will be layed off unless an adequate number of 2,4,5-T employees can be obtained. Exhibit #P0072 PIN # Date Author Addressee 75409-38 01-Dec-54 D P CLAYPOOL ET AL J CRESCE & C M EAKER R E HOWARD & VARIOUS OTHERS Description Final Report On 2-(2,4,5-Trichlorophenoxy) Propionic Acid dated 12/1/54. Exhibit #P0075 PIN # 74597- Date Author Addressee Description 05-Jul-55 MONSANTO CO UNKNOWN Numerous 2,4,5-T Butyl Ester Brush Killer Labels. ,, a r O IV. A. 103 Exhibit #P0076 PIN # Date Author Addressee Description 74530-91 05-Jul-55 COMPANY MONSANTO UNKNOWN 2,4,5-T Butyl Ester B.K. Registration No 524-83. Exhibit #P0082 PIN # Date Author Addressee Description 42170-73 18-NOV-55 L C WEGER SODEN, R & MCCLAIN, J R KELLY MD, R E Letter discussing in part psychoneurosis amongst Nitro workers dated 11/18/55. Exhibit #P0084 PIN # Date Author Addressee 21663-68 13-Dec-55 R A MURIE LESSLIE, T E SOLSTEN, R T & ROARK, J N & STEAHLEY, G W Description Method of analysis for 2,4,5-T BE Ester. Exhibit #P0086 PIN # Date Author Addressee 22986-87 16-Feb-56 R W WISE GEISMAN, R A & EDWARDS, P W LUECKE, C P & LESSLIE, T E Description Method of analysis for the purpose of determining sodium 2,4,5-T in 2,4,5-T acid. Exhibit #P0089 PIN # Date Author Addressee Description 73926 13-Apr-56 T R BOCH UNKNOWN Document lists total number of workers and number of chloracne cases since January 1953 in the Monsanto plant. Exhibit #P0090 PIN # Date Author Addressee Description 41652-42177 13-Apr-56 NONE NONE NONE Transcript of Workmens Compensation Hearing of Louis Hallman, individual injured in the Nitro incident in 1941. Exhibit #P0091 PIN # Date Author Addressee 5867-69 12-Jun-56 ELMER P WHEELER KELLY, R EMMET & NASON, H K SODEN, R E & WEGGER, L C Description Letter discusses meeting with German scientist, Dr. Oettel, wherein it was discussed that the Germans exposed in the 1953 Badische incident had similar symptoms as the Nitro workers, i.e., fatigue, vertigo, loss of libido, painful joints, etc. Exhibit #P0092 PIN # Date Author Addressee Description 75448-73 i 1 1 n,<; 11 -Sep-56 T E LESSLIE ET AL NUMEROUS MON. EMP. Study of prepn. of 2-butoxyethyl 2,4,5-trichlorophenoxyacetate from the reaction of sodium trichlorophenate with 2-butoxyethyl chloroacetate is described. tv a ins Exhibit #P0097 PIN # Date Author Addressee 77-80 03-May-57 J AND K H KIMMIG SCHULTZ LUECKE & SILVERSTEIN TRAPP & OTHER Description Rough draft translation "of the 1957 Kimmig and Schultz article. Exhibit #P0098 PIN # Date Author Addressee 65551 13-Jun-57 L P HARICH MCCLAIN, J R 5c LUECKE, C F CONWAY, C S 5= SHIFT FOREMAN Description Document indicates in part that the 2,4,5-T Plant had a crew of 5 men. Exhibit #P0101 PIN * Date Author Addressee Description 87829-Jul-57 C H BOEHRINCER SOHN DR. PRAHL Partial translation of letter from C.H. Boehringer Sohn, on Hooker Electrochemical Company stationery, which identifies Dioxin in Tri-Chlorophenol. Said document further discusses the properties of Dioxin. Exhibit #P0108 PIN # Date Author Addressee Description 71273-330 06-Feb-58 L P HARICH ET AL NUM. DEPTS. MONSANTO Standard Manufacturing Process for 2,4,5-T Acid, revised 11/24/53. Exhibit #P0114 PIN # Date Author Addressee Description 1836-1891 30-JuI-58 L HARICH NITRO RESEARCH ET AL PAPER DESCRIBES STANDARD MANUFACTURING PROCESS FOR SODIUM 2,4,5-TRICHL0R0PHENATE CONSISTS OF 56 PAGES IN DATA SHEETS, EXHIBITS AND APPENDICES. NOTED IN PAPER THAT SODIUM TCP PRODUCES A FORM OF DERMATITUS KNOWN AS CHLORACNE AND THAT CARE MUST BE TAKEN TO AVOID CONTACTING SOLUTION OR HOT VAPORS OF THE SOLUTION. ALSO NOTED AS A CORROSIVE MATERIAL. Exhibit #P0118 PIN # Date Author Addressee Description 73736 25-Mar-59 PAUL N BIVEN NONE Specifications for 2,4,5-T Acid. Exhibit #P0119 PIN # Date Author Addressee Description 73065 01-May-59 JOHN RODDY STARRETT ATTORNEY FROM WAUSAU INSURANCE COMPANY OF WISCONSIN REQUESTS INFORMATION REGARDING THE TOXICITY OF 2,4-D AND 2,4,5-T AS AN EMPLOYEE ALLEGED SPRAYING OF THESE CHEMICALS ADVERSELY AFFECTED HIM. REQUEST PERTAINS TO ANY DATA, PAMPHLETS OR OTHER REFERENCES REGARDING CHEMICALS AND THEIR EFFECTS ON HUMANS. Exhibit #P0120 PIN it Date Author Addressee Description 73063 06-May-59 J. Starrett Kelly & Olcott Zorsch Letter requested that letter of Roddy dated Dr. Kelly respond 01-May-59. to Exhibit #P0121 PIN it Date Author Addressee 73064 08-May-59 Emmett Kelly Roddy & Olcott Zorsch & Starrett Description Kelly responded that they had not been encountered any clinical evidence of injury to their employees. / Exhibit #P0122 PIN # Date Author Addressee Description 5695 12-May-59 L WEGER WHEELER Letter states that John Burton of Diamond Alkali had seen the article on chloracne by Kimming and Schultz while in Germany in Dermatologicia 1957. Weger stated that a translated copy will be available upon reques t . Exhibit #P0123 PIN # Date Author Addressee Description 0 01 -Jun-59 L WEGER WHEELER Letter confirms that Diamond Alkali is receipt of German Article on Choracne. in Exhibit #P0125 PIN # Date Author Addressee Description 5693 16-Jun-59 ELMER WHEELER WEGER Acknowledges receipt of German Article on Chloracne and translation acknowledges translation thereof, chlorinated dibensedioxine acknowledged as an important causing agent of the disorder. Exhibit #P0127 PIN # Date Author Addressee 33394 14-Aug-59 UNKNOWN BLAGG ET AL STUBBS & WORK COMP Description Letter attached to brief of Monsanto's regarding Workmen's Compensation cases of the 2,4,5-T manufacturers. / Exhibit #P0131 PIN # Date Author Addressee 2210-11 14-Jan-60 M A TERPSTRA BROWN, R T & CROUCH, J L GEISMAN, R A & HUBBARD, H L Description Document deals with what should be done with "off-quality" 2,4,5-T. Exhibit #P0133 PIN # Date Author Addressee Description 19470-475 23-Feb-60 G W OLSEN VARIOUS INDIVIDUALS & NITRO RESEARCH & GENERAL OFFICE OTHER Procedure to expand 2,4,5-T production capacity from 175,600 lbs. per month to 3.2 million lbs. per month. Exhibit #P0134 PIN # Date Author Addressee Description 18982-87 16-Mar-60 L C WEGER MILLER, R L & EKBERG, J B EDWARDS, P W & COHN, L A OTHERS Trip report to the Diamond Alkali Company for the purpose of investigating the 1960 Diamond Alkali incident. 15195 Exhibit #P0135 PIN * Date Author Addressee Description 18998 29-Mar-60 L P HARICH EDWARDS, P W & STEAHLY, G W WEGER, L C & HINCHCLIFF, W B GALLOWAY, H M Meeting recommendations resulting from Weger's investigation of the Diamon Alkali incident and what could be done to avoid a reoccurence. / Exhibit #P0136 PIN # Date Author Addressee 21377-79 27-Apr-60 D L MANSFIELD ROARK, J N & HINCHCLIFF, JR W B Description 2,4,5-Trichlorophenol-Sodium Salt assay procedure. Exhibit #P0138 PIN # Date Author Addressee Description 23156 23-May-60 UNKNOWN UNKNOWN VARIOUS EMPLOYEES Butyl 2,4,5-Trichlorophenoxyacetate specs. Exhibit #P0142 PIN # Date Author Addressee 76294-76350 06-Jul-60 L P HARICH ET AL TECHNCL SRVCS DEPT & PLANT MANAGER DIRECTOR OF MFG. ft DEPT. SUPERVISOR DEPT. FOREMAN ft NITRO RSRCH DPT LIBR Description Standard Manufacturing Process for Sodium 2,4,5-Trichlorophenate in Department 817.35, written July 6, 1960, supercedes Standard Manufacturing Process Manual prepared by L.P. Harich July 30, 1958. -j Ji. IV. A. 110 Exhibit #P0143 PIN # Date Author Addressee Description 5971 22-Jul-60 R EMMET KELLY MD WALLACE MD, RICH & WEGER, L C OTHER Document indicating that there was to be a meeting 8/4/60 with Dr. Oettel, Dr. Susskind, Mr. Wheeler, and Dr. Kelly for the purpose of updating Monsanto's information regarding the German experiences. Exhibit #P0146 PIN # Date Author Addressee Description 05024-41 12-Aug-60 B 0 SEVERSON THRODAHL, M C it ZERBE, R 0 STEAHLY, G W & EDWARDS, P W NITRO RSRCH LAB & OTHERS Report on the 245-T engineering study of continous acidification and recovery of TCP. Exhibit #P0147 PIN # Date Author Addressee Description 18967 13-Oct-60 G W OLSEN HARICH, L P & EDWARDS, R W COHN, L A & HINCHCLIFF, W B OTHERS The document refers to a progress report dated 10/13/60 and refers to the need for a capacity increase in the NaTCP plant within the next two years. Exhibit #P0148 PIN # Date Author Addressee Description 73773-77 01-Nov-60 UNKNOWN UNKNOWN FOR NITRO, W. VA Standard Manufacturing Process for 2,4,5-T Acid dated November 1960, Nitro, W. Va. Document includes section on current problems and refers to the "wild Sod TCP batch" incident in Building 41. Also refers to increased resistance from all plant personnel to work assignments in either the Sod. TCP or 2,4,5-T departments. Exhibit #P0149 PIN # Date Author Addressee Description 1407-08 01-Nov-60 NONE MAW UNKNOWN Document sets forth the analytical procedure in which one can determine the amount of TDD in 2,4,5-T. Exhibit #P0150 PIN # Date Author Addressee Description 23225-30 01-Jan-61 WILLIAM R UDELL BARKLEY, L B Progress Report from William R. Udell stating the need to find an economical route to 2,4,5-T Acid. Said document states project was initiated with the ultimate aim of reducing cost of manufacture of 2,4,5-T acid. Exhibit #P0153 PIN # Date Author Addressee 19530-34 03-Jan-61 M T WHITE JR COHN, L A & HINCHCLIFF, W B KELLOGG, W R & OLSEN, G W STEAHLY, G W & OTHERS Description Progress Report 2,4,5-T Capacity Increase dated January 3, 1961. IV. A. 112 Exhibit #P0155 PIN t Date Author Addressee Description 75773-77 28-Jun-61 FRED M YOUNGER MONSANTO CHEMICAL CO Study from Younger Laboratories of CP 18443-(2) - 0-Ethyl 0 - ( 2 ,4,5-trichlorophenyl) methylphosphonothionate, requested by Monsanto Chemical Company. Said study states that product was fed to Sprague-Dawley strain albino rats, male and female. Product was applied to New Zealan white rabbits, male and female. The compound was classed as highly toxic by oral ingestion in both female and male rats. Said document also states that compound was classed as highly to extremely toxic by skin absorption in female rabbits and compound was classed as highly toxic by skin absorption in male rabbits. Exhibit #P0156 PIN # Date Author Addressee 73908-09 28-Aug-61 C M RUSSELL STITES, J & ROARK, J W BARKLEY, L B & LUECKE, C F WEBBER, R T & OTHERS Description Letter from Russell providing stites with 2,4,5-T acid specifications. Exhibit #P0158 PIN # Date Author Addressee Description 51851-59 27-Nov-1 RESEARCH LAB DOW CHEMICAL UNKNOWN Results of 90-day Dietary Feeding Studies of Dowanol 97B Ester 2,4,5-T in Rats. IV. A.. 113 15200 Exhibit #P0159 PIN # Date Author Addressee Description 21391 13-Dec-61 C H RUSSELL ROARK, J N Separation and Identification of 2,4-D and 2,4,5-T Acid by Paper Chromatography. Exhibit #P0160 PIN # Date Author Addressee / 22268 01-Jan-62 A J BURNS ET AL STEPHENS, J A & LUECKE, C F RUSSELL, C H & COPANAS, F W WISE, W R fit KOLLOFF, R H Description The Analysis of Sodium 2,4,5-Trichlorophenate by Gas Liquid Chromatography. Exhibit #P0164 PIN # Date Author Addressee Description M 0 148 05-Apr-62 R EMMET KELLY MD EDWARDS, PAUL W Document discusses the general disregard of worker hygiene. Document also discusses medical implications which might occur as a result of same. Exhibit #P0165 PIN # Date Author Addressee 828 1O-May-62 F M CALKINS WEBBER, R T & LUECKE, C F HINCHCLIFF, W & HARICH, L P STICKLEY, J F & NUMEROUS OTHERS Description DEVELOP NEW CAPITAL REQUIREMENTS, CAPACITY, AND MANUFACTURING COST DATA FOR 2,4,5-T. ESTER MANUFACTURE IN THE BUILDING 46 AVADEX EQUIPMENT. oi Ani Exhibit #P0167 PIN # Date Author Addressee Description 73068 15-May-62 L EDWARD GAUL MD MONSANTO CHEMICAL CO Letter dated May 15, 1962 from Dr. L. Edward Gaul to Monsanto Chemical Company. Said document states patient complained after using Brush Killer, 2,4-D, 2,4,5-T. Exhibit #P0168 PIN # Date Author Addressee Description 21544 29-May-62 C H RUSSELL ROARK, J K & LUECKE, C F COPON??, ? W Russell's letter to Roark in which Dow's infrared method for analyzing 2,4,5-T was discussed. Exhibit #P0169 PIN # Date Author Addressee 62976-90 01-Jun-62 F B MATTHEWS ET AL LUECKE, C F & KUHN, W A MATTHEWS, F B & ST LOUIS RESEARCH VITAL RECORDS CNTR & VARIOUS OTHERS Description Process Description for the Manufacture of Isobutyl 2,4,5-T in Dept. 268. Exhibit #P0170 PIN # Date Author Addressee 62926-54 01-Jun-62 F B MATTHEWS ET AL LUECKE, C F & KUHN, W A RUMER, R R & MATTHEWS, F B VITAL RCRDS CNTR St VARIOUS OTHERS Description Process Description for the Manufacture of Butyl 2,4,5-T in Dept. 268 (894.12) (June, 1962) . Exhibit #P0172 PIN # Date Author Addressee Description 24598-24642 26-Jun-62 J T PEBWORTH UNKNOWN Standard Manufacturing Process for Sodium 2,4,5-Trichlorophenate in Department 895.06. Standard Manufacturing Process Manual prepared by L s F . Harich, July 6, 1960, revised June 26, 1962 by J.T. Pebworth. Document states the Sodium TCP solution produced contains chemical compounds known as "chloracnegens." Exhibit #P0173 PIN # Date Author Addressee Description 76236-41 26-Jun-62 J T PEBWORTH UNKNOWN Standard Manufacturing Process For Sodium 2,4,5-Trichlorophenate In Department 895.06 dated June 26, 1962, revises Standard Manufacturing Process Manual prepared by L.P. Harich dated July 6, 1960. Exhibit #P0174 PIN # Date Author Addressee 1778-1835 26-Jun-62 J T PEBWORTH DEPT. SUPERVISOR & DEPT. FOREMAN TECHNICAL SRVCS LIBR & VARIOUS OTHERS Description Standard Manufacturing Process for Sodium2, 4 ,5-Trichlorophenate In Department 895.06, revises Standard Manufacturing Process Manusl prepared by L.P. Harich July 6, 1960. f,T V A 1 1 152uo Exhibit #P0176 PIN * Date Author Addressee 76242-93 01-Jul-62 J T PEBWORTH PROD. SUPERVISOR & PRODUCTION FOREMAN TECHNICAL SRVS DEPT. ft NITRO RSRCH LIBRARY DIRECTOR OF MFG. Ft OTHERS Description Standard Manufacturing Process for 2,4,5-T Acid Department 57./ Exhibit #P0177 PIN # Date Author Addressee Description 24664-714 01-Jul-62 J T PEBWORTH UNKNOWN Standard Manufacturing Process for 2,4,5-T Acid in Nitro Dept. 57. Includes finished product specifications, physical constants data, and matters relating to safety and toxicity. Exhibit #P0179 PIN # Date Author Addressee Description 74217-19 02-Aug-62 G ROBERT SIDO LABELING FILE Letter from Sido about 2,4,5-T Amine Brush Killer labels. Exhibit #P0192 PIN # Date Author Addressee Description 32308 02-Jan-63 H E WEBB JR BOWLES, P N Employee discussed was R.E. Adkins in regard to award being high considering alleged degree of disability. Webb inclined to leave award as is. the Exhibit #PO195 PIN # Date Author Addressee 24660-61 14-Jan-63 J T PEBWORTH EDWARDS, P. W. ft COPANAS, F. W. GORDON, R. S. ft STEPHENS, J. A. SOLSTEN, R. T. * OTHERS Description Tentative Amendment F to Standard Manufacturing Process for 2,4,5-T Acid contains an objective permitting the use of spent acid from the TCP recovery step. Exhibit #P0197 PIN # Date Author Addressee 24658-59 23-Jan-63 J T PEBWORTH EDWARDS. P. W. ft COPANAS, F. W. RUMER, R. R. ft GORDON, R. S. STEPHENS, J. A. ft OTHERS Description Tentative Amendment G to Standard Manufacturing Process for 2,4,5-T Acid with objective of permitting the use of acid filtrate to partially acidify the TCP in the recovery step. The proposal calls for a 60 day test period. Exhibit #P0198 PIN # Date Author Addressee 73051 29-Jan-63 R EMMET KELLY MD BAVER D R . , L D & HANNAH, L H Description Document discusses pentachlorophenol causing chloracne in Europe and reports of acute intoxication with reports of death using pentachlorophenol in Borneo as well as France and Mexico. Exhibit #P0200 PIN # Date Author Addressee Description 247-48 08-Feb-63 C RUSSELL ARVAN Document acknowledges that Russell worked out tentative specifications for the Government. A meeting was to be held with Mr. Pearson on February 18, 1963. 15205 Exhibit #P0202 PIN # Date Author Addressee 241-43 22-Feb-63 C H RUSSELL HOFFMAN, DR & ARVAN DR., P G DANIELS, S D & KUHN, W A LUECKE, C F & MATTHEWS Description 2/8/63 meeting, Russell & Bourland, U.S. Army Biological Laboratories. Purpose was to satisfy U.S. Army about specs & physical properties on next type of blend they will be purchasing, normal butyl D and normal butyl T. Exhibit #P0238 PIN # Date Author Addressee 21754-55 09-Jul-63 R KOLLOFF ROARK, J & COPANAS CANOBEKK & KUECKE RUSSELL & STEPHENS, JA Description GLC Analysis of 2,4,5-TCP & 2,4,5-T acid. Exhibit #P0245 PIN # Date Author Addressee 63998-64076 01-Aug-63 R A VODER WEBBER, R. T. ft YODER, R. A. LUECKE, C. F. & PEBWORTH, J. T. STEPHENS, J. H. ft OTHERS Description 2,4,5-T plant expansion at Nitro BLdg. 92 is the subject of this document. The document addresses the need for a major increase in production of 2,4,5-T for a month. Exhibit #P0249 PIN * Date Author Addressee Description ILLEGIBLE 04-Oct-63 UNKNOWN UNKNOWN 1KO r J *' - UNKNOWN Product label registration record for 2 ,4-D/2,4,5-T Butyl Ester Brush Killer. Exhibit #P0250 PIN # Date Author Addressee 18782-83 1O-Oct-63 P W EDWARD DIR OF MFG & COVERT, M. C. EDWARDS, P. W. & RUMER, R. R. LUECKE, C. F. ft OTHERS Description Document makes rfrenc to a request for agitation in NaTCP storage tank for the purpose of keeping undissolved salts in suspension, thereby eliminating problems of cleaning out accumulated salts and inaccurate inventory of NaTCP. Exhibit #P0252 PIN # Date Author Addressee 24654-57 05-Nov-63 F M CALKINS STEPHENS J. A. COPANAS, F. W. EDWARDS, P. W. & PEBWORTH, J. T & SPEZIALE, A. J Ft UNKNOWN OTHERS Description Tentative Amendment H to Standard Manufacturing Process for 2,4,5-T Acid with objective of exploring effect on 2,4,5-T yield, quality, and cost of the condensation reactor variables. Exhibit #P0254 PIN # Date Author Addressee 65436 25-Nov-63 F W COPANAS CALKINS, F. M. & PEBWORTH, J. T. LUECKE, C. F. & EDWARDS, P. W. HINCHCLIFF, W. B. Ft OTHERS Description Document advising that there is 200,000 lbs. of "out of spec" 2,4,5-T. 15207 Exhibit #P0258 PIN # Date Author Addressee 004756-85 1O-Dec-63 W R UDELL SPEZIALE, A. J. St WALDO, W. H. STEPHENS, J. A. & CONNAUGHTON, J. M. LUECKE, C. F. & OTHERS Description Literature survey-review of 2,4,5-T Acid process includes physical constants data of 12/10/63 for 2,4,5-T and NaTCP. Exhibit #P0259 PIN # Date Author Addressee Description 65437-38 11-Dec-63 M T WHITE LUECKE, C. F. h EDWARDS. P. W. KELLOGG, W. R. h PEBWORTH, J. T. CALKINS, F. M. & OTHERS It is proposed that 200,000 lbs. of out-of-spec. 2,4,5-T be reworked in the old 2,4,5-T Dept, in Bldg. 34. Exhibit #P0260 PIN # Date Author Addressee 7421 1 18-Dec-63 G R SIDO LABELING FILE & HOFFMAN, RUSSELL, C. H. & SAMAHA, P. R. D. Description Document confirming conversation with Russell and Hoffman regarding text of label for 2 ,4-D/2,4,5-T Amine Brush Killer (USDA Registration 524-99 dated 12/16/57). Exhibit #P0264 PIN t Date Author Addressee Description ILLEGIBLE 15-Jan-64 UNKNOWN UNKNOWN UNKNOWN Product Label Registration Record for 2.4.5- T Butyl Ester Brush Killer, consisting of 37.5% isobutyl ester of 2.4.5-T trichlorophenoxyacetic acid, 15.3 % n-Butyl ester of 2.4.5-Trichlorophenoxyacetic acid, and 47.2 % inert ingredients. Exhibit #P0265 PIN # Date Author Addressee Description 054547 15-Jan-64 UNKNOWN UNKNOWN UNKNOWN PRODUCT LABEL REGISTRATION RECORD FOR 2,4,5-T ACID REPLACES RECORD OF OCT 1963. / Exhibit #P0266 PIN # Date Author Addressee Description 054549 15-Jan-64 UNKNOWN UNKNOWN UNKNOWN PRODUCT LABEL REGISTRATION RECORD FOR 2,4,5-T AMINE BRUSH KILLER REPLACES RECORD OF OCT 1963. Exhibit #P0267 PIN # Date Author Addressee Description ILLEGIBLE 15-Jan-64 UNKNOWN UNKNOWN UNKNOWN PRODUCT LABEL REGISTRATION RECORD FOR BRUSH-O-CIDE BRUSH KILLER REPLACES RECORD OF OCT 1983. BRUSH-O-CIDE'S ACTIVE INGREDIENTS INCLUDE 46.6% ISOOCTYL ESTER OF 2,4-DICHL0R0PHEN0XYACETIC ACID AND 44.5% ISOOCTYL ESTER OF TRICHLOROPHENOXYACETIC ACID, WITH 8.9% OF THE PRODUCT CONSISTING OF INERT INGREDIENTS. Exhibit #P0268 PIN # Date Author Addressee Description 054554 15-Jan-64 UNKNOWN UNKNOWN PRODUCT LABEL REGISTRATION RECORD FOR BRUSH-BLITZ BRUSH KILLER REPLACES RECORD OF OCT 1963. 88% OF INGREDIENTS IN BRUSH-BLITZBRUSH-BLITZ IS AN ISOOCTYL ESTER OF 2,4,5-TRICHLORO-PHENOXYACETIC ACID AND 12% INERT INGREDIENTS. 19PQ X o f*!v ^ Exhibit #P0269 PIN # Date Author Addressee 21697 29-Jan-64 C H RUSSELL ROARK, J. N. * LUECKE, C. F. HOFFMAN, P. F. ft CONNAUGHTON, J. M. Description RUSSELL SENDING J.N. ROARK AT NITRO A SAMPLE OF 2,4,5-T ACID MADE BY HERCULES BECAUSE MONSANTO IS CONSIDERING PURCHASING SOME TO MAKE UP FOR DEFICIENCIES DUE TO DIFFICULTIES AT NITRO. RUSSELL ASKED THAT THE 2,4,5-T ACID BE ASSAYED USING "OUR TRADITIONAL METHODS" AND STRESSES THAT THE REQUEST IS URGENT. Exhibit #P0270 PIN # Date Author Addressee Description 21695 07-Feb-64 J N ROARK RUSSELL, C. H. & CONNAUGHTON, J. M. RINCHELIFF, W. B. ft HOFFMAN, P. F. LUECKE, C, F. ANALYSIS OF HERCULES 2,4,5-T ACID SAMPLE #B-1-12464 SHOWS LEVELS OF 1.3% TCP AND 90.3% 2,4,5-T AS COMPARED WITH .2% TCP AND 93.4% 2,4,5-T BEING TYPICAL IN MONSANTO'S PRODUCT." "THERE IS A CONSIDERABLE AMOUNT OF LUMPY MATERIAL IN THIS PRODUCT, CECIL." Exhibit #P0283 PIN # Date Author Addressee Description 64955-65037 01-Apr-64 L E DOTSON UNKNOWN SECTIONS OMITTED INCLUDE: 10) OPERATION OF T-ACID RECOVERY SYSTEMS; 2) DETAILED OPERATIONS FOR TCP RECOVERY SYSTEM; AND 3) DETAILED OPERATIONS FOR T-ACID RECOVERY SYSTEM. ALSO, PART OF SECTION ENTITLED, OPERATION OF TCP RECOVERY SYSTEM, IS OMITTED. THE AFOREMENTIONED WAS INADVERTENTLY NOT SUPPLIED TO PLAINTIFFS BY DEFENDANTS. 15210, 5 Exhibit *P0286 PIN # Date Author Addressee Description 21987 14-Apr-64 F L RUPEL RUSSELL, C. H. Sc LUECKE, C. F. CONNAUGHTON, J. M. ft ROARK, J. N. STEPHENS, J. A. Document Lists an analysis of Dow's 2,4,5-T. Exhibit #P0291 PIN t Date Author Addressee 010667 01-May-64 CHARLES P ZORSCH DEF FUEL SUPP CENT Sc FILE Description Document describes modifications of Agent Orange specifications. Exhibit #P0292 PIN # Date Author Addressee 21385 13-May-64 D L MANSFIELD RUMER, R. R. & RUSSELL, C. H. ROARK, J. N. Sc CONNAUGHTON, J. M. KELLOGG, W. R. ft OTHERS Description Document discusses need to recover 2,4,5-T in Nitro's production process. It is estimated that approximately 1,000/lbs per day was being lost. Exhibit #P0295 PIN # Date Author Addressee Description 055514 28-May-64 ILLEGIBLE ILLEGIBLE RESEARCH NOTES USEFULNESS OF RESEARCH NOTES SHOWING ANALYSIS OF 2,4,5-T IS UNCLEAR. 1521 1n / t Exhibit #P0300 PIN # Date Author Addressee 010782-83 04-Jun-64 G F LUECKE PAYTON ft HOFFMAN, P. F. KAMENKO ft CONNAUGHTON, J. M. Description Document advises that Hooker does not have TCB and cannot comply with their old schedule of production. Exhibit #P0302 PIN # Date Author Addressee 010784 05-Jun-64 CARL SCHUMACHER TIPPEE, H. W. ft HOFFMAN, P. F. LUECKE, C. F. ft ZORSCH, C. P. DYKSTRA, R. A. & OTHERS Description BOB DYKSTRA CALLED SCHUMACHER AND SAID HE COULD BEGIN PRODUCING 2,4,5-T ESTERS FOR MONSANTO ON A FIVE DAY A WEEK BASIS STARTING JUNE 11. Exhibit Exhibit JP0307 PIN # Date Author Addressee 010683-84 25-Jun-64 C P ZORSCH FILE ft SCHUMACHER, C. P. LUECKE, C. F. ft HOFFMAN, P. F. MCCARVILLE, W. J. ft OTHERS Description Contract for Governmental purchase of 48,950 gallons of a product containing 50% 2,4-D N-Butyl Ester; 30% 2,4,5-T N-Butyl Ester; and 20% 2,4,5-T Iso-Butyl Ester. Exhibit #P0315 PIN # Date Author Addressee Description 008255-57 01-Aug-64 UNKNOWN UNKNOWN UNKNOWN Label for 2,4,5-T acid. Exhibit *P0316 PIN # Date Author Addressee ILLEGIBLE 12-Aug-64 UNKNOWN UNKNOWN KRUMMRICH PLANT ^ & OTHERS UNKNOWN Description GAS-LIQUID CHROMATOGRAPHIC PROCEDURE FOR DETERMINING THE COMPOSITION OF THE ESTER ALONE OR IN A MIXTURE WITH ONE OR MORE OF THE ESTERS. Exhibit #P0324 PIN # Date Author Addressee 046115-21 01-Oct-64 R M DICKEY COLLERAN, W. E. ft COMERFORD, EASLEY, K. W. & EBY, C. J. LINXWEILER, T. G. ft OTHERS D. G. Description DEFOLIANT SYNTHESIS MODIFICATION NO.3 TO CONTRACT NO. DA18-0648.064.A M C .69(A). Exhibit #P0327 PIN # Date Author Addressee Description 2623-26 20-Oct-64 FRED YOUNGER MONSANTO Study performed by the Younger Lab regarding the toxic effects of TCP Distillation Residue. Study dealt with rabbits and it was discovered that four of the six tested died within 4-8 weeks. Jaundiced livers were noted as well as renal congestion. 15213 Exhibit #P0329 PIN # Date Author Addressee 73242-73249 22-Oct-64 WILLIAM H HUNT PHD STEPHENS, J A & LUECKE, C F UDELL, W R & NUMEROUS OTHERS Description Circulation of study referred to in document #2700, the rabbit study done by the Younger Lab showing their death when exposed to TCP distillation residue. Document also contains a comparison chart to other compounds. Exhibit #P0332 PIN # Date Author Addressee Description 460 24-Nov-64 C H RUSSELL CARTY, C W & ZORSCH, CP HOFFMAN, P F Document whereby Russell informs the Army that the Government specs are identical to Monsanto's "official specification". Exhibit #P0349 PIN # Date Author Addressee 20696 06-Jan-65 J STRUM SPRINGGATE & KELLOGG HAMILTON & BRICK SOLSTEN & PRITCHARD ET AL Description PROGRESS REPORT ON ATTEMPT TO INCREASE NITRO PLANT CAPACITY OF PRODUCTION OF 2,4,5-T FROM 400,000 LBS. PER MONTH TO 500,000 LBS. PER MONTH TO MEET SALES COMMITMENTS. RECOMMENDATION OF INSTALLATION OF A SURGE HOPPER AND A VARIABLE-SPEED FEEDER TO ELIMINATE PROCESS DOWNTIME. 152:& Exhibit #P0350 PIN # Date Author Addressee Description 9815-9816 08-Jan-65 UNKNOWN UNKNOWN COMMANDER & DEFENSE GENERAL & SUPPLY CENTER CONFIDENTIAL MESSAGE ON FORM TO COMMANDER OF DEFENSE GENERAL SUPPLY CENTER IN RICHMOND, VA. MESSAGE SETS FORTH PURITY LEVELS FOR A 50/50 BLEND OF 2,4-D AND 2,4,5-T, DATE OF DELIVERY, AMOUNTS, PRICES. Exhibit #P0377 PIN # Date Author Addressee 5972-73 24-Feb-65 R EMMET KELLY MD FILE & WHEELER E P Description Memo of conversation between Kelly and Roe whereby Kelly was advised that the contaminant in 2,4,5-T was dioxin. Exhibit #P0392 PIN # Date Author Addressee Description 000229 11-Mar-65 CARL SCHUMACHER HOSTETTER COVER LETTER AND MEMO REGARDING GOVERNMENT BIDS FOR 50/50 2,4 D AND 2,4,5 T BLENDS AND MOSANTO'S POSITION REGARDING ACCEPTANCE OF BIDS BASED ON SUCH VOLUME. Exhibit #P0396 PIN # Date Author Addressee 73255 17-Mar-65 EMMETT KELLY STEPHENS & HOFFMAN Description Warning letter regarding 2,3,7,8tetrachlorodibenzyl- dioxin received from the DOW CHEMICAL COMPANY. Therein it is claimed that DOW had thought it to be the "... most toxic compound they have ever ^ experienced." ,, ,, T T 7 1 <"t1 Exhibit #P0419 PIN # Date Author Addressee 72054 30-Mar-65 EMMETT KELLY HOFFMAN & ARVAN DUNLAP 5c RUMER Description LETTER DESCRIBES MEETING BETWEEN DOW, HOOKER, DIAMOND, HERCULES AND OTHERS OF REGARDING THE CONTENT OF DIOXIN IN DOW'S 2,4,5-T ACID. AUTHOR AGREES THAT DIOXANE IS "... A POTENT CONTAMINANT." ALSO THAT "...IT CAN BE A POTENT CARCINOGEN." HE ALSO VOICED CONCERN ABOUT ANOTHER EPIDEMIC OCCURRING AT NITRO. Exhibit #P0422 PIN # Date Author Addressee Description 5983 01 -Apr-65 E WHELLER FRAWLEY COVER LETTER ENCLOSING ARTICLE ENTITLED "OCCUPATIONAL ACNE" BY KIMMING AND SCHULTZ. AND OTHER FILES ON THE SUBJECT IN CONTROL OF AUTHOR. Exhibit #P0439 PIN # Date Author Addressee Description 20824-20828 07-Jun-65 R NULL SPRINGGATE, ET AL PROGRESS REPORT ON 2,4,5-T TO NITRO PLANT OFFICIALS AND OTHERS REGARDING RIGID QUALITY IMPROVEMENT. PROGRAM. Exhibit #P0456 PIN # Date Author Addressee Description 75614-75635 13-Sep-65 S NORBERT SIDE ROBERT ELKINS 5c JACKSON KELLY 5c HOLT O 'FARRELL COVER LETTER REGARDING WARNING LABELS TO BE AFFIXED ON PRODUCT FOR WEED 5c BRUSH CONTROL THAT CONTAIN 2,4-D AND 2,4,5-T. Exhibit #P0458 PIN # Date Author Addressee 1564-1569 14-Sep-65 W UDELL TAKE & DUNLAP STEPHENS & SHARP Description MEMO FROM AGRICULTURAL RESEARCH-ST. LOUIS TO NITRO PLANT REGARDING FORMATION AND CONCENTRATION OF TDD WITH ATTACHED GRAPHS. MEMO NOTES RECENT INCREASE IN TDD FORMATION AND STATES THAT A DETAILED LABORATORY STUDY IS IN THE PLANNING STAGES AND SHOULD REVEAL REASONS FOR RECENT INCREASES IN FORMATION. Exhibit #P0468 PIN # Date Author Addressee 8223-8226 22-Dec-65 ROBERT BRANDON KUHN & LANDWEHR TRAIL & TAKE Description MEMO REGARDING VIABILITY OF EXPANDING THE NITRO 2,4,5-T PLANT. SEEK ADDITIONAL TESTING TO BE DONE IN ORDER TO DETERMINE THE EFFECT OF PARTICLES IN AIR LEAVING THE DRYING SYSTEM. Exhibit #P0470 PIN # Date Author Addressee Description 76884-76888 30-Dec-65 L DOTSON UNKNOWN MANUFACTURING AND PROCESS DATA REGARDING TOXICITY OF 2,4,5-T WITH ATTACHED CHARTS AND GRIDS. WARNING THAT EXTREME CARE MUST BE USED IN HANDLING THE COMPOUND BECAUSE OF ITS TOXICITY AND CONTAINMENT OF CHLOROACNEGEN AGENTS. Exhibit #P0471 PIN * Date Author Addressee Description 1402 30-Dec-65 L DOTSON PROCESS BRIEF Document displays process of T and further indicates that the raw materials and final product are toxic. / Exhibit #P0472 PIN # Date Author Addressee Description 63212-66 01-Jan-66 D R MIDDLETON LUECKE, C F & STEPHENS, J A ARMSTRONG, D C & LEISY, A E ROBIRDS, W R Sc OTHERS Standard Manufacturing Process For ISO OCTYL 2,4-D ISO OCTYL 2,4,5-T, dated 11/69 Exhibit #P0476 PIN # Date Author Addressee Description 21396 04-Jan-66 M A WILLIAMS ROARK, J N & DOTSON, L E KELLOGG, W R Sc STRUM, J C TAKE, E F Document indicates that in 12/65 all time production record 571,220 lbs. were achieved. Previous operating conditions called for less than recent production, which may account for poor quality. Exhibit #P0478 PIN # Date Author Addressee 5996 13-Feb-66 CARL BOHL FILE St MED DEPT Description 2,4,5-T PLANT MEDICAL DEPARTMENT MEMO FROM CARL BOHL, INDUSTRIAL HYGIENIST, REGARDING REMOVAL OF TOXIC MATERIAL TDD FROM THE FINAL PRODUCT. STATES THAT MR. RHODES SUGGESTED TWO APPROACHES; ADD METHANOL SODIUM HYDROXIDE UNDER PRESSURE AND, SECONDLY, CLOSE CONTROL OF THE TEMPERATURE IN THE REACTOR. Exhibit #P0488 PIN # Date Author Addressee Description 2081 5 22-Apr-66 J C STRUM FILE & SPRINGGATE, J E RHODES, V L & TAKE, E F OTHERS Late 1965 production increase of more than 25% in the T Plant without major equipment revisions. / Exhibit #P0495 PIN # Date Author Addressee 22362 23-Jun-66 F L RPEL JR RUSSELL, G H & OUTRIGHT, RHODES, V L & BOLLINGER, EA PG Description Document lists analysis of Dow's dried 2,4,5-T. Exhibit #P0499 PIN # Date Author Addressee 1560 11-Jul-66 W R UDELL BOLLINGER, F G & BALDERSON, SHARP, D B & STEPHENS, J A PB Description Letter from Udell to the aforementioned addressees which enclosed GLC procedure to detect TDD in T. Document also indicates that the samples are highly toxic. Exhibit #P0502 PIN # Date Author Addressee Description 1487 22-Jul-66 F L RUPEL JR CUTWRIGHT, E A & BALDERSON, P B RUSSELL, C M & STEPHENS, J A UDELL, W R Analysis of 1966 2,4,5-T reaching as high as 28ppm. Document also indicates that the "typical values should range between 5 to 18ppm." Exhibit #P0507 PIN # Date Author Addressee Description 1179-81 11-Aug-66 J C STRUM SPRINGGATE, J E & CUTWRIGHT, E A RHODES, V L & NUMEROUS OTHERS / Document states that TDD is a toxic material and is contained in NaTCP, recovered TCP and dry 2,4,5-T . Exhibit #P0549 PIN # Date Author Addressee 1697-1770 01-Dec-66 L E AND V L DOTSON RHODES LUECKE, C F & CUTWRIGHT, E A RHODES, V L & STEPHENS, J A DUNLAP, W P & OTHERS Description Standard Manufacturing for 2,4,5-Trichlorophenoxyacetic Acid, revised November 1966, issued December 1966. Exhibit #P0586 PIN # Date Author Addressee 5993 23-Feb-67 CARL D BOHL WHEELER, ELMER P & KELLY, R E Description Document discusses February 22, 1967 meeting between Stephens, Udell, Sharp and Bohl regarding Dioxin. Document also refers to contamination levels between 10 and 30ppm. The group decided that they needed animal testing so that they could gain further information. Said testing was discussed and Kelly was apprised. Exhibit #P0592 PIN # Date Author Addressee Description 5995 01-Mar-67 ELMER P WHEELER DUNLAP, W P & BOHL, C D KELLY, R E The document addresses the fact that V. K. Rowe "opened the can of worms" on the 2,4,5-T situation. /Indicated further is the fact that Dow isolated tetrachlordiphenylen-dioxyd. Also, Rowe indicated that the materials were so potent that putting it on the skin of an animal regardless of location resulted in a "positive" response. Exhibit #P0593 PIN # Date Author Addressee Description 5994 06-Mar-67 CARL D BOHL KELLY, R E & SPRINGGATE, J E CUTRIGHT, E A & STEPHENS, J A DUNLAP, W P Report Bohl's trip to Nitro on 2/27/67 and 2/28/67. Document further indicated that TDD is created in hold cycle of TCP Process. Cutright suggested either a cutdown of hold time or a cutdown in charge time in order to significantly reduce TDD in the final product. Exhibit #P0595 PIN # Date Author Addressee 1296 09-Mar-67 PETER M HOWELL SPRINGGATE, J & KELLOGG, RHODES, V L & OTHERS WR Description Document indicates that personnel exposed to 2,4,5-T dust constituted a serious hazard. Exhibit #P0596 PIN # Date Author Addressee Description 681-84 16-Mar-67 COMPANY DEF GEN SUP MONSANTO Production and Forecast of D and T for 1966 and 1967. / Exhibit #P0606 PIN # Date Author Addressee 1145 03-Apr-67 UNKNOWN PMH WRK & BFP VLR & HAD EAC & JES Description AUTHORIZATION FOR EXPENDITURE FOR THE NITRO PLANT TO INSTALL 2,4,5-T AUTOCLAVE SAMPLERS AS IT IS NOTED THAT THE EXISTING SAMPLER IS CONSTITUTES A SEVERE EXPOSURE HAZARD. Exhibit #P0631 PIN # Date Author Addressee Description 1495 12-Jun-67 P B BALDERSON RHODES, V L Document indicates TDD levels as of 6/12/67 as high as 24ppm. Exhibit #P0637 PIN # Date Author Addressee Description 8938-8960 30-Jun-67 UNKNOWN UNKNOWN COVER LETTER OVER GOVERNMENT DOCUMENTS DELINIATING REQUIREMENTS FOR BIDS ON DEFOLIANT; ORANGE, ORANGE II, AND ORANGE III. T V A 1 ' R 15 9/ss* Exhibit #P0639 PIN # Date Author Addressee 40421 05-Jul-67 UNKNOWN UNKNOWN TSD FILE & RHODES, V L Description Document indicates that exact hold periods are necessary in order to reduce the personnel exposure problem in 2,4,5-T. Manual control varies as much as 30 minutes. Exhibit #P0651 PIN # Date Author Addressee Description 73288-73307 23-Aug-67 UNKNOWN UNKNOWN NONE List of equipment used in the manufacturer of 2,4,5-T. Exhibit #P0652 PIN # Date Author Addressee 1451 24-Aug-67 VERNE L RHODES WOODS, W. C. h OUTRIGHT, E. A. DOLIN, OWEN & MILLER, H. K. Description ANALYSIS OF CONTROL SAMPLES FOR TDD IN NATCP. Exhibit #P0665 PIN # Date Author Addressee Description 1436 08-Sep-67 JR Q C LAB UNKOWN Analysis of T dated 09-08-67 with readings as high as 22 ppm. Exhibit #P0676 PIN # Date Author Addressee Description 1432 06-Oct-67 JMS Q C LAB UNKNOWN Analysis of 2-4-5-T for TDD with readings as high as 25ppm. / Exhibit #P0679 PIN # Date Author Addressee Description 206-207 11-Oct-67 C H RUSSELL ZORCH, C.P. & CAYARD,D .B . STEPHENS, J .A. h FISCHER, D.R. OTHERS Letter discusses a meeting in Washington which addressed the issue of what analysis of the esters was being performed. Russell also admits that it was he who wrote the n-butyl D, T, and Orange specifications. Exhibit #P0681 PIN # Date Author Addressee 84-85 13-Oct-67 C H RUSSELL WISWESSER, W J & CAYARD, D E STEPHENS, J A 6c ZORSCH, C P Description Letter setting forth the fact that it was Russell who worked on writing the military specifications. Exhibit #P0682 PIN # Date Author Addressee Description 86 16-Oct-67 C H RUSSELL WISWESSER, W J & CAYARD, D E CONNAUGHTOU, J M & HOFF, D N ZORSCH, C P Document indicating that Monsanto was opposed to having the free acid specification reduced from 1% to .5%. eo X3-=' Exhibit #P0689 PIN # Date Author Addressee Description 1426 06-Nov-67 C R Q C LAB UNKNOWN Analysis of 2,4,5-T by C.R. dated 11/6/67 for TDD with readings at 25ppm. Exhibit #P0690 PIN # Date Author Addressee 1485 07-Nov-67 W C WOODS RHODES, V L & OUTRIGHT, DOLIN, 0 E & BALDERSON, EA PB Description Analysis of TDD, 25ppm as one of the readings. Exhibit #P0704 PIN # Date Author Addressee 21403 13-Dec-67 W C WOODS DOLIN, 0 & OUTRIGHT, E A RHODES, V L & KELLOG, W R Description Document indicated that cost savings was more important than safety of product. Exhibit #P0709 PIN # 68 Date Author Addressee 28-Dec-67 C H RUSSELL MIDDLETON, D R & ZORSCH, C P OARTY, CARL W & WISWESSER, W J Description Document requesting modification of proposed military specification. Said document outlines numerous requests for change in said specification. Exhibit #P0713 PIN # Date Author Addressee 66038 01-Jan-68 V RHODES OUTRIGHT & ATKINSON DOLIN & KELLOGG Description REQUEST TO ANALYZE AND COMPARE PURCHASED NaTCP WITH NITRO PRODUCT. SERVICE REQUEST STATES THAT NaTCP STEP IS LIMITING PRODUCTION OF 2,4,5-T ACID AND DOWNTIME RE SULTS IN LOST PRODUCTIVITY. Exhibit #P0726 PIN t Date Author Addressee Description 53636 25-Jan-68 UNKNOWN UNKNOWN UNKNOWN DOCUMENT INDICATES THAT WELDON SPRINGS PROBABLY COULD PROBABLY NOT FUNCTION AFTER THE WAR IF MONSANTO WERE TO BUILD A NEW PLANT. MONSANTO MUST IMPROVE COSTS OR WELDON SPRINGS COULD "RUN THEM OUT".WELDON SPRINGS PROBABLY CAN'T RUN AFTER WAR IF MONSANTO BUILDS NEW D PLANT. MONSANTO MUST IMPROVE COST OR WELSON SPRINGS COULD RUN THEM OUT. Exhibit #P0732 PIN # Date Author Addressee Description 11112-11114 30-Jan-68 GEORGE KEMPSON BARTLETT DISCUSSION OF MONSANTO'S OBJECTION TO SPECIFICATIONS REGARDING THE CONTENT OF ORANGE FSC 684Q. Exhibit #P0741 PIN * Date Author Addressee Description 11165-11166 23-Feb-63 UNKNOWN DOCUMENT CONTAINS INFRARED METHOD FOR ANALYZING ORANGE HERBICIDE. / Exhibit #P0742 PIN # Date Author Addressee Description 8893-8948 23-Feb-68 UNKNOWN UNKNOWN UNKNOWN PURCHASE DESCRIPTION FOR HERBICIDE-ORANGE WHICH SETS FORTH REQUIREMENTS AND DELINIATES QUALITY ASSURANCE PROVISIONS. Exhibit #P0750 PIN # Date Author Addressee Description 53773-53781 01-Mar-68 CHARLES ZORSCH ROY MEYERS DOCUMENT IS A NINE PAGE PERFORMANCE SUMMARY FOR DEFENSE CONTRACT FOR ORANGE BEGINNING 6/1/67 THROUGH 2/29/68 PREPARED BY MONSANTO. Exhibit #P0763 PIN # Date Author Addressee 74220-74221 23-Apr-68 LARITA IVES VIRGINIA KOENIG & J J JURKIEWICZ Description MEMO CONCERNING LISTED LABELS AND NOTATION OF WHERE STOCK IS LOCATED AND QUANTITY OF KNOWN STOCK. Exhibit #P0769 PIN # Date Author Addressee Description 160-65 1O-May-68 C P ZORSCH NUMEROUS EMPLOYEES Document addresses meeting held with the General Supply Division of Government whereby supply and demand was discussed. / Exhibit #P0771 PIN # Date Author Addressee Description 53742 17-May-68 JANE LEWIS ZORSCH LEWIS NOTIFIED ZORSCH THAT THEIR MILITARY DEFOLIANT CONTRACT HAD BEEN SIGNED. Exhibit #P0785 PIN # Date Author Addressee 66601-747 11-Jul-68 CARL BOHL MCGUIRE, B. C. ft WEBB, H.R. STRATMEYER, R.J. Ft MEDICAL DEPT. Description Document is a Comprehensive Survey of the entire Nitro Plant operation. The document exhibits in part that there is a chloracne problem resulting from an impurity in the final product. It was hoped that at the end of two years, this contaminant would be eliminated. 15228 Exhibit #P0797 PIN # Date Author Addressee 53744-46 16-Sep-68 TRB KRUMMRICH LAB & OTHERS UNKNOWN Description Document discusses some of the risks associated with use of a product containing 2,4,5-T. Exhibit #P0801 PIN # Date Author Addressee Description 004073 25-Sep-68 V L RHODES NITRO TECH SERV & CUTRIGHT, E. A. DOTSON, L. E. & RHODES, V. L. RUSSELL, G. P. TEMP CONTROL IS = PLUS OR MINUS 4 DEGREES CENT FROM TARGET. "WE NOW HAVE INFORMATION LEAKED FROM HERCULES THAT PRECISE TEMPERATURE CONTROL MAY BE THE KEY TO CHLORACNE REEDUCTION. FOR THIS REASON WE NOW REQUEST INSTALLATION OF INSTRUMENT HARDWARE TO ALLOW US TO REMOVE THE HUMAN ELEMENT AND CONTROL AUTOCLAVE TEMPERATURES AT PLUS OR MINUS 1 DEGREE CENT." Exhibit #P0803 PIN # Date Author Addressee Description 001344-57 01-Oct-68 R A ATKINSON UNKNOWN 2,4,5-T PROCESS IMPROVEMENT PLAN. Exhibit #P0311 PIN # Date Author Addressee 000692-704 29-Oct-68 JOHN D CONNER MORRIS, THOMAS D. & WELD Description LAW FIRM SELLERS, CONNOR & CUNEO WRITING ON BEHALF OF DIAMOND SHAMROCK, HERCULES, MONSANTO, T.H. AND CHIPMAN REGARDING THEIR OPPOSITION TO THE BUILDING OF THE WELDON SPRING PLANT. ON BEHALF OF CONCERN OF D.S., HERC., MONSANTO, T . H . , AND CHIPMAN OF IMPLICATIONS OF WELDON SPRING PLANT ON THESE PHENOXY HERBICIDE PRODUCERS. 152^ 2^ 9,, IV. A. 142 I r Exhibit #PU813 PIN t Date Author Addressee 000690-91 31-Oct-68 JOHN D CONNER HOWARD, HAROLD H. & WILKERSON, M. F. GIVENS, KENNETH T. & MATTISON, S. A. RUMER, ROBERT & OTHERS Description ACKOWLEDGEMENT THAT LETTER TO ASST S E C Y DEFENSE THOMAS D. MORRIS WAS FILED ON OCT 30, 1968 WITH DEPT OF COMMERCE AND DEPT OF DEFENSE, AND WAS HAND DELIVERED TO MR . KOSTER AND MISS LEWIS, REGARDING THE WELDON SPRING PROJECT. Exhibit #P0814 PIN # Date Author Addressee 001407-08 01-Nov-68 MAW NITRO ORGAN CHEM DIV & OTHERS UNKNOWN Description DETERMINATION OF TDD IN 2,4,5-T ACID FROM SOLID SAMPLE, INCLUDING METHOD FOR CALCULATING PPM OF TDD. Exhibit #P0815 PIN # Date Author Addressee 75645-73 08-Nov-68 G R SIDO ARK POIS LABEL FILE & LITTEKEN, M. F. Description MEMO CONFIRMS DISCUSSION WITH HENRY D SALVO REGARDING ALLOWABLE COLORS OF LABELS FOR 2,4,5-T & 2,4-D IN ARKANSAS. Exhibit #P0821 PIN # Date Author Addressee Description 001521-48 12-Dec-68 J C STRUM NITRO TECH SERV DEPT PLAN TO IMPROVE PERFORMANCE OF 2,4,5-T PROCESS IN THE AREAS OF RATE, RAW MATERIAL USAGE, QUALITY, SAFETY, POLLUTION, MECHANICAL RELIABILITY, AND MANUFACTURING TECHNOLOGY. 15230 IV. A. 143 Exhibit #P0822 PIN # Date Author Addressee 000704 19-Dec-68 JOHN D CONNER WILKERSON, M. F. ft GIVENS, KENNETH T. HOFF, DOUGLAS N. ft MCCOY, W. G. THOMPSON, R. S. ft OTHERS Description Document indicating that Government contract for Agent Orange had been cancelled. Exhibit #P0826 PIN # Date Author Addressee Description 76062-81 01-Jan-69 W R KELLOG NITRO ft MONTHLY REPORT TECH SERVICE DEPT. Nitro Tech Service Monthly report dated 1/69, indicating that a trial run of the autoclaves is planned with the intention of reducing the TDD content in NaTCP from 40-50 ppm to 5-6 ppm. Exhibit #P0827 PIN # Date Author Addressee 4800-47 01-Jan-69 J L W R SIMS UDELL LUECKE, C. F. & RUSSELL, CUTRIGHT, E. A. ft KELLY, RHODES, V. L. & OTHERS C.F. R. E. Description Final report #150 regarding attempts to reduce TDD in 245-T. The report addresses the acute toxicity of TDD as well as the process of production and analysis. CO IV. A. 144 1^9 Exhibit #P0833 PIN # Date Author Addressee 1063 09-Jan-69 J C STRUM RHODES, V & EAC STRUM, J C & DOLIN, Description January, 1969 document which discusses plan to reduce the level g TDD in NaTCP from 50 to 5 ppm. Document also discusses the belief that TDD is produced in the NaTCP autoclaves. Exhibit #P0834 PIN # Date Author Addressee Description 1062 09-Jan-69 J C STRUM OUTRIGHT, E A & RHODES, V L HELMER, F J & STRUM, J C DOLIN, 0 E Jan. 9, 1969 plan to reduce TDD in NaTCP from 50 ppm to 5 ppm. Exhibit #P0835 PIN # Date Author Addressee Description 1452-54 15-Jan-69 J C STRUM ET AL RESEARCH DEPT. & RHODES, VL CUTRIGHT, E A & STEPHENS, J A OTHERS Formal tentative amendment to reduce TDD in NaTCP from 40-50ppm to 5-6ppm. Lists present NaTCP reaction conditions and the newly proposed plan. IV. A. 145 1523 r Exhibit #P0836 PIN # Date Author Addressee Description 1517-1520 19-Jan-69 UNKNOWN UDELL, W R & OUTRIGHT, E A RHODES, V L h STRUM, J C PATRICK, C E & OTHERS "Minutes of Meeting With W R Udell". Document indicates that he believes that approximately 35 ppm is being produced in the autoclaves consistently. It states that TDD is highly sensitive to temperature , with slight increases resulting in significant increases in TDD. Exhibit #P0844 PIN # Date Author Addressee 1502-04 21-Feb-69 J C STRUM CUTRGHT,E A & DOTSON, L E BALDERSON, P B 4 UDELL, W R LEUCKE, C F & OTHERS Description Progress report for plan to reduce TDD level from 40 ppm as in 1968 experience to 5 - 7 ppm. Present trial run showed reduction to 3.05 ppm. A 30-day plant trial run will begin on February 24 to complete the demonstration. Exhibit #P0846 PIN # Date Author Addressee Description 76101-19 01-Mar-69 W R KELLOG NONE Document speaks of a problem with the GLC analysis which appears to be resolved with the flame detection method. .L Kf' IV. A. 146 Exhibit #P0847 PIN # Date Author Addressee 6002 16-Apr-69 R EMMET KELLY EAKIN, FRANK & BOHL, C.D. Description Letter from Dr. Kelly indicating that even less that 1 ppm could cause chlorachne. / Exhibit #P0849 PIN # Date Author Addressee 76138-155 01-May-69 W R KELLOG JACKSON, D W & SAVAGE, J R LEUCKE, C F & WEBBER, R T EDWARDS, P w & OTHERS Description Tech. Service monthly report indicating a significant reduction of TDD in NaTCP, an average of 4ppm. Exhibit #P0850 PIN # Date Author Addressee Description 1500 08-May-69 J C STRUM BAKIN, F. A. & DOLIN, C. B. HELMER, F.J. ft BALDERSON, P WOODS, W. C. May 1969 document which states that Curt Woods was to set up a program for routine analysis for the TDD in 245-T finished goods. Routine is indicated to mean between 2-4 per week. Exhibit #P0851 PIN # Date Author Addressee Description 6000 14-Jun-69 R EMMETT KELLY MD WEBB, H B Memo of Dr. Kelly asking "I don't want to be cynical, but are there any employees in the department who don't have chloracne already? ^0 ,, Exhibit #P0852 PIN t Date Author Addressee 76171-82 01 -Jul-69 W R KELLOGG LUECKE, C F & WEBBER, R T SAVAGE, J R & SEPULVEDA, C H DODD, H A & OTHERS Description Document indicating that TDD is highly toxic. / Exhibit #P0853 PIN # Date Author Addressee 11227 14-Jul-69 C H RUSSELL MIDDLETON, D R & ZORSCH C P ROBIRDS, W R & LEISY, A E Description The document indicates they were discontinuing their investigation of VPC analysis procedures of Orange when their contract was cancelled. Exhibit #P0855 PIN # Date Author Addressee 76183-94 01-Aug-69 W R KELLOGG NITRO & GENERAL OFFICES KRUMMRICH & QUEENY ANNISTON & OTHER PLANTS Description August, 1969, monthly report of Nitro's technical service dept. It is noted that approval was received on Tentative Amendment No. N which permits control of the condensation reaction pH with 34% NaTCP solution instead of 25% NaOH--a trial run on August 19--23 showed no adverse effects on quality or yield. Exhibit #P0858 PIN # Date Author Addressee Description 22929-34 29-Aug-69 J C STRUM SAFETY DEPT. Ft PLANT MANAGER OTHERS Document is entitled "Process Safety Audit" and addresses, in question and answer form, safety questions regarding: raw materials, process, finished goods and equipment and layout. Document also indicates that the finished goods may be somewhat toxic and that the containers are properly labelled for toxicity. Exhibit #P0859 PIN t Date Author Addressee 76195-205 01-Sep-69 W R KELLOGG NITRO & GENERAL OFFICES KRUMMRICH & ANNISTON QUEENY & OTHER PLANTS Description SEPTEMBER, 1969, MONTHLY REPORT FOR THE TECHNICAL SERVICES DEPARTMENT OF THE NITRO PLANT. Exhibit #P0860 PIN # Date Author Addressee Description 29050-144 15-Sep-69 E M EMERY ET AL SHARP, D B & DOLIN, 0 EMERY E M & MEADE, FRANK NUMEROUS OTHERS Monsanto Organic Chemicals Division Research Report -3598;"Final Report on Gas Chromatography Method Development - L968. Exhibit #P0872 PIN # Date Author Addressee Description 1693-96 05-Dec-69 R L DILLON ET AL ROBIRDS, W R & STRUM, J C PAYNE, R L & EAKIN, F A RESEARCH DEPT. Ft OTHERS Official tentative amendment to the manufacturing process for 2,4,5-T acid. Amendment requires in part reduction of the TCB feed time from 2 1/2 hrs to 1 hr. Exhibit #P0876 PIN # Date Author Addressee 68292 16-Dec-69 WILLIAM H HUNT SPEZIALE, A. J. Ft SHARP, D. B. Description Reference to preliminary mutagenic report of NCI. Hunt says Medical Dept, has report but feels data is meaningless and that mutagenic activity in bacteria cannot be extrapolated to mammals until mammalian data are available. Exhibit #P0877 PIN # Date Author Addressee 73231-41 19-Dec-69 A J SPEZIALE BALDESCHWEILER, J D & BURGER DR. STEPHENS J A & UDELL W R KELLY, R E & OTHERS Description Letter indicating Monsanto's knowledge of TDD as well as levels of contamination from 1953, methods of analysis for TDD in autoclave and technical 2,4,5-T, sample chromatograms, and numerous forms of correspondence. CERTIFICATE OF SERVICE The undersigned Benton Musslewhite, Esq. does hereby certify that on the 11th day of April, 1984 he served the enclosed Pre-trial Order on aU those shown on the attached / service list by hand delivery through a Delivery Service. 15238 SERVICE LIST Leonard Rivkin, Esq. Rivkin, Leff, Sherman & Radler Attorneys for Dow Chemical Company 100 Garden City Plaza Garden City, N.Y. 11530 Wendell B. Alcorn, Jr., Esq. Cadwallader, Wickersham & Taft Attorneys for Diamond-Shamrock One Wall Street New York, New York 10005 Judith L. Spanier, Esq. Shea. & Gould Attorneys for Uniroyal, Inc. 330 Madison Avenue New York, New York 10017 OS David R. Gross, Esq. Budd, Larner, Kent, Gross, Picillio & Rosenthal Attorneys for Thompson Chemical 33 Washington Street Newark, New Jersey 17102 William A. Krohley, Esq. Kelley Drye & Warren Attorneys for Hercules, Inc. 101 Park Avenue New York, N.Y. 10178 Phillip E. Brown, Esq. Hoberg, Finger, Brown, Cox & Molligan, P.C. Central Tower 703 Market Street San Francisco, California 94103 David J. Dean, Esq. Dean, Falanga & Rose One old Country Road Carle Place, New York 11514 Gene Locks, Esq. Greitzer & Locks 1500 Walnut Street - 21st Floor Philadelphia, Pennsylvania 19102 John C. Sabetta, Esq. Townley & Updike Attorneys for Monsanto Co. 405 Lexington Avenue New York, New York 10017 Thomas Beck, Esq. Arthur, Dry & Kalish Attorneys for Uniroyal, Inc. 1230 Avenue of the Americas New York, New York 10020 Morton B. Silberman, Esq. Clark, Gagliardi & Miller Attorneys for T&H Agriculture 99 Court Street White Plains, New York 10601 Arvin Maskin, Esq. Civil Division United States Department of Justice Safeway Building, Room 9040 Washington, D.C. 20530 Hon. Shira Scheindlin Magistrate United States District Court 225 Cadman Plaza East, Rm. 285 Brooklyn, New York 11201 Stanley M. Chesley, Esq. Waite, Schneider, Bayless & Chesley, Co., L.P.A. 1513 Central Trust Tower Cincinnati, Ohio 45202 Thomas W Henderson, Esq. Henderson & Goldberg Frick Building, Rm. 1601 Pittsburgh, Pennsylvania 15219 Benton Musselwhite, Esq. 609 Fannin, Suite 517 Houston, Texas 77002 15239 John O'Quinn/ Esq. O'Quinn, Hagans & Wettman 3200 Travis Commerce Tower 600 Travis Houston, Texas 77003 Newton B. Schwartz, Esq. Houston Bar Center Building 723 Main, Suite 325 Houston, Texas 77002 Stephen J. Schlegel, Esq. Schlegel 4 Trafelet, Ltd. One N. LaSalle St., Suite 3900 Chicago, Illinois 60602 / * /* 15240 Exhibit #P0878 PIN # Date Author Addressee Description 73727-29 19-Dec-69 C H RUSSELL UNKNOWN Product specification for 2,4-D/2,4,5-T Butyl Ester Brush Killer. / Exhibit #P0879 PIN # Date Author Addressee Description 73730-31 19-Dec-69 C H RUSSELL UNKNOWN Product specification for 2,4-D/2,4,5-T Low Volatile Brush Killer. Exhibit #P0880 PIN # Date Author Addressee Description 73732-33 19-Dec-69 C H RUSSELL UNKNOWN Product specification for Brush-O-Cide Brush Killer. Exhibit #P0881 PIN t Date Author Addressee Description 73734-35 19-Dec-69 C H RUSSELL UNKNOWN Product specification for 2,4-D/2,4,5-T Amine Brush Killer. Exhibit #P0896 PIN # Date Author Addressee 1894-1949 01-Feb-70 J C STRUM STEPHENS, J A & ROBIRDS, LEUKE, C F & OTHERS WR Description Standard Manufacturer Process for 2,4,5Trichlorophenoxyacetic Acid Department 895.01 supersedes Standard Manufacturing Process for 2,4,5-T dated January, 1966, by L.E. Dotson, revised November, 1966 by V.L. Rhodes. Exhibit #P0897 PIN # Date Author Addressee 1894-1949 01-Feb-70 J C STRUM STEPHENS, J A & ROBIRDS, W R LEUKE, C F & NUMEROUS OTHERS Description Standard Manufacturing Process For 2,4,5- Trichlorophenoxyacetic Acid Department 895.01. Supercedes Standard Manufacturing Process for 2,4,5-T dated January, 1966, by L.E. Dotson, revised November, 1966 by V.L. Rhodes. TDD 1968 as high as 50ppm. Good process description. Exhibit #P0900 PIN # Date Author Addressee Description 040807-70 07-Feb-70 L G SILVERSTEIN UNKNOWN Report on safe handling of tetrachlorodibenzo-p-dioxin points out TCBD's extreme toxicity and necessary safety procedures. IV A. 152 i Exhibit #P0910 PIN # Date Author Addressee Description 1444-45 22-Feb-70 C H RUSSELL EAKEN, D A & ELLIOTT UDELL & DOLIN STEPHENS Nitro needs extra equipment for analysis of each lot. / Exhibit #P0915 PIN # Date Author Addressee 15613-17 11-Mar-70 JACK FARLY MCCARVILLE DR, WM J & SPEZIALE DR, A J Description Present were, J. Mason, J. Early,(Monsanto); George Lynn, Dr. Blair(Dow); Harris Miller, Jerome Wildenfeld , A1 Schlumberger(Hooker); Charles Dunn, A.E. Sidwell (Hercules). All in agreement that 2,3,7,8tetrachlorodibenzo-p-dioxin is contaminant causing high level teratogenicity, possibly less than 1ppm will cause harm. Exhibit #P0922 PIN # Date Author Addressee 76005-15 19-Mar-70 JACK D EARLY SPEZIALE DR, A J & SHARP, D B Description Dow Teratology Studies. Note in Monsanto possession. 2,3,7,8-Tetrachlorodibenzo-p-Dioxin highly toxic to embryos of pregnant rats. Exhibit #P0925 PIN # Date Author Addressee Description 73896 24-Mar-70 MATHEW HUDSON BOCK, EDWARD J. Letter from shareholder to President/Monsanto re: findings Bionetics study. in 152_ 4,,3~ T V A 1T Exhibit #P0931 PIN # Date Author Addressee Description 52983 01-Apr-70 J L SIMS EMERY, E M & LIPPMAN, A E CONKIN, R A Ascertain low limits/of detection, descriptions of analysis. Exhibit #P0933 PIN # Date Author Addressee Description 73897-98 02-Apr-70 R EMMET KELLY MD HUDSON, MATHEW Kelly responds to the letter of Hudson in which he states in part that there are no teratological effects and does not know where Agent Orange was used. Exhibit #P0944 PIN # Date Author Addressee Description 7825 17-Apr-70 DON R FISCHER DISTRICT MGRS. & REGIONAL SALES DIR. PROD.MGRS.&SUPRVSRS & MRKT DVLPMNT MGRS MRKT DVLPMNT SPRVSR Document pushes for sales of all 2,4,5-T Acid, ester and formulation products or else substantial financial loss will occur if government bans product. Exhibit #P0953 PIN # Date Author Addressee Description 7658-61 24-May-70 C P ZORSCH FISCHER, D R Summarization of current situation relating to federal restrictions for the use of 2,4,5-T. Exhibit #P0976 PIN / Date Author Addressee 1012 28-Sep-70 LOWELL E MILLER MANUFACTURERS OF & ECONOMIC POISONS Description Notice to Manufacturers, Formulators, Distributors and Registrants of Economic Poisons. Can't use chlorodioxin products. Exhibit #P0977 PIN # Date Author Addressee Description 72953 06-0ct-70 R EMMET KELLY GILLESPIE, JOSEPH Regarding rework of 2,4,5-T to get rid of the dioxin - document states should be meeting with Garrett or Wheeler of industrial hygiene group to avoid epidemic of chloracne in workers handling the impurity during stages of removal and cleanup. Exhibit #P0983 PIN # Date Author Addressee Description 146 08-Dec-70 V G PRITCHARD HABERMOHL, D E No method of analysis available for 2,4,5-T ester formulations in order to determine chlorodioxin content. Exhibit #P0991 PIN # Date Author Addressee Description 96-97 15-Jan-71 CHARLES P ZORSCH GEORGIA-PACIFIC CORP & BLACK, REX HARRIS, WERNER Working to reduce TDD to less than .5ppm for sale since Monsanto claims that said level is not detectable, and thus implicitly safe. Exhibit #P0992 PIN # Date Author Addressee Description 74229-33 25-Jan-71 UNKNOWN UNKNOWN DUNLOP, R H & BURKE, B J WESSELS, R G & BAILEY, R E BONHAM, F S & NUMEROUS OTHERS / Monthly Report - Labeling - Registration and Transportation Claims January 1971. Exhibit #P1002 PIN # Date Author Addressee 74223-26 30-Apr-71 T E ADAMCZYK LETTEKEN, MARK F & MONSANTO COMPANY Description Will not grant continuous registration must petition for renewals every 5 years, responded the U.S.D.A. to Monsanto's reques t . Exhibit #P1003 PIN # Date Author Addressee Description 40890-93 07-May-71 JAMES G WILSON UNKNOWN Mr. Wilson in this document indicated that TDD was not rapidly degradeable in the environment and that the data available substantiates embryotoxicity. He further believes that all species would have the same results if doses of 2,4,5-T were high enough. T TT 1 C / 15246 Exhibit #P1004 PIN # Date Author Addressee 6426-27 07-May-71 GLYNN DAVIS ROBIRDS, W R & UDELL, W R WILLIAMS, H L 4 BRATSC.l, G L JACKSON, D W 6c NUMEROUS OTHERS Description Document contains his-tory of process used to reduce dioxin levels in Isooctyl T Ester of 2,4,5-Trichlorophenoxyacetic Acid. Exhibit #P1030 PIN # Date Author Addressee Description 74600-17 23-Mar-72 G ROBERT SIDO US DA Various applications for registration renewals for: 2,4,5-T Isopropyl Ester, dated 3/22/72; 2,4,5-T Isopropyl Ester dated 4/1/66; 2,4,5-T Isopropyl Ester, dated 3/15/51 . Exhibit #P1072 PIN # Date Author Addressee Description 5665-66 05-Feb-79 UNKNOWN UNKNOWN UNKNOWN Document includes, in part, key dates with regard to Monsanto's manufacture of 2,4,5-T. Exhibit #P1073 PIN # Date Author Addressee Description 90000-01 19-Feb-79 UNKNOWN UNKNOWN UNKNOWN Accident in plant involving spillage of 2,4,5-trichlorophenol which generates the highly carcinogenic dioxins. One hundred and fourteen employees with chloracne have been identified as being involved in the operation in which accident the occurred. IV. A. 157 Exhibit #P1074 PIN # Date Author Addressee Description 88721-24 26-Jun-79 G EDWARD PAGET UNKNOWN Document entitled "Chlorinated Dibenzo Dioxins" - A Position Paper For Consideration By M^G. Throdahl. Exhibit #P1075 PIN # Date Author Addressee 91348-50 20-Aug-79 F J HOLZAPFEL BISHOP, D R & CALLIS, C F GAFFEY, W R & MCCARVILLE, W J MEYER, F C & NUMEROUS OTHERS Description Nitro Health Study Task Force Minutes of Meeting of 8/17. Dr. Sudking suggested changes in Monsanto draft of "Mortality Study". Exhibit #P1076 PIN # Date Author Addressee 87695-96 24-Aug-79 F J HOLZAPFEL GAFFEY, W R & MCCARVILLE, MEYER, C & PARK, P S WANDER, B J & OTHERS WJ Description Nitro Health Study Task Force Minutes of Meeting 8/24/79. Dr. Suskind has not yet approved draft of Monsanto "Mortality Study". Study involved 121 people involved in 1949 Nitro incident who had chloracne. Carbide/University of Pittsburgh study higher incidences of 3 types of cancer in 819 deceased workers. Exhibit #P1077 PIN # Date Author Addressee Description 90240-50 24-Oct-79 UNKNOWN UNKNOWN UNKNOWN Dioxins - Dibenzofuranes/Status Summary. Contains all incidents worldwide of human exposure. Exhibit #P1085 PIN # Date Author Addressee Description 91563-66 01-Mar-80 UNKNOWN UKNOWN UNKNOWN Agent Orange...What are the facts? Monsanto article in its own publication addresses AO lawsuit - highly emotional issue. Didn't produce TCB as raw material of 2,4,5-T. Exhibit #P1086 PIN # Date Author Addressee Description 91517-18 17-Mar-80 COMPANY MONSANTO UNKNOWN Monsanto News Backgrounder. Publication by Monsanto entitled "Agent Orange...What are the facts?" Monsanto Company Perspective. Exhibit #P1 087 PIN # Date Author Addressee 91514-16 07-Apr-80 R M SCOTT NITRO PLANT & EMPLOYEE RETIREE & AND FAMILY Description Letter in response to an inquiry regarding Agent Orange in which articles published by Monsanto were enclosed. Exhibit #P1092 PIN # Date Author Addressee 90035-36 27-Apr-81 WILLIAM R GAFFEY ROUSH, G. & MCCARVILLE, W. .1. LEVINSKAS, G. J. ft COLEMAN. D. L. PARK, P. S. & OTHERS Description Report on Selikoff study criticizes presentation of chloracne cases as not surprising. / Exhibit #P1096 PIN # Date Author Addressee Description 94391-95 16-Dec-81 UNKNOWN UNKNOWN UNKNOWN Monsanto Company Response to Nitro W. VA Lawsuit Allegations. Press release re Nitro W. VA lawsuit, pg. 4 - 1 2 1 employees developed symptoms including skin rash known as chloracne, eye & respiratory tract irritation, headache, dizziness, nausea and liver disorders. Exhibit #P1098 PIN # Date Author Addressee Description 90157-59 16-Dec-82 JAMES H SPRAUL MD UNKNOWN Draft by James H. Spraul, M.D., document states that TCDD is highly toxic. Exhibit #P1099 PIN # Date Author Addressee Description 94334-38 21-Dec-82 UNKNOWN UNKNOWN UNKNOWN Article which discusses the effects of 2,4,5-T. 15250 Exhibit #P0163 PIN # Date Author Addressee 01912-45 04-Apr-62 J E WILDER EAGAN, J.M. ABORN, H.F. & DELLINGER, R. & SIDWELL, A . E . Description Wilder to Egan memo re: facts concerning Jacksonville, Arkane, Arkansas plant; plant manual - prohibits tentperature in excess of 180 degrees c . Exhibit #P0236 PIN # Date Author Addressee 26114-5 03-Jul-63 JOHN F FRAWLEY ROWE, V .K . & HUNT, W.H. Description Frawley relates clinical reports of neuropathy. . . " On the basis of these reports Leary feels that the hazards associated with the use of 2,4-D and 2,4,5-T should be understood more thoroughly" - suggests Dow and Hercules conduct a study. Exhibit #P0237 PIN # Date Author Addressee Description 26116 03-Jul-63 JOHN FRAWLEY Note re: letter of 07/03/63 from Rowe to Frawley. Note reads in reference to anti-trust laws. Exhibit #P0294 PIN # Date Author Addressee Description 00000 20-May-64 W A SMITH TURK, E. & BELLINGER, E. EAGAN, J.M. & BECKROTH, M . F . DISWELL, A.E. Progress Report - discusses recognition of an "unknown" constituent in the 2,4,5-T of approximately 8% by volume. Exhibit #P0305 PIN # Date Author Addressee Description 28118 17-Jun-64 WILD RICE ELECTRIC LYON CHEMICAL Letter from Wild Rice lectric Cooperative, Inc. to Lyon Chemical, Inc. re: report of person becoming ill after eating berries from an area sprayed with a 2,4-D and 2,4,5-T brush spray. Exhibit #P0333 PIN * Date Author Addressee Description 00000 30-NOV-64 DOW CHEMICAL Dow Analytical Method - Dow report provided to Hercules recognizing existence of dioxin and that it causes chloracne - includes example of gas chromatogram for dioxin. Exhibit #P0368 PIN # Date Author Addressee 28122 16-Feb-65 H F PIERCE FRAWLEY, J. & NEAL, J. YATES, R. & SPELTZ, D. FEDDERMAN, M. & KUNTHOLM, J. Description Letter from Pierce to Frawley re: relates a claim regarding injuries to powerline construction employees. Exhibit #P0373 PIN # Date Author Addressee 281 23 22-Feb-65 JOHN F FRAWLEY WYMAN & OTHER DOW EMPLOYEES Description Letter from Frawley to Wyman relate C: claim re: injuries to powerline construction employees. Exhibit #P0406 PIN t Date Author Addressee 01282-3 19-Mar-65 V K ROWE KELLY, MONSANTO & WILKNFELD, HOOKER VERHOEZE, HOOKER & KENNEDY, DIAMOND CHANDLER, DIAMOND & FRAWLEY, HERCULES Description Rowe to each chemical company inviting manufacturers to Midland meeting . .to discuss the toxicological problems caused by the presence of certain highly toxic impurities in certain samples of 2,4,5-TLP It Exhibit #P0408 PIN # Date Author Addressee Description 01297-304 24-Mar-65 C L DUNN HERCULES FILE Dunn's handwritten minutes and notes relating to Dow's discovery of employee chloracne; 2,4,5-T; TCP; fatigue and that chloracne may be systemic; cases 25 years before; rabbit tests and damaged livers. Exhibit #P0409 PIN # Date Author Addressee Description 01290 24-Mar-65 C L DUNN HERCULES FILE Detailed Notes on Dow Visit of 03/24/65 re toxic materials in 2,4,5-TCP. Exhibit #P0410 PIN # Date Author Addressee 706001-3 25-Mar-65 E L CHANDLER KENNEDY, F.R. & KING, J.O. Description WILKERSON, M.F. Chandler reports on meeting of 03/24/65 at Dow; employees listless, fatigued; Dow concluded 1 ppm with repeat exposure can create problem; purpose of meeting to help solve "problem before outsiders confuse issue." Exhibit #P0412 PIN # Date Author Addressee Description 01347 26-Mar-65 HERCULES CORP HERCULES FILE Hercules Animal Study PPM - test results of positive response to exposure to as little as 0.4 ppm. Exhibit #P0413 PIN # Date Author Addressee 32466-7 26-Mar-65 JOHN P FRAWLEY COPELAN, JOHN G. & MAYFIELD, PAUL MADDOCK, CHARLES & MCGEE, LEMUEL RENO, P.J. & 6 OTHERS AT HERCULES Description Frawley report of 03/24/65 meeting with Dow - chloracne a systemic disease, a potent liver toxicant, lethal to rabbits; discusses constant monitoring of TCP and 2,4,5-T production for protection against illegitimate claims. Exhibit #P0414 PIN # Date Author Addressee 032489-90 26-Mar-65 C L DUNN COPELAND, J.G. & GEORGE, R.S. SCOTT, R.B. & BELLINGER, E.S. EAGAN, J.M. & 5 OTHERS AT HERCULES Description Memo from Dunn to Copeland re: "Highly Toxic Impurities in 2,4,5-TCP." t v , a . 164 Exhibit #P0418 PIN # Date Author Addressee Description 32488 29-Mar-65 J M EAGAN WILDER, H.E. Letter from Eagan to Wilder re: toxic impurities in 2,4,5-TCP; operation of Hercules' TCP process; reactions and recommendations. / Exhibit #P0420 PIN # Date Author Addressee Description 32514-5 30-Mar-65 A E SIDWELL FRAWLEY, JOHN F. & WILDER EAGAN, J.M. & DUNN, C.L. TECH. FILE Memo from Sidwell to Frawley "confidential" report of Dow meeting will be held in confidence. Exhibit #P0423 PIN # Date Author Addressee 32464-87 01-Apr-65 C L DUNN HALL, R. T . & COPELAND, J.G. GEORGE, R.S. & YATES, R.T. SCOTT, R.B. & 11 OTHERS Description Memo from Dunn to Hall re: Toxic Impurities in 2,4,5-T; establish periodic examination of further production. Exhibit #P0425 PIN # Date Author Addressee Description 01 348 09-Apr-65 JOHN F FRAWLEY DUNN, C.L. & EAGAN, J.M. SIDWELL, A .D . Memo from Frawley to Dunn re: Frawley aware of Monsanto and Badische history of problems which " . . . confirm the high degree of toxicity of the chloracnegens. . Exhibit #P0426 PIN # Date Author Addressee Description 01348 14-Apr-65 JOHN P FRAWLEY JACKSONVILLE FILE & DUNN, C.L. EAGAN, JOHN Frawley note to Jacksonville plant file re: 2.4.5- T; Dow test results on Hercules 2.4.5-T acid shipments; some Dow rejections because a third in increasing amounts of acnegens was indicated. Exhibit #P0432 PIN # Date Author Addressee HERC0484 13-May-65 V K ROWE FRAWLEY, JOHN P. & WHEELER, E.P. Description Letter from Rowe to Frawley relates problem in analyzing for dioxin. Exhibit #P0435 PIN # Date Author Addressee Description HERC0486-7 27-May-65 P A TIFFANY FORD, JOHN Letter from Tiffany at Dow to Ford re: retesting 2,4,5-T acid; higher ppm than before. Exhibit #P0437 PIN # Date Author Addressee Description 00000 01-Jun-65 FRED HAGER SIDWELL, A.E. Letter from Hager at Naugatuck to Sidwell relates 1 ppm "have induced serious industrial hygiene problems." Exhibit #P0444 PIN # Date Author Addressee Description 32952 30-Jun-65 HERCULES CORP HERCULES FILE Notes re: samples. Exhibit #P0448 PIN # Date Author Addressee / 01384 12-Jul-65 JOHN P FRAWLEY JACKSONVILLE FILE & COPELAND, EAGAN, JOHN & DUNN, C.L. WILDER, H.E. & 2 OTHERS JACK Description Memo to Jacksonville plant reports Dow's and Hercules' awareness that no one else has done anything to clean up their 2,4,5-T. Fears Congressional investigation and restrictive legislation. Exhibit #P0450 PIN # Date Author Addressee Description 00000 19-Jul-65 HERCULES CORP DEFENSE SUPPLY Contract between Defense Supply Agency and Hercules Power Co. date 07/19/65 to supply 638,400 lbs. of, and more at a sale price of $1,501,200; all supplies, free from defects. Exhibit #P0453 PIN # Date Author Addressee Description 32512-3 26-Aug-65 J FORD TAVES, M. Memo from Ford to Taves re: summary of analytical data showing dioxin content of current production of 2,4,5-T highest single value = 4.8 ppm and lowest being 1.1 ppm. Exhibit #P0463 PIN # Date Author Addressee 32497-8 21-Oct-65 JOHN P FRAWLEY COPELAND, JACK & GEORGE, R.S. EAGAN, JOHN & DUNN, C.L. WILDER, H.E. & 2 OTHERS Description Memo from Frawley to Copeland relates Frawley trip to Badische (BASF) and learning details of 1953 epidemic at plant and learned of their bio assay evaluation techniques. Exhibit #P0464 PIN # Date Author Addressee 32509-10 27-Oct-65 J J FORD GILL & DUNN, G.L. FRAWLEY, J.F. & CHRISTOFANO, K.E. TAVES, M. & 2 OTHERS Description Letter from Ford to Gill demonstrates that Dow and Hercules test results are inconsistent with Dow's analysis of a given product being substantially lower. Exhibit #P0465 PIN # Date Author Addressee 03892-3 18-Nov-65 E E CHRISTOFANO DUNN, C.L. & EAGAN, J.M. TAVES, M.A. & FORD, J.J. CONNER, A .Z . & SIDWELL, A.D. Description Memo from Christofano to Dunn relates investigations comteraplated in future and indicates still not accomplished as of 6/1/66. Exhibit #P0467 PIN # Date 21-Nov-65 15258 TV. A. 1fifl Author Addressee Description J HARVEY PIERCE, HENRY F. Letter from Lyon to Piercerelating that a Visko-Rhap employee hadchroniccomplaint resulting in surgery at Mayo Clinic; how to respond to questions on the herbicide's toxicity. Exhibit #P0469 PIN # Date Author Addressee Description / 28125 22-Dec-65 JOHN F FRAWLEY HARVEY, JOE Letter from Frawley to Harvey at Lyon re: Pierce letter of 11/21/65. Exhibit #P0473 PIN # Date Author Addressee Description 00000 01 -Jan-66 HERCULES CORP HERCULES FILE Clinical Studies - Occupational Acne (1966) - Translated by Z.B. Blums May 4, 1967. Exhibit #P0479 PIN # Date Author Addressee 03896 24-Feb-66 E E CHRISTOFANO WILDER & SIDWELL, A.D. FORD, J.J. & EAGAN, J.M. Description Memo from Christofano to Wilder re: possible NAL study of Jacksonville plant. Exhibit #P0493 PIN # Date Author Addressee 01466 20-Jun-66 J J FORD CHRISTOFANO & DUNN, C.L. TAVES, N.A. & CONNER, A.Z WILMINGTON FILE 3 Description Memo from Ford to Christofano re: Samples for acute oral toxicity studies. Exhibit #P0503 PIN # Date Author Addressee 01450-1 28-Jul-66 JOHN P FRAWLEY OETTEL & DIELEMAN, R1EN PHILLIPS, R.C. & CHRISTOFANO, TAVES, N.A. & 3 OTHERS E.E. Description Cover letter from Frawley to Oettel for samples sent to BASF for analysis of dioxin content as discussed in September of 1965. Exhibit #P0508 PIN # Date Author Addressee Description 06346-51 23-Aug-66 J A NOONE HERCULES EMPLOYEES Minutes of NACA meeting on August 23, 1966. Exhibit #P0509 PIN # Date Author Addressee Description 06339-44 23-Aug-66 C L DUNN FILE Handwritten notes of Dunn of NACA meeting of August 23, 1966. Exhibit #P0510 PIN # Date Author Addressee 01246 29-37 26-Aug-66 R DIELEMAN FRAWLEY, J.P. & PHILLIPS, H.C. Description Letter from Diehlman to Frawley reports on visit of Oettel at BASF and attaches the 1955 report by Oettel re: 1953 exposure; 1526ureport has evidence compelling punitive TU 170 damages: no summary possible. Exhibit #P0511 PIN # Date Author Addressee Description 13970-86 01-Sep-66 HERCULES CORP GOVERNMENT Contract between Government and Hercules, Inc. (DSA-400-67-C-1633), effective date September 1, 1966,. 437,000 gal. AO for $2,923,530 from 10/1/66 to 6/1/67; free from defects. Exhibit #P0516 PIN # Date Author Addressee Description 06362-5 27-Sep-66 C L DUNN FILE Minutes of NACA meeting of 09/27/66. Exhibit #P0517 PIN # Date Author Addressee Description 01985-6 01-Oct-66 HERCULES CORP HERCULES Dechlorination Manual - "CAUTION!!! Do not let temperature get above 170 degrees and do not let pressure get above 315 pounds." Exhibit #P0525 PIN # Date Author Addressee 00000 19-Oct-66 JOHN P FRAWLEY OETTEL & SCOTT, R.B. PHILLIPS, R .C. & DIELEMAN, TAVES, M.A. & FORD, J.J. R. Description Letter from Frawley to Oettel of BASF re: bioassay for dioxin and Hercules rejecting new efforts to determine a new method; (Dow) reports positive results with samples of 2,4,5-T acid containing 1 ppm dioxin. 152B1 IV. A. 171 Exhibit #P0526 PIN # Date Author Addressee Description 06366-70 25-Oct-66 C L DUNN Minutes of NACA meeting on October 25, 1966. ^ Exhibit #P0527 PIN # Date Author Addressee Description 06366-70 25-Oct-66 C L DUNN Handwritten notes of Dunn on NACA meeting of October 25, 1966. Exhibit #P0532 PIN # Date Author Addressee Description 31639-50 Q3-Nov-66 BIOTEST LABORATORIES HERCULES Biotest Laboratories report to Hercules, Inc. on acute oral toxicity studies on three materials. Exhibit #P0534 PIN # Date Author Addressee Description 00000 04-Nov-66 INC HERCULES Esterification manual; essential materials; formulas. Exhibit #P0563 PIN # Date Author Addressee 06399-401 18-Jan-67 C L DUNN -9 'L 4 Description Minutes of NACA meeting of January 18, 1967. Exhibit #P0567 PIN # Date Author Addressee 15034-44 27-Jan-67 K WILDER EAGAN, J. & GIVENS, K.T. x Description Memo from Wilder to Eagan re: visit to U.S. Army phosphate development works, Muscle Shaols, Alabama; describes usage in V N , 2-4 applications, 30 days apart. Exhibit #P0587 PIN # Date Author Addressee 17060-1 23-Feb-67 K T GIVENS TRAUB, JOHN L. 6c COPELAN, J.G. EAGAN, J.M. 6c YATES, R . T . RENO, P.J. 6c 2 OTHERS Description Letter from Givens to Traube re: Hercules' proposal of building a new plant. Exhibit #P0601 PIN # Date Author Addressee Description 08406-10 28-Mar-67 G E LYNN US DA Lynn speech to USDA re: collect data on toxicity pertinent to use of phenoxy herbicides. Exhibit #P0604 PIN # Date Author Addressee Description 01247 29-Mar-67 P OETTEL FRAWLEY, JOHN P. Letter from Oettel to Frawley re: photographs of people with acne. IV. A. 173 %"ii*.D. . . ... w Vl -WIt-S Exhibit #P0607 PIN # Date Author Addressee Description 017052-4 03-Apr-67 K T GIVENS YATES, R.T. & RENO, P.J. EAGAN, J.M. & MILLER, J. COPELAN, J.G. & 4 OTHERS / Letter from Givens re: Orange Production, Edgewood Arsenal. Exhibit #P0612 PIN # Date Author Addressee Description 06411-15 20-Apr-67 C L DUNN Minutes of NACA meeting of April 20, 1967. Exhibit #P0619 PIN # Date Author Addressee Description 06422-3 11-May-67 G E LYNN HAZLETON LAB. Letter from Lynn to Hazleton Lab., Inc. re: verbal arrangement of 04/20/67 between Lynn and Hazleton to prepare petitions for negligible tolerances for use on crops for phenoxy herbicides. Exhibit #P0620 PIN # Date Author Addressee Description 06420-1 12-May-67 G E LYNN MEMBERS NACA & NOONE, J.A. HALEY, DENIS Memo from Lynn re: NACA and Hazleton meeting of May 11, 1967. Exhibit #P0630 3 PIN # Date Author Addressee 32493-4 08-Jun-67 EMIL E CHRISTOFANO FANCHER, OTIS & SIDWELL, A.E. DUNN, C.L. & SCOTT, R.B. Description Letter from Christofano to Fancher re: Hercules Project No. 67-13; liver damage studies; toxicity of three materials to rabbits. Exhibit #P0635 PIN # Date Author Addressee 03904-5 . 29-Jun-67 JOHN P FRAWLEY OETTEL, PROF. H. & DIELEMAN, R. PHILLIPS, H.C. & SCOTT, R.B. DUNN, C.L. & SIDWELL, A.E. Description Letter from Frawley to Oettel re: Columbian study. "I agree with you that this report is very disturbing." States that 2,4,5-T acid and ester are significantly more toxic than TCP. Exhibit #P0638 PIN # Date Author Addressee 32452-62 30-Jun-67 J M EAGAN WILDER, H . E . & FRAWLEY, J.P. Description Memo from Eagan to Wilder re: chloracne cases in Columbia, South America. Exhibit #P0640 PIN # Date Author Addressee Description 14692-704 06-Jul-67 C W CARTY HERCULES Letter from Carty to Hercules Powder Co., Inc. demonstrates private industry's input in reviewing commentary and affecting redrafting of government specs, at government's request. 26d IV. A. 175 Exhibit #P0641 PIN # Date Author Addressee Description 15600-13 11-Jul-67 W W RAYNOLDS WILDER, H.E. Memo re: July 6, 1967 letter of Hercules Powder Co., Inc. / Carty's to Exhibit #P0644 PIN # Date Author Addressee Description 32149 18-JuL-67 MITCHELL R ZAVON CHRISTOFANO, E.E. Letter of Zavon to Christofano re: his request for a meeting regarding comparative industry study of employees. Exhibit #P0646 PIN # Date Author Addressee Description 32148 28-Jul-67 EMIL E CHRISTOFANO ZAVON, M. & EAGAN, J.M. SIDWELL, R. Letter from Christofano to Zavon rejecting proposed study. Exhibit #P0649 PIN # Date Author Addressee Description 15392-94 11-Aug-6 7 A E SIDWELL EAGAN, J.M. & SCOTT, R. WILDER Memo from Sidwell to Eagan re: "Orange quality problem - recites that Hercules has produced nearly 15,000,000 pounds of Agent Orange since November 15, 1964. Exhibit #P0650 PIN # 06436-7 Date Author Addressee Description 17-Aug-67 G E LYNN NACA MEMBERS Memo from Lynn to Members of Industry Task Force on Phenoxy Herbicide Tolerances re: 2,4,5-T formulations. Exhibit #P0653 PIN # Date Author Addressee Description 31918 28-Aug-67 A E SIDWELL / Appropriation Request signed by A.E. Sidwell re: infrared spectrophotometer. Exhibit #P0657 PIN # Date Author Addressee Description 15468-9 02-Sep-67 A L TREISBACK WILDER Handwritten notes from Treisback to Wilder re: "quality, purity, and chemistry of our operation." Exhibit #P0660 PIN # Date Author Addressee 15454-6 05-Sep-67 M A TAVES EAGAN, J.M. & RENO, P.J. TURK, E. & SCOTT, R.B. GIVENS, K . T . & 3 OTHERS Description Memo from Taves to Eagan re: "Orange" Analysis; Govt, does not know components in products which are known to Hercules; before advising Govt., Hercules will study. Exhibit #P0663 PIN # Date Author 15443-6 07 -Sep-67 R B SCOTT jro Addressee TAVES, M.A. & CLARK, W.H. GIVENS, K . T . & EAGAN, J.M. TURK, E. & 2 OTHERS Description Memo from Scott to Taves re: Orange testing September 5, 1967. Exhibit #P0664 PIN # Date Author Addressee / 15449-50 0 7 -Sep-67 E T GIVENS EAGAN, J.M. & YATES, R.T. RENO, F.J. & 3 OTHERS Description Memo from Givens to Eagan re: NACA's proposed guidelines. Exhibit #P0666 PIN # Date Author Addressee Description 15903-4 101 12-Sep-67 J M EAGAN Notes of Eagan re: Synthetics Dept. Proposed Meeting, etc. Exhibit #P0669 PIN # Date Author Addressee Description 14716 19-Sep-67 UNKNOWN Notes. Exhibit #P0671 PIN # Date Author Addressee 13903-4 26-Sep-67 K T GIVENS EAGAN, J.M. & SCOTT COPELAND, J.G. & TURK, YATES & 2 OTHERS E. Description MEMO RE: "ORANGE QUALITY" Exhibit #P0677 PIN # Date Author Addressee Description 32150 1O-Oct-67 E E CHRISTOFANO DUNN, C.L. & EAGAN, J.W. WILDER, H.E. & SIDWELL, A.E. / Memo from Christofano to Dunn re: Dr. Zavon at Kettering Lab doing a prospective study of 15 - 20 year duration. Exhibit #P0683 PIN # Date Author Addressee Description 06475-9 17-Oct-67 C L DUNN Minutes of meeting of October 17, 1967 NACA Exhibit #P0685 PIN t Date Author Addressee 02986PLUS 25-Oct-67 R B SCOTT VANDOVENIER, W. & COPELAND, J.C. CRITTENDEN, K.D. & EAGAN, J.M. GIVENS, K.T. & 2 OTHERS Description Letter from Scott to Vandovenier and copy of proposed specifications for herbicide Orange; cover letter for 10/24, proposed specs as drafted by Hercules. Exhibit #P0698 PIN # Date Author Addressee Description 06549 27-Nov-67 C L DUNN MEMBERS NACA Letter from Dunn to members of NACA re: conference with USDA. Exhibit #P0699 PIN # Date Author Addressee 06547-8 27-Nov-67 C L DUNN HAYS, HARRY & ANDERSON, USDA IRVING, ARS & DANIELSON, ARS Description Letter from Dunn to Hays requesting Extension for 1 year tjeyond 12/31/67 for cancellation date at registrations of 2,4-D and 2,4,5-T and others. Exhibit #P0702 PIN t Date Author Addressee 06554-56 08-Dec-67 C L DUNN FDA & USDA Description Letter from Dunn to FDA on behalf of NACA Industry Task Force on phenoxy herbicide tolerance. Exhibit #P0703 PIN # Date Author Addressee 06580-1 12-Dec-67 C L DUNN FDA & USDA Description Letter from Dunn to FDA similar to letter of 12/8/67. Exhibit #P0708 PIN # Date Author Addressee Description 15514 27-Dec-67 A E SIDWELL LOWE, L.E. Memo from Sidwell to Lowe re: unknown, still at 8.5%. Factor "X" Exhibit #P0710 PIN # 06584 Date Author Addressee Description 29-Dec-67 HAROLD G ALFORD HERCULES Letter from Alford at USDA to Dunn at Hercules re: 11/27 request granted until 1/1/69. Exhibit #P0715 PIN # Date Author Addressee & SCOTT, 14671-8 02-Jan-68 K T GIVENS WILDER & K.E. CRITTENDEN, E.D. EAGAN, J.M. R. B. / & RENO, P.J. Description Memo from Given to Wilder re: New contract - Herbicide Orange; Hercules participation in reviewing and redrafting proposed government specs with portions of contract attached. Exhibit #P0716 PIN # Date Author Addressee Description 06592-98 04-Jan-68 UNKNOWN Minutes of meeting of NACA meeting of January 4, 1968. Exhibit #P0718 PIN # Date Author Addressee 14664-70 1O-Jan-68 A E SIDWELL EAGAN, J.M. Sc CRITTENDEN, E.D. GIVENS, K.T. & RENO, D.J. SCOTT Sc WILDER Description Memo from Sidwell to Eagan re: "New Contract, Orange" detailing critiques and suggested changes - "you will remember that we have the unsolved problem of compound 'x'- in the butyl and ester. . ." Exhibit #P0721 PIN # Date Author Addressee 15478-9 11-Jan-68 K T GIVENS WILDER, H.E. EAGAN, J.M. & CRITTENDEN, & RENO, P.J. E.D. Description Memo and attachment from Givens to Wilder re: use of imported 2^4,5-T; refers to authority to use imported 2,4,5-T for Agent Orange production. Exhibit #P0724 PIN t Date Author Addressee 17041 20-Jan-68 A E SIDWELL TAVES, M.A. & EAGAN, J.M. SCOTT, R.B. & WILDER, H.E. FISHER, J.R. & TECH. FILE Description Memo re: Compound "X" in Production n-Butyl-T. Exhibit #P0727 PIN # Date Author Addressee Description 15474-6 25-Jan-68 K T GIVENS COLLNS, G.F. & CRITTENDEN, E.D. EAGAN, J. & SCOTT, K. WILDER, N.E. Letter from Givens to Collins demonstrating Hercules' role in preparation and drafting of specs. Exhibit #P0730 PIN # Date Author Addressee Description 17050 29-Jan-68 K T GIVENS WILDER Memo from Givens to Wilder re: Herbicide Samples; use of foreign 2,4,5-T acids. 1i.. 0!..^*.9 TV. A. 189 Exhibit #P0731 PIN # Date Author Addressee 15400 29-Jan-68 A L TREISBECK GIVENS, K. T . & EAGAN, J.W. SCOTT, R.B. & SIDWELL, A.E. Description Memo re: Orange Analyses; Contract DSA-400-67-C-8314; changing specs. Exhibit #P0739 PIN # Date Author Addressee Description 13706 20-Feb-68 R W HUSTON TREISBACK, A .L . Note from Huston to Treisback re: being below specs. Exhibit #P0748 PIN # Date Author Addressee Description 15344-55 27-Feb-68 GEORGE F COLLINS HERCULES POWDER Letter from Collins of Defense Supply to Hercules; enclosing copies of a review purchase description for herbicide qrange requesting Hercules' comments. Exhibit #P0749 PIN # Date Author Addressee Description 06669 29-Feb-68 CHIPMAN BALES MCCOLLISER, RON Letter from Bales at Chipman Chemical Co. to McCollister re: subacute toxicity data requested by FDA. Exhibit #P0753 PIN # Date 15343-53 04-Mar-68 i Author Addressee K T GIVENS SCOTT, R. & TREISBACK, A.L. Description Memo from Givens to Scott and Treisback re: demonstrating Govt's acceptance of Hercules' changes in specs. Exhibit #P0754 PIN # Date Author Addressee 06670 04-Mar-68 C L DUNN BAKER & HEW Description Letter from Dunn to Baker at HEW re: Pesticide Petition 8F0676 for negligible residues of the herbicide. Exhibit #P0759 PIN # Date Author Addressee Description 06691-2 08-Apr-68 HEW BAKER DUNN, C.L. & ARS US DA Letter from Baker at HEW to Dunn re: Hercules' inability to establish tolerances as requested; Hercules may amend or withdraw petition. Exhibit #P0761 PIN # Date Author Addressee Description 06701 15-Apr-68 C L DUNN NACA MEMBERS & KRAUSCHE, K CANKIN, R .A . Memo from Dunn to NACA members re: 2,4,5-T petition; re: 4/8/68 letter. Exhibit #P0762 PIN # Date Author Addressee 06700 15-Apr-68 C L DUNN BAKER, HEW & MCCOLLISTER, D.D. IV. A. 184 BALES, I.W. & KRAUSCHE, K. HOLSING, G. CARL & NACA Description Letter from Dunn to Baker at HEW request NACA's pesticide petitions for negligible residue of herbicide MCPA be withdrawn without prejudice. Exhibit #P0765 PIN # Date Author Addressee Description / 15389 0 9 - H a y - 68 A L TREISBACK EAGAN, J.W. & GIVENS, K.T. SCOTT, R.B. & SIDWELL, A.E. BENNETT, T. Memo from Treisback to Eagan re: Recovered Acids - Addenda; government rewriting specs as requested by Hercules. Exhibit #P0766 PIN # Date Author Addressee Description 15342 09-May-68 GOVT GIVENS, K.T. Teletype message from Government on Hercules letterhead for Givens re: changes in tolerances (for percentage of 2,4-D and 2,4,5-T in Agent Orange); 810,000 gal. @ 7.25 per gal. for $5,872,500 offer; delivery at 90,000 gal. per month from 6/68-2/69. Exhibit #P0767 PIN # Date Author Addressee Description 15390-4 09-May-68 A L TREISBACK EAGAN, J. & GIVENS, E. SCOTT, R. & SIDWELL, A. BENNETT, T. Memo from Treisback to Eagan re: Recovered Acids; Orange quality problems and reference to attached letter of August 11, 1967. Exhibit #P0768 PIN # Date Author Addressee Description 15395 09-May-68 A L TREISBACK GIVENS & EAGAN, J. BENNET, T. Memo from Treisback to Givens re: Orange; imported 2,4,5-T. / Exhibit #P0774 PIN # Date Author Addressee 15288-319 05-Jun-68 K T GIVENS TREISBACK, A.L. & CRITTENDEN, EAGAN, J.M. & RENO, P.J. E.D. Description Memo from Givens to Treisback re: "Orange" Contract; attached new contract; 90,000 gal. per month from 6/30/68-2/28/69 for $5,872,500; free from defects; attached copies of 2/23/68 specs and amendment of 4/11/68. Exhibit #P0776 PIN # Date 13664 11-Jun-68 Author Addressee Description A S SIDWELL TREISBACK, A.L. Memo from Sidwell to Treisback re: Conference on Contract DSA-400-68-C-6093; conference with government. Exhibit #P0778 PIN # Date Author Addressee 13662-3 12 -Jun-68 K W HUSTON TREISBACK, A.L. & BUMP, R.A. BENNETT, T. & RAY, F.H. PENNOCK, J.G. & FISHER, J.R. Description Memo from Huston to Hercules employees re: DSA Contract DSA-400-68-C-6093; meeting 15276 IV. A. 186 with government to discuss.and agree on contract. Exhibit #P0799 PIN # Date Author Addressee 15245 18-Sep-68 R W HUSTON BUMP, R.A. & PAMRY, S.A. GIVENS, K . T . & TREISBACK, SIDWELL, A.E. & 2 OTHERS A.L. Description Memo from Huston to Bump re: Documents "Orange" Contract. Exhibit #P0808 PIN # Date Author Addressee Description 04030-1 16-Oct-68 EMIL E CHRISTOFANO ROWE, V.K. Letter from Christofano to Rowe re: bioassay methods inconsistant and usefulness as a test for dioxin is questionable. Exhibit #P0816 PIN # Date Author Addressee Description 18121 O8-N0V -68 TREGUA HERCULES Memo from Treglia at Dept, of Army to Hercules re: invitation to comment on proposed specs - suggestions that may result in a savings to Govt. Exhibit #P0818 PIN # Date Author Addressee Description 06888 03-Dec-68 ALFORD DUNN, C.L. Letter from Alford at USDA to Dunn re: Extension of Registrations for 2,4,5-T acid; Dunn's letter of 10/29/68; extends^c^r IV. A. 187 date for finite tolerances to 1/1/70. Exhibit #P0824 PIN # Date Author Addressee Description 25992-4 30-Dec-68 J CHRISTOFANO DUNN, C.L. & OTHERS / Memo from Christofano to Dunn re: Dioxin studies; biotest lab report on dioxin studies; studies inconsistent and inconclusive. Exhibit #P0870 PIN # Date Author Addressee Description D0W754889 25-NOV-69 J E JOHNSON Page two of Johnson report. Exhibit #P0890 PIN # Date Author Addressee Description 01540-2 16-Jan-70 J J FORD TAVES, M.A. & SCOTT, R.B. DUNN, CL.L & WALKER, J. CONNER, A. Memo from Ford to Taves re: analysis of 2,4,5-T Acid for "Dioxin" Content; further development indicated; 4-6 weeks to evaluate proposed modifications. Exhibit #P0911 PIN # Date Author Addressee Description 26964 24-Feb-70 J P FRAWLEY Notes of Frawley re: findings of cleft palate. Exhibit #P0923 PIN # Date Author Addressee 01588-9 19-Mar-70 J J FORD TAVES, M.A. & SCOTT, R.B. DUNN, C.L. & WALKER, J.F. CONNER, A.Z. & SIDWELL, A.E. Description Memo from Ford to Taves re: Analysis of 2,4,5-T Acid for "Dioxin" Content; retesting of old samples produced in 1965; attached chart shows dioxin content as high as 3.5 ppm in 1965. Exhibit #P0938 PIN # Date Author Addressee Description 03877 10-Apr-70 J G COPELAND Synthetics Dept. R&D Newsletter of Copeland; " . . . dioxin, which is highly toxic, a severe skin irritant, and a suspected teratogen." Exhibit #P0942 PIN # Date Author Addressee 04032 15-Apr-70 R B SCOTT DUNN, C.L. & PIERCE, H.F. LEMONS, E.W. & GIVENS, K.T. FRAWLEY, J.P. & 2 OTHERS Description Memo from Scott to Dunn reL: 2,4,5-T Analyses. Exhibit #P0959 PIN # Date Author Addressee 04034-5 10-Jun-70 JOHN J FORD PETERSON, R. &KOPKINS SCOTT, R. &TAVES, M.A. Description Memo from Ford to Peterson re: Separation of the Toxic Contaminant 2,3,7,8-TCP from I 2,4,5-TCP acid; dioxin is a highly toxic contaminant; teratogenic effects recently attributed to 2,4,5-T may be due to dioxin contaminant. Exhibit #P0980 PIN # Date Author Addressee Description 27817-18 23-Nov-70 y JOHN P FRAWLEY HIGGIN, JOHN C. Memo from Frawley to Higgin discussion whether teratology was associated with dioxin; government agency sponsoring study not familiar with toxicity of dioxin; Surgeon General declared 2,4,5-T hazard to health; 2,4,5-T banned. Exhibit #P0981 PIN # Date Author Addressee Description 27349 24-Nov-70 J P FRAWLEY DUNN, C.L. Memo from Frawley to Dunn re: Bionetics study on 2,4,5-T. completed Exhibit #P0993 PIN # Date Author Addressee Description 27396-402 26-Jan-71 JOHN P FRAWLEY WILSON Letter from Frawley to Wilson, Advisory Committee on 2,4,5-T; lack of hazard presented; Hercules acknowledges past history of U.S. and Germany. Exhibit #P0994 PIN # Date Author Addressee 27462 17-Feb-71 J P FRAWLEY DUNN, C.L. & COPELAND, PIERCE, H.F. 5c GIVENS, OTHERS J.G. K.T. 1528 IV. A. 190 Description Memo from Frawley to Dunn re: Dosing Error in Bionetics Study on 2,4,5-T; mistake in bionetics report and what they should do. Exhibit #P0999 PIN # Date Author Addressee 27656 30-Mar-71 JOHN P FRAWLEY / WILSON, JAMES G. & MEMBERS ADVISORY COMMITTEE & ON 2,4,5-T Description Letter from Frawley to Wilson on Advisory Committee on 2,4,5-T suggesting the restriction of dioxin content . . to a safe level." Exhibit #P1006 PIN # Date Author Addressee Description 03579 01-Jun-71 GEORGE H HOPKINS SIDWELL, A . E . & FORD, J.J. SCOTT & GIVENS, K.T. DUNN, C.L. Memo from Hopkins to Sidwell and Ford re: Removal of "Dioxin" from Silvex and removal of "Dioxin" from 2,4,5-T; patent in removal process. Exhibit #P1007 PIN # Date Author Addressee 03576-8 03-Jun-71 A E SIDWELL HOPKINS, GEORGE H. & SCOTT, GIVENS, K.T. & DUNN, C.L. TREISBACK, A.L. & 2 OTHERS R.B. Description Memo from Sidwell to Hopkins re: Removal of "Dioxin" from Silvex. Exhibit #P1011 PIN # Date 27741 29-Jul-71 TT7 A m i Author Addressee Description R STEHL DOW Analytical Laboratories report of July 29, 1971; 4/4/71 sample tested and Hercules rated it 0.18 ppm and Dow rated it less than 5 ppb. Exhibit #P1015 PIN # Date Author Addressee Description / 27788-9 28-Oct-71 D D MCCOLLISTER WEIR, ROBERT J. Letter from McCollister to Weir re: importance of not publishing difference and how to describe difference of 0.18 ppm v. 0.005 ppm. Exhibit #P1021 PIN # Date Author Addressee Description 01740 15-Nov-71 W C KENYON TAVES, M.A. & HALL, R.T. FORD, J.J. Memo from Kenyon and Shearer to Taves re: reports of Dow on 2,4,5-T from Hercules; attempted explanation. Exhibit #P1029 PIN # Date Author Addressee Description 01754-5 17-Jan-72 D D MCCOLLISTER HART, E. ROSS Deposition of A.E. 18, 1980; Sidwell taken on April Exhibit #P1089 PIN # Date Author Addressee Description 00000 28-Apr-80 UNKNOWN Trial testimony of A.E. Sidwell. Exhibit #P1105 PIN # Date Author Addressee Description 00000 02-May-83 UNKNOWN Affidavit of Charles L. Dunn^date 05/02/83, 15283 Exhibit #P0025 PIN t Date Author Addressee DS00017892 F R KENNEDY SAVAGE & CORT Description Memorandum dated March 20 [year illegible] from F. R. Kennedy to S. Savage, New York Sales, stating that the suspect batch samples from the susppct batches have been segregated and put aside for safekeeping. He also reports that Dr. Bleiberg said that he had been contacted, had asked for follow-up materials, and had not done anything more when these materials (photographs of the affected personnel) were not forthcoming. Exhibit #P0026 PIN # Date Author Addressee Description DS00001061 F GORDON STEWARD Staff memorandum of unclear date from F. Gordon Steward reporting on technical operations for the month of April, 1967. The report notes that the use of porosities to filter dioxins was not very encouraging, but that the carbon filter seemed to be effective. Plugging seemed to be a continuing problem. Exhibit #P0027 PIN # Date Author Addressee Description DS 2271 3 UNKNOWN SCRATCH PAD NOTES REGARDING LETTER OF 10/9/64. Exhibit #P0028 PIN # Date Author Addressee 24673 UNKNOWN Description OPERATING COMMENTS PLANT TECHNICAL JUNE, 1969. Exhibit #P0029 PIN # Date Author Addressee Description 27928 PAUL GROSS, MD DIAMOND ALKALI CO JANUARY, 1960, SEVENTH REPORT ON EVALUATION OF CHLORACNE. Exhibit #P0074 PIN # Date Author Addressee DS00022493 290655 J M YORK SCOVILLE & INGLEY BURTON & KIRP Description Memorandum dated June 29, 1955 from J. M. York, MD, to L. P. Scoville concerning chloracne at the Newark plant. Recites visit by the author to the plant, where fumes were noxious but of unknown toxicity. Describes chloracne and its mechanisms, stating that there is really no cure, and further stating that a case has to be seen to appreciate how socially debilitating it can be. Recommends sending some of the worst cases to a Dr. Marion B. Sulzberger in New York city, but further recommends that this be deferred until the plant is cleaned up or it will be an illusory remedy. Also recommends that better physical examinations be given to employees so that blood and liver damage can be assessed. Exhibit #P0080 PIN * Date Author Addressee DS00008854 30-Aug-55 GEORGE H BURRIS ROSENFELD & BURTON FROWNE & PORTER TOWLE & OTHERS * eQQt: Description Technical Memorandum dated August 30, 1955, from G. H. Burris and M. Rosenfeld to Mr. IV. A. 195 J. Burton describing the methods used to establish absorption curves to identify the impurities in 2,4,5-T by means of chromotography. Suggests that the curve is close to the curve established for dichlorosorcinol, but allows that a polychlorinated diphenyl ether compound may also be indicated in small amounts. Exhibit #P0081 PIN # Date Author Addressee Description DS00024253 23-Sep-55 J BURTON GLEISSNER & BROWNE TOWLE Memorandum dated September 23, 1955, from J. Burton to Dr. B. D. Gleissner reporting on toxicology tests run on rabbits by the Industrial Toxicological Laboratories. The tests on crude TCP showed that reactions to the August production samples existed but were less serious than reactions to May production samples. This indicated that they were on the right track in lower autoclave temperatures, according to the author, but that that alone would not solve the problem. Exhibit #P0093 PIN # Date Author Addressee Description DS00019554 20-Oct-56 JACOB BLEIBERG J BURTON Letter dated October 20, 1956, from Dr. Jacob Bleiberg to Mr. J. Burton summarizing his recommendations concerning chloracne at the Newark plant. He notes that the probable chloracnogen is a chlorinated di-phenyl. For Prophylaxis purposes, he recommends cleanliness and special soaps. For treatment he recommends using creams, but suggests looking for systemic disorders as well. The report contains numerous recommendations concerning diet, etc. IV. A. 196 Exhibit #P0100 PIN # Date Author Addressee DS0G008217 21-Jun-57 J BURTON GUIDI & BROWNE Description Memorandum dated June 21, 1957, from J. Burton to R. Guidi and referenced to a file, 2,4,5-TCP Process Development. Memo outlines the need to double TCP production and to eliminate chlor.cne impurities. Also wants to run at a lower pressure as a safety matter. Explores various suggestions for accomplishing these objectives from an engineering point of view. Exhibit #P0103 PIN # Date Author Addressee DS00017415 18-Sep-57 D J PORTER BURTON & LUKES SUTTER & CLEVELAND Description Memorandum dated September 18, 1957 from D. J. Porter at Painesville to J. Burton at Newark reporting on meeting with Dr. Kudesus of Boehringer to discuss acquisition of know-how for production of penta- chlorophenol. Told Kudesus that since the work of A1 Hirsch and Irving Rosen "several years ago" and the more recent work of Jack Jenney and A1 Lewis, they had no indication of chloracne trouble. Dr. Kudesus said he would send them a copy of his report on the problem which had caused them to shut down one of their plants and, in the meantime, he identified the culprit with a diagram which is reported in the memorandum. It was said that the material is not formed if the triTCP autoclave temperature is kept below 155 degrees C, and if the caustic mixture is not more than 120 C. Writer suggests trying this in the TCP plant in view of the problems there. Exhibit #P0105 PIN # DS00022024 15287 IV. A. 197 Date Author Addressee Description 11-Oct-57 D J PORTER GUIDI & BURTON LUKEE Memorandum dated October 11, 1957 from D. J. Porter to R. A. Guidi reporting the forwarding of a transalation of a memo from C. H. Boehringer Sohn, Ingelheim, reiterating comments previously made "some time back" by Dr. Kudesus of Boehringer. Cover letter suggests*, that if there are problems running a syline at Newark, a test could be done at the autoclave at Painesville. The attachment advises of the steps in the reaction where acnegen can be seen to be formed, and of the further steps (principally temperature control) that can be used to minimize that risk. Exhibit #P0106 PIN # Date Author Addressee Description DS 27915 19-Dec-57 MARIAN L WESTRICK, PHD J. BURTON SIXTH REPORT ON EVALUATION OF CHLORACNE NOV 1957 Exhibit #P0115 PIN # Date Author Addressee 000000 19-Sep-58 DONALD M PURDY DIAMOND ALKALI & MANK EDWARD Description Agreement dated September 10, 1958 by employee, Donald M. Purdy, to assign any patent for work done for Diamond to Diamond. Exhibit #P0128 PIN # Date Author Addressee DS00017413 30-Sep-59 THORNTON HOLDER BURTON & BRUMBAUGH BORROR & EVERSON PORTER & GOYB IV. A. 198 Description Internal Diamond Memorandum dated September 30, 1959 reporting information from Boehringer that they had not had a chloracne case for several years by reason of changes in process and a major overhaul of their factory. The memo notes that Boehringer continued to have liver cases several years after clearing up their chloracne problems. / Exhibit #P0137 PIN # Date Author Addressee DS00010807 20-May-60 THORNTON HOLDER SCOVILLE & HONOUR Description Memorandum dated May 20, 1960 from Thornton F. Holder to L. P. Scoville referring to differences in accidents at Newark and at Ingelheim and stating that he would be willing to use his offices to have a meeting with Boehringer (Cela) if that was desireable. Exhibit #P0140 PIN # Date Author Addressee Description DS00008450 21-Jun-60 J BURTON BORROR & GUIDI LINDEMANN & SCOVILLE WEINER Confidential Memorandum dated*June 21, 1960 from J. Burton to J. A. Borror reporting on laboratory work concerning the 2,4,5-T process. The memo suggests that yields are satisfactory at a 2:2 mol ratio. Identifies information on Newark that chlorinated dyphenyl ethers are the probable cause of chloracne. Suggests that if lab results cannot be duplicated at the plant, then the recommendation is to increase the caustic ratio rather than the heat of reaction because higher temperatures promote chloracnegen (chlorinated diphenyl ethers) formation. The memo suggests that a dilutent might be used to moderate the reaction also. 5-3 JL Q IV. A. 199 Exhibit #P0141 PIN # Date Author Addressee Description DS00022022 23-Jun-60 J J BURTON CONRAD & DELL CELA Copy of a letter datel June 23, 1960 from J.Burton to Herr. Conrad and Dell of Cela describing in some detail Diamond's process, experience, their attempts to understand how to avoid future explosions and their request for a similar exchange of information from Cela. Exhibit #P0145 PIN # Date Author Addressee Description DS00021951 10-Aug-60 NONE BOEHRINGER SOHN BORROY Letter from illegible person at Boehringer Sohn to J. A. Borror, Diamond Alkali Company dated August 10, 1960 describing in detail their process [CELA] for processing TCP to avoid chloracnegens. Asks for confidential exchange of information on the subject. Refers to September 20, 1957 letter addressed to Plainsville, Ohio. Exhibit #P01 61 PIN # Date Author Addressee DS00011518 06-Mar-62 R L ANNIS EVERSON & CROSS DUNNING & ENTEMANN HIRSCH & OTHERS Description Memorandum dated March 6, 1962 from R. L. Annis to H. E. Everson with a wide distribution list reporting on progress of 2,4-D and 2,4,5-T Process Studies. The studies look toward expansion of production outputs. The report states a revised 2,4-D process has been virtually completed, and that it is hoped that a 2,4,5-T process can be developed from that process, but notes that this will require higher temperatures and higher pressures. The report is emphatic that the plant will require updating at some expense for the new processes. No mention is made of health considerations. Exhibit #P0166 PIN # Date Author Addressee / 24256 11-May-62 W GOODLOE R. A. GUIDI & R. F. LINDEMANN Description UNSIGNED MEMO BY W.GOODLOE TO R. A. GUIDI DATED 11 MAY 1962 ADVISING ALL CHLORACNE SAMPLES (14) PREPARED AS REQUESTED & READY FOR SHIPMENT TO MELLON INSTITUTE. DESCRIPTION OF EACH SAMPLE ATTACHED. Exhibit #P0171 PIN # Date Author Addressee Description DS 27937 07-Jun-62 JAMES M MC NERNEY DR. GUIDI 8TH REPORT ON EVALUATION OF CHLORACNE. Exhibit #P0178 PIN # Date Author Addressee DS00017412 09-Jul-62 K L CHANDLER GUIDI & WEINER Description Memo dated July 9, 1962 from Chandler to Guidi reporting that Riverdale Chemical and Quaker City Tree had serious complaints aobout chloracne associated with Diamond's product and asking whether there is a likelihood that these incidents will recur. Exhibit #P0185 PIN * Date Author Addressee Description DS00019539 06-Nov-62 H C BAISALO HILL W C 5c BAISALO H C GUIDI R A Confidential Memorandum re Chloracne containing what appears to be the outline of a speech concerning the chloracne problem and which is dated November 6, 1962. Document is incomplete as we have it. ' Exhibit #P0186 PIN # Date Author Addressee DS0000715 1O-Nov-62 EUGENE BAK BRAUN & GOODLOE WEINER 5c GUIDI HILL 5c OTHERS Description Detailed report concerning existing processes for 2,4-D and 2,4,5-T and making recommendations for changing processes for economy. Report is prepared by Eugene Bak with the assistance of Daniel Braun and William Goodloe, and is signed by Hill and Guidi. Exhibit #P0193 PIN # Date Author Addressee Description DS00008832 07-Jan-63 RF LINDEMANN HILL Memorandum dated January 7, 1963 from R. F. Lindemann to W. E. Hill, Jr. reporting on his effort to identify the impurities in 2,4,5-T and TCP. States that the chromotograph of the impurity is close to the basic chemical, but with a slightly higher boiling point. Exhibit #P0201 PIN # Date Author DS00017405 15-Feb-63 R A GUIDI < r n O, Xu Addressee Description WEINER Memorandum dated February 15, 1963 from R. A. Guidi to H. S. Weiner re: forwarding an article given to him by Dr. Bleiberg suggesting the development of porphyria from the ingestion of hexachlorobenzene. Memo notes presence of porphyrins in urine samples collected from workers and at a level indicating liver disturbance. Says the article will set off the health authorities and that' Bleiberg is already in contact with Dr. Birmingham for advice. Exhibit #P0206 PIN # Date Author Addressee DS00017400 25-Mar-63 H S WEINER GUIDI & WILKERSON Description Confidential Memorandum from H. S. Weiner to R. A. Guidi dated March 25, 1963 re: "Chloracne." The memo refers to a March 20 memo and states that USPH should, not be allowed to visit the plant unless a full program concerning the visit is developed with Diamond's medical advisor and Marty Wilkerson. The memo suggests that thought be given to the possibility that the visit might be used as a sensational event in the news- papers. Exhibit #P0208 PIN t Date Author Addressee Description DS00024455 27-Mar-63 RICHARD W MCBURNEY JARVIS & BROWN OCIDI Memorandum dated March 27,1963 from Richard W. McBurney, MD, to Frank W. Jarvis in Cleveland. It notes the history with chloracne and states that recent articles have convinced Dr. Bleiberg that they may also be dealing with a liver problem. The letter states that the only way to begin to solve the problem was to renovate the old plant, subject to available financing. 15233 IV. A. 203 Exhibit #P0211 PIN # Date Author Addressee Description DS00017963 09-Apr-63 GUILLERMO CECIL Translation of a letter written in Spanish on April 9, 1963 by Leon R. Guillermo of Quimor to L. L. Cecily Jr. re: "Problem in the Application of Weed Killers". The communication informs Mr. Cecil that workers in the Bucaramanga area have suffered severe reactions after using Diamond's 2,4-D and 2,4,5-T products. Exhibit #P0212 PIN # Date Author Addressee Description DS00019524 11-Apr-63 R A GUIDI WILKERSON & BROWN MCBURNEY Memo dated April 11, 1963 from R. A. Guidi to M. F. Wilkerson reporting on a visit of Drs. Key and Birmingham to Newark. Memo encloses a copy of a report from McBurney to Jarvis previously prepared. Guidi reports that two men are to be admitted to Beth Israel Hospital for further tests, "with specific emphasis on the kidneys and liver." Exhibit #P0222 PIN # Date Author Addressee DS00017940 02-May-63 R J MARRESE GUIDI R A & KING, J. 0. CHANDLER E. L. & L L CECIL Description Confidential Memorandum dated May 2, 1963 from R. J. Marrese to Larry L. Cecil arguing that the Quimor incident did not involve a product quality question as much as a personal hygiene factor. 15294 Exhibit #P0223 PIN # Date Author Addressee DS00017939 08-May-63 L L CECIL CLAGHORN & CREAMER KNOBLOCK & CLAIR Description Memorandum dated May 8, 1963 from L. L. Cecil to D. A . Claghorn, Herbicides, Columbia, forwarding materials for confidential consideration. Exhibit #P0227 PIN # Date Author Addressee Description DS00019506 20-May-63 JACOB BLEIBERG GUIDI & DIAMOND NEWARK Letter from Dr. Jacob Bleiberg to Guidi at Shamrock reporting findings of liver damage among plant workers in Newark. The letter suggests the source of the problem is the old factory building. Exhibit #P0229 PIN # Date Author Addressee Description DS00019523 31-May-63 R A GUIDI MC BURNEY & BROWN CORT MEMO OF FINAL HOSPITAL REPORT RE: 2 CASES Exhibit #P0230 PIN # Date Author Addressee Description DS00019518 07-Jun-63 R W MCBURNEY GUIDI & BROWN CORT Memorandum dated June 7, 1963 from Dr. McBurney to Mr. Guidi advising that workers affected by plant contamination no longer should be hospitalized since there is no treatment that can really help them, apart from removal from the contamination. Dr. McBurney opinions that the company's 15285 IV. A. 205 decision to renovate the old building will go far toward solving this problem. Exhibit #P0231 PIN # Date Author Addressee DS 19520 1O-Jun-63 R A GUIDI DR. R. MC BURNEY & C.R. BROWN J. S. CORT, JR. & F.'fc. KENNEDY Description 1-0 MEMO SUBJECT CHLORACNE - MEDICAL REPTS ON AN UNK. Exhibit #P0247 PIN # Date Author Addressee Description DS00017393 14-Aug-63 R W MCBURNEY GUIDI 5c BROWN JARVIS Letter from Richard W. BcBurney MD dated August 14, 1963 to Raymond A. Guidi recommending a urine test for persons affected by chloracne. Exhibit #P0248 PIN # Date Author Addressee Description DS00017392 01-Oct-63 J CORT KENNEDY Memo from J. S. Cort, Jr. to F. R. Kennedy, dated October 1, 1963 asking if urine tests had been started. Exhibit #P0255 PIN # Date Author Addressee Description DS00017390 25-Nov-63 F R KENNEDY CORT Memorandum dated November 25, 1963 from F. R. Kennedy to J. S. Cort, Jr. in Cleveland sending a copy of the notice that was posted telling the employees they were all IV. A. 206 going to be given urine checks. Exhibit #P0272 PIN # Date Author Addressee DS00019479 05-Mar-64 J S JR CORT MCBURNEY RICHARD & MASEK E J Description Memorandum dated March 5,^ 1964 from J.S. Cort, Jr. to Dr. Richard McBurney (cc. to Masek-legal) asking whether a purchaser of raw TCP should be warned of health hazards. Exhibit #P0273 PIN # Date Author Addressee DS00019480 06-Mar-64 RICHARD W MCBURNEY CORT & MASEK Description Internal Memorandum dated March 6, 1964 from Dr. Richard W. McBurney, M.D. to J. S. Cort, Jr., stating that TCP is a definite chloracne hazard to workers. It states that the customer may or may not be aware of this, and defers to the legal department (Mr. Masek) the issue of what duty there is to tell them.1, 11, but suggests that the obligation exists anyway. Responds to a memorandum of March 65, 1964 Exhibit #P0275 PIN # Date Author Addressee DS00017895 17-Mar-64 S B HONOUR QUIMOR LTDS & CORT GILES & PURDY Description Letter dated March March 17, 1964 from S. B. Honour to Guillermo Leon R. at Quimor acknowledging receipt of his letter of March 2d and saying that tests show that the samples of the product being ques tioned are identical to other batches of Diamond's product. Nonetheless, the letter t S-v IV. A. 207 says that the matter has been turned over to Diamond's insurance representative and that it has also agreed to take back all questioned product provided its drums are in marketable condition. Exhibit P0276 PIN # Date Author Addressee DS00017893 18-Mar-64 LEX CREAMER DIAMOND ALKALI ^ & NEW YORK Description Memorandum dated March 18, 1964 from Lex Creamer to "New York" reporting on 2,4,5-T outbreaks in Bucaramangea, Cali and Medellin, and describing the severity of those outbreaks. States that distributor, Quimor, is in ioeopardy because of bad publicity. Exhibit #P0277 PIN # Date Author Addressee DS L7890 20-Mar-64 S B HONOUR JOHN BINGHAM, V P & QUIMOR LTDA Description LETTER RECOMMENDING BINGHAM ACT AS CONSULTANT & CONTACT DR. DIAZ. Exhibit #P0278 PIN # Date Author Addressee Description DS00017888 23-Mar-64 UNKNOWN CECIL Letter dated March 23, 1964 (incomplete) from Alexander & Alexander, insurance brokers, to Lawrence Cecil, Jr., Sales Manager, Agricultural Chemicals, Diamond Alkali Company, advising that American Foreign Insurance Association had given assurances to their Bogota representative that matters were in hand, and assuring Diamond that instructions had been given to keep the identity of the American manufacturer a secret. i IV. A. 208 X Exhibit #P0279 PIN # Date Author Addressee Description 17888 23-Mar-64 C W GILES LAWRENCE L. CECIL & D. M. PURDY DIAMOND ALKALI LETTER REGARDING DIAMOND'S PRODUCT LIAB. INSURANCE ' Exhibit #P0280 PIN # Date Author Addressee 19474 23-Mar-64 J S JR CORT J .A. FLOBECK & F.R. KENNEDY R. W. MC BURNEY & E. J. MASEK Description REGULATIONS RE HANDLING TRICHLOROPHENOL OR ITS SODIUM SALT. Exhibit #P0281 PIN # Date Author Addressee Description DS00017865 25-Mar-64 C W GILES CECIL LAWRENCE & PURDY D M DIAMOND ALKALI Letter dated March 25, 1964 from C. W. Giles, Asst. Vice President, Alexander & Alexander, to Lawrence L. Cecil, Jr., Sales Manager for Agricultural chemicals at Diamond Alkali reporting a request from American Foreign's Mr. George W. Arenas that the sample from "assurd's distributor" be tested by an independent laboratory. Exhibit #P0282 PIN # Date Author Addressee 117865 25-Mar-64 C W GILES LAWRENCE L. CECIL & SALES MANAGER AGRICULTURAL CHEM. & DIAMOND ALKALI IV. A. 209 3 Description SIGNED COPY OF LTR 3/25/64 RE PROD LIAB INS8 Exhibit #P0284 PIN # Date Author Addressee DS00017885 08-Apr-64 L L CECIL CORT & KENNEDY/ Description Confidential Memorandum dated April 8, 1964 from L. L. Cecil, Jr., to J. Cort in Cleveland and referring to Mr. Kennedy's letter of March 31. The Memo states that the Kennedy letter is possibly incorrect because no "formal" complaints were ever filed and investigated. States, however, that "we feel obligated" to tell you that Lex Creamer has advised "by way of conversation" that there are more problems, especially in El Salvador. Exhibit #P0285 PIN # Date Author Addressee DS17885Y 08-Apr-64 L L CECIL, JR J. CORT & F R KENNEDY Description UNSIGNED COPY OF MEMO DATED 4/8/64 BY CECIL TO CORT. Exhibit #P0287 PIN # Date Author Addressee Description DS00017881 20-Apr-64 L L CECIL QUIMOR LTDA & CORT ALEXANDER & A Letter dated April 20, 1964 from L. L. Cecil, Manager, Agricultural Chemicals, Quimor, Ltda. [Attn: Guillermo ] authorizing return of 1,725 gallons of weedkiller from Columbia and $907.12. Requests expedited handling. to 1530Q IV. A. 210 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK In re "AGENT ORANGE" Product Liability Litigation X MDL N< X DEFENDANT DIAMOND SHAMROCK CHEMICALS COMPANY'S SUPPLEMENTAL . LISTING OF FACT WITNESSES___ Pursuant to Magistrate's Pretrial Order No. 16 and t Magistrate's directions at the March 7, 1984 pretrial conferenc defendant Diamond Shamrock Chemicals Company ("Diamond Shamrock sets f o r t h b e l o w its l i s t of f a c t w i t n e s s e s w h o m a y gi\ test i m o n y at trial in support of Diam o n d Shamrock's claims ar defenses. Diamond Shamrock also joins in Defendants' List c Fact W i t n e s s e s dated March 26, 1984, which is being served an filed under separate cover. Diamond Shamrock reserves the right to supplement a m amend this list based on information developed in continuing discove-ry proceedings or other trial preparations, and to call a a live w i t n e s s or use the d eposition test i m o n y of any persor listed by any other party. D i a m o n d S h a m r o c k also reserves th< right to supplement and amend this list in the "witness lists section of the pretrial order f o l l o w i n g receipt and review oi plaintiffs' final fact witness list, now due on March 27, 1984. V .. >, * Name and Present Address Louis Anderson 220 E. 17th Street Chicago Heights, Illinois 60411 Eugene Bak* Dr. Donald J. Birmingham* 19811 Wedgewood Drive Gross Point Woods, Michigan Jack. A. Borror* Dr. Roger H. Brodkin 769 Northfield Avenue West Orange, New Jersey 07052 Lawrence L. Cecil, Jr. 12825 S.W. 69 Oourt Miami, Florida 33156 Edward L. Chandler* Robert L. Chonoles* Diamond Shamrock Chanicals Company Berry Avenue at Route 17 North Carlstadt, N? Jersey 07072 Howard E. Everson* Raymond A. Guidi* Alfred M. Hauser Diamond Shamrock Chemicals Company Berry Avenue at Route 17 North Carlstadt, New Jersey 07072 Description of General Natore_oO^imany__ Testimony concerning purchases by Riverdale Chemical Compary of 2,4,5-T acids and esters supplied by Diamond Shamrock. Testimony concerning research and investigation of chloracne by U.S. Public Health Service in the 1950,s and 1960's, including visits to Diamond Shamrock's former Newark plant. Testimony concerning medical condi tions at the Newark plant, including: communications with and investigations by the U.S. Public Health Service; and preparation and publication of the article by Bleiberg, al. (1964). Testimony concerning foreign sales of Diamond Shamrock's 2,4,5-T products, including sales in Colombia. Testimony concerning manufacturing operations at Diamond Shamrock's former Newark plant, including: the removal of dioxin from trichlorophenol; and the U.S. Public Health Service study of the Newark workers in 1968-69. Testimony concerning Diamond Sham rock's contractual arrangements with the United States for the sale of Agent Orange. * Witnesses designated by an asterisk (*) have been deposed m MDL No. 381. , 15302 -2- 4 Name and Present Address Melvin Hochberg* Stanley B. Honour* 829 Eggleston Fort Collins, Goloracb 80524 Francis R. Kennedy* 2711 Bernadette Lane Houston, Texas 77043 Dr. Marcus M. Key* University of Texas Health Science Center P.O. Box 20186 Houston, Texas 77025 James 0. King* P.O. Box 900 Alpharetta, Georgia Jane Lewis* 5125 Tsnple Hills Road Tsnple Hills, Maryland 20748 Richard J. Marrese* Dr. Richard W. McBurney 315 Steeple Chase Drive Irving, Texas 75062 Description of General Nature of Testimony Testimony concerning foreign sales of Diamond Shamrock's 2,4,5-T products, including sales in Colombia. Testimony concerning manufacturing operations at Diamond Shamrock's former Newark plant, including: the development, installation and opera tion of a method for removing dioxin from trichlorophenol; visits to the Newark plant hy the U.S. Public Health Service in the 1960's; and the produc tion and shipment of Agent Orange pursuant to contracts with the United States. Testimony concerning research and in vestigation of chloracne by U.S. Pub lic Health Service in the 1960's, including visit to Diamond Shamrock's former Newark plant. Testimony concerning domestic and foreign sales of Diamond Shamrock's 2,4,5-T products, including sales of Agent Orange pursuant to contracts with the United States. Testimony concerning the procurement and production of Agent Orange pur suant to the Defense Production Act, including directives and priority rat ings issued fcy the United States. Testimony concerning medical condi tions at the Newark plant, including communications with U.SL Public Health Service and with treating physicians at Newark. -3- 15303 Name and Present Address Dr. Alan P. Poland* 2918 Nottingham Way Madison, Wisconsin Dr. Raul A. Possick* 46 Winding Way Woodeliff Lake, New Jersey Donald M. Purdy* F. Gordon Steward* Diamond Shamrock Agricultural Chemicals Inc. P.0. Box H Tuscaloosa, Alabama 35404 Dated: New York, New York March 26, 1984 Description of General Nature of Testimony - Testimony concerning medical study of the workers at Diamond Shamrock's former Newark plant in 1968-69, and research and investigation of trichlorophenol, 2,4,5-T and dioxin at National Communicable Disease Center in the 1960's. Testimony concerning medical study of the workers at Diamond Shamrock's former Newark plant in 1968-69. Testimony concerning manufacturing operations at Diamond Shamrock's former Newark plant, including: the development, installation and opera tion of a method for removing dioxin from trichlorophenol; the U.S. Public Health Service study of the Newark workers in 1968-69; and the production and shipment of Agent Orange pursuant to contracts with the United States. Respectfully submitted, CADWALADER, WICKERSHAM & TAFT ArByi^ jL r y /U tf Q/l A Member of the Fi rifi Attorneys for Defendant Diamond Shamrock Chemicals Company One Wall Street New York, New York 10005 (212) 908-7000 _ _4_ 15304 AFFIDAVIT OF SERVICE STATE OF NEW YORK ) : ss : COUNTY OF NEW YORK ) JEFFREY SAPER, being duly sworn, deposes and says: 1. I am not a party to this action, am over 18 years of age and reside in Queens County, New York. 2. On March 26, 1984, I served the annexed Defendant Diamond Shamrock Chemicals Company's Supplemental Listing of Fact Witnesses on each of the persons named on the annexed list by depositing a true copy of same enclosed in a postpaid properly addressed wrapper, in an official depository under the exclusive care and custody of the United States Postal Service within the State of New York. The copy to the Agent Orange Plaintiffs' Management Committee was sent by Federal Express. Sworn to before me this `2 . ^ ^ day of March, 19 84 . Notary Public CoNmiQMnomutIaCairslHysifiAioPenEudNbLEiolnix.Mcp,3NAi1Sre-Cet4wasK0t4eIMY5N0ooa6rrfG6kcNOhCeR3woD0u,OYn1tNo0yr.k0n. j*/-- FGR DEFENDANTS SERVICE LIST r Leonard L. Rivkin Rivkin, Leff, Sherman & Radler (for DOW CHEMICAL) 100 Garden City Plaza Garden City, New York 11530 Morton G. Silberman Clerk, Gagliardi & Miller (for T H AGRICULTURE & NUTRITION COMPANY, INC.) The Inns of Court 99 Court Street White Plains, New York 10601 John C. Sabetta Townley & Updike (for MONSANTO) 405 Lexington Avenue New York, New York 10174 William Krohley Kelley Drye & Warren (for HERCULES, INC.) 101 Park Avenue New York, New York 10178 John M. Fitzpatrick Dilworth, Paxson, Kalish & Levy (for HOOKER PLASTICS & CHEMICALS CORP.) 2600 The Fidelity Building Philadelphia, Pennsylvania 19109 Richard Goldstein Shea & Gould 330 Madison Avenue New York, New York 10017 Thomas Beck Arthur, Dry & Kalish, P.C. (for UNIROYAL) 1230 Avenue of the Americas New York, New York 10020 David R. Gross Budd, Larner, Kent, Gross, Picillo & Rosenbaum (for THOMPSON CHEMICALS) 33 Washington Street Newark, New Jersey 07102 Arvin Maskin Department of Justice (for THIRD PARTY DEFENDANT USA) Safeway Building 521 12th Street, N.W. Washington, D.C. 20530 L. Kevin Sheridan Executive Assistant U .S . Attorney Eastern District of New York United States Courthouse 225 Cadman Plaza East Brooklyn, New York 11201 COPIES OF ALL DOCUMENTS MUST BE SENT TO;___________________ Clerk of the Panel Judicial Panel -on Multidistrict Litigation 1120 Vermont Avenue, N.W. Suite 1002 Washington, D.C. 20005 FOR PLAINTIFFS Victor J. Yannacone, Jr. Yannacone & Yannacone Post Office Drawer #109 Patchogue, New York 11772 Stephen J. Schlegel Schlegel & Trafelet, Ltd. One North LaSalle Street Suite 3900 Chicago, Illinois 60602 Benton Musselwhite Law Offices of Benton Musselwhit Inc. Suite 517 609 Fannin Houston, Texas 77002 Thomas Henderson Henderson & Goldberg 1612 Frick Building Pittsburgh, PA 15219 David J. Dean, Esq. Dean, Falanga & Rose 1 Old Country Road Carle Place, New York 11514 Agent Orange Plaintiffs' Management Committee 26 Court Street, Suite 304-8 Brooklyn, N.Y. 11242 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK IN RE "AGENT ORANGE PRODUCT LIABILITY LITIGATION X MDL No. 381 (All Cases) X SECOND LIST OF MONSANTO FACT WITNESSES To w n l e y & U pdike CHRYSLER BUILDING 4 0 S LEXINGTON AVENUE N E W Y O R K, N . Y. 1 0 1 7 4 TELEPHONE 1 5 Vw- 7 UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW YORK ---------------------------------------- X IN RE "AGENT ORANGE" PRODUCT LIABILITY LITIGATION X MDL No. 381 (All Cases) r SECOND LIST OF MONSANTO FACT WITNESSES Defendant Monsanto Company ("Monsanto"), pursuant to the schedule established by Magistrate Scheindlin, hereby submits a second list of fact witnesses who might give testimony at trial in support of Monsanto's claims. This list supplements the First List of Monsanto Fact Witnesses Identified Pursuant to Order of the Court Dated January 10, 1984, which was served on February 29, 1984. Monsanto reserves the right to amend the descriptions that follow of the general nature of the testimony to be given, should Monsanto's continuing trial preparation indicate any such amendment is appropriate. 1. Richard A. Atkinson. 4242 Kanawha Turnpike South Charleston, West Virginia Monsanto's production of 2,4,5-T in the 1960's; Monsanto's efforts to reduce worker exposure to its 2,4,5-T process; Monsanto's efforts to reduce or to remove dioxin in its 2,4,5-T process; the health experience of Monsanto workers involved in the 2,4,5-T process. 15308  2. Philip B. Balderson. 101 Stewart Park Cross Lanes, West Virginia Monsanto's analytic efforts to detect and to measure the presence of dioxin in its 2,4,5-T. 3. Robert Baynard. 231 Jeffrey Lane Newton Square, Pennsylvania ^ The marketing and sale of herbicides containing Monsanto-manufactured 2,4,5-T, both to the United States Government and to commercial customers; the health experience of persons who used or were otherwise exposed to herbicides containing 2,4,5-T. 4. Stanley C. Beach. 760 Sotano Drive Sacramento, California 95833 The methods and procedures used to aerially disseminate herbicides in Vietnam; the duties and responsibilities of a flight mechanic of a C-123 airplane during herbicide operations in Vietnam; the health experience of persons in Vietnam who used or were otherwise exposed to herbicides containing 2,4,5-T. 5. Donald J. Birmingham. 19811 Wedgewood Drive Gross Point Woods, Michigan The United States Government's investigation of the health experience of Monsanto workers involved in the 2,4,5-T process in the 1950's and/or exposed to the materials formed during a runaway reaction in the manufacture of sodium trichlorophenate at Monsanto's Nitro, West Virginia plant in 1949. O -2- 6. Russell Bishop. Ambler, Pennsylvania The health experience of commercial formulators of 2,4,5-T produced by Monsanto. 7 Carl D. Bohl. / 455 Wildwood Parkway Ballwin, Missouri The historical knowledge of the toxicity of herbicides containing 2,4,5-T and the toxicity of dioxin; the health experience of Monsanto workers involved in the 2,4,5-T process; Monsanto's efforts to reduce or to remove dioxin from its 2,4,5-T process and to reduce worker exposure to that process. 8. John S. Bush, Jr. 2232 North Military Road Arlington, Virginia Monsanto's contracts with the United States Government for the production of Agent Orange and other military herbicides; the Government's plan to build and to operate an Agent Orange plant at Weldon Spring, Missouri. 9. Robert E. Cox. 203 East Belerest Road Bel Air, Maryland Visit to Monsanto's Nitro plant in connection with the proposed manufacture of Agent Orange by the United States Government. 10. Eugene A. Cutright. 1474 Maplewood Drive Macon, Georgia Monsanto's production of 2,4,5-T in the 1960's; Monsanto's efforts to reduce worker exposure to its 15310 2,4,5-T process; Monsanto's efforts to reduce or to remove dioxin in its 2,4,5-T process; the health experience of Monsanto workers involved in the 2,4,5-T process. 11. Burnie R. Dallas, Jr. 1775 East 20th Street Apt. D-8 San Bernardino, California / The methods and procedures used to aerially disseminate herbicides in Vietnam; the duties and responsibilities of a flight engineer of a C-123 airplane during herbicide operations in Vietnam; the health experience of persons in Vietnam who used or were otherwise exposed to herbicides containing 2,4,5-T. 12. Stewart D. Daniels. Monsanto Singapore Co. PTE Ltd. 2601-2606 Clifford Center Raffles Place Singapore The manufacture, marketing, and sale of herbicides containing 2,4,5-T, both to the United States Government and to commercial customers; the health experience of persons who used or were otherwise exposed to those herbicides. 13. Robert A. Parrow. 7613 Baltimore National Pike Frederick, Maryland The United States Government's development, testing, and use of Agent Orange; the Government's specifications for Agent Orange. 14. Robert Dennis. Route 6, Box 302 Yakima, Washington The methods and procedures used to aerially disseminate herbicides in Vietnam; the duties and X 5311 -4- responsibilities of a pilot of a C-123 airplane during herbicide operations in Vietnam; the health experience of persons in Vietnam who used or were otherwise exposed to herbicides containing 2,4,5-T. 15. Jon R. Dudenhoeffer. 5639 King Road Erie, Pennsylvania The methods and procedures used to aerially disseminate herbicides in Vietnam; the duties and Responsibilities of a navigator of a C-123 airplane during herbicide operations in Vietnam; the duties and responsibilities of a targeting officer for herbicide operations in Vietnam; the health experience of persons in Vietnam who used or were otherwise exposed to herbicides containing 2,4,5-T. 16. Jack D. Early. 8024 Lakenheath Way Potomac, Maryland Monsanto's contacts with the United States Government in the 1960's regarding pesticide regulation; the activities of the National Agricultural Chemicals Association. 17. Henry Good. The methods and procedures used to aerially disseminate herbicides in Vietnam; the duties and responsibilities of a pilot of a C-123 airplane during herbicide operations in Vietnam; the duties and responsibilities of a targeting officer for herbicide operations in Vietnam; the health experience of persons in Vietnam who used or were otherwise exposed to herbicides containing 2,4,5-T. 18. Paul D. Halley. The involvement of the West Virginia occupational health authorities in an investigation of the runaway reaction that occurred in 1949 during the manufacture -5- of sodium trichlorophenate at Monsanto's Nitro, W Virginia plant, including efforts to identify and determine the toxicity of materials formed during reaction; the health experience of Monsanto worke: exposed to those materials and/or the 2,4,5-T pro in the 1950's . 19. Frank Helmer. 2825 Flsmevood Drive ~C ' s' - < / . `C - s S s s :- / Monsanto's manufacture of 2,4,5-T at its Nitro, West Virginia plant; improvements in Monsanto's manufacturing process for 2,4,5-T. 20. Paul F. Hoffman. 1202 Lakeshore Drive North Barrington, Illinois Monsanto's marketing and sale of herbicides containing 2,4,5-T in the 1960's, both to commerical customers and to the United States Government; the health experience of persons who used r were otherwise exposed to herbicides containing 2,4,5-T. 21. Charlie Hubbs. Camp Springs, Maryland The methods and procedures used to aerially disseminate herbicides in Vietnam; the duties and responsibilities of a pilot of a C-123 airplane during herbicide operations in Vietnam; the health experience of persons in Vietnam who used or were otherwise exposed to herbicides containing 2,4,5-T. 22. Allan M. Jokela. 1511 North Rock 38th Road Rock, Michigan The methods and procedures used to aerially disseminate herbicides in Vietnam; the duties and .3